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Abstract 
Abstract 
 
Synthetic studies towards the total synthesis of the macrocyclic marine alkaloid 
‘upenamide (I) are reported. After an introduction (Chapter 1), Chapter 2 describes 
an extension of some methodology utilised during the total synthesis project. Both 
the polycyclic ABC and DE core units of ’upenamide were formed by a stannous 
chloride dihydrate mediated cyclisation reaction and the methodology described 
involves using stannous chloride dihydrate to deliver novel polycyclic heterocycles, 
for example II, III and IV. 
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In Chapter 3, a shortened synthetic route to the ABC core unit V is described, using a 
novel azide as a protected amine. 
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A route to the DE core unit VI was developed and is described in Chapter 4. Chapter 
5 describes the coupling of the DE core unit VI with the ABC core unit precursor 
VII, giving the ABC and DE cores joined through the fully saturated chain in the 
advanced intermediate VIII. Chapter 5 also contains a discussion of future research 
needed to complete the program of research into ’upenamide. 
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Chapter 1 – Introduction 
1.1 Introduction 
 
’Upenamide 1 is a macrocyclic marine natural product, isolated by Jiménez et al. in 
2000 from a branching sponge of the genus Echinochalina, found in the coastal 
waters of Indonesia.1 The complete structural assignment could not be completed (see 
Section 1.2) and the authors suggested that the structure was either 1a or its 
diastereoisomer 1b (Figure 1.1).  
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Figure 1.1 The two possible structures of ’upenamide 1. 
 
’Upenamide has a unique structure, with two highly functionalised hemi-aminal cores 
linked to form a twenty membered macrocycle by an all-trans triene chain and a fully 
saturated four carbon chain. There are eight chiral centres in the molecule, five in the 
tricyclic ABC core, and the remaining three found in the DE core. 
 
The name given to this natural product is derived from the Hawaiian word ’upena, 
meaning fishing net or trap. It was chosen to describe ’upenamide’s meshlike 
structure. What appears to be an apostrophe at the beginning of the name is in fact an 
okina, or glottal stop, which is a letter in the Hawaiian alphabet. 
 
The unique structure of ’upenamide and its scarcity (2.2 mg from 590 g of wet 
sponge, representing a yield of 0.00037%)1 make it an attractive target for total 
synthesis.  
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1.2 Structural determination 
1.2.1 ABC core unit 
Comprehensive nOe studies allowed Jiménez et al. to establish the relative 
stereochemistry possessed by the five chiral centres contained in the ABC core unit. 
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Figure 1.2 nOe correlations observed in the ABC core unit. 
 
This was followed by Mosher’s ester derivatization of the allylic alcohol present at C-
11. The Mosher’s ester derivatives confirmed the absolute stereochemistry of the 
ABC core unit. 
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Figure 1.3 Mosher’s ester derivatives of ’upenamide. 
 
The configuration of esters 2 proposed by the Mosher’s study is such that the methine 
CH of the chiral alcohol (i.e. H-11 in 2) and the CF3 group of the derivatizing agent 
are syn-periplanar to the carbonyl group, as illustrated in Figure 1.4. This results in 
the phenyl group eclipsing a specific region of the molecule – either L1 or L2 as 
labelled in Figure 1.4. The phenyl group exerts an anisotropic effect on the area of the 
molecule it eclipses; shielding the nuclei and moving the chemical shifts observed in 
the NMR spectrum upfield. The difference between the chemical shifts of specific 
protons in the (11-R,S) and (11-R,R) diastereoisomers is defined as "#SR = (#RS-#RR). 
All the protons shielded in the (S)-MTPA ester will have a negative "#SR while those 
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shielded in the (R)-MTPA ester will have a positive "#SR. An examination of these 
numbers allows the absolute stereochemistry of the molecule to be assigned. 
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Figure 1.4 Eclipsing interactions of Mosher’s ester in the ABC core unit.1 
 
Thus the C-11 stereocentre was assigned as R, giving the ABC ring system as 2R, 9S, 
10S, 11R, 15R. 
 
1.2.2 DE core unit 
nOe studies allowed the relative stereochemistry of the DE core unit to be determined 
(Figure 1.5). Reduction of the hemi-aminal and derivatisation as the MTPA ester was 
achieved, but no chemical shift differences were observed between the 
diastereoisomers produced. Thus, only the relative stereochemistry of the DE core 
unit is known. 
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Figure 1.5 nOe correlations observed in the DE core. 
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1.3 Proposed biosynthesis of ’upenamide 
 
A large number of macrocyclic diamine alkaloids have been isolated from marine 
sponges. To date, more than ten classes of polycyclic alkaloids have been described in 
the literature: saraines,2-7 haliclamines,8-10 xestospongins,11-16 petrosins,17-21 
papuamines,22 manzamines,23-32 cyclostellettamines,33-35 mandangamines,36, 37 
xestocyclamines,38, 39 ircinols,40-42 ingenamines,34, 43-45 and halitoxins.46-48 
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Figure 1.6 Macrocyclic diamine alkaloids.12, 20, 27, 49 
 
Despite the huge structural variation between these compounds it has been proposed 
that all the diamine macrocyclic alkaloids described share the same biogenetic 
precursor.50 The haliclamines (ie 3, 4) are a class of simple diamine natural products 
isolated from a variety of marine sponges.49 Baldwin and Whitehead proposed bis-
dihydropyridines, closely structurally related to the haliclamines, as intermediates in 
the biosynthesis of the structurally complex diamine natural product manzamine B (5) 
(Scheme 1.1). The structural similarities led to Baldwin’s theory that all the diamine 
macrocyclic alkaloids described to date may be derived in vivo from bis-
dihydropyridines. 
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Scheme 1.1 Baldwin’s proposed bioynthesis of manzamine B: A Diels–Alder reaction between the two 
dihydropyridine rings constructs the octahydroisoquinoline present in the natural product. 
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Based on this work, Jiménez and co-workers proposed a biosynthesis of ’upenamide 
which begins with a hypothetical member of the haliclamine class of natural products 
10 (Scheme 1.2). The formation of the hypothetical 10 is envisaged from ammonia, a 
three carbon unit (acrolein), a saturated dialdehyde (8) and an unsaturated linear 
dialdehyde (9). Enzymatic oxidations at the indicated positions would furnish 
intermediate 11 which then could undergo intramolecular cyclisation to afford the 
final ’upenamide skeleton. 
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Scheme 1.2 Proposed biosynthesis of ’upenamide.1 
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1.4 Biological activity 
 
The scarcity of the natural product means the biological activity of ’upenamide is yet 
to be widely investigated. In preliminary bioassays, ’upenamide did not show any 
inhibition effects against P388, A549, and HT29 (cancerous cell lines from human 
leukaemia, lung carcinoma, and colon adenocarcinoma). However, it should be noted 
that full biological evaluation is unlikely to be possible until a synthetic route is 
established as very large quantities of sponge would otherwise be required. 
 
1.5 Background literature 
 
To date there has been no total synthesis of ’upenamide, but a number of papers have 
been published detailing synthetic studies towards both core systems. Publications 
from the groups of Mons,51 Sulikowski52 and Taylor53 have tackled the bicyclic DE 
core, while the only synthesis of the ABC core fragment comes from the Taylor 
group.54 Sulikowski’s group have published the most advanced intermediate to date, 
with their paper describing a partial “BC” ring system coupled with the DE core.55 
 
1.5.1 Mons et al., DE core fragment51 
In 2004, Mons and co-workers published their studies towards the cis-decalin hemi-
aminal DE core unit (Scheme 1.3).51 The route begins from pyridine 12, which was 
alkylated with n-butyl bromide. The aromatic system was then partially reduced with 
sodium borohydride to provide the tertiary amine 13. The alcohol was then oxidised 
under Swern conditions to provide the aldehyde, which was reacted with MeMgCl in 
a one-pot process. Oxidation of the tertiary amine with mCPBA delivered the N-oxide 
15. This compound was subjected to treatment with TFAA, effecting a 
Polonovski$Potier reaction, a mild version of the Polonovski reaction employing 
TFAA in the place of acetic anhydride. The iminium ion generated was subsequently 
reacted with cyanide and the trifluoroacetate group removed in situ, delivering 
alcohol 17. The double bond was removed by hydrogenation over Pd/C to give 
amino-nitrile 18. Treatment with silver tetrafluoroborate regenerated the iminium ion, 
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which then cyclised to give the desired product 19 in an inseparable mixture of 
diastereoisomers in a 81:3:16:trace ratio (Figure 1.7). The major diastereoisomer was 
tentatively assigned as the desired (2S*, 4aR*, 8aS*) isomer 19a by nOe studies. 
 
N
OH
N
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i) n-BuBr, 80 °C
ii) NaBH4, MeOH/H2O
68%
N
O
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F
F
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N
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CN
KCN, CH2Cl2/H2O,
pH 1, deprotection in situ
N
OH
n-Bu
CN
5% Pd/C
MeOH
37% from 
15
N
n-Bu
O
AgBF4
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N
OH
n-Bu
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40% N
OH
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CH2Cl2
O
12 13
1514
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Scheme 1.3 Mons’ DE core unit synthesis. 51 
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Figure 1.7 Diastereoisomers of 19 (86:3:16:trace 19a: 19b: 19c: 19d) 
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1.5.2 Sulikowski et al., DE core fragment52  
In 2005, the group of Sulikowski published a stereocontrolled route allowing access 
to both enantiomers of the DE core unit of ’upenamide. The initial steps of their 
synthesis involved the 2 step formation of the iodo-enecarbamate 22 from the 
enecarbamate 20 (Scheme 1.4). This was accomplished by the iodomethoxylation of 
20 with ICl, which proceeded in excellent yield, without purification. Heating this 
product in toluene with TFA resulted in the rapid elimination of methanol to give the 
desired iodo-enecarbamate 22. 
N
Boc
ICI, NaOMe
MeOH, rt, 30 min
95%
N
Boc
I
OMe
TFA,
PhMe, 140 oC,
5 min
95%
N
Boc
I
20 2221  
Scheme 1.4 Synthesis of iodoenecarbamate 22. 
 
The synthesis of the alkyne coupling partner 26 (Scheme 1.5) commenced with the 
condensation of %-caprolactone (23) with N,O-dimethylhydroxylamine hydrochloride 
in the presence of trimethylaluminium to generate the Weinreb amide 24. This was 
followed by protection of the alcohol as the TBS derivative, giving the amide 25 in 
excellent yield. Treatment with ethynylmagnesium bromide gave an alkynone in good 
to excellent yield. This alkynone was reduced with (R)-Alpine borane giving the 
desired (R)-isomer of propargyl alcohol 26 in good yield and excellent enantiomeric 
excess. 
 
O
O
i) MeONHMe.HCl
Me3Al, CH2Cl2, 0 °C, 24 h
ii) TBSCl, Imidazole, DMF,
rt, 24 h
95% (over 2 steps) OR
N
O
OMe
Me
24 R = H
25 R = TBS23 OTBS
OH
i) 
THF, 50 oC, 45 min,
85-95%
ii) (R)-Alpine
borane, rt, 8 h
74% (+)-26
97:3 e.r.
MgBr
 
Scheme 1.5 Synthesis of propargyl alcohol (+)-26. 
 
The Sonogashira coupling of iodide 22 and alkyne (+)-26 proceeded well, delivering 
the enyne (–)-27 in excellent yield (Scheme 1.6). Selective reduction of the triple 
bond gave the alcohol (+)-28, which upon treatment with acid cyclised to the hemi-
aminal system (–)-29, with only one isomer observed. Boc-cleavage was achieved 
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under mild conditions by first making the TBS carbamate, then cleaving this by 
treatment with fluoride. Allylation of the free nitrogen, TBS cleavage and Swern 
oxidation gave the final product (–)-30 as a single enantiomer. 
N
I
Boc
Pd(PPh3)4,
(+)-26, CuI,
i-Pr2N, 40 °C,
1 h
97%
N
Boc
OH
TBSO
H2, Pd/C, Et3N,
rt, 36 h
98%
N
Boc OTBS
OH
HCl,CH2Cl2, 
rt, 5 min
80% N
Boc
O
OTBS
H
H
N O
O
H-32
H
i)   TBSOTf, 2,6-lutidine, '
CH2Cl2, rt, 3 h 
ii)  TBAF, THF, !30 °C, 1
5 min
92-97% over 2 steps
 
iii) 31, DIPEA, 40 °C, 18 h
52%
iv) TBAF, THF, rt, 4 h
v) Swern oxidation
90-95% over 2 steps
Br
I
I
22 (!)-27 (+)-28
(!)-29 (!)-30
H-30
31  
Scheme 1.6 DE core unit synthesis. 
 
The critical cis-ring fusion stereochemistry was assigned by the small coupling 
constant (<2 Hz) and chemical shift of the hemi-aminal proton (>4.0 ppm). The 
relative stereochemistry of the side chain was assigned by a nOe correlation between 
H-30 and H-32 (Figure 1.8). 
ON
H-32 H-30
O
I
H
(!)-30
nOe
 
Figure 1.8 Stereochemistry assigned by nOe. 
 
Sulikowski’s observation that a single isomer was formed in the key ring formation 
contrasts with the result obtained by Mons, who saw a mixture of the 4 possible 
diastereoisomers. Sulikowski rationalises this by noting the main difference is the 
substituent present on the nitrogen of the ‘D’ ring; Mons’ work has a n-butyl 
substituent while Sulikowski’s compound uses a Boc protecting group (Figure 1.9). 
Sulikowski suggests the carbamate favours a kinetic reaction, while if the nitrogen 
substituent is alkyl the reaction is reversible and thus the thermodynamic mixture of 
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products is observed. 
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H
H
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(2S, 4aR, 8aS)-30
2
4a
8a
2
2 2
4a
4a 4a
8a
8a
8a
8a
4a
2
 
Figure 1.9 Isomers observed by Sulikowski and Mons. 
 
Sulikowski’s use of Alpine borane to effect the chiral reduction allows access to both 
enantiomers of the alcohol 26. This in turn facilitates the synthesis of both 
enantiomers of the DE core; essential for the full structural elucidation of the natural 
product.  
 
Sulikowski does not describe the synthesis of the enecarbamate starting material 20 
(Scheme 1.4) stating only “prepared by electrochemical oxidation” but not specifying 
what the starting material for that oxidation is. Referencing Shono56 suggests that it 
might formed from the corresponding &-methoxy carbamate by loss of methanol 
(Scheme 1.7).56 
 
N
OO
OMe N
OO
91%
!2e-
 
Scheme 1.7 Enecarbamate formation under electrochemical conditions.56 
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1.5.3 Taylor and Ménard-Moyon, DE core fragment53 
In 2007 Taylor and Ménard-Moyon published two syntheses of the bicylic DE core.53 
The first synthesis was racemic and constructed both the ring systems by malonate 
chemistry (Schemes 1.8 and 1.9). The second synthesis detailed the elaboration of the 
dihydropyran 50 (Schemes 1.10 and 1.11). The chemistry of the second synthesis 
allowed the development an enantioselective route. 
 
Route 1 
 
The initial steps of the first route are described in Scheme 1.8. Alkylation of di-tert-
butyl malonate 32 with 3-bromopropylphthalimide and sodium hydride gave the 
phthalimide 33. This was used unpurified in a second alkylation at elevated 
temperatures with 4-bromo-1-butene. This double alkylation gave the allyl adduct 34 
in good yield over 2 steps. Ester hydrolysis with TFA gave the bis-acid 35, which was 
decarboxylated at 150 °C to give the acid 36 in excellent yield. Formation of the 
mixed anyhyride of the acid allowed for selective reduction using lithium tri-tert-
butoxyaluminium hydride to deliver alcohol 37. 
 
32
33
tBuO2C CO2tBu CO2tBu
NPhth
34
tBuO2C CO2tBu
NPhth
tetrachloroethane, 
150 °C, 2 h
92%
HO2C CO2H
NPhth
i) ClCO2Me, NMM
ii) LiAlH(OtBu)3,
Et2O, 0 °C, 2.5 h
81%
NPhth
CO2H
NPhth
OH
NaH, NaI, DMF,
0 °C - rt, 15 h
35 36 37
tBuO2C
NPhthBr
Br
NaH, NaI, DMF
40 °C, 15 h
64% over 2 steps
TFA, H2O, 
0 °C - rt, 1.5 h
95%
Scheme 1.8 Initial steps of Taylor and Ménard-Moyon’s malonate-based route. 
 
Oxidation of alcohol 37 with PCC gave the aldehyde 38 (Scheme 1.9) which was 
protected as the 1,3-dioxolane by refluxing under Dean–Stark conditions with para-
toluenesulfonic acid and ethylene glycol. Dihydroxylation of actetal 39 with catalytic 
osmium trichloride and stoichiometric potassium ferricyanide gave the diol 40 (1:1 
 Chapter 1 
 
 12 
mixture of diastereoisomers). Protection of the primary alcohol as the pivaloate ester 
was accomplished by treatment with the acid chloride to give 41. Deprotection of the 
phthalimide group with hydrazine was accomplished in good yield, giving the amine 
42. Finally Boc protection of the amine gave the cyclisation precursor 43. On 
treatment of this with stannous dichloride dihydrate the bicyclic octahydropyrano[2,3-
b]pyridine of the DE core unit was produced in a 65% yield. The cyclisation was 
stereoselective producing a single diastereoisomer of the hemiaminal ring. The cis-
ring junction was once again assigned on the basis of chemical shift and small 
coupling constant (singlet observed) H-32. The same nOe correlation used by 
Sulikowski (H-32 – H-30) allowed the ring fusion stereochemistry to be assigned. 
Pleasingly, this was the same as present in the natural product. The route is lengthy if 
high yielding (11% over 12 steps) but produced a racemic product. 
 
NPhth
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NPhth
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93%
NPhth
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N O
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H
H
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40 41 42
43 44
OsCl3!H2O,
K3Fe(CN)6, K2CO3
tBuOH/H2O, rt, 4 h
92%
(CH3)3C(O)Cl, 
Et3N, DMAP,
CH2Cl2, rt, 3 h
Boc2O, NEt3, 
CH2Cl2, rt, 1 h
SnCl2!2H2O, 
CH2Cl2, rt, 4 h
NH2NH2.H2O, 
EtOH, reflux, 1 h
PCC, 4 Å MS, 
CH2Cl2, 0 °C - rt, 1 h
 
Scheme 1.9 Later steps of Taylor and Ménard-Moyon’s malonate-based route. 
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Route 2 
 
Taylor and Ménard-Moyon’s second synthesis of the DE core unit was based on the 
derivatisation of the commercially available dihydropyran 45. TIPS protection 
furnished 46, which was treated with NIS and benzyl alcohol to give compound 47 as 
a mixture of diastereoisomers. Treating this with acrylonitrile in the presence of of 
AIBN and tributyltin hydride in refluxing benzene gave the adduct 48 in high yield. 
The nitrile was reduced with nickel boride in the presence of di-tert-butyl dicarbonate 
gave the Boc-protected amine 49 in good yield. As in the previous work, the key 
cyclisation sequence proceeded well, once again giving the DE core unit as a single 
diastereoisomer. Analysis of coupling constants and nOe studies once again 
elucidated the relative stereochemistry of the 3 chiral centres. 
O
OTIPS
O
OH
45
O
OTIPS
I
BnO
O
OTIPS
BnO
NC
O
OTIPS
BnO
N
H
Boc
46 47
48 49
N O
OTIPS
Boc
H
H
27
32 30
50
TIPSCl, Imid.,
DMF, 0 °C - rt, 8 h
85%
NIS, BnOH, 
CH3CN, rt, 1 h 
77%
NiCl2!6H2O, NaBH4,
Boc2O, MeOH, rt, 19 h
80%
AIBN, Bu3SnH,
acrylonitrile, PhH,
reflux, 1 h
71%
SnCl2!2H2O, CH2Cl2,
rt, 12 h
76%
 
Scheme 1.10 Taylor and Ménard-Moyon’s second DE route. 
 
Because the total synthesis of ’upenamide requires an enantioselective route to the DE 
core, Taylor prepared enantiopure 51 following a procedure by Ley et al. 57 The 
chemistry described in Schemes 1.9 and 1.10 was applied to this material, generating 
the DE core unit as a single enantiomer (Scheme 1.11). Derivatisation with para-
nitrobenzoic acid gave the ester 53 and allowed confirmation of the stereochemistry 
by X-ray crystallography. 
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THF, 0 °C, 1 h
93%N O
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N O
O
Boc
H
H
O
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OHO
(S)-51 (+)-50
(+)-52 (+)-53  
Scheme 1.11 Taylor and Ménard-Moyon’s enantioselective DE synthesis. 
 
1.5.4 Taylor and Reid, ABC core unit 158 
Both publications concerning the ABC core unit come from the Taylor group. The 
first, by Reid and Taylor, describes a stannous dichloride dihydrate mediated 
synthesis of the skeleton of the ABC core.58 
 
Cyclohexane carboxaldehyde 54 was converted into tert-butyl imine 55 by treatment 
with tert-butylamine (Scheme 1.12). Imine 55 was alkylated using acrylonitrile and 
catalytic hydroquinone and the product hydrolysed under acidic conditions to give the 
desired aldehyde 56. The aldehyde was protected as the dioxolane 57 in good yield by 
treatment with ethylene glycol, then the nitrile reduced with lithium aluminium 
hydride. The resulting amine 58 was used in a nucleophilic ring opening of !-
propiolactone to furnish amide 59 in a moderate yield. Treatment of this with stannous 
dichloride dihydrate delivered the desired spirooxaquinolizidinone framework of the 
ABC core unit 60 in a quantitative yield.  
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Scheme 1.12 Taylor and Reid’s synthesis of the ABC skeleton. 
 
Reid and Taylor continued their studies into the model system for the ABC core 
fragment by investigating substitution at C-2. This was achieved by employing a 
substituted !-propiolactone, allowing them to probe the stereochemical outcome of 
the key cyclisation reaction. 
 
Treatment of amine 58 with racemic 4-(benzyloxymethyl)oxetan-2-one (61) (Scheme 
1.13) gave the cyclisation precursor 62. Treatment of this with stannous dichloride 
dihydrate under the conditions used to form 60 gave the desired ABC skeleton 63 in 
high yield, but as a 1:1 mixture of diastereoisomers. It was postulated that the 
cyclisation might be reversible, and thus the reaction time was extended considerably 
from 1 hour to 2 days. This resulted in a 94:6 ratio, in favour of 63b, which, 
pleasingly, has the stereochemistry present in the natural product. The structure and 
stereochemistry of 63a and 63b were confirmed by X-Ray crystallography. 
 
The 1H NMR spectrum of 63a and 63b differ primarily about the chemical shift of H-
2. In the ‘natural’ isomer 63b H-2 has a chemical shift of #H 3.86 – 3.80, while in 63a 
H-2 is shifted downfield to #H 4.29 – 4.25. In the natural product 1 H-2 has a chemical 
shift of #H 3.62. The 13C NMR spectrum differs primarily about the shift of C-10, 
with 63b #C 92.9 and 63a #C 88.8. ’Upenamide has a chemical shift of #C 88.7. 
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Scheme 1.13 C-2 substituted ABC skeleton. 
 
1.5.5 Taylor and Schmidt, ABC core unit 254 
In the second paper by Taylor detailing studies towards the ABC core, the first 
synthesis of the fully functionalised spirooxaquinolizidinone is described (Scheme 
1.14).54 An enzymatic desymmetrisation was used to provide an enantioselective 
route, while the key allylic oxygen was introduced by a selenium dioxide mediated 
allylic oxidation. 
 
OH
AcO
OBn
O
O
OPMB
OBn
O
NH
O
O
O
O
N
OBn
HO
O
OTIPS
(!)-64 (+)-65 (+)-66 (!)-67
H
 
Scheme 1.14 Schmidt and Taylor’s route to the fully functionalised ABC core. 
 
Much of the work described in this Thesis is based on this chemistry, and this route 
will be discussed in detail in Chapter 3. 
1.5.6 Sulikowski et al., DE & BC core units55 
The final paper detailing studies toward ’upenamide is a second from the group of 
Sulikowski. It details a route to a spirocyclic compound which forms two of the three 
rings of the tricyclic ABC core unit of ’upenamide, and the coupling of this “BC” ring 
system to the DE core unit to generate an advanced intermediate.55 The key step in the 
synthesis is a microwave-mediated Staudinger/ aza-Wittig/ imine hydrolysis sequence 
which generates the spirocyclic BC core. 
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From 2-bromobutenolide 68 (Scheme 1.15), a Diels–Alder reaction delivered the 
endo-adduct 69 as a single diastereoisomer. A Keck allylation introduced the required 
3-carbon fragment to give 70 in a moderate yield after chromatographic separation of 
the mixture of isomers generated. Hydroboration of the desired isomer followed by 
oxidation gave alcohol 71 in good yield. The alcohol was then converted into the 
azide via treatment with DPPA, giving the azide 72 in good yield. Treatment with 
potassium hydroxide and acetyl chloride removed the methoxy substituent and 
replaced it with an acetate, generating the cyclisation precursor 73. The methyl ester 
71 had been shown to give undesired epimerisation in the following step (note, no 
yields given for the hydroysis or acetate protection). 
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AIBN, PhMe, 80 °C
8 h
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(PhO)2P(O)N3, DBU,
PhMe, rt, 5 h
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68 69 70
71 72
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Scheme 1.15 Sulikowski’s initial BC synthesis. 
 
In the key triphenyl phosphine microwave-mediated Staudinger/ aza-Wittig/ imine 
hydrolysis sequence, the acetate was transformed into the spirocyclic product 75 as a 
single diastereoisomer but as a mixture of enantiomers (Scheme 1.16). Subsequent 
Takai olefination and nitrogen acylation gave the spirocyclic imide 76 in good yield. 
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Scheme 1.16 Later steps in Sulikowski’s BC synthesis. 
 
Sulikowski continued with the coupling of this ‘BC’ fragment to the DE core unit of 
’upenamide52 via an aldol reaction. The use of Ti(Oi-Pr)3Cl allowed the control of the 
stereocentre produced at the C-2 position. The racemic BC core fragment coupled 
with the enantiomerically pure DE core unit to give the inseparable diastereoisomers 
78a and 78b in a 1:1 ratio. 
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Scheme 1.17 Coupling BC core unit to DE core. 
 
It appears the aim of Sulikowski was to install the ‘A’ ring of the ABC core unit of 
’upenamide as one of the final stages of the total synthesis, as the route described 
does not allow its introduction earlier. However, given the publication describes only 
the late stage intermediate it can be assumed that this has proved more difficult than 
anticipated. 
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1.6 Project aims 
 
The ultimate aim of this project was the development of a viable, efficient synthetic 
route to the natural product ’upenamide. Previous studies within the group 59-61 sought 
to achieve this by the separate synthesis of each core system followed by uniting the 
cores in the macrocyclic structure of ’upenamide. 
 
Firstly a short methodology project was planned to explore the scope of the 
SnCl2'2H2O methodology used by Taylor in both the ABC and DE core structures,53, 
54, 58 and apply it to the synthesis of a range of small heterocycles. The background to 
this project, and the results, are detailed in Chapter 2. 
 
Studies on model systems by Taylor and Jean had identified possible routes for 
coupling the ABC and DE cores.59 Application of this methodology to the “real 
system” required multi-gram quantities of both ABC and DE core structures. Thus, 
the major aim of the project was the modification of existing routes52-54 to both core 
structures to make this possible. This would be followed by coupling studies to 
complete the ’upenamide synthesis. 
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Chapter 2 – Results and discussion 1: Novel routes to heterocyles mediated by tin 
(II)  
 
2.1 Background to methodology project 
 
Polycyclic heterocycles are considered to be “privileged structures” in the 
pharmaceutical and agrochemical industries,62 and new methods for their construction 
are invaluable in the search for bioactive lead compounds in medicinal chemistry.  
 
This project concerned the use of stannous dichloride dihydrate (SnCl2!2H2O) to 
perform a deacetalisation-bicyclisation sequence, producing polycyclic heterocycles 
in a single step from simple precursors. The work was inspired by previous synthetic 
efforts within the group towards natural product targets. Initially the core structure of 
the of the HIV-1 integrase inhibitors integrastatins A and B (±)-80 was constructed 
from stilbene 79 using this methodology,63 and it was used further in the synthesis of 
the ABC core fragment of ’upenamide (Scheme 2.1). Treatment of the acetal 
precursor (+)-66 with SnCl2!2H2O gave the tricyclic ABC core of ’upenamide ($)-81 
in excellent yield.54 
O
O
OBn
SnCl2!2H2O,
CH2Cl2, rt, 48 h
66%
O
O
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(±)-80
O
HN
O
O
O
OBn
SnCl2!2H2O,
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91%
N
O
O
OH
OBn
AB
C
(+)-66
(")-81
 
Scheme 2.1 The construction of the integrastatin core and the ABC core unit of ’upenamide.54, 63 
 
It was envisaged that this methodology could be applied to allow access to a focussed 
library of compounds, of the general structures 82 and 87 (Scheme 2.2). 
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Scheme 2.2 Retrosynthetic analysis of heterocycles. 
 
The SnCl2!2H2O methodology would allow compounds of types 82 and 86 to be 
accessed from an amide of the general form 83, which in turn could be disconnected 
to reveal the amine 84, to be coupled with a range of acids 85. Compounds like 87 
and 91 could be accessed from the amides of general form 88, which can be further 
disconnected to reveal the dioxolane acid 89 coupled with a range of amines 90 
(Scheme 2.2). 
 
Compounds with the general structure 82 had been previously studied within the 
group, along with a few examples of compounds in the series 87 and a single example 
of the general structure 86 (Figure 2.1). A communication describing this 
methodology was published in 2007.64 
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Figure 2.1 Compounds accessible from acid 89 and amine 84. 
 
2.2 Aims and objectives: Methodology project 
The initial aim of the project was to optimise the synthesis of the aromatic product 96 
(Scheme 2.3), apply these optimised conditions to a range of systems, then follow the 
same procedure for the series 87. It was hoped that the results obtained would provide 
a greater understanding of the chemistry of these targets and allow for the publication 
of a full paper describing examples accessible by the application of this methodology. 
 
The initial series worked on comprised compounds with the general structure 86. The 
single example 96 had been previously synthesised, using the peptide coupling 
reagent HATU to form the amide bond, resulting in a moderate yield of 45% over the 
two steps (Scheme 2.3).64 
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Scheme 2.3 Cayley’s HATU coupling.64 
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2.3 Results 
 
Previous work in the group suggested that the SnCl2!2H2O cyclisation step was 
generally high yielding,63, 64 and so initial efforts concentrated on optimising the 
amide formation. 
 
2.3.1 Synthesis of amine 94 
The amine 94 was synthesised according to the procedure developed by Shimizu and 
co-workers.65 Commercially available 2-(2-bromoethyl)-1,3-dioxolane 97 was treated 
with sodium cyanide in water in the presence of a phase transfer catalyst, and the 
crude reaction purified by flash column chromatography to give the desired product in 
62% yield (Scheme 2.4). The purified nitrile 98 was reduced with lithium aluminium 
hydride to afford the primary amine 94 in 88% yield. The amine 94 was >95% pure 
by 1H NMR spectroscopy. Purification of this highly polar amine was problematic, 
and thus 94 was used without further purification. 
 
O
O NH2Br
O
O CN
O
O
NaCN, H2O, Et3BnNCl,
90 °C, 4 h
LiAlH4, Et2O, 
reflux, 12 h
62% 88%
97 98 94  
Scheme 2.4 Synthesis of amine 94. 
 
2.3.2 Initial coupling studies 
Initial optimisation was carried out on the system illustrated in Scheme 2.5 and 
focussed on the isolation of the intermediate amide 99. A range of standard coupling 
reagents were screened. 
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Scheme 2.5 Coupling reaction. 
 
Table 2.1 Amide bond formation on amine 94. 
Entry Conditions Yield of amide 99 and observations 
1 HATU, DIPEA, CH2Cl2, 0 ºC - 
rt. * 
Aqueous workup. 
~10% mass recovery 
many unidentified by-products 
2 HATU, DIPEA, DMF, 0 ºC - rt* 
Aqueous workup. 
~10% mass recovery 
many unidentified by-products 
3 Acid chloride, CH2Cl2, rt. † 
 
Trace of coupling observed, mainly recovered 
starting material. 
4 i-BuOCOCl, NMP, 0 ºC - rt. § Isolation of mixed anhydride 
5 i-BuOCOCl, NMP, rt - 60 °C. § Some reaction observed by 1H NMR 
spectroscopy, but deprotection of acetal main 
product 
6 T3P®, rt- 40 ºC. ¶ 
 
No reaction at rt. 
Heating resulted in deprotection of aldehyde 
7 HATU, DIPEA, DMF, filtered 
through pad of silica. * 
11% yield amide, however recovered some 
cyclised product 96 
*According to procedure described by Cayley et al.64 (with a standard aqueous 
workup or DMF replacing CH2Cl2)  
† Acid chloride formed according to the procedure described by Wu et al.66 
§ As described by Cayley et al.64 
¶ According to the procedure described by Taylor et al.67 
 
The single example of this type of system studied from the previous work within the 
group used HATU as the coupling reagent, and thus this was initially tried (Table 2.1, 
Entries 1 and 2), but the results observed were poor.  
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The literature for amide bond formation on salicylic acid derived systems suggests the 
use of acid chlorides as the preferred method of coupling, and that the favoured 
method of formation of the acid chloride is treatment with PCl3.68, 69 Given the 
difficulty of handing PCl370 it was decided to prepare the acid chloride via another 
method. 
 
The formation of an amide bond on a similar system via the acid chloride was 
described by Boxer et al. (Scheme 2.6).71 
 
100
Cl OH
OH
O
Cl OH
Cl
O
H2N
CN
Cl OH
O
H
N
CN(COCl)2, DMF, CH2Cl2, rt, 24 h DIPEA, CH2Cl2, rt, 24 h
102101  
Scheme 2.6 Amide bond formation on salicylic acid 100 (no yields reported).71 
 
Based on this, the next coupling protocol attempted was the synthesis of the acid 
chloride and its displacement by amine 94 (Table 2.1, Entry 3), was unsuccessful. The 
acid chloride was formed by the standard procedure of thionyl chloride and pyridine 
(for an example see Wu et al.66), and its formation was confirmed by TLC analysis 
(quenching a small sample into excess MeOH yielded only the methyl ester, 
suggesting complete consumption of the acid). However, reaction of this activated 
species with amine 94 returned only the amine. It was presumed that either the amine 
was not nucleophilic enough to displace the chloride or the acid chloride itself was 
not stable. 
 
The mixed anhydride coupling method via the use of isobutyl chloroformate (Scheme 
2.7) was next attempted. However, this reaction returned the mixed anhydride 103 at 
rt, while heating the reaction cleaved the acetal (Entries 4 and 5, Table 2.1).  
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Scheme 2.7 Mixed anhydride coupling. 
 
The final method tried was a return to the coupling reagent tried initially, HATU, but 
with a variation in the workup conditions (Entry 7, Table 2.1). Instead of an aqueous 
workup the reaction was filtered through a pad of silica to remove the HATU 
residues, and then concentrated and purified by column chromatography. The yield of 
amide 99 was still disappointingly low, although a trace of the desired cyclised 
product 96 was observed.  
NH2
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iii) purification by SiO2 column
trace  
Scheme 2.8 HATU coupling gave some cyclisation. 
 
At this point it was concluded that the intermediate amide was not stable. The 
cyclisation that would be effected with SnCl2!2H2O appeared to be taking place 
slowly. It seemed likely that this was occurring during the chromatographic 
purification, but attempts to induce this cyclisation with SiO2 failed (Scheme 2.9). 
O
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N
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O99
SiO2, CH2Cl2, rt - 50 °C
 
Scheme 2.9 Treatment with silica failed to induce the desired cyclisation. 
 
2.3.3 Phenol protection 
The presence of the phenol group seemed likely to be causing the problems with the 
amide bond formation reactions. It is possible that when the active ester or acid 
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chloride was formed during the coupling reaction, either another molecule containing 
the nucleophilic OH group is displacing it to form the ester 106, or it was cyclising 
with itself to give 105 (Scheme 2.10). This could be prevented by the protection of the 
phenol group. If the cyclisation of the intermediate amide was the reason behind the 
difficulties in amide bond formation this should also be prevented. 
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Scheme 2.10 Proposed undesired reactions of phenol 95. 
 
A silyl protecting group was chosen, as it was hoped that it would protect the phenol 
during the planned amide coupling step, and then be cleaved under the SnCl2!2H2O  
cyclisation conditions, with the stannous dichloride performing a one pot desilylation-
deacetalisation-bicyclisation sequence (Scheme 2.11). 
 
HO
O
TBSO
HO
O
HO
H
N
O
TBSO
O
O
O
O
N
96
10895 107  
Scheme 2.11 Envisaged protected phenol coupling and cyclisation. 
 
The silyl-protected phenol 107 was not known in the literature, but it was envisaged 
that it would be synthesised in a standard manner for the formation of TBS ethers: 
DIPEA and TBSCl. It was assumed that the TBS ester 109 would be formed first, but 
that it would be readily cleaved upon aqueous workup (Scheme 2.12). 
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Scheme 2.12 Envisaged synthesis of protected phenol 107. 
 
The standard TBS protection conditions (2 eq.), however, yielded only the bis-
protected salicylic acid derivative 109, even after an aqueous workup. This surprising 
stability may simply be a steric issue – the TBS groups are in very close proximity, 
and the presence of a large region of very non-polar alkyl groups might prevent the 
approach of water to hydrolyse the silyl ester. 
 
The desired mono-protected salicylic acid 107 could be isolated by careful treatment 
of 109 with either 10% citric acid (aq.), or TBAF in THF. However, 107 appeared to 
be unstable, even when stored at freezer temperatures (~ –18 °C). The estimated pKa 
of the acid proton is 3.06 (ACD labs predictor), and while there is no precedent in the 
literature for the deprotection of phenolic silyl ethers with acids as mild as this, there 
is considerable precedent for the deprotection of alkyl silyl ethers under similar 
conditions; formic acid (pKa 3.772) has been shown to remove TBS ethers,73 and 
Dowex resin, a carboxylic acid immobilised on polystyrene beads, has also been used 
in alkyl systems.74 
 
A small amount of the TBS-protected material 107 was prepared and used 
immediately in the HATU mediated coupling, followed by immediate treatment with 
SnCl2!2H2O to effect cyclisation. This sequence gave a slightly higher yield of the 
desired heterocycle 96 (Scheme 2.13). However, analysis of the crude reaction 
mixture after the coupling stage indicated that the silyl protecting group had been 
cleaved under the coupling reaction conditions. This, combined with the difficulty in 
preparing the mono-protected material led to the route being abandoned. 
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Scheme 2.13 Coupling of mono-protected 107. 
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2.3.4 Direct ester displacement 
It is possible to form amide bonds via the direct displacement of an ester by an 
amine75 and this method was attempted next. Literature precedent on similar salicylic 
acid derived systems under both thermal76 and microwave conditions provided 
encouragement.77 Norman et al.76 suggested the use of the methyl ester while Toma 
and co-workers suggested the use of the phenyl ester under microwave conditions.77 It 
was decided to synthesise both and test them in the displacement reactions. 
 
2.3.4.1 Synthesis of esters 
The methyl ester 110 was synthesised from the corresponding acid under standard 
Fischer esterification conditions,78 with catalytic H2SO4 in MeOH at reflux (Scheme 
2.14). An acid-base workup gave ester 110 in a low but unoptimised yield of 27%. 
 
HO
O
HO
95
O
O
HO
110
H2SO4, MeOH, 
reflux, 19 h
27%
 
Scheme 2.14 Methyl ester formation. 
 
The synthesis of the phenyl ester 111 proved to be more problematic, perhaps due to 
the lability of the desired product. Standard coupling conditions, heating with 
Amberlite® acidic resin and phenol, returned only starting material (Entry 1, Table 
2.2).  
  
Literature reports suggested the use of polyphosphoric acid (PPA) on similar 
systems.79 It is reported that PPA acts as both a dehydrating agent and acid catalyst. 
Initial attempts at this reaction were promising, heating to 100 °C with excess PPA 
and 4 eq. of phenol in xylene gave yields in the region of 65% of the desired phenyl 
ester 111 after column chromatography. However, when a new bottle of PPA was 
used the reaction returned only starting material until the temperature reached ~50 °C, 
when the starting material polymerised. Attempts to ‘age’ the new PPA by adding 
water gave the same result (Entries 2 and 3, Table 2.2).  
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The final approach optimised for the formation of the ester bond was a return to some 
of the chemistry tried in making the amide bond. Work then had shown that it was 
possible to make the acid chloride of 3-methyl salicylic acid. Repeating this and 
treating the acid chloride with PhOH (2 eq.) gave a reasonable yield of the desired 
product 111 after chromatographic purification (Scheme 2.15) (Entry 4, Table 2.2). 
 
HO
O
HO
95
O
O
HO
111
Conditions: see Table 2.2
 
Scheme 2.15 Phenol ester formation. 
 
Table 2.2 Phenol ester formation. 
Entry Conditions Yield of ester 111 and observations 
1 Amberlite resin, 4 eq. PhOH, neat, 
80 °C, 4 h. 
0%, Recovered starting material. 
2 PPA (old bottle), xylene, PhOH, 
100 °C, 18 h.79 
65% 
3 PPA (new bottle), xylene, 100 °C, 
PhOH 1 h. 
0% 
Dark red polymeric material formed 
when reaction heated above 50 °C. 
4 Thionyl chloride, pyridine, 
CH2Cl2, PhOH, 0 °C - rt, 30 min. 
65% 
 
2.3.4.2 Ester displacements 
Both the methyl and the phenyl ester were treated under the conditions described by 
Toma et al.77 heating neat to 135 °C for 10 minutes under microwave irradiation. The 
methyl ester 110 was recovered unchanged from the reaction, whilst the phenyl ester 
111 was converted cleanly into the amide. With concerns about the stability of the 
intermediate amide, the neat reaction mixture was immediately dissolved in CH2Cl2, 
and treated with SnCl2!2H2O (2 eq.), to yield the desired cyclised product, in an 
almost quantitive yield of 98% over the two steps (Scheme 2.16). 
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N
O
O
PhO
HO
O 111
96
NH2
O
O 94
i) 94, 135 °C, 
10 min, µW, 50 W input
ii) SnCl2!2H2O, CH2Cl2,
rt, 18 h
98%
 
Scheme 2.16 Phenyl ester displacement and subsequent cyclisation. 
 
2.3.4.3 Solvent screening  
While the neat reaction protocol gave very good results it was difficult to handle the 
viscous, oily amine 94 on a small scale. A reaction which could be carried out under 
the same microwave conditions, but with the amine in solvent would make handling 
easier. With this aim a series of reactions in various solvents were carried out using 
ester 111. The reactions were performed on the same scale as the neat reaction, and 
heated in the microwave to the same temperature. Each reaction was monitored by 
TLC for the disappearance of starting material (Table 2.3). 
 
Table 2.3 Solvent screen for amide bond formation of phenyl ester 111 and amine 94 
to give amide 96. 
Entry Solvent Result:   
1 None (control reaction) No starting material observed by TLC 
after 10 minutes. Complete conversion to 
96. 98% isolated yield of 96 after 
treatment with SnCl2!2H2O. 
2 Xylene Some conversion by TLC, but mainly 
starting material 111 after 30 minutes. 
3 Chlorobenzene ~ 50% conversion by TLC after 30 
minutes.  
4 Chloroform  Only trace of desired product after 30 
minutes, recovered 111. 
 
The non-polar high boiling solvent xylene (a mixture of isomers, boiling point around 
140 °C) gave a disappointing result, with some conversion observed by TLC analysis. 
The slightly lower boiling (131 °C) but more polar chlorobenzene gave a more 
promising result, with approximately 50% conversion by TLC. Chloroform (boiling 
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point 61 °C) resulted in only a trace of reaction, with phenyl ester 111 recovered 
unreacted. None of these results were comparable to the neat reaction (98% isolated 
yield Entry 1, Table 2.3), and so while handling the amine neat was difficult it 
appeared to be the most appealing of the routes studied. The methodology for forming 
the phenyl esters and then the displacement with the primary amine was applied to a 
range of compounds. The results are summarised in Table 2.4. 
 
NH2
O
O
94
HO
O
PhO
O
N
O
RR
HO
O
H
N
RO
O
94, 135 °C, 10 min SnCl2!2H2O, CH2Cl2,
rt, 18 h
µW, 50 W input
111-117
118 96, 119-124
Scheme 2.17 General reaction for bond formation and cyclisation. 
 
Table 2.4. Phenol ester displacement and cyclisations. 
Entry Ester 
Yield of 
ester* 
Cyclised 
Yield of 
heterocycle 
1 
PhO
HO
O 111  
65% 
N
O
O
96  
98% 
2 
O
PhO
HO F
112  
32% O
N
O
F
119  
98% 
3 
113
O
PhO
HO
 
45% 
O
N
O
120  
84% 
4 
PhO
O
HO
Cl
114  
34% O
N
O
Cl
121  
87% 
5 HO
O
PhO
115  
commercial O
N
O 122  
75% 
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6 HO
O
PhO
116  
commercial O
N
O 123  
65% 
7 HO
O
PhO
117  
commercial O
N
O
124  
56% 
* Prepared by treatment with thionyl chloride, pyridine, CH2Cl2 and PhOH. 
 
Each of the heterocyles produced had a characteristic hemi-aminal proton doublet of 
doublets (J 5.5 – 6.0 Hz) in the 1H NMR spectrum between 5.33 and 5.65 ppm, and a 
hemi-aminal 13C NMR signal between 88.2 and 89.1 ppm. All compounds were 
further characterised by mass spectrometry, high resolution mass spectrometry and IR 
spectroscopy. 
 
2.3.5 Studies towards a one-pot procedure 
While the purification of the intermediate amide had been kept to a minimum in these 
sequential reactions, the ideal situation would be a tandem process where all the 
reagents were charged to the flask at the beginning of the reaction. 
 
A series of experiments were carried out to investigate this possibility. These were 
carried out on the HATU-mediated coupling (Scheme 2.18) and the phenyl ester 
displacement (Scheme 2.19). 
 
2.3.5.1 HATU coupling 
NH2
O
O
HO
O
HO
O
O
N
+
94 96
SnCl2!2H2O
95
HATU
 
Scheme 2.18 Envisaged tandem process with HATU. 
 
After carrying out the HATU coupling between amine 94 and acid 95, SnCl2!2H2O 
was added in a single portion to the reaction mixture and the reaction monitored by 
TLC. The standard loading of 2 eq. of SnCl2!2H2O gave no conversion to product, 
and the loading was increased in increments of 2 until 10 eq. had been added. At this 
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point the reaction was worked up in the standard fashion, filtering through a celite 
pad, washing with CH2Cl2. After column chromatography the desired product 96 was 
isolated in a slightly lowered yield of 38%. It was assumed that by-products from the 
HATU coupling reaction formed a complex with the tin present in the reaction 
mixture and prevented the acetal deprotection-bicyclisation reaction occurring. 
 
With this reasonably positive result in hand attention was turned to the true ‘tandem’ 
process: adding all the reagents at the beginning of the reaction. Disappointingly, 
charging the SnCl2!2H2O to the reaction mixture of amine 94 and acid 95 with the 
HATU coupling reagent resulted in the recovery of only starting materials. 
  
2.3.5.2 Ester Displacement  
 
NH2
O
O
HO
O
PhO
O
O
N
+
94 96
SnCl2!2H2O
111
µW
 
Scheme 2.19 Envisaged tandem process with phenyl ester displacement. 
 
As the only byproduct of the ester displacement is phenol, it was hoped that this 
coupling method would allow the sequential process to become tandem. Adding 2 eq. 
of SnCl2!2H2O to the reaction mixture of amine 94 and phenyl ester 111 before 
subjecting it to the microwave heating required for coupling however resulted only in 
degradation of the starting material. It was assumed that the microwave conditions 
combined with the SnCl2!2H2O were simply too harsh for the starting material. 
 
This concluded the work on the initial series of compounds to be investigated. The 
second series of compounds to be investigated also completed some work started by 
Cayley.64 
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2.3.6 Reversed coupling partners 
2.3.6.1 Acid synthesis 
The dioxolane acid 127 was synthesised from the commercially available bromide 97 
according to the procedure of Shea et al.80 The Grignard reagent was formed by 
treatment with magnesium and catalytic iodine, then cooled, and the acid moiety 
installed by the addition of solid carbon dioxide. An acid-base workup gave the acid 
127 in a moderate yield requiring no further purification (Scheme 2.20). 
 
O
O
OH
O
O
O
Br
i) Mg, I2, THF, 
15 - 20 °C, 2 h
ii) CO2(s), !78 °C, 2 h
 67%
97 127  
Scheme 2.20 Synthesis of acid 127. 
 
2.3.6.2 Initial series 
A synthesis of the compounds illustrated in Scheme 2.21 had been investigated by 
Cayley. Initially attempting to form heterocycle 130, Cayley had isolated only 
intermediate amide 129. It was assumed that the 5-membered ring in 130 was too 
strained for the desired product to be formed. It was hoped that replacing oxygen with 
sulfur, to make compound 133, would solve this problem given the longer sulfur-
carbon bond length (183 pm vs 143 pm); however, a mixture of the desired compound 
133 and partially cyclised 134 was isolated. It was assumed 134 was an intermediate 
in the formation of 133 and Cayley predicted that moving to the larger 6-membered 
ring of 137 would reduce ring strain and hence favour the formation of the cyclic 
product 137. 
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CO2H
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CO2H
O
O
HO
H2N
HS
H2N
N
O
O
SH
OH
31%
14%
O
N
O
S
N
O
O
O
HO
N
H
O
SnCl2!2H2O, CH2Cl2, 
rt, 48 h
intermediate amide 129
obtained
O
O
HS
N
H
O
i) i-BuOCOCl
NMP, CH2Cl2, "10 °C -
rt, 2 h
ii) Filtration
SnCl2!2H2O, CH2Cl2, 
rt, 48 h
127 128
131127 132
129
133
134
i) i-BuOCOCl
NMP, CH2Cl2, "10 °C -
rt, 2 h
ii) Filtration
130
 
Scheme 2.21 Cayley’s work on compounds derived from acid 127. 
 
We were pleased to observe that this was the case. Treatment of 2-aminobenzyl 
alcohol 135 under the standard conditions developed by Cayley64 of isobutyl 
chloroformate amide coupling, filtration through a pad of silica, and treatment of the 
crude amide with SnCl2!2H2O gave the desired compound in a high yield of 80% over 
two steps (Scheme 2.22). 
 
CO2H
O
O
O
N
O
H2N
O
O
N
H
O
SnCl2!2H2O, CH2Cl2, 
rt, 48 h
80%
OH OH
127 135 136 137
i) i-BuOCOCl
NMP, CH2Cl2, "10 °C -
 rt, 2 h
ii) Filtration
 
Scheme 2.22 Synthesis of hemi-aminal 137. 
 
The synthesis of the sulfur analogue of 137, 140 also proceeded smoothly, giving the 
desired compound in an 86% yield (Scheme 2.23). 
 
CO2H
O
O
S
N
O
H2N
O
O
N
H
O
SnCl2!2H2O, CH2Cl2, 
rt, 48 h
86%
SH SH
127 138 139 140
i) i-BuOCOCl,
NMP, CH2Cl2, "10 °C -
 rt, 2 h
ii) Filtration
 
Scheme 2.23 Synthesis of thio-aminal 140. 
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The hemi-aminal 137 and thio-aminal 140 each had distinctive signals for the hemi-
/thio- aminal proton and carbon (#H=5.27 and #C=87.2 for the oxygen-containing 137, 
and #H=5.04 and #C=60.9 for the sulfur-containing 140). Both compounds were fully 
characterised by NMR spectroscopy, mass spectrometry, high resolution mass 
spectrometry and IR spectroscopy. 
 
 
2.3.6.3 Synthesis of thiol 138 
The seemingly trivial thiol 138 for the coupling illustrated in Scheme 2.35 is not 
commercially available. It is reported in the literature, but all references suggest a 
preparation described by Kitamura,81 compromising 6 steps from the corresponding 
benzyl alcohol 135 and with an overall yield of less than 10%. For this reason a more 
facile route to prepare the starting material was required. 
 
Lawesson’s reagent is widely used for the conversion of ketones to thioketones82 and 
alcohols to thiols,83 and the first attempts made to synthesise the thiol 138 were based 
on the use of this reagent. However treatment of amino alcohol 135 under standard 
conditions (e.g. those described by Nishio83 or Taylor84) returned no product, 
although all the starting material was consumed. The reaction was very messy and the 
isolated products appeared to consist entirely of byproducts of Lawesson’s reagent. 
Varying the workup conditions had no effect on the reaction and the route was 
abandoned. 
 
OH
NH2
SH
NH2
Lawesson's reagent
135 138  
Scheme 2.24 Lawesson’s reagent did not deliver the desired thiol 138. 
 
The second route investigated (Scheme 2.25) involved starting from 2-nitrobenzyl 
bromide (142), displacing the bromine with thiourea, followed by hydrolysis of the 
resulting thiourea with NaOH. This sequence delivered the nitrobenzyl thiol 143 in a 
moderate yield. Reduction of the nitro group with tin, HCl and acetic acid (following 
the procedure of Kandler et al. described for a very similar substrate85) returned none 
 Chapter 2 
 
 38 
of the desired product. Treatment with SnCl2!2H2O in HCl (aq.) gave a similar result, 
but pleasingly treatment of the nitro thiol 143 with SnCl2!2H2O in THF gave the 
desired product 138 in a reasonable yield after purification by cation exchange 
chromatography. 
 
SH
NH2
Br
NO2
SH
NO2
H2N
S
NH2
SnCl2!2H2O, 
THF, rt, 16 h
83 %NaOH, H2O,
reflux, 4 h
31 %142 143 138  
Scheme 2.25 Synthesis of thiol 138. 
 
2.3.6.4 Aminal heterocycle formation 
To complete the series the final example was to be an aminal-containing heterocycle 
of the form 146. The free amine 144 (Scheme 2.26) however proved difficult to 
handle under the standard methodology used for the rest of the series. Neither the 
desired compound 146 or the amide 145 were isolated and it was assumed that this 
was due to the high polarity of the intermediate amide 145, which is likely to have 
remained on the silica plug used to remove the isobutyl chloroformate coupling 
residues. 
 
i)  i-BuOCOCl,
NMP, CH2Cl2, !10 °C -
 rt, 2 h
ii) FiltrationCO2H
O
O
N
H
H2N
O
O
O
NH2
NH
H2N
N
O
146145144127  
Scheme 2.26 Envisaged formation of aminal 146. 
 
It was hoped that methylating the free amine to generate heterocycle 149 would solve 
this problem, and allow the methodology to be applied unchanged to this example. 
 
i)  i-BuOCOCl,
NMP, CH2Cl2, !10 °C -
 rt, 2 h
ii) Filtration
CO2H
O
O
NNH
O
O
ONH2
NH
N
H
N
O
149148147127  
Scheme 2.27 Envisaged synthesis of aminal 149. 
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2.3.6.5 Synthesis of methylated amine 147 
Initial attempts were made to synthesise methylated amine 147 via the initial 
formylation of nitrile 151 under conditions described by Hays et al.86(sodium hydride, 
ethyl formate). TLC showed complete consumption of starting material, but 1H NMR 
spectroscopic analysis of the unpurified reaction mixture showed none of the desired 
material. No signal for the formamide proton was present, and the integration of the 
aromatic proton signals suggested one had been consumed in the reaction.  
 
H2N
NC
151
HN
NC
HO
NaH, HCO2Et
152  
Scheme 2.28 Formylation gave an unknown product. 
 
Attention was then focussed on direct methylation of 2-aminobenzonitrile 151. 
Literature suggested that this could be achieved by heating with neat MeI and 
Na2CO3.87 Treatment of nitrile 151 under the conditions described by Antonini et al. 
gave a mixture of the mono- and di- methylated compounds 154 and 155 in a ratio of 
1:1 and a yield of 70%. 
 
H2N
NC
151
N
H
NC
N
NC
+
154 155
Na2CO3, MeI
Sealed tube, 90 °C, 
18 h, 70%
 
Scheme 2.29 Direct methylation resulted in a mixture of mono- and di- methylation. 
 
Given the difficulty in separating the mono- and di- methylated products, a further 
method was tried. Following the procedure described by Fernandez et al.,88 the amino 
nitrile 151 was treated with n-BuLi (0.45 eq.) followed by MeI. The desired product 
154 was isolated in 81% yield. Reduction with LiAlH4 afforded the amine 147 in a 
quantitive yield, requiring no further purification (Scheme 2.30). 
 
N
H
NH2
147
H2N
NC
151
N
H
NCn-BuLi, MeI, THF,!50 °C, 30 min
81%
LiAlH4, THF, 
rt, 4 h
quantitative
154  
Scheme 2.30 Synthesis of amine 147. 
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Pleasingly, methylation of the amine allowed the application of the method previously 
described unchanged, which generated the heterocyclic product 149 in moderate yield 
of 43% after purification by preparative TLC. 
 
CO2H
O
O
NNH
O
O
ONH2
NH
N
H
N
O
149148147127
SnCl2!2H2O, CH2Cl2, 
rt, 18 h
43%
i) i-BuOCOCl,
NMP, CH2Cl2, "10 °C -
rt, 2 h
ii) Filtration
 
Scheme 2.31 Methylated 147 cyclised to give the desired aminal heterocycle. 
 
The aminal 149 had distinctive hemi-aminal 1H NMR (#H=4.56) and 13C NMR signals 
(#C=71.9), and was fully characterised by NMR spectroscopy, mass spectrometry, 
high resolution mass spectrometry and IR spectroscopy. 
 
2.3.6.6 Disulfide example 
It is possible to use tin to reduce disulfide bonds (usually in combination with HCl.89, 
90). It was hoped that the conditions developed to perform the deacetalisation-
bicyclisation sequence would allow the reduction of a disulfide bond in situ. This 
would allow heterocycles such as the thio-aminal 140 to be prepared in two steps 
from the corresponding disulfide, with the SnCl2!2H2O performing a disulfide 
reduction-deacetalisation-bicyclisation sequence in a single pot.  
 
Given the difficulties in synthesising 138, the target heterocycle chosen for this study 
was the cysteine-derived thio-aminal ($)-158. This molecule had been synthesised by 
Cayley64 in a reasonable yield over two steps from L-cysteine methyl ester (156), 
giving the desired compound ($)-158 as a single diastereoisomer (Scheme 2.32). This 
was tentatively assigned the 3R,7aS-configuration shown, on the basis of NMR 
studies.64 The methyl ester of L-cysteine (156) is commercially available as the 
disulfide. 
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O
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i) i-BuOCOCl,
NMP, CH2Cl2, !10 °C -
 rt, 2 h
ii) Filtration
SnCl2"2H2O, CH2Cl2, 
rt, 48 h
68 % over 2 steps
 
Scheme 2.32 Cayley’s synthesis of 158. 
 
We were delighted to observe that applying the methodology unchanged to the 
disulfide 159 facilitated the one-pot coupling-disulfide reduction-deacetalisation-
bicyclisation smoothly in a 59% yield over the 4 steps performed, delivering the thio-
aminal ($)-158 as a single diastereoisomer{["]D $250.7 (c 1.25, CHCl3)}. This is 
comparable to the yield achieved by Cayley over 3 steps.64 
 
H
N
S
O
O
O
CO2Me
CO2H
O
O
HCl.H2N
S
CO2Me
N
S
CO2Me
H
O
160127 159 (-)-158
i) i-BuOCOCl,
NMP, CH2Cl2, !10 °C -
 rt, 2 h
ii) Filtration
SnCl2"2H2O, CH2Cl2, 
rt, 48 h
59% over 2 steps
22
 
Scheme 2.33 ($)-158 from the disulfide. 
 
This completed the methodology project. This work was published as a full paper in 
Synthesis in 2008.91 This paper is included as Appendix 1. 
 
2.4 Conclusions 
 
A novel tin(II) chloride dihydrate-mediated deacetalisation-bicyclisation procedure 
has been described for the construction of novel polycyclic heterocycles from amides 
possessing a pendant acetal group. The methodology developed allows access to a 
range of aminal, hemi-aminal and thio-aminal containing heterocycles in a two step 
process from easily synthesised precursors. The novel ring-fused heterocyclic systems 
produced have been fully characterised. 
 
Development of a tandem process was unsuccessful, but the sequential process 
described is simple to carry out and gives high yields. 
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The small library of compounds examined for each series could easily be expanded to 
include more examples. If the compounds were to show any biological activity this 
would allow full structure-activity relationships to be established. 
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Chapter 3 – Results and discussion 2: Synthesis of ABC core unit 
 
3.1 Previous work on the ABC core unit 
 
The ABC core unit of ’upenamide is a tricyclic spirooxaquinolizidinone ring system. 
It has received considerable attention in the Taylor group, who reported the only 
synthesis of the fully functionalised core unit to date.54 The stereochemistry of the 
ABC core unit is difficult to draw without overlapping bonds, so for clarity the 
stereochemistry of the ‘up’ hydrogen at the hemiaminal centre is abbreviated as a dot 
for the remainder of this Thesis.92 
 
O
N
OBn
O
OTIPS
H
(!)-67
O
N
OBn
O
OTIPS"
(!)-67
HO HO
 
Figure 3.1 Stereochemical notation used for ABC core unit. 
 
The synthesis of the ABC core unit by Schmidt, McAllister and Beltrán-Rodil was 
based on chemistry developed within the Taylor group by Reid.58 The route is high 
yielding, but involves many steps, some of which are detailed in Scheme 3.1. Starting 
from the commercially available meso-anhydride 164, seven steps including an 
enzymatic desymmetrisation deliver the ester (–)-165 in an enantio-enriched form 
(~94% e.e.) and in high yield. The carbon atoms which will comprise the key 
spirocyclic six membered B-ring are installed by alkylating with the three-carbon 
PMB-protected iodo alcohol 166 to deliver the protected alcohol (+)-65. After 
reduction of the ester and TIPS protection of the resulting alcohol, the PMB group is 
removed under oxidative conditions and the alcohol (+)-167 transformed to the azide 
(+)-168 via a Mitsunobu reaction. Staudinger reduction of the azide (+)-168, coupling 
of the amine 169 with the carboxylic acid 170, and finally deprotection and oxidation 
of the alcohol to the aldehyde give the cyclisation precursor (+)-66. In the key 
reaction, treatment of this intermediate with SnCl2'2H2O effects an acetal 
deprotection and condensation onto the resulting aldehyde to give the skeleton of the 
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ABC core unit (–)-172. TIPS protection of the primary alcohol was followed by 
allylic oxidation effected by selenium dioxide, installing the required allylic alcohol 
(–)-173. The stereocentre created was the opposite epimer to the natural product, and 
so in two final steps the alcohol was oxidised to the enone (–)-174 using manganese 
dioxide, then reduced under Luche conditions to give the desired (R)-epimer (–)-67. 
 
HN
O
O
O
OTIPS
OBn
O O
O
N
O
O
OH
HO2C O
O
7 steps
(including 
desymmetrisation) OBn
N3
OTIPS
OBn
170, T3P!, i-PrNEt2, THF, 
rt, 16 h
86% over 2 steps
HN
O
OBn
O O
O
99%
i) TIPSOTf, 2,6-lutidine,
CH2Cl2, rt, 3 h
ii) SeO2, EtOH, 
reflux, 17  h N
O
O
OTIPS
OBn
HO
63 % over 7 steps
PPh3, THF, 
H2O, reflux, 6 h
170 i) TBAF,THF, rt, 14 hii) TPAP, NMO, CH2Cl2,
rt, 30 min
99% over 2 steps
77 % over 2 steps
OBn
OPMB
i) LiHMDS, "78°C
ii) 166, THF, rt, 14 h
88%
I OPMB
166
OBn
OH
OTIPS
i) DIBAL-H, CH2Cl2, 
"20 °C,  30 min
100%
ii) TIPSOTf, 2,6-lutidine
CH2Cl2, 0 °C, 1 h
97%
iii) DDQ, CH2Cl2, 
H2O, rt, 10 min
94%
PPh3, DIAD, 
DPPA, THF,
0 °C - rt, 5 h 
83%
164 (")-165 (+)-65
(+)-167 (+)-168
(+)-171 (+)-66
(")-172 (")-173
SnCl2#2H2O,
CH2Cl2, rt, 60 h
N
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O
OTIPS
OBn
O
(")-174
MnO2, CHCl2, 
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O
O
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OTIPS
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Scheme 3.1 Schmidt and Taylor’s synthesis of the ABC core unit (–)-67.54 
 
 
 
 
Chapter 3  
 
 45 
3.2 Aims and objectives: Improved synthesis of the ABC core unit 
 
The ABC synthesis is 20 steps long but despite the length of the synthesis the yields 
are high (18% from commercially available starting materials). Initially the 
development of a shortened route, allowing easier access to the fully functionalised 
ABC core unit, was to be examined. Attention was first to be focussed on shortening 
the number of steps to install the three carbon chain aminated chain [i.e. (–)-165 ! 
169 in fewer than six steps]. Further studies were then to be carried out to see if the 
reduction, protection, oxidation sequence performed on carbon 10 ((+)-65, (+)-167 
Scheme 3.1) could be simplified. Finally a modified synthesis of the carboxylic acid 
170 employed in the amide coupling was to be investigated. 
 
3.3 Results 
3.3.1 Previous alkylation results 
One of the major reasons why the published route to the ABC core unit was so long is 
the nature of the alkylating agent employed on ester (–)-165. Ideally, the amine 
required in the final product would be present on the three carbon chain before the 
alkylation, but Schmidt’s route installed a protected alcohol, and then required three 
steps to deliver the amine present in 169. However, previous work had shown that 
alkylation reactions on ester (–)-165 with alkylating agents 175 containing a variety 
of protected nitrogen groups, yielded either only starting material, or gave very low 
yields of the desired compound. The attempted reaction is illustrated in Scheme 3.2. 
Alkylation with Y = OPMB was successfully optimised to give the desired compound 
in high yield. A selection of alkylating agents investigated is illustrated in Table 3.1.60 
i) base
THF, !78 °C
ii) 175, !78 °C - rt
OBn
O OMe
OBn
Y
I Y
(!)-165 176
175
O
OMe
 
Scheme 3.2 Schmidt and McAllister’s alkylation studies.60 
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Table 3.1 Schmidt and McAllister’s work on alkylating ester (–)-165.54 
Entry Base Solvent Conditions 175, Y Yield 
1 NaHMDS THF –78 ˚C then rt N(PMB)2  23% 
2 NaHMDS THF –78 ˚C then rt N(Allyl)2 - 
3 NaHMDS THF –78 ˚C then rt NPhth - 
4 LiHMDS THF –78 ˚C then rt OPMB 88% 
 
Initial studies by Jean59 suggested that alkylation with an azide as a masked amine 
moiety might be successful. If this were successful, alkylation followed by Staudinger 
reduction would deliver amine 178 in 2 steps from the ester (–)-165 (Scheme 3.3). 
OBn
base
OBn
N3
O
OMe
X N3 OBn
NH2
O
OMereduction
(!)-165 177 178
OMeO
 
Scheme 3.3 Envisaged alkylation with azide. 
 
3.3.2 Synthesis of a racemic system for model studies 
Rather than waste valuable chiral material while searching for a suitable alkylating 
agent a racemic synthesis of the ester 165 was developed. Following the procedure 
described by Schmidt,54 the meso-anhydride 164 was reduced to the diol 179 in 
excellent yield by treatment with LiAlH4 (Scheme 3.4). Mono-benzylation with 
sodium hydride and benzyl bromide delivered the mono-protected alcohol 180 in 
reasonable yield. The alcohol was then treated with Jones’ reagent,93 again following 
a procedure described by Schmidt,54 to yield the carboxylic acid. Subsequent 
treatment with methanolic HCl delivered the desired racemic methyl ester 165, in a 
moderate yield. 
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OMeO
O
HO
OOH
HO
O
O
O
LiAlH4, THF
0 °C - rt, 14 h
97%
NaH, BnBr, THF,
0 °C - rt, 18 h
66%
i) Jones Oxidation
ii) AcCl, MeOH, rt, 48 h
46 % over 2 steps
180164 179
165  
Scheme 3.4 Synthesis of racemic ester 165. 
  
3.3.3 Synthesis of iodo-azide 183 
With the aim of optimising the reaction illustrated in Scheme 3.3, the iodo azide 183 
was to be synthesised (X = I). This was prepared according to the procedure 
developed by Yao et al.94 As noted by the authors, these compounds are likely to be 
explosive. Consequently all procedures involved in their synthesis were carried out 
behind blast shields, and on small scales. Following the procedure of Yao, 1-bromo-3-
chloropropane 181 was treated with sodium azide in DMF to give the volatile chloro-
azide 182, which was used directly after in a Finkelstein reaction to deliver the iodo-
azide 183 in a reasonable yield after aqueous workup (Scheme 3.5). 
 
Cl N3 I N3Cl Br
NaN3, DMF,
rt, 18 h
NaI, acetone, 
reflux, 18 h
61% over 2 steps182181 183  
Scheme 3.5 Synthesis of azide 183. 
3.3.4 Potentially explosive nature of azide 183 
As advised by Yao,94 the azide 183 was treated at all times as  though it was 
explosive. This explosive nature, however, was an assumption based only on its 
structure. In order to gain more of an understanding of the behaviour of this 
compound a series of tests were carried out on it by the Process Safety group at 
AstraZeneca, Macclesfield. The first of these was differential scanning calorimertry 
(DSC). DSC is a technique which measures the energy output of a substance as a 
function of the temperature to which it is heated. The energy output is measured in  
Jg-1, and anything with an energy greater than 800 Jg-1 is considered to be a potential 
explosive. 
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Figure 3.2 The DSC tracing for azide 183. 
 
The DSC trace (Figure 3.2) suggests that if the azide were heated to ~180 °C it would 
decompose, giving off 1558 Jg-1 of energy, over the 800 Jg-1 suggested as the lower 
limit for a potential explosive. The DSC however, can give no measure of the 
explosive nature of the compound, only the energy it has the potential to release.  
 
In order to determine if the high energy observed in the DSC had the potential to lead 
to explosion, the shock sensitivity of the compound was investigated. AstraZeneca 
carried out a further series of tests called Fall Hammer Testing. This involves weights 
being repeatedly dropped onto a small sample of the material from various heights, 
increasing in energy until an explosion or flame is observed and can be recorded by 
camera or microphone. 
 
The results of the fall hammer testing were negative and no explosion or flame was 
observed. This result makes it unlikely that the material would explode under standard 
laboratory handling conditions, although as a precaution the azide was still handled 
behind a blast shield. 
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3.3.5 Alkylation studies 
With the racemic ester 165 and azide 183 in hand, alkylation studies could begin. 
Attempts to optimise the alkylation reaction (Scheme 3.6) focussed on the base used 
to perform the deprotonation. A repeat of the reaction carried out by Jean (Entry 1, 
Table 3.2) treating the ester 165 with lithium hexamethyldisilylazide (LiHMDS), then 
quenching with the azide 183 gave the initially promising result of a 1:1.2 mixture of 
starting material and the desired product by 1H NMR spectroscopy of the unpurified 
material. Column chromatography gave the desired product 177 in a 40% isolated 
yield, and the presence of the azide was confirmed by IR spectroscopy, with a 
stretching band observed at 2095 cm-1.95 
 
OMe
OBn
base
OBn
N3
O
OMe
N3 I
165 177
O
183
 
Scheme 3.6 Reaction to be optimised. 
 
Increasing the equivalents of base to two had little effect on the isolated yield of the 
product, and the 1H NMR spectrum of the unpurified reaction mixture suggested more 
side products were formed (Entry 2, Table 3.2). Increasing the loading of the azide 
under the same reaction conditions had the opposite effect to that desired: returning 
more starting material (Entry 3, Table 3.2). A change in the base from LiHMDS to 
lithium diisopropylamide (LDA), which was formed in situ by the treatment of 
diisopropylamine with n-butyl lithium, gave similar isolated yields (Table 3.2, Entries 
4 and 5). Changing the cation to sodium by employing sodium hexamethyldisilylazide 
(NaHMDS) yielded only the starting material (Table 3.2, Entry 6). Changing the 
cation to potassium however, increased the yield markedly (Table 3.2, Entries 7 and 
8). Using 1.1 eq. of KHMDS gave the desired product 177 in an 83% isolated yield. 
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Table 3.2 Changing the base in the synthesis of azide 177. 
* Product: SM ratios were determined by 1H NMR spectroscopy. 
† Supplied by Acros. 
 
The excellent result observed by employing KHMDS was not as straightforward as 
appeared on first inspection. The KHMDS is supplied in toluene, while LiHMDS and 
NaHMDS are supplied in THF: is the increased yield observed a solvent or cation 
effect? A second observation was noted on attempting to repeat this reaction: 
KHMDS supplied by either Aldrich or Alfa Aesar gave much poorer yields than that 
supplied by Acros. While this reaction initially gave excellent yields it clearly 
required more detailed investigation. 
 
3.3.6 Further investigations into KHMDS 
It appeared the KHMDS solution supplied by Acros somehow differed from those 
supplied by Aldrich and Alfa Aesar. Identical reaction conditions to those employed 
Entry Base (equivs) 
Azide 
(eqivs) 
Yield of azide 177 and 
observations* 
1  LiHMDS in THF 
(1 eq.)  
1.1 1:1.2 Product: SM  
40% yield 
2 LiHMDS in THF 
(2 eq.) 
1.1 ~2:1 Product: SM  
43% yield 
3 LiHMDS in THF 
(1 eq.) 
2.2 1:4 Product: SM  
4 LDA made in situ 
(1 eq.)  
1.1 1:1 by NMR 
41% yield 
5 LDA made in situ 
(2 eq.) 
1.1 ~2:1 Product: SM  
51 % yield 
6 NaHMDS in THF 
(1 eq.) 
1.1 RSM 
7 KHMDS in toluene 
(1 eq.)† 
1 4:1 Product: SM  
8 KHMDS in toluene 
(1.1 eq.)† 
1.1 >19:1 Product: SM  
83 % 
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for the Acros material using the Aldrich or Alfa solutions resulted in lowered yields 
and the formation of undesired side products. A series of titrations gave some insight 
into the reasons behind these differences. Quenching a known volume of the KHMDS 
solution into water, then titrating the hydroxide generated against acid of an 
accurately known molarity gives a value for the total base concentration of the 
solution, including any hydroxide present as an impurity. 
 
It is also possible to determine the HMDS concentration base by applying the 
procedure described by Duhamel et al.96 Using indicator 184 (Scheme 3.7) the base is 
added dropwise to a known volume of butanol in xylene. The solution stays 
colourless until all the butanol is consumed, then the first drop of excess HMDS base 
deprotonates the indicator giving the anion 185 and an easily observable deep blue 
colour. 
 
N NMHMDS
184 185,  deep blue colour  
Scheme 3.7 HMDS titration indicator 184. 
 
A comparison of the total base and HMDS concentrations of the KHMDS obtained 
from the three different companies, illustrated in Table 3.3, gave an indication of the 
reasons behind the differing reactivities observed. All of the base supplied by Acros 
appeared to be HMDS, which the solutions supplied by Alfa and Aldrich contained 
significant quantities of KOH. 
 
Table 3.3 HMDS and total base concentrations for KHMDS from different sources. 
Entry Supplier Total base concentration HMDS concentration 
1 Acros 0.67 M 0.67 M 
2 Aldrich 0.53 M 0.48 M 
3 Alfa 0.82 M 0.71 M 
4 Made from solid 0.25 M 0.24 M 
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As well as solutions of KHMDS it is possible to purchase solid KHMDS. The solid is 
very deliquescent and best stored and used in a glove box. The solid KHMDS gave 
the opportunity to investigate the effect of the mixed solvent systems generated by the 
commercial KHMDS in toluene. 
  
Initially the solid was dissolved in toluene. Pleasingly, using this solution in the 
standard azide alkylation reaction illustrated in Scheme 3.6 gave excellent results, 
with yields of azide 177 comparable to those obtained using the solution purchased 
from Acros. Total base and Duhamel titrations confirmed there was very little KOH 
present in the solution produced (Entry 4, Table 3.3). Dissolving the solid in THF 
gave the non-commercial solution of KHMDS in THF. The solution was pale yellow, 
but became opaque on storage. It was possible to determine the total base of this 
solution by titration, but the Duhamel HMDS titration method failed for the THF 
solution; the end point was no longer a sharp colour change, instead the solution 
slowly darkened. Duhamel does not mention this, but nor does he make any attempt 
to titrate non-commercial THF solution of KHMDS. Using the THF solution in the 
azide alkyation reaction (Scheme 3.6) gave disappointing results. Analysis of the 
unpurified reaction mixture by 1H NMR spectroscopy suggested an approximately 2:1 
mixture of product: starting material, with a significant quantity of undesired side 
products. It was unclear if this result demonstrated the instability of the THF solution 
or indicated that toluene was required for the clean conversion observed with the 
commercial solutions of KHMDS. 
 
Various other modifications were made to the reaction in an attempt to understand it 
better. The addition of hexamethylphosphorylamide (HMPA), which is known to 
enhance the reactivity of KHMDS by decreasing the aggregation state, resulted in a 
complex mixture of products. Variations in the time the reaction was maintained at    
–78 °C for gave identical yields. Reverse addition, adding the ester to the base, also 
gave the same yield. Adding the base to a mixture of the ester and azide, removing the 
hold time resulted in a 1:1 mixture of starting material and product. 
 
It seemed that a mixture of toluene and THF was required for the reaction to proceed 
to completion, and that KHMDS supplied as a solution from Acros was the easiest 
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way to ensure clean reactions. In the event of supply problems, then it was possible to 
buy solid KHMDS, store and weigh in a glove box, and achieve the same results. 
 
3.3.7 Reduction 
With the alkylation process optimised, it was next hoped to reduce the azide 177 to 
generate the amino ester 178, and then perform an amide coupling with acetal acid 
170, followed by reduction of the ester to the aldehyde and cyclisation as described by 
Schmidt54 (Scheme 3.8). 
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Scheme 3.8 Envisaged shortened synthesis from azide 177. 
 
Following the procedure described by Schmidt for the classical Staudinger reduction 
from azide to amine,97 good yields of amine 178 were obtained after purification by 
ion exchange resin (SCX column). The amine could also be purified by 
chromatography, but it was difficult to separate the triphenylphosphine oxide residues 
from the mixture. With the aim of minimising time spent handling the potentially 
explosive azide 183 in mind, the Staudinger reduction was tried on the unpurified 
reaction mixture resulting from the alkylation. This worked well, and purification by 
SCX allowed easy separation of any unreacted ester 165 or alkyl azide 183, as well as 
triphenylphosphine (Scheme 3.9). 
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Scheme 3.9 Staudinger reduction and one pot alkylation-reduction procedure. 
 
3.3.8 Stability of amine 178 
The amine 178 initially appeared stable, but on standing at room temperature the 
undesired spirocyclic lactam 187 was formed (Scheme 3.10). Using the amine within 
2 days resolved this problem. 
 
OBn
NH2
O
OMe O
OBn
NH
Standing, 14 days,
~50% conversion.
187178  
Scheme 3.10 Formation of undesired lactam 187. 
 
3.3.9 Acid synthesis 
With the amine 178 in hand, attention was turned to the synthesis of the protected !-
hydroxy acid 170 required for the amide coupling step. Schmidt60 had prepared this in 
4 steps from the commercially available diacid 188, following a procedure described 
by Ley et al.98 
HO
O
OH
O
OH
HO
O
O
O
170188
17% over 4 steps
 
Scheme 3.11 Schmidt’s formation of acid 170. 
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A literature search revealed a patent describing the synthesis of the same acid in a two 
step process from the commercially available chiral hydroxy butyrolactone 189 
(Scheme 3.12).99 Treatment of (S)-hydroxy butyrolactone 189 with MeOH and 
catalytic p-TSA in 2,2-dimethoxy propane and acetone gave the methyl ester 190 in 
moderate yield, and subsequent hydrolysis with LiOH delivered the desired acid 170, 
again in moderate yield (Scheme 3.12). The ester hydrolysis is neutralised by the 
addition of oxalic acid, and yields were better when this was monitored by pH meter, 
as opposed to pH paper, as the acid was prone to !-elimination to 191 under acidic 
conditions. The acid was not very stable, and so was made and used on the same day. 
On prolonged storage the acetal appeared to deprotect and a very polar material 
(assumed to be the diol 192) was isolated. Despite the modest yield (22% over two 
steps) this two step procedure was simpler and higher yielding than Schmidt’s 17% 
over four steps. 
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MeOH, p-TSA,
2,2-dimethoxypropane, 
acetone, reflux, 3 h
49 %
LiOH,THF, 
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189 190 170
O
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excess acid
O
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Scheme 3.12 Shortened synthesis of acid 170. 
 
3.3.10 Amide coupling 
The amine 178 and acid 170 were successfully coupled employing DCC and catalytic 
DMAP to generate the amide 186 in excellent yield (Scheme 3.13). 
HN
OMe
O
OBn
O
O
O
O
O
O
OH
H2N
OMe
O
OBn
178 186
170
DCC, DMAP, CH2Cl2, 
0 °C - rt
80-91%  
Scheme 3.13 Amide coupling. 
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3.3.11 Ester reduction attempts 
With the amide in hand the key step in the synthesis was now to reduce the ester to 
generate the desired aldehyde 66. At this point the SnCl2'2H2O methodology 
described previously could be used to cyclise and generate the deoxy-ABC core unit 
of the target natural product. It was hoped that the ester would be directly reduced to 
the aldehyde by the action of diisobutylaluminium hydride (DIBAL-H), but if this 
was not possible then a reduction-oxidation sequence via alcohol 195 was proposed 
(Scheme 3.14). 
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Scheme 3.14 Envisaged synthesis of aldehyde 66 and its cyclisation. 
 
Disappointingly, after a number of attempts it appeared that the ester 186 was too 
sterically hindered to reduce to either the aldehyde or the alcohol. All attempts 
resulted in recovered starting material, followed by degradation to a very polar 
material, with apparent amide bond cleavage (Table 3.4). 
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Table 3.4 Attempts to reduce ester 186 to aldehyde 66. 
Conditions Results 
DIBAL-H, 2 eq., THF, –20 °C – rt, 18 
h 
Mixture of starting material 186 and 
degradation 
DIBAL-H, 2 eq., THF, –78 °C, 1 h, 
then quenched at –15 °C 
No reaction, recovered 186 
DIBAL-H, 3.5 eq., THF, 0 °C, 2 h No reaction, then degradation 
DIBAL-H, 4 eq., THF, –20 °C, 2 h No reaction, then degradation 
NaBH4, MeOH, 65 °C, 18 h Degradation 
LiAlH4, 1 eq., THF, rt, 1 h No reaction, recovered 186 
LiAlH4, 1 eq., THF, 50 °C, 2 h No reaction, then degradation 
SuperHydride 0 °C – rt, 18 h No reaction 
 
3.3.12 Ester Saponification  
With the apparent difficulty of direct ester reduction, attention was turned to the 
possibility of saponification of the ester 186 to generate the acid 196. It was hoped it 
would then be possible to reduce 196 (Scheme 3.15). 
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Scheme 3.15 Envisaged saponification of ester 186 to acid 196. 
 
Disappointingly, on exposure of the ester to saponification conditions (TMSOK, 
NaOH) no reaction was observed, followed by degradation if forcing conditions were 
employed. 
 
At this point it was decided to attempt to reduce the ester at an earlier stage in the 
synthesis. 
 
Chapter 3  
 
 58 
3.3.13 Proposed early reduction 
After alkylation of the ester with the azide, reduction of the ester to the alcohol was 
envisaged, generating the hydroxy-azide 198; then a further reduction of the azide to 
the amine would be attempted. It was then proposed to subject the amino alcohol 199 
to a sequence of coupling, oxidation and cyclisation similar to those described earlier 
(Scheme 3.16). 
 
OBn
183, KHMDS
OBn
N3
O
OMeN3 I
OBn
N3
OH
O
O
O
OH
OBn
HN
O
O
O
O
OBn
N
O
O OH
OBn
HN
OH
O
O
O
OBn
NH2
OH
TPAP/NMO SnCl2!2H2O
ester
reduction
azide
reduction
165 177
183
198 199
170
200
66
172
coupling
OMeO
 
Scheme 3.16. Envisaged earlier reduction. 
 
This sequence should deliver the alcohol 200, which is known, after oxidation to the 
aldehyde 66,54 to cyclise to the desired spirooxaquinolizidinone system. 
3.3.14 Azide and ester reduction 
Reduction of 177 with DIBAL-H gave a more polar compound (Scheme 3.17), which 
was shown by IR spectroscopy to still contain the azide moiety (( = 2095 cm-1). Mass 
spectrometry confirmed the compound to be 198. In a further step, the azide was 
easily reduced to the amine under the mild conditions described by Lin and co-
workers using zinc and ammonium chloride100 generating the very polar desired 
amino alcohol 199. 
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Scheme 3.17 Synthesis of amino alcohol 199. 
 
Pleasingly, the yield could be maintained and the sequence shortened, by reducing 
both the ester and azide in a single step. This was achieved with lithium aluminium 
hydride in diethyl ether at room temperature, and delivered the desired amino alcohol 
199 in 67% yield. Workup conditions were key: aqueous workup resulted in the loss 
of most of the very polar 199, as did filtration through Celite. The LiAlH4 reaction 
could be quenched by the addition of Glauber’s salt (Na2SO4'10H2O) which was then 
removed by filtration. Purification of the filtrate by SCX chromatography delivered 
the product 199. 
 
The reduction could also be conducted directly on unpurified 177 with no purification 
of the azide after alkylation. The trace of ester 165 remaining after the alkylation was 
removed by the SCX purification. The yields were comparable with the two step 
process, and easier to perform. 
  
3.3.15 Amide coupling 
With amino alcohol 199 in hand the next stage of the shortened synthesis was to 
couple this to acid 170. This was complicated by the free alcohol in the molecule, and 
care was needed to minimise the formation of ester 202, or the di-coupled compound 
201. 
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Scheme 3.18 Envisaged coupling of amino alcohol 199 to acid 170, and possible byproducts. 
 
Treatment of amino alcohol 199 with DCC and catalytic DMAP, under identical 
conditions to those employed in the previous synthesis (Scheme 3.13), generated the 
product 200 in good yield (75%), but we were unable to separate it from the DCU 
produced in the coupling. T3P® gave the desired compound 200 in 67% yield, but the 
di-coupled side product 201 was present in ~3% yield. We were pleased to observe 
that using HATU as the coupling reagent gave the desired product 200 in quantative 
yield after chromatography. The di-coupled product 201 was not observed. 
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Scheme 3.19 HATU coupling of amino alcohol 199 and acid 170. 
 
3.3.16 Final steps in the racemic route 
The final steps of the synthesis were followed according to the procedure developed 
by Schmidt and McAllister54 and generated an inseparable 1:1 mixture of the known 
diastereoisomeric spirooxaquinolizidinones60 203a and 203b, in a good yield over 3 
steps (Scheme 3.20). The diastereoisomers arise from the racemic amine 199, coupled 
with the chiral acid 170. 1H NMR data was comparable to that published for (–)-20354 
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and for similar diastereoisomeric spirooxaquinolizidinones synthesised by Schmidt.60 
It was planned to use enantio-enriched material in later steps, now that the route had 
been optimised on the racemic system. 
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Scheme 3.20 Final racemic steps in the ABC synthesis. 
3.3.17 Enantio-enriched synthesis 
A synthesis of the enantio-enriched ester (–)-165 was developed by Schmidt and 
McAllister.54 This chemistry was repeated to generate the bisacetate 205 (Scheme 
3.21) by the reduction of anhydride 164 to the diol 179 and acetate protection with 
acetyl chloride and pyridine. The bisacetate 205 was then treated under the 
desymmetristaion conditions first described by Von Langen and co-workers101 and 
applied to this system by Schmidt.54 The enzymatic hydrolysis generates AcOH, 
which would denature the enzyme if allowed to build up. Adding base at the 
beginning of the reaction would also render the enzyme inactive, and so the pH is 
monitored and NaOH added by an autoburette.* 
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Scheme 3.21 Synthesis of acetate 206. 
 
The final stages of the ester synthesis were repeated exactly as described by 
Schmidt.54 Benzylation under neutral conditions was achieved in good yield with 
Dudley’s reagent.102 This was required as the substrate had been shown to epimerise 
under standard basic or acidic conditions.54 Acetate hydrolysis was followed by the 
                                                
* Carried out at AstraZeneca, Macclesfield. Thanks to Ian Ashworth and Jan Cherrywell of the Process 
Support group at AstraZeneca for setting this equipment up. 
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previously described oxidation and ester formation to give ester (–)-165 in good yield. 
1H NMR data of (–)-165 was consistent with literature and [&]D {[&]D –14.9 (c 1.2, 
CHCl3 ) (Lit.54 15.5 (c 1.1, CHCl3)} confirmed the e.e. to be comparable with that 
obtained by Schmidt (94%). 
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  Scheme 3.22 Synthesis of ester (–)-165. 
 
The ester (–)-165 was then subjected to the shortened synthesis developed on the 
racemic system (Scheme 3.23). 
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Scheme 3.23 Synthesis of chiral ABC core unit. 
 
The alkylation, reduction and coupling reactions proceeded in yields comparable to 
those observed on the racemic system, and delivered the alcohol (+)-200. Problems 
were experienced with purification of the final product (–)-203 as there was a leak in 
the inlet system of the purification system and some material was lost, which lowered 
the yield to 14% over the oxidation, cyclisation, and TIPS protection steps. NMR data 
for (–)-203 matched that obtained by Schmidt.54 
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3.3.18 Allylic oxidation. 
The final steps described by Schmidt54 in the synthesis of the fully functionalised 
ABC core unit involved selenium dioxide mediated allylic oxidation to furnish the 
alcohol 173. This was then inverted by an oxidation and Luche reduction sequence, 
giving the desired isomer (–)-67. Schmidt’s work proved troublesome to repeat on the 
mixture of diastereoisomers 203a and 203b with only small amounts of oxidation 
being observed and mainly recovered starting materials. Pleasingly, however, the 
chemistry was repeated on the chiral system (–)-203 in yields comparable to 
Schmidt’s. The key to this chemistry lay in the ethanol used in the selenium dioxide 
oxidation. Initial attempts used dry ethanol, when in fact slightly wet ethanol was 
required. Using 95:5 ethanol: water gave the best results (Scheme 3.24). All data for 
(–)-67 was in good agreement with the published data.54 
OBn
N
O
O OTIPS
OBn
N
O
O OTIPSHO
OBn
N
O
O OTIPSO
OBn
N
O
O OTIPSHO
SeO2, EtOH, H2O
80 °C, 17 h
CeCl3!7H2O, 
NaBH4, MeOH, 
rt, 30 min
55%
75% over 2 steps
MnO2, CH2Cl2, 
40 °C, 1 h
(")-203
(")-174
(")-67
(")-173
 
Scheme 3.24 Allylic oxidation on the chiral ABC core unit (–)-67. Reactions carried out by Unsworth. 
 
Applying these modified “wet” conditions to the racemic system 203a and 203b 
revealed a second observation: the “correct” diastereoisomer of the ABC core unit 
203a reacted under these conditions, leaving the “wrong” diastereoisomer 203b 
untouched and easily removed by chromatography (Scheme 3.25). 
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Scheme 3.25 Allylic oxidation acts only on one isomer of ABC core unit. Reaction carried out by 
Unsworth. 
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3.4 Conclusions 
 
A shortened synthesis of the ABC core unit of ’upenamide is described, the key step 
utilising an alkylating agent containing an azide as a masked amine moiety. This 
modification allowed the synthesis to be shortened from the published 21 steps (17% 
overall yield) to 16 steps (9% overall yield) and allowed easier access to large 
quantities of material for coupling studies. The problematic selenium dioxide 
mediated allylic oxidation was resolved by the use of 95:5 ethanol: water as a solvent. 
 
Attention was now turned to synthesis of the bicyclic DE core unit.
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Chapter 4 – Results and discussion 3: DE core unit 
 
4.1 Previous work on DE core unit 
 
The DE core unit of ’upenamide is a cis-fused bicyclic hemi-aminal. As discussed in 
the Introduction (Chapter 1), only the relative stereochemistry of the system is known. 
Thus, for a successful total synthesis of ’upenamide, any route developed to the DE 
core unit should give access to both of the possible enantiomers (Figure 4.1). A 
synthesis of the DE core unit was developed in the Taylor group by Ménard-Moyon,53 
but was lengthy and subsequently proved difficult to reproduce,103 and so a new route 
was sought.  
 
N O
H
H N O
H
H  
Figure 4.1 Both enantiomers of the DE core unit. 
 
Jean developed a second route to the DE core unit,59 based closely on the route 
published by Sulikowski.52 The route described by Sulikowski begins from the ene-
carbamate 20, which he describes only as being “prepared by electrochemical 
oxidation,” and elaborated this to the iodide 22. To avoid the potentially problematic 
undescribed electrochemistry step, Jean instead began by forming the triflate 213 
from the piperidone 212 (Scheme 4.1). 
 
N
Boc
OTf
N
Boc
N
Boc
I
213212
2220
N
Boc
O
 
Scheme 4.1 Sulikowski’s iodide and Jean’s triflate. 
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Triflate 213 was formed by treatment of piperidone 212 with LDA, and was coupled 
with alkyne 214 under Sonogashira coupling conditions in an analogous reaction to 
Sulikowski’s iodide 22. This delivered the enyne 215 in excellent yield (92%). The 
selective alkyne hydrogenation described by Sulikowski for the longer chain system 
worked well, and treatment with HCl in dichloromethane and methanol cyclised 
alcohol 216 to deliver the TBS-protected DE core unit 217 in good yield (Scheme 
4.2). 
HCl, CH2Cl2, MeOH,
rt, 15 min
67%
N
O
N
OTf
N
OH
OTBS
N O OTBS
LDA, PhNTf2, 
!78 °C - rt, 17 h
OH
OTBS
N
212
217
215
214
216
213
42%
92%
Pd(PPh3)4, CuI, LiCl, i-Pr2NH, 
DMF, 40 °C,14 h
H2, Pd/C, Et3N, 
EtOAc, rt, 17 h
OTBS
OH
Boc Boc Boc
BocBoc
H
H
 
Scheme 4.2 Jean’s synthesis of the DE core unit. 
 
As discussed in Chapter 1 (Section 1.5.2) Sulikowski observed the formation of a 
single isomer of the DE core unit on cyclisation effected by treatment with HCl. By 
analysis of the 1H NMR data he assigned this as the desired cis-fused hemi-aminal: 
“The ring fusion stereochemistry was assigned based on the small constant observed 
between the ring fusion protons (ca. J < 2 Hz) and chemical shift of the hemiaminal 
proton (! >4.0).”52 Pleasingly, we also observed this in the 1H NMR spectrum of 217. 
As racemic alcohol 214 was used for the coupling studies the products produced were 
a racemic mixture of the two cis-fused ring products.  
 
The alcohol 214 employed in the Sonogashira coupling was synthesised by Jean 
following the procedure described by Gung and co-workers.104 Treatment of 1,3-
propane diol with n-butyllithium and TBSCl gave the mono-protected 220, which was 
subjected to Swern oxidation to deliver the aldehyde 221. Treatment of the aldehyde 
221 with ethynylmagnesium bromide 222 gave the desired alkyne 214 (Scheme 4.3). 
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OTBS
OH
214
HO OH HO OTBS O OTBS
n-BuLi, TBSCl,
THF, 0 °C - rt,
1 h
MgBr
THF, rt, 12 h, 
61%
221220219
(COCl)2, DMSO, Et3N,
CH2Cl2, !78 °C - rt
2 h
74%35%
222  
Scheme 4.3 Synthesis of alcohol 214. 
 
4.2 Aims and objectives: DE core unit synthesis 
 
The first aim for this part of the project was to optimise the low yielding formation of 
triflate 213 (Scheme 4.2). This would be followed by the asymmetric preparation of 
both enantiomers of alcohol 214 (Scheme 4.2). Both enantiomers of 214 would then 
be used in synthesis illustrated in Figure 4.2, with the aim being to deliver both 
enantiomers of the DE core unit. At this stage, the later direction of the synthesis 
would depend on coupling strategies being developed in parallel to this work. 
 
4.3 Results 
4.3.1 Triflate formation 
The yields obtained in Jean’s synthesis were high, aside from the initial triflate 
formation step. The modest yield of 213 (Scheme 4.2) could be explained due to the 
uncontrolled formation of undesired regioisomer 223 (Scheme 4.4). 
N
O
N
OTf
N
OTf
Boc
223212 213
+
LDA, THF, PhNTf2, 
THF, !78 °C - rt, 17 h
Boc Boc
 
Scheme 4.4 Formation of triflates 213 and 223. 
 
In the current work investigations were carried out to determine if it was possible to 
improve this yield. The conditions developed by Jean involved treating the carbamate 
212 with LDA (formed in situ from diisopropylamine and n-butyllithium), using N-
phenyl-bis(trifluoromethanesulfonimide) (PhNTf2) as the triflate source (Entry 1, 
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Table 4.1). The reaction was carried out at –78 ºC and allowed to warm slowly to 
room temperature overnight. The workup comprised concentrating the reaction, then 
immediately purifying by column chromatography. It seemed important to column the 
product quickly, as on standing it quickly turned into a dark brown material, insoluble 
in all solvents investigated, which was assumed to be polymeric. For this reason it 
was hard to quantify the amount of 223 obtained in each case, as attention was 
focussed on obtaining 213 and using it quickly. 
 
Zheng and co-workers105 claimed an 80% yield of triflate 213 and the formation of 
single isomer under very similar reaction conditions to those initially tried, with the 
only difference being that the reaction was warmed to room temperature quickly. This 
was tried (Entry 2, Table 4.1) but the reported result was not reproduced, in fact a 
lower yield was obtained, and the undesired isomer 223 was observed. 
 
It was hoped that running the reaction in a less coordinating solvent than THF would 
encourage a chelation interaction between the carbamate protecting group and the 
metallic base, favouring removal of the !-proton. This would lead to preferential 
formation of the desired isomer (Figure 4.2). This was attempted by employing both 
diethyl ether and toluene as solvent (Entries 3 and 4, Table 4.1) but resulted in the 
formation of undesired side-products and lower yields. Once again the undesired 
isomer 223 was observed, but not quantified. 
 
N
O
OO
H
BASE
 
Figure 4.2 Possible chelation effect. 
 
A total synthesis paper by Overman et al. described problems with triflate 
regioisomers in similar systems.106 Their best results were achieved by using 
LiHMDS as the base, but when this was tried (Entry 5, Table 4.1) it gave a lower 
yield than LDA. A change in workup conditions to incorporate an aqueous workup 
(Entry 6, Table 4.1) then confirmed the suspicion that the product 213 is unstable to 
water. 
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Classic conditions for thermodynamic enolate formation with either triethylamine and 
heating107, 108 (Entry 7, Table 4.1) or di-tert-butylmethylpyridine (DTBMP) and 
heating109, 110 led only to decomposition, in the various solvents examined (Entries 8-
11). 
 
Finally, a less hindered version of LDA was employed: the base resulting from the 
treatment of diethylamine (DEA) with n-butyllithium. Disappointingly, however, this 
led only to a small increase in yield – 48% when allowed to warm to room 
temperature overnight, and a comparable 46% yield when quenched at –78 °C. In this 
case the undesired regioisomeric triflate 223 was observed but not isolated. 
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Table 4.1. Attempted optimisation of formation of triflate 213 
¶ 2,6-di-tert-butyl-4-methylpyridine. 
* Decomposition was observed. 
† made in situ
Entry Base Solvent Temp Time 
Triflate 
source 
Workup 
Yield 
213 
1 LDA† THF –78 °C To rt o/n PhNTf2 Concentrated 42%  
2 LDA† THF –78 °C To rt 
quickly 
PhNTf2 Concentrated 30%  
3 LDA† Et2O –78 °C To rt o/n PhNTf2 Concentrated 24%  
4 LDA† toluene –78 °C To rt o/n PhNTf2 Concentrated 35%  
5 LiHMDS THF –78 °C To rt o/n PhNTf2 Concentrated 38%  
6 LiHMDS THF –78 °C To rt o/n PhNTf2 Aqueous 
workup 
(EtOAc + 
water) 
0% 
7 Et3N DMF 80 °C 12 h PhNTf2  0% * 
8 DTBMP¶ DCE 90 °C  PhNTf2 n/a 0% * 
9 DTBMP¶ toluene 80 °C  PhNTf2 n/a 0% * 
10 DTBMP¶ CH2Cl2 rt  Tf2O n/a 0% * 
11 DTBMP¶ DCE 60 °C  Tf2O n/a 0% * 
12 DEA+n-
BuLi 
THF –78 °C To rt 
o/ns 
PhNTf2 Concentrated 48%  
13 DEA+n-
BuLi 
THF –78 °C 2 h PhNTf2 Quenched at 
–78 °C by 
adding 
NH4Cl 
46% 
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Overman106 found that greater selectivity could be obtained in similar systems by 
changing the nature of the nitrogen protecting group on the piperidone to either a Cbz 
group or a tosyl group. Zheng105 claimed full regioselectivity with the Cbz group.   
 
The Cbz-protected piperidone 227 was synthesised from 3-hydroxypiperidine 225 
according to the procedure described by Aitken et al.111 followed by Jones oxidation93 
to the piperidone (Scheme 4.5). 
 
N
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OH
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N
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92%
CrO3, H2SO4,
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Scheme 4.5 Synthesis of Cbz-protected piperidone 227. 
 
With the Cbz-protected piperidone in hand, triflate formation was attempted. 
Disappointingly this gave lower yields than the Boc-protected compound when 
treated with LDA and PhNTf2 (23-24%), and only decomposition on treatment with 
DTBMP. 
 
At this point it was concluded that further study was not worthwhile. As this step was 
the first in the synthesis a low yield could be tolerated here. 
4.3.2 Stannous dichloride dihydrate cyclisation 
Sulikowski’s HCl-mediated cyclisation conditions worked well to deliver the TBS-
protected DE core unit 217. We were delighted to observe that on applying the 
previously developed SnCl2!2H2O methodology conditions to the cyclisation 
precursor 216 the unprotected DE core unit 230 was produced in comparable yield to 
Sulikowski’s HCl method (Scheme 4.6). Direct access to the free alcohol 230 without 
a separate deprotection step should allow for easier elaboration to the final skeleton of 
’upenamide. 
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SnCl2!2H2O, CH2Cl2,
rt, 2 h
63%
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Scheme 4.6 Treatment of cyclisation precursor 216 with SnCl2!2H2O and HCl.  
4.3.3 Synthesis of enantio-enriched alcohol 214 
Using either enantiomer of alcohol 214 in the synthesis described in Scheme 4.2 
would allow both enantiomers of the DE core unit to be produced. With a simple 
route to the racemic alcohol 214 in hand, and the requirement for both enantiomers, 
resolving the chiral material seemed an attractive option. 
 
This resolution was achieved according to the procedure of Gung,104 resolving alcohol 
214 with lipase AK from pseudomonas sp. and vinyl acetate. The enzyme selectively 
acetylated the (S)-(–)-enantiomer of the alcohol, giving acetate (–)-231 and alcohol 
(R)-(+)-214. Chromatographic separation, followed by hydrolysis of the acetate with 
lithium hydroxide gave the desired alcohols (–)-214 and (+)-214 in good yield 
(Scheme 4.7). 
 
OTBS
OH
OTBS
OH
OTBS
O
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Amano lipase,
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35 °C, 3.5 h +
OTBS
OH
LiOH!H2O, 
MeOH, H2O,
0 °C - rt, 1 h
95%
45%44%
214 (")-231
(")-214
(+)-214
 
Scheme 4.7 Resolution of alcohol 214. 
 
The e.r. of (+)-214 and (")-214 were determined by Mosher’s ester analysis: both 
enantiomers were treated with (R)-MTPACl to generate the corresponding Mosher’s 
ester (Scheme 4.8, Figure 4.3). 
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OH
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0 °C - rt, 1 h
90%
O
OMe
Ph
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93:7 d.r.  
Scheme 4.8 Mosher’s ester of (S)-(–)-214. 
 
Integration of signals in the 19F NMR spectrum suggested an e.r. of 93:7 for the (S)-
compound (!)-214. Identical conditions generated the ester 233 from (R)-(–)-214 
with 19F NMR suggesting an e.r. of 90:10 for the alcohol (–)-214.  
OTBS
O
O
OMe
Ph
F3C
233  
Figure 4.3 Mosher’s ester of (R)-(+)-214. 
 
4.3.4 Enantio-enriched DE synthesis 
With the enantio-enriched alcohols (–)-214 and (+)-214 in hand the synthesis of both 
enantiomers of the DE core unit was straightforward. Minimal purification of the 
intermediate alkyne gave the best results, and the alcohols (–)-217 and (+)-217 were 
successfully synthesised (Scheme 4.9), using the conditions described in Scheme 4.2. 
The Sonogashira coupling was problematic in both cases – reducing the yield to 29% 
for the (–)-217 and 13% for the (+)-217. Repeating Jean’s synthesis proved this 
reaction to be remarkably capricious, appearing to require rigorously dry solvents, 
flame dried reagents and glassware for high yields. With these modifications yields 
were still very variable. Alternatives to the Sonogashira strategy were investigated on 
the short chain DE core 217 (Section 4.3.5) and later again when the extended chain 
DE core was investigated (see Section 4.3.9). The e.r. of  (–)-217 and (+)-217 were 
not determined, but it was assumed that the 93:7 and 90:10 ratio observed in alcohols 
(+)-214 and (–)-214 were retained in the products (–)-217 and (+)-217. 
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Scheme 4.9 Synthesis of chiral DE core units. 
4.3.5 Alternative acetylene route 
Given the regiochemistry problems encountered with the triflate formation and the 
capricious nature of the Sonogashira reaction an alternative sequence illustrated in 
Scheme 4.10 was also considered. If it were possible to react the protected piperidone 
212 with the lithium acetylide 235 to afford the alcohol 236, then regioselective 
dehydration would yield the desired compound 237, potentially removing the problem 
of triflate regioselectivity. 
N
O OPG
Li
OTBS
+
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OH
OPG
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OTBS
regioselective
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236235 237
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Scheme 4.10 Envisaged nucleophilic attack and dehydration sequence. 
 
A model system utilising lithium phenylacetylide 238 formed in situ from phenyl 
acetylene and n-butyllithium successfully formed the alcohol 239 (Scheme 4.11). 
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Scheme 4.11 Model system to investigate the dehydration chemistry. 
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Disappointingly, under all the dehydration conditions examined, the undesired isomer 
241 predominated, or no reaction was observed (Table 4.2). Martin’s sulfurane 242 
(Figure 4.4) at 40 °C gave the most promising results, but all attempts to push the 
reaction to completion resulted in the isolation of only the undesired isomer in very 
low yield (13%). Thus, the addition – elimination route was abandoned. 
S
O
O
F3C CF3
CF3F3C
242 Martin's sulfurane
S NN
O
O
O
O
243 Burgess reagent
 
Figure 4.4 Martin’s sulfurane and Burgess reagent. 
 
Table 4.2. Attempted elimination to alkene 240. 
Entry Conditions Result 
1 MsCl, Et3N, CH2Cl2, 0 °C - rt, 5 min, 
Then PhMe, DBU, rt - 100 °C 
Recovered mesylate (96% 
yield) 
2 BF3!OEt2, CH2Cl2, 0 °C - rt RSM 
3 Burgess Reagent 243, PhMe, 80 °C 19 h 241 (100% yield) 
4 Burgess Reagent 243, PhMe, rt, 19 h RSM 
5 Burgess Reagent 243, PhMe, 40 °C, 4 h 241 
6 Martin’s Sulfurane 242, CH2Cl2, rt, 2 h No reaction 
7 Martin’s Sulfurane 242, CH2Cl2, 40 °C, 2 h 1.3:1 240:241  
20% isolated yield + RSM 
 
4.3.6 DE core unit with an extended side chain 
With the short chain DE core unit successfully completed the project began to move 
in a different direction. In collaboration with Dr W. Unsworth (Postdoctoral 
Researcher), attention was turned to an alternative route: the possibility of installing 
the saturated linking chain earlier in the synthesis. The idea was for the DE core unit 
to contain the four carbon saturated chain, and a "-hydroxy acid functionality. The "-
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hydroxy acid moiety would, after coupling to amine 245, oxidation and cyclisation, 
make up the “A” ring of the ABC system. In theory this should deliver the ABC and 
DE core units likened through the saturated chain (compound 247, Scheme 4.12). The 
full route is described in Chapter 5. 
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Scheme 4.12 Envisaged coupling of long chain DE core unit to amino alcohol ABC precursor. 
 
For this route to succeed a two carbon homologue of the DE core unit 230 produced 
previously was required. It was hoped this could then be elaborated to the !-hydroxy 
ester 255 (Scheme 4.13). 
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Scheme 4.13 Two carbon homologue of DE core unit 253 
 
The longer chain alcohol 26 required for the 2 carbon homologue of the DE core was 
synthesised by a modified procedure to that used by Jean on the shorter chain 
compound. Treatment of 1,6-hexanediol with sodium hydride and TBSCl gave the 
mono-protected alcohol 249 in excellent yield. Tandem Swern oxidation–Grignard 
reaction with ethynylmagnesium bromide 222 as described by Ireland112 gave alcohol 
26 in good yield (Scheme 4.14). 
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63%  
Scheme 4.14 Synthesis of alcohol 26. 
 
We were pleased to observe that the chemistry developed by Jean to produce the 
shorter chain 217 and 230 translated well to the longer chain system, and the 
Sonogashira and hydrogenation steps worked well (Scheme 4.15). Treating alcohol 28 
produced with SnCl2!2H2O to effect the cyclisation to 253 delivered the deprotected 
compound, in good yield. The in situ deprotection effected by SnCl2!2H2O allowed 
for easier elaboration to install the required "-hydroxy acid without the requirement 
for a separate deprotection step. 
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Scheme 4.15 Synthesis of long chain DE core unit 253. 
 
The cis-ring fusion stereochemistry was again confirmed by 1H NMR spectroscopy, 
with the hemi-aminal proton splitting small enough not to be observed. The hemi-
aminal proton appeared as a ~ 1:1 mixture of rotamers at 5.30 and 5.10 ppm, (Figure 
4.6). As the alcohol 26 employed was racemic, the product 253 was once again a 
racemic mixture of the cis-ring fused products. 
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Figure 4.6 The 1H NMR spectrum of alcohol 253. 
4.3.7 !-Hydroxy ester synthesis 
With the alcohol 253 in hand, attention turned to modifying this to give the !-hydroxy 
ester 255 required for coupling. It was hoped this could be synthesised from the !-
keto ester 254 by an enantioselective Noyori reduction. The !-keto ester was to be 
installed by a Roskamp reaction113 on the aldehyde formed by oxidation of alcohol 
253 (Scheme 4.16). 
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Scheme 4.16 Envisaged !-hydroxy ester synthesis. 
 
The mono-protected diol 249 was used as a model system to investigate this 
sequence. Performing a Swern oxidation gave the aldehyde 256, which was then 
treated with ethyl diazoacetate 257 in the presence of catalytic SnCl2"2H2O at rt. This 
performed a Roskamp reaction and delivered the !-keto ester 258 (Scheme 4.17). 
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Scheme 4.17 Model system for oxidation and Roskamp sequence. 
 
The next stage in the synthesis was the reduction of the !-keto ester to deliver a !-
hydroxy ester via a Noyori asymmetric hydrogenation. Classical Noyori 
hydrogenation reactions take place at high pressures of hydrogen (100 atmospheres) 
and involve oxygen sensitive catalysts.114 The high pressure hydrogenator at York is 
not designed for air-sensitive material, and thus the classical Noyori procedure was 
not practical. Genêt and co-workers115 reported an alternative Noyori catalyst which 
can be used at 1 atmosphere of hydrogen and was much better suited to our needs. 
Thus, following the procedure of Genêt the catalyst (R)-260 was synthesised from 
Ru(COD)(methylallyl)2, (R)-BINAP and HBr (Scheme 4.18). 
 
Ru(COD)(2-methylallyl)2
(R)-BINAP, HBr, Acetone
RuBr2P
P
*
P
P
* = BINAP
rt, 30 min (R)-260
 
Scheme 4.18 Synthesis of Genêt’s Noyori catalyst. 
 
Pleasingly, the Noyori reduction using Genêt’s catalyst was successful when applied 
to the model !-keto ester 258, giving complete reduction to the alcohol 259 (Scheme 
4.19). The e.r. of 259 was not determined but is generally high in Noyori !-keto ester 
reductions. This promising result meant that elaboration of the real system could now 
be attempted. 
 
TBSO
O
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TBSO
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OEt
O259
catalyst (R)-260, H2, 
MeOH, rt, 2 h
 
Scheme 4.19 Noyori reduction model system. 
 
The oxidation and Roskamp conditions developed on the model system were applied 
to the DE core unit alcohol 253 to elaborate to the required !-keto ester. Swern 
oxidation gave 60% after chromatography of the aldehyde 264 but this compound 
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proved to be unstable on standing. Changing the oxidation method to TPAP and 
NMO removed the requirement for a column; 264 could instead be purified by 
filtration through a silica plug and used immediately in the subsequent Roskamp step 
which worked well, delivering the desired !-keto ester 254 in good yield (Scheme 
4.20). 
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Scheme 4.20 Synthesis of !-keto ester 254. 
 
It was now hoped to reduce the !-keto ester 254 to the corresponding !-hydroxy ester 
255 The stereocentre generated at C-2 in 255 would be incorporated into the ABC 
core, and was required to be of the configuration (R) (Scheme 4.21). 
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Scheme 4.21 Envisaged Noyori reduction of 254. 
 
The absolute stereochemistry of the product of Noyori reduction of !-keto esters to !-
hydroxy esters is well established.116 In systems like these where R1 (261, Scheme 
4.22) is an alkyl group (R)-BINAP gives the (R)-alcohol, while using (S)-BINAP 
would deliver the corresponding (S)-enantiomer.  
R2O
O
R1
O
R2O
O
R1
OH
R2O
O
R1
OH
Noyori reduction
with (R)-BINAP
Noyori reduction 
with (S)-BINAP
(S)-262
(R)-262261  
Scheme 4.22 Stereochemical outcome of Noyori reduction. 
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This can be explained by the conformation the BINAP ligand adopts in the Ru-
BINAP complex. Figure 4.7 shows the chiral environment around the Ru centre 
viewed from above, illustrating how the rigid BINAP ligand forces the phenyl rings to 
protrude in two quadrants. This view also demonstrates how access to one face of the 
structure is blocked by the naphthyl rings. In the side view in Figure 4.7 (with 
naphthyl rings omitted) it is clear that the protruding phenyl rings block access to two 
of the possible four quadrants of the accessible face. This is illustrated by the circle 
split into four quadrants, with the shaded areas suggesting no coordination can occur. 
 
 
Figure 4.7 (R)-BINAP complexed to Ru. Figure taken from Noyori et al.116 
 
The stereochemistry determining step is the coordination of the !-keto ester to the Ru-
BINAP complex. Preferential binding of the !-keto ester occurs in order to minimise 
non-bonding interactions between the protruding phenyl ring and the ketone 
substituent. Figure 4.8 illustrates the diastereoisomeric transition states leading to the 
two possible enantiomeric products. (S)-263, which would lead to the (S)-alcohol is 
unlikely, as the R1 substituent clashes with the equatorial phenyl ring. The transition 
state (R)-263, leading to the (R)-product does not suffer from this interaction and thus 
is favoured. 
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(S)-263(R)-263
 
Figure 4.8 Transition states leading to enantioselective reduction. Figure taken from Noyori et al.116 
 
With the ester 254 in hand, the Noyori reduction could now be attempted on the real 
system. The catalyst (R)-260 described by Genêt was synthesised in an identical 
manner as previously, and the !-keto ester 254 was added to the Schlenk tube. The 
reduction appeared slow at room temperature and so, as suggested by Genêt,115 the 
reaction was heated to 40 °C. This resulted in complete consumption of starting 
material in 19 h. The yield was reasonable after chromatography, with the racemic 
254 giving an inseparable 1:1 mixture of diastereoisomers 255a and 255b in a 68% 
yield (Scheme 4.23). 
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Scheme 4.23 The two enantiomers of 254 give two diastereoisomers of 255. 
 
The (R)-stereochemistry of C-2 was assumed due to the well known stereochemical 
outcome of the Noyori reduction of a number of closely structurally related !-keto 
esters.114, 116 
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4.3.8 !-Hydroxy acid synthesis 
The final steps to produce allow the DE core unit suitable for coupling to the ABC 
precursor involved protecting the alcohol and hydrolysing the ester to reveal the 
carboxylic acid. These proceeded smoothly, yielding the acid 267 as an inseparable 
1:1 mixture of diastereoisomers (Scheme 4.24). 
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Scheme 4.24 !-hydroxy acid synthesis. 
 
The !-hydroxy acid 267 produced was used to investigate conditions to couple the DE 
core unit to the ABC precursor. These investigations are described in detail in Chapter 
5. 
 
4.3.9 Stille coupling route 
The Sonogashira coupling was generally high yielding, but was remarkably 
capricious, with yields sometimes dropping to around 20%. For consistently high 
yields the solvents had to be dry and thoroughly degassed, the Pd(PPh3)4 fresh and the 
lithium chloride flame-dried immediately before use. It was hoped that by replacing 
the Sonogashira coupling with a Stille reaction, some of these problems could be 
removed. 
 
The Stille sequence would involve the treatment of the triflate 213 used previously, 
with the stannane 268 to give the diene 269. Although hydrostannylation usually 
affords a mixture of E/Z-alkene isomers this would not be problematic since the 
subsequent step would involve alkene hydrogenation (Scheme 4.25). 
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Scheme 4.25 Envisaged Stille route. 
 
The stannane 268 was synthesised in a single step from the alkyne 26 by treatment 
with tributyltinhydride and AIBN (Scheme 4.26). Only the E isomer (J = 19.0 Hz) 
was isolated. 
 
Bu3Sn
OH
OTBS
OH
OTBS
Bu3SnH, AIBN, PhMe, 
110 °C, 20 h
52%
26 268  
Scheme 4.26 Synthesis of stannane 268. 
 
The stannane 268 and triflate 213 were treated under conditions developed in the 
Taylor group117 to effect the Stille reaction to 269 in good yield (Scheme 4.27). Once 
again only the E-isomer was isolated (J = 15.5 Hz). The product was contaminated 
with a small quantity of tin residues. 
 
Bu3Sn
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OTBS
N
OTf
Boc
N
Boc
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NMP, rt, 21 h
86%
269213
268
 
Scheme 4.27 Stille reaction to give diene 269. 
 
The diene 269 was subjected to the reduction conditions of palladium on carbon, ethyl 
acetate, triethylamine and 1 atmosphere of hydrogen which had been successfully 
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applied to the enyne 27 in the Sonogashira route. Disappointingly these returned only 
the starting material. Increasing the catalyst loading gradually (from 10% weight to 
100% weight) resulted in no reaction, however on stirring for 24 h with 100% catalyst 
loading the over-reduced product 271 was obtained. 
 
It was also noted that the diene 269 was prone to elimination, losing water on 
standing in NMR solvents at room temperature to give the compound 272 (Figure 
4.9). 
N
Boc
OH
OH
N
Boc
OH
over reduction product 271 elimination product 272  
Figure 4.9 unwanted byproducts from 269. 
 
It was assumed that the tin residues present in the compound were poisoning the 
catalyst. Attempts to remove these by working the reaction up with base,118 aqueous 
potassium fluoride119 or potassium carbonate returned tin-contaminated material, as 
did triturating with pentane. Attempts to purify by chromatography on silica, alumina, 
and silica doped with potassium carbonate120 or potassium fluoride121 were 
unsuccessful, returning only the eliminated product 272. The use of palladium 
hydroxide as a catalyst returned only starting material, as did increasing the 
temperature at which the reduction was run. Diimide reduction (TsNH2NH2 and 
sodium acetate) gave a complex mixture of products.  
 
With the difficulty in reducing the double bond apparent this route was abandoned 
and the Sonogashira sequence (Scheme 4.14) returned to. 
 
4.3.10 Preparation of enantio-enriched (–)-253 and (+)-253 
The enantio-enriched alcohol 26 was synthesised according to the procedure 
described by Sulikowski.52 
 
Chapter 4 
 
 86 
O
O
OH
O
N
OMe
OTBS
O
N
OMe
OTBS
O OTBS
OH
Me3Al, 
MeONHMe.HCl
DCM, 0 °C, 3 h
TBSCl, Imid., DMF, 
rt, 2 h
MgBr
(R)-alpine borane, THF,
rt, 24 h
76%
 87% over 2 steps
71%
23
24 25
277
THF, 50 °C, 1 h (+)-26
(S)-alpine borane, THF,
rt, 24 h
OTBS
OH
222
(!)-26  
Scheme 4.28 Synthesis of enantio-enriched alcohols (+)-26 and (–)-26. 
 
Treatment of !-caprolactone 23 with N,O-dimethylhydroxylamine hydrochloride and 
trimethylaluminium gave the Weinreb amide 24. TBS-protection was achieved with 
TBSCl and imidazole, giving the protected alcohol 25. Treatment of this with 
ethynylmagnesium bromide generated the ketone 277. Asymmetric reduction of the 
ketone moiety with (R)-Alpine borane gave the alcohol (+)-26, and analogously 
treatment of the ketone 277 with (S)-Alpine borane under identical conditions gave 
the enantiomeric alcohol (–)-26 (Scheme 4.28).  
 
Synthesis of the benzoate ester of (+)-26, 278 allowed the e.r. of the chiral reduction 
to be determined by chiral HPLC* (Scheme 4.29).  
OTBS
OH
(+)-26
OTBS
O Ph
O
PhCOCl, Py, 
CH2Cl2, rt, 2 h
quant.
278  
Scheme 4.29 Derivatization for chiral HPLC. 
 
The benzoate ester 278 showed an e.r. of 93:7. This was slightly lower than that 
reported by Sulikowski who claimed 97:3 e.r. for the same reaction, but high enough 
to proceed with. 
 
Under identical conditions to those described for the racemic alcohol (Scheme 4.15) 
the chiral alcohols were coupled with the triflate 213, reduced and cyclised to give the 
two enantiomeric DE cores (+)-253 and (–)-253 (Scheme 4.29). These were further 
                                                
* Column: Chiralpak IA-3. Full details in experimental Chapter 6. Thanks to Andy Hard at 
AstraZeneca for running the sample. 
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elaborated via a Roskamp reaction to give the enantiomeric !-keto esters (+)-254 and 
(–)-254 (Scheme 4.31). 
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Scheme 4.30 Chiral DE cores. 
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Scheme 4.31 Synthesis of chiral !-keto esters. 
 
Each enantiomer of 254 was then treated separately under Genêt’s115 Noyori 
conditions to deliver the diastereoisomeric !-hydroxy esters 255a and 255b. Minimal 
purification of the Noyori reaction by filtering through a silica “plug” gave the best 
yields, with both products formed in quantitative yield (Scheme 4.32). 
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Scheme 4.32 Noyori reduction of both enantiomers of DE core unit. 
 
The diastereoisomeric !-hydroxy esters 255a and 255b were separately TBS-
protected and then the ethyl ester hydrolysed to deliver both the required DE 
containing acids 267a and 267b, ready for coupling to the ABC core unit (Scheme 
4.33). 
 
267a255a
267b
255b
N O
H
H
Boc OH O
OEt
N O
H
H
Boc OH O
OEt
N O
H
H
Boc TBSO O
OH
N O
H
H
Boc TBSO O
OH
i) TBSOTf, 2,6-lutidine,
CH2Cl2, 15 min
ii) NaOH, EtOH, H2O,
100 °C, 2 h
61% over 2 steps
i) TBSOTf, 2,6-lutidine,
CH2Cl2, 15 min
ii) NaOH, EtOH, H2O,
100 °C, 2 h
65% over 2 steps
 
Scheme 4.33 TBS protection and hydrolysis on chiral DE core units. 
 
4.3.11 Determination of diastereoselectivity of Noyori reduction 
The d.r. of the Noyori reductions was determined by chiral HPLC. A sample of the 
enantio-enriched Roskamp product (–)-254 was reduced with NaBH4, giving a 50:50 
mixture of diastereoisomers at the newly formed stereogenic centre. This was 
converted to its benzoate ester to give UV activity and became our comparative 
sample. The analogous chiral benzoate ester was formed on alcohol 255a (Scheme 
4.34). 
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Scheme 4.34 Synthesis of UV tagged HPLC samples. 
 
The three chiral centres in the DE core unit are all determined by the single chiral 
centre introduced by the Alpine borane reduction, meaning the reduction was 
performed on a 93:7 mixture of the two enantiomers (–)-254 and (+)-254 (Figure 
4.10). The Noyori reduction installs another stereocentre, leading, after ester 
formation, to the 4 possible diastereoisomers 280a, 280b, 280c, and 280d illustrated 
in Figure 4.10. For the sodium borohydride reduced (R,S)-280 we were expecting to 
see 4 peaks in an approximate ratio of 47:47:3:3 in the HPLC trace. Pleasingly this 
was the case, as illustrated in the trace depicted in Figure 4.11. 
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Figure 4.10 Possible diastereoisomers of 280. 
 
 
 
RT  Area Area% 
1.7 4483.3 45.2% 
2.6 882.1 8.9% 
3.1 544.9 5.5% 
3.7 4001.6 40.4% 
 
 
Figure 4.11 NaBH4 280 sample HPLC trace† 
 
The “chiral” sample (–)-280 was run under the same conditions, giving the trace 
illustrated in Figure 4.12. 
 
 
                                                
† Thanks to Andy Hard at AstraZeneca for running these samples. Column: Chiralpak IA-3, Full details 
in Experimental (Chapter 6). 
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Figure 4.12 (–)-280 HPLC trace. 
 
Peak integration gives a ratio of 92.5: 5.4: 2.1: 0.  An overlay of the racemic and 
chiral samples confirmed the peaks corresponded to the sample compounds (Figure 
4.13). 
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Figure 4.13 Overlay of racemic and chiral samples. 
 
The ratio of the major peaks should be the ratio of isomers observed in the Alpine 
borane reduction ! ratio from the Noyori reduction. As we know that the Alpine 
borane was 93:7 we have 0.93 ! x = 0.925 – thus x = 0.99, suggesting that the Noyori 
reduction gave a 99:1 e.r. Integration of the minor peaks suggests slightly different 
ratios, however it is assumed that the error on the minor peaks would be much greater. 
 
A benzoate ester was also formed from the diastereoisomeric Noyori reduction 
product 255b (Scheme 4.33). 
 
RT Area Area% 
2.0 41.2 2.2% 
2.9 100.3 5.4% 
3.4 None detected 
4.0 1723.5 92.4% 
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Scheme 4.33 Benzoate ester of 255b. 
 
This was subjected to the same HPLC conditions as (–)-280, giving the trace 
illustrated in Figure 4.14. The separation was not as clear as with the previous 
sample‡ but the ratio of peaks was 1.0:89.1:0:10. By the same method as previously 
this suggested that the Noyori was 96:4 e.r. This was not as good as that observed on 
the previous sample, but high enough to proceed with. 
 
 
 
 
Figure 4.14 HPLC trace of (–)-280.§ 
 
 
                                                
‡ Possibly due to sample degradation; the machine was busy and the sample left in solution at room 
temperature for ~ 10 weeks before the HPLC was recorded. 
§ Chiralpak IA-3. Full details in Experimental (Chapter 6). 
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4.4 Conclusions 
 
The synthesis of the original DE core unit developed by Jean was extended to 
enantio-enriched material (+)-217 and (–)-217, and optimisation attempted on the 
initial triflate formation step. The same route was applied to give an enantio-enriched 
synthesis of both enantiomers of the redeveloped DE core unit 267. A !-hydroxy acid 
moiety, which would allow coupling to the ABC core, was incorporated and the e.r. 
of both asymmetric steps was determined by chiral HPLC analysis. Attention then 
moved to the possible coupling strategies between the ABC and the DE core units as 
described in Chapter 5. 
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Chapter 5 – Results and discussion 4: Linking the ABC and DE core units 
 
5.1 Background  
 
5.1.1 Schmidt’s approach 
The ABC and DE core units need to be linked to form the macrocycle of ’upenamide 
by both a fully saturated chain and an all-trans triene chain. It was reasoned that the 
fully saturated chain would be harder to form, given the plethora of double bond 
forming reactions available for the unsaturated chain; attention was thus initially 
focussed on linking the ABC and DE core units through the saturated chain, giving a 
target molecule of the form 282 (Scheme 5.1). 
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Scheme 5.1 The structure of upenamide and initial retrosynthesis. 
 
Initial work by Schmidt60 focussed on forming the fully saturated chain via a Negishi 
coupling, such as that reported by Organ and co-workers to couple two sp3 hybridised 
alkyl centres.122 It was possible to perform a tandem oxidation-olefination to give the 
unsaturated ester (!)-283, however, reduction to the desired alcohol 284 was 
unsuccessful. Schmidt had hoped to elaborate this alcohol to the zinc species 285, 
then couple with the iodo-DE compound 286 (Scheme 5.2). 
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Scheme 5.2 Synthesis of alcohol 284 was not successful. 
 
Later work by Schmidt concentrated on performing a similar coupling via sulfone 
290, which was itself synthesised by converting alcohol (!)-172 into iodide (!)-288 
followed by a radical reaction in which the primary radical was trapped with phenyl 
vinyl sulfone (Scheme 5.3). Disappointingly, however, all attempts to perform the 
subsequent deprotonation and alkylation with the iodo-DE compound 286 were 
unsuccessful. 
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Scheme 5.3 Schmidt’s attempted sulfone route.60 
 
5.1.2 Jean’s approach 
Jean focussed on a similar approach to Schmidt’s sulfone strategy, employing instead 
the cyclic sulfone benzodithiole tetraoxide (BDT) 292. This was first reported by 
Kündig and co-workers123 who claimed that it offers higher reactivity in alkylation 
reactions than bis-sulfones. BDT was coupled with the ABC core unit (!)-172 via a 
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Mitsunobu reaction, affording sulfone 293 (Scheme 5.4), which was then alkylated 
with the iodo compound 294 (used as a model for the DE core unit). This marked the 
first successful coupling of the ABC core fragment through the fully saturated linker, 
albeit with a simplified model DE core unit. Jean failed to remove the BDT moiety in 
reasonable yield at this stage but hoped to do so later, and therefore continued with 
the synthesis on this model system. 
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Scheme 5.4 Jean’s ABC-DE model linked through saturated chain. 
 
After protecting group manipulation, Dess–Martin oxidation and Takai olefination 
delivered the vinyl iodide 298. Jean then removed the Boc group by treating with 
acetyl chloride in methanol to reveal the free amine of the model DE system 299 
(Scheme 5.5). 
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Scheme 5.5 Jean’s later stages 
 
Allylation of the amine 299 with bromo-stannane 300 gave the Stille cyclisation 
precursor 301. Treatment with Pd2(dba)3 and triphenylarsine generated a small 
quantity of the macrocycle 302, observable only by mass spectrometry (Scheme 5.6). 
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Scheme 5.6 Jean’s ring-closing approach. 
5.2 Results 
 
At this point Dr W. Unsworth joined the project and a new strategy involving pre-
forming the saturated chain was examined. The work described below was carried out 
in partnership with Unsworth, with due credit being given. 
 
5.2.1 Amino alcohol coupling partner 
Given the problems encountered by Schmidt and Jean forming the fully saturated 
linking chain, and in particular concerns about the cleavage of the sulfone auxiliary, 
an alternative method for its installation was sought. Instead of assembling the 
saturated chain at a latter stage of the synthesis it was decided to incorporate the 
saturated chain into the DE core unit. It was hoped that the coupling of a suitable 
extended DE-containing substrate (e.g. 267) to a precursor of the ABC core unit 
would give an intermediate amide, and following the previously described 
oxidation/cyclisation methodology, give the ABC and DE core units linked through 
the fully saturated chain (Scheme 5.7). Furthermore, with the problems encountered 
installing the allylic oxygen on the fully formed ABC core unit system in mind 
(Chapter 3), it was hoped to synthesise an ABC precursor already containing the 
required allylic oxygen. A route to the benzyl-protected amino alcohol 199 (Figure 
5.1), described in Chapter 3, which was an intermediate on the shortened ABC 
synthesis, had already been developed. Thus, an oxygenated version of this, ideally 
containing a more advanced handle in place of the benzyl-protected alcohol to allow 
elaboration to the triene chain, was the target. With the Boc-protected acid 267 in 
hand (Chapter 4), this made the ABC precursor 303 (Figure 5.1) the next target. 
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Figure 5.1 Proposed ABC precursor for coupling. 
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Scheme 5.7 Proposed early installation of the saturated chain. 
 
In order to test this methodology a deoxy-version of the desired amino alcohol 303, 
excluding the allylic oxygen present in the natural product, was synthesised by 
Unsworth with an unsaturated ester in place of the benzyl-protected alcohol. This 
modification was made in the hope that it would eventually allow elaboration to the 
triene chain more easily and avoid synthetic problems differentiating between the two 
similar alcohols present. 
 
To produce the deoxy-amino alcohol coupling partner 313 Unsworth began with the 
synthesis of the lactam (+)-187 (Scheme 5.8). This was originally isolated as an 
undesired side product resulting from the cyclisation of amino ester (+)-178 during 
studies into the ABC synthesis. It was possible to promote this cyclisation by treating 
amino ester (+)-178 with aqueous potassium carbonate. The procedure could be 
simplified by telescoping the alkylation, reduction and cyclisation reactions, without 
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purification at any step. This resulted in similar yields (66% over 3 steps). It was 
possible to purify the amine (+)-178 by ion exchange chromatography before the 
cyclisation. If this was not undertaken the material was contaminated with a trace of 
triphenylphosphine oxide. This, however, made no difference to the later steps, and 
so, aside from for characterisation purposes, no purification was undertaken. 
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Scheme 5.8 Unsworth’s lactam synthesis. 
 
To reduce the lactam to the desired amino alcohol, an activating group was needed on 
the nitrogen, and so a Boc group was installed by treatment with n-butyllithium and 
di-tert-butyl dicarbonate (Scheme 5.9). This facilitated reductive ring-opening with 
sodium borohydride, delivering the benzyl-protected compound 307. Treatment of 
this compound with lithium naphthalide in THF allowed cleavage of the benzyl group 
without reduction of the double bond, such as would be observed if hydrogenation 
had been employed to cleave the benzyl group.124 
 
(+)-187
NH
OBn
O
NBoc
OBn
O
n-BuLi, Boc2O,
THF, !78 °C - rt, 1 h
56%
BocHN
OBn
OH
NaBH4, EtOH,
0 °C - rt, 18 h
64%
Li, naphthalene,
THF, !20 °C, 5 min
80%
BocHN
OH
OH
306 307
308  
Scheme 5.9 Unsworth’s synthesis of amino alcohol coupling partner 308. 
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Unsworth found it very difficult to differentiate between the newly revealed alcohol 
and the primary alcohol present in 308 (e.g. TBSCl gave statistical mixtures). IBX 
oxidation gave some selectivity, preferentially oxidising the desired alcohol, albeit to 
a small degree, delivering the lactols 309 and 310 in a 2:1 ratio (Scheme 5.10). These 
could be separated by column chromatography, the undesired lactol reduced to 
recover 308, while the desired isomer 310 was reacted in a Wittig reaction with the 
stabilised ylide 311 to install the unsaturated ester with complete E selectivity. 
Cleavage of the Boc group with TFA revealed the required amine 313. 
BocHN
OH
OH
IBX, DMSO,
50  °C, 2 h
BocHN
OH
O
BocN
Ph3P CO2Et
51%
O
HO
BocHN
OH
CO2Et
TFA, CH2Cl2,
0 °C - rt, 10 min
H2N
OH
CO2Et
.TFA
311, CH2Cl2, AcOH,
75%
quant.
NaBH4, MeOH, rt, 1 h, quant.
312
313
309
310308
311
 
Scheme 5.10 Unsworth’s synthesis of amino alcohol 313. 
 
Unsworth carried out initial coupling studies with a 1:1 mixture of the two 
diastereoisomers 267a and 267b (Figure 5.2). The chiral centre at C-2 would become 
part of the ABC core unit (of which the absolute stereochemistry was known) and was 
introduced using a Noyori reduction (see Chapter 4). This material was more readily 
accessible than the enantio-enriched version described in Chapter 4, which was 
retained for use later, after this coupling strategy was more fully explored. 
 
267a 267b
N O
H
H
Boc TBSO O
OH
N O
H
H
Boc TBSO O
OH
22
 
Figure 5.2 The two diastereoisomers of acid 267 coupled. 
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Unsworth successfully coupled amino alcohol 313 with acid 267 to deliver the amide 
315 in good yield on treatment with HATU. The Ley–Griffith oxidation step also 
worked, albeit in a poor yield of 36%. However, in the key step this material cyclised 
on treatment with SnCl2!2H2O to give the deoxy-ABC and DE core units joined 
through the fully saturated chain (Scheme 5.11). Disappointingly, all attempts to 
reduce the unsaturated ester returned only starting material. 
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2R, 27S*, 30R*, 32R*-317
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2R, 27S*, 30R*, 32R*-318
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Scheme 5.11 ABC and DE core units linked through saturated chain, giving two diastereoisomers of 
318. 
 
Despite the difficulties encountered in reducing the unsaturated ester, this was an 
excellent result, representing the first coupling of the deoxy-ABC core unit with the 
fully formed DE core unit. With this hugely encouraging result in hand, attention was 
now turned to the synthesis of the C-11 oxygenated system, which it was hoped 
would ultimately lead to the total synthesis of the natural product. 
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5.2.2 Oxygenated amino alcohol system 
Attempts to synthesise the C-11 oxygenated variant of the amino alcohol 313 began 
with the attempted allylic oxidation of the lactam (+)-187. Compound (+)-187 was a 
very different molecule to the fully formed ABC core unit (–)-203 on which Schmidt 
had originally developed the selenium dioxide mediated allylic oxidation (Scheme 
5.12), but shared the spirocylic, bicyclic BC core unit in common with this molecule. 
It was hoped they would be similar enough to allow the regioselective oxidation 
observed by Schmidt to occur.  
 
OBn
N
O
O OTIPS
OBn
N
O
O OTIPSHO
SeO2, EtOH, H2O
80 °C, 17 h
55%
(!)-173(!)-203  
Scheme 5.12 Schmidt’s SeO2 oxidation on the ABC core unit (–)-203. 
 
We were delighted to observe this was the case, and compound (+)-187 was oxidised 
by selenium dioxide (Scheme 5.13), giving a single isomer of product. X-Ray 
crystallography (Figure 5.3) confirmed the product of allylic oxidation on lactam (+)-
187 to be the correct regioisomer, but the undesired stereoisomer, mirroring the result 
obtained by Schmidt on oxidation of the ABC core unit. 
 
 
(+)-319(+)-187
NH
OBn
O
SeO2, EtOH, H2O, 
reflux, 3 days,
52%
NH
OBn
OHO
 
Scheme 5.13 Allylic oxidation on lactam (+)-187. 
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Figure 5.3 X-Ray structure of (+)-319. 
 
With the oxygenated lactam (+)-319 in hand, attention turned to inversion of the 
alcohol centre. Schmidt54 achieved this on the fully formed ABC core unit by 
oxidation to the enone, followed by a Luche reduction. Oxidation of (+)-319 with 
manganese dioxide gave the desired enone 320 and we were delighted to find Luche 
reduction of this material was successful, giving a 10:1 mixture of the desired product 
321 to the undesired isomer (+)-319 (Scheme 5.14). These were easily separated 
following TIPS protection of the alcohol; the desired product reacted to give the 
protected (!)-322, while (+)-319 was inert under these conditions and was returned 
unprotected. Thus, following purification by column chromatography, the synthesis of 
the desired protected oxygenated lactam (!)-322 was complete. 
 
(!)-322
(+)-319
NH
OBn
OHO
NH
OBn
OO
NH
OBn
OTIPSO
MnO2, 4 Å MS,
PhMe, reflux, 18 h NaBH4, CeCl3"7H2O, MeOH, !78 °C, 30 min
NH
OBn
OHO
TIPSOTf, 2,6-lutidine,
CH2Cl2, rt, 1 h
55% over 3 steps
+ 14% (+)-319 (64% BRSM)
321
320
 
Scheme 5.14 Synthesis of oxygenated lactam. 
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Unsworth later modified the selenium dioxide oxidation conditions; solvent screening 
revealed that by changing the solvent to dioxane, the yield could be increased and 
reaction time reduced (Scheme 5.15). 
(+)-319(+)-187
NH
OBn
O
NH
OBn
OHO
SeO2, 95% dioxane,
H2O, reflux, 18 h
64%
 
Scheme 5.15 Unsworth’s modified oxidation conditions 
 
A slight change to the to the previous route was made, with the benzyl protecting 
group cleaved at this stage to give alcohol (!)-323. The alcohol revealed was oxidised 
to aldehyde (!)-324 and protected as the acetal 326 rather than the unsaturated ester 
used previously (Scheme 5.16). This would change the triene disconnection, but this 
approach had the added bonus that the acetal protecting group should be deprotected 
in the SnCl2"2H2O mediated cyclisation step to reveal the aldehyde.  
326
NH
OBn
OTIPSO
NH
OH
OTIPSO
NH
OTIPSO
Li, naphthalene,
THF, !20 °C, 5 min
57%
O
O
(!)-322 (!)-323
NH
O
OTIPSO
(!)-324
TPAP, NMO, 
4Å MS, CH2Cl2
 rt, 
81%
HO
OH
325, PPTS, PhH,
reflux, 4 h
83%
325
 
Scheme 5.16 Acetal synthesis. Carried out by Unsworth. 
 
In an analogous manner to the deoxy-(+)-187, it was possible to protect the lactam 
nitrogen with using di-tert-butyl dicarbonate, to give the imide 327. Disappointingly, 
all attempts to ring-open this to give the desired amino alcohol 328, e.g. using 
SuperHydride, or lithium aluminium hydride, gave a mixture of products, primarily 
the lactam 326 resulting from Boc cleavage. Diisobutylaluminium hydride returned 
only starting material. The change in preference from lactam carbonyl reduction in the 
deoxy-system to Boc cleavage in the oxygenated system is most likely to be explained 
by steric hindrance. The bulky TIPS group is in close proximity to the lactam 
carbonyl and presumably prevents approach of the reducing agent.  
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328
NH
OTIPSO O
O n-BuLi, Boc2O, THF, !78 °C - rt
1 h
51%
X
NBoc
OTIPSO O
O
NHBoc
OH
TIPSO O
O
326
327
reduction  
Scheme 5.17 attempted ring opening. 
 
Making an oxygenated version of the amino alcohol coupling partner seemed to be 
difficult, presumably due to steric hindrance caused by the bulky TIPS protecting 
group, located close to the carbonyl centre. Attention turned to a different coupling 
strategy. 
 
5.2.3 Imine coupling partner 
Given the problems reducing lactam 327 further studies were undertaken by 
Unsworth using deoxy-model compound 330. In this case reduction was much easier, 
presumably due to the decreased steric hindrance, with deoxy-330 affording the hemi-
aminal 331. It was then hoped to remove the Boc protecting group, prior to coupling 
with a suitable carboxylic acid derivative, but, on Boc cleavage with TFA, the 
compound eliminated water to give the imine 332 (Scheme 5.18). 
 
NBoc
O
O
O
SuperHydride, 
THF, !78 °C, 30 min
NBoc
OH
O
O
TFA, CH2Cl2
0 °C, 1 h
N
O
O
62%
over 2 steps
NH
OH2
O
O
330
331 332
 
Scheme 5.18 Imine formation. 
 
Imine 332 was surprisingly stable, and this led to the idea of using it as a coupling 
partner, by coupling with DE intermediate 267 to form an intermediate N-acyl 
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iminium species 333, which following treatment with SnCl2!2H2O, should deliver the 
ABC core unit 334 (Scheme 5.19).  
H
H
N
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O
via N-acyl iminium ion 333
NO
HO
O OTBS Boc
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O
N
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334
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H
H
H
H
i) 267, coupling reagent
ii) SnCl2!H2O
 
Scheme 5.19 Proposed imine coupling partner. 
 
Pleasingly, Unsworth found the imine coupling proceeded as envisaged; treatment of 
imine 332 and acid 267 with the peptide coupling reagent T3P,125then stirring with 
SnCl2!2H2O gave the desired ABC-DE system 334. As expected, concomitant acetal 
cleavage also took place to reveal the aldehyde (Scheme 5.20).  
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i) 267, T3P, DIPEA, THF, rt, 18 h
Boc
ii) SnCl2!2H2O, CH2Cl2, rt, 1 h
32%
H
H
H
H
332
2R,27S*,30R*,32R*-267
2R,27S*,30R*,32R*-334
2
2
 
Scheme 5.20 Imine coupling. Carried out by Unsworth. 
 
Unsworth next converted the aldehyde into 334 vinyl iodide 335 using a Takai 
olefination. The DE core unit is not stable to acidic conditions, and so the Boc group 
was removed by a basic method as used by Sulikowski; treatment of the Boc-
carbamate with TBSOTf generates the corresponding TBS-carbamate, which is then 
cleaved with TBAF, revealing the amine 336 (Scheme 5.21). 
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Scheme 5.21 Takai olefination and Boc deprotection. Carried out by Unsworth. 
 
Jean59 showed the bromide 300 to be unstable, and so in the current strategy 300 was 
prepared in situ from the alcohol 337 and used directly without workup (Scheme 
5.22). The ABC-DE compound 336 was treated with this unpurified reaction mixture 
and DIPEA, generating a small quantity of the desired allylated product 338. 
Disappointingly, the major product was the quaternary ammonium salt 339. It was 
hoped that, in future, this problem would be removed by using only one equivalent of 
the bromide 300, rather than the two equivalents employed in this instance. 
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 Scheme 5.22 Allylation studies. Carried out by Unsworth. 
 
Despite the small quantity of 338 isolated it was still possible for Unsworth to 
perform the desired Stille ring closing by treatment of iodo-stannane 338 with 
Pd(PPh3)4 in THF. The scale was so small that it was possible to analyse this reaction 
only by mass spectrometry, but this appeared to indicate that “deoxy-’upenamide” 
340 was successfully formed (Scheme 5.23). 
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Scheme 5.23 Ring closure giving deoxy-’upenamide. Carried out by Unsworth. 
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5.2.4 Oxygenated imine system 
Following this hugely promising result, attention was turned to the synthesis of the 
oxygenated form of the imine coupling partner 332. It was hoped to use a more 
advanced handle to allow the construction of the triene chain chain, replacing the 
acetal used in the deoxy-version, and thus limiting the number of steps the sensitive 
DE core unit was exposed to. A test reaction (Scheme 5.24) suggested the possibility 
of using a vinyl iodide as this coupling partner, as vinyl iodide 342 was stable to the 
SnCl2!2H2O mediated ‘A’ ring forming cyclisation conditions. 
 
342
NH
O
I
SnCl2!2H2O (5 eq.)
CH2Cl2, rt, 3 h
NO REACTION
 
Scheme 5.24 Vinyl iodide stable to cyclisation conditions. Carried out by Unsworth. 
 
Vinyl iodide containing imine 345 was synthesised starting from the alcohol (")-323 
(synthesis described in Scheme 5.16). This was oxidised to the aldehyde (")-324 via a 
Ley–Griffith oxidation followed by a Takai olefination to deliver the vinyl iodide (")-
343 (Scheme 5.25). Imidate formation with Meerwein's salt delivered the imidate (")-
344 and then careful partial reduction with sodium borohydride gave the desired 
imine (+)-345. 
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Scheme 5.25 Synthesis of vinyl iodide imine. 
 
This imine was to be coupled with acid 267 in a similar way to the coupling of deoxy-
332. As mentioned earlier, only the relative stereochemistry of the DE core unit was 
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elucidated by Jiménez et al.1 and thus both possible DE core units 267a and 267b 
were synthesised as described in Chapter 4. This enantio-enriched (e.r. 93:7) material 
was now used – giving two series of compounds. These were labelled R and S, with 
R derived from the (R)-alcohol 250 and S from the (S)-250 (Scheme 5.26). According 
to Jiménez’s assignment, one of these should result in ’upenamide. 
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267b
N O
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(+)-250
OTBS
OH
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Scheme 5.26 DE core units. 
 
5.2.5 R Series 
We were delighted to observe that the oxygenated imine compound (+)-345 reacted 
very similarly to the deoxy-model system. Treatment with T3P and DIPEA promoted 
the coupling of (+)-345 and acid 267a, which was followed by cyclisation with 
SnCl2!2H2O, delivering the desired coupled compound 346R (Scheme 5.27). 
346R
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N O
H
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H
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ii) SnCl2!2H2O, CH2Cl2, rt, 1 h
40%
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Scheme 5.27 Series R coupling. 
 
In the key SnCl2.2H2O cyclisation step the ABC-DE couple 346R was formed in a  
>10:1 mixture of diastereoisomers with the major diastereoisomer isolable cleanly 
following column chromatography. It was assumed that the major diastereoisomer 
was as drawn, with the hemiaminal proton H-10 syn to H-2. This assumption was 
based on the work by Reid126 and Schmidt60 who showed that the reaction conditions 
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promote equilibrium of this stereocentre, and that the isomer shown is 
thermodynamically stable in model systems. 
 
The Boc protecting group was removed under the basic conditions described 
previously, by forming the TBS carbamate and cleaving with TBAF (Scheme 5.28). 
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Scheme 5.28 Boc deprotection of 346R. 
 
Allylation of the deprotected 347R was successful under the previously described 
conditions, making one equivalent of the bromide 300 in situ and treating with 
DIPEA. These conditions delivered the desired Stille cyclisation precursor 348R 
(Scheme 5.29), with none of the undesired quaternary ammonium salt observed 
previously being isolated. Compound 348R showed notable destannylation on 
storage, and so was used immediately without purification in the key ring-closing 
Stille reaction to deliver the TIPS-protected compound 349R. Disappointingly, all 
attempts to remove the TIPS group were unsuccessful. TBAF returned the TIPS-
protected 349R, and treatment with HF!pyridine resulted in degradation, with only 
TIPS residues recovered. Despite this setback, this was a very exciting result, 
representing the first union of the fully formed ABC and DE core units in the 
macrocycle of ’upenamide. 
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Scheme 5.29 Allyation and Stille on TIPS-protected R series. No yields reported as on a very small 
scale. Carried out by Unsworth. 
 
It was assumed that the difficulties encountered attempting to remove the TIPS 
protecting group were due to steric hinderance in the cyclised material, and it was 
hoped it would be possible to remove it at an earlier stage. We were gratified to find 
that this was readily achieved by treating the amine 347R obtained after hydrolysis of 
the Boc group with TBAF, giving the very polar amino alcohol 351R (Scheme 5.30). 
 
TBAF, THF, 1 h, rt,
quant.
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Scheme 5.30 Early TIPS deprotection. Carried out by Unsworth. 
 
Pleasingly, amino alcohol 351R was successfully N-alkylated with bromide 300 under 
the conditions described previously, delivering the stannane 352R. In the key Stille 
reaction the material was cyclised, to deliver the desired ‘R’ isomer of ‘upenamide 
(Scheme 5.31).  
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Scheme 5.31 The ‘R’ isomer of ‘upenamide. Carried out by Unsworth. 
 
The product isolated from the Stille reaction was a white film, which was insoluble in 
CD3OD. This was surprising, as the isolated natural product was described with NMR 
data collected in deuterated methanol. The 1H NMR spectrum of the product in CDCl3 
(Figure 5.4) contained the expected signals with the distinctive doublet and doublet of 
doublet vinyl iodide 1H signals at !H ~ 7.2 and 5.9 no longer present, and new alkene 
peaks present as a multiplet between 6.3 and 5.8. However the spectrum appeared 
quite different from the data described for ‘upenamide by Jiménez (Figure 5.5), 
especially in the alkene region. It was possible this was a solvent effect, as NMR data 
in different solvents can vary considerably. The unexpected CD3OD insolubility of 
the material isolated, combined with the inconclusive NMR data, led to the 
assumption that the DE stereochemistry was wrong: that the DE core unit resulting 
from the S-series would result in the total synthesis. Attention was thus turned to this 
compound. 
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Figure 5.4 1H NMR spectrum (400 MHz, CDCl3) of 350R. 
 
 
Figure 5.5 Reported 1H NMR spectrum of ’upenamide.1 
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5.2.6 S Series  
Coupling the imine (+)-345 with the S-isomer of carboxylic 267b and treating with 
SnCl2!2H2O to cyclise gave the ABC-DE compound 346S. The Boc group was 
removed under the basic conditions described for the R-series delivering the amine 
347S, which was then treated with TBAF to cleave the TIPS protecting group and 
give the amino alcohol 351S (Scheme 5.32). 
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Scheme 5.32 S-series coupling and Boc deprotection. 
 
Amino alcohol 351S was then allylated with bromide 300 and the Stille cyclisation 
performed in an identical fashion to R-series (Scheme 5.33), delivering 350S the 
reported structure S diastereoisomer of ’upenamide. 
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Scheme 5.33 S series cyclisation. Carried out by Unsworth. 
 
Once again, all of the data collected suggested the desired cyclised product 350S was 
formed, but the 1H and 13C-NMR data did not match those reported by Jiménez and 
co-workers for the natural product. In this series, the product was soluble in CD3OD, 
allowing direct comparison of the NMR data. The 1H NMR spectrum is illustrated in 
Figure 5.6. The vinylic region (insert in Figure 5.6) is again particularly different to 
that of the natural product (Figure 5.7). 
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Figure 5.6 1H NMR Spectrum of 350S (400 MHz, CD3OD). 
 
 
Figure 5.7 Vinylic region of isolated material.1 
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Disappointingly, neither 350R or 350S matched the literature data for ’upenamide 
described by Jiménez et al.1 Investigations are ongoing to confirm the structure of 
both 350R and 350S and to confirm where the differences lie. Attempts to obtain 
crystallographic data for 350R and 350S are in progress, as this would definitively 
confirm the structure of the molecules synthesised. 
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5.3 Conclusions 
 
This Thesis describes a shortened route to the ABC core unit of ’upenamide (!)-67 in 
15 steps from the commercially available meso-anhydride 164, a new route to both 
enantiomers of the DE core unit 217 from piperidone 212. The chemistry developed 
to synthesise 217 was then applied to the synthesis of both enantiomers of the DE 
core unit incorporating the fully saturated linking chain and a "-hydroxy ester 267 
moiety for coupling studies.  
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Scheme 5.34 Shortened synthesis of ABC core (!)-67. 
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Scheme 5.35 Synthesis of both enantiomers of 217. 
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Scheme 5.36 Synthesis of DE core 267 incorporating linker chain. 
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The final Chapter details attempts to join the ABC and DE core units via a novel 
tandem acyl iminium formation/SnCl2!2H2O mediated cyclisation, which successfully 
gave the ABC and DE units linked through the fully saturated chain. Further studies 
produced both of the reported possible structures of ’upenamide 350R and 350S, and 
attempts to confirm if either are the natural product are under way. The route 
described comprises a 19 step synthesis of the bicyclic BC ring-containing 267 from 
anhydride 164, a 9 step synthesis of the bicyclic DE ring-containing (+)-345 from 
piperidinone 212, and a further 6 steps to couple the fragments and complete the 
synthesis. This represents in total a longest linear sequence of 25 steps. 
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Scheme 5.37 Current route to the reported structure of ’upenamide. 
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5.4 Future work 
 
The priority is to confirm the structure of the compounds 350R and 350S, ideally by 
X-ray crystallography. A thorough examination of the published isolation data has 
revealed no obvious weaknesses in the original structural assignment of ’upenamide. 
The isolation group have been contacted, however no sample of the natural product 
remains; but it is hoped we will be able to access the original data. Hopefully this, 
combined with the confirmed structure of the material synthesised, will allow us to 
understand the differences, and see where the discrepancies lie. If the incorrect 
structures have been prepared, then modifications of the route developed to allow 
access to the correct material will be sought. If the reported structure turns out to be 
incorrect, then a rethink will be required, but again, perhaps modification of the 
ssynthetic route described here would allow access to the correct structure of 
’upenamide. These studies are ongoing in the group. 
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Chapter 6 – Experimental  
 
Diethyl ether (Et2O) was dried using an MBraun MPS solvent purification system. 
Anhydrous tetrahydrofuran (THF) was obtained by distillation over sodium 
benzophenone. Methanol (MeOH) was distilled from magnesium.127 Petroleum ether 
(PE) refers to light petroleum ether, b.p. 40–60 oC. All reagents were used as supplied 
by the manufacturers, unless otherwise stated. Stannous chloride dihydrate was 
purchased from Aldrich (Cat No. 20803-5) and was used without further purification. 
Column chromatography was performed using Fluka silica gel 60 at a low positive 
pressure. Analytical thin layer chromatography was performed on aluminium sheets 
pre-coated with Merck silica gel 60 F254, and visualised with ultraviolet light (254 
nm), aqueous potassium permanganate or alcoholic vanillin solutions, as appropriate. 
Preparative TLC was performed on Whatman Partasil K6F pre-coated 60 Silica Gel 
Glass plates, and visualised with ultraviolet light (254 nm). 
SCX refers to the use of prepacked Varian BondElut SCX colums (1 g, 20 g). All 
melting points were taken on a Gallenkamp apparatus. Proton magnetic resonance (1H 
NMR) spectra were recorded at 400 MHz on a JEOL ECX 400 spectrometer or a 
JEOL ESC 400 spectrometer, or at 270 MHz on a JEOL ECX 270 spectrometer and 
are reported as follows: chemical shift ! (ppm) (number of protons, multiplicity, 
coupling constant J (Hz), assignment). The coupling constants are quoted to the 
nearest 0.5 Hz (s = singlet, d = doublet, t = triplet, q = quartet, quin. = quintet, m = 
multiplet, br = broad, app = apparent) and are reported as measured splittings on each 
individual resonance. The residual protic solvent CHCl3 (!H = 7.26 ppm) was used as 
an internal reference. 13C NMR spectra were recorded at 100 MHz on a JEOL ECX 
400 spectrometer or at 125 MHz on a Bruker AV500 spectrometer. The central 
reference of CDCl3 (!C = 77.0 ppm, t) was used as an internal reference. 19F NMR 
spectra were recorded at 254 MHz on a JEOL ECX 400 spectrometer. Chemical shifts 
are reported in parts per million (ppm) to the nearest 0.01 ppm for 1H and the nearest 
0.1 ppm for 13C and 19F. Infrared spectra were carried out on a ThermoNicolet IR100 
spectrometer and are recorded as a thin film between NaCl disks. Absorption maxima 
are reported in wavenumbers (cm-1) and only selected absorbances are reported. Mass 
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spectra and accurate mass measurements were recorded on a Micromass Autospec 
spectrometer.  
Microwave irradiation refers to the use of a CEM ‘Discovery’ reactor, with reactions 
contained in 10 mL CEM tubes with Intellivent! caps. 
 
All numbering of the structures below is for characterisation and does not conform to 
IUPAC rules. 
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6.1 Methodology compounds 
 
3-[1,3]Dioxolan-2-ylpropionitrile (98) 
O
O
CN
1
2
3
4
5
 
 
Prepared according to the procedure described by Shimizu and co-workers.65  
To a stirred solution of sodium cyanide (1.20 g, 30.6 mmol) and 
benzyltriethylammonium chloride (570 mg, 2.55 mmol) in water (10 mL) was added 
2-(2-bromoethyl)-1,3-dioxolane (3.00 mL, 25.5 mmol) maintaining a temperature of 
20 oC with a water bath. The resulting emulsion was heated to 90 oC for 4 h then 
cooled, diluted with water (10 mL) and extracted with Et2O (4 x 10 mL). The organic 
extracts were combined, washed with brine (20 mL) and dried over MgSO4. The 
volatiles were removed under reduced pressure to yield the crude nitrile 98 which was 
purified by column chromatography. Eluting with 1:1 PE:Et2O gave the title 
compound 98 as a clear colourless oil (2.01 g, 62%); Rf 0.20 (1:1 PE:Et2O); !H (400 
MHz, CDCl3) 4.96 (1H, t, J 4.0, H-3), 3.98–3.94 (2H, m, H-1/H-2), 3.88–3.83 (2H, 
m, H-1/H-2), 2.44 (2H, t, J 7.5, H-5), 2.01 (2H, td, J 7.5, 4.0, H-4).  
1H NMR data consistent with literature.65 
KAG/1/9 
 
 
3-[1,3]Dioxolan-2-ylpropylamine (94) 
O
O
1
2
3
4
5
NH2
6  
 
Prepared according to the procedure described by Shimizu and co-workers.65  
To a stirred slurry of LiAlH4 (900 mg, 23.6 mmol) in Et2O (40 mL) under a stream of 
nitrogen was added nitrile 98 (2.00 g, 15.7 mmol) in Et2O (30 mL) at such a rate as to 
maintain a gentle reflux. The reaction mixture was heated to reflux for 12 h and then 
cooled and quenched by the careful addition of a mixture of Celite and Na2SO4"10H2O 
(1:1) until the evolution of gas was complete (~ 5 g). The reaction was filtered, the 
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solids washed with Et2O (3 x 20 mL) and the volatiles removed from the filtrate under 
reduced pressure to yield the title compound 94 as a colourless oil (1.80 g, 88%) 
which was used without further purification; IR !max (neat) 3627, 2930, 2868, 1602, 
1408, 1139, 1036, 944; "H (400 MHz, CDCl3) 4.78 (1H, t, J 4.5, H-3), 3.89–3.86 (2H, 
m, H-1/H-2), 3.78–3.74 (2H, m, H-1/H-2), 2.64 (2H, t, J 7.0, H-6), 1.64–1.44 (6H, m, 
H-4, H-5, NH2); "C (100 MHz, CDCl3) 104.4 (C-3), 64.8 (C-1, C-2), 42.0 (C-6), 31.1 
(C-4), 28.1 (C-5); m/z (ESI) 132 (100), [MH]+; [HRMS (ESI) calcd. for C6H14NO2, 
132.1019. Found: [MH]+ 132.1025. (4.4 ppm error)]. 
1H NMR data consistent with literature.65 
KAG/1/8  
This reaction can also be performed in THF, using either LiAlH4 solid, or as a 
solution in THF (commercially available), in comparable yields. 
KAG/1/12, KAG/1/38 
 
 
tert-Butyldimethylsilyl 2-(tert-butyldimethylsilyloxy)-3-methylbenzoate (109) 
O
O
O
1
2
3
4
5
6
Si
Si
7
 
 
To a stirred solution of 3-methylsalicylic acid (500 mg, 3.28 mmol) and N,N-
diisopropylethylamine (1.26 mL, 7.22 mmol) at 0 °C was added tert-butyldimethyl 
silyl chloride (1.14 g, 7.54 mmol) portionwise. The reaction was warmed to rt and 
stirred for 5 hours under an atmosphere of argon, then partitioned between CH2Cl2 
(75 mL) and water (75 mL), the organic layer was sequentially washed with water (3 
x 100 mL), aqueous CuSO4 (sat., 100 mL) and water (100 mL). The organic layer was 
dried over MgSO4 and volatiles were removed under reduced pressure to yield the 
crude 109 which was purified by column chromatography. Eluting with 9:1 PE:Et2O 
gave the title compound 109 as a yellow oil (1.19 g, 96%); Rf 0.90 (1:1 PE:Et2O); "H 
(400 MHz, CDCl3) 7.56–7.53 (1H, m, H-3), 7.25 (1H, dd, J 7.5, 2.0, H-5), 6.87 (1H, 
dd, J 7.5, 7.4 H-4), 2.23 (3H, s, CH3), 1.02 (9H, s, H-1), 0.99 (9H, s, H-7), 0.35 (6H, 
s, H-2), 0.11 (6H, s, H-6). 
1H NMR data consistent with literature.128 
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KAG/1/21 
 
 
2-(tert-Butyldimethylsilyloxy)-3-methylbenzoic acid (107) 
OH
O
O
1
2
3
4
5
Si
 
 
To a stirred solution of tert-butyldimethylsilyl 2-(tert-butyldimethylsilyloxy)-3-
methylbenzoate 109 (200 mg, 0.526 mmol) in THF (10 mL) at 0 °C under an 
atmosphere of argon was added slowly TBAF (1 M in THF, 0.53 mL, 0.526 mmol). 
The reaction was stirred at rt for 10 minutes, then partitioned between water (10 mL) 
and CH2Cl2 (10 mL). The organic layer was washed with water (10 mL), then dried 
over MgSO4 and volatiles removed under reduced pressure to yield the title 
compound 107 as a colourless solid (91 mg, 65%) which was used without further 
purification; Rf 0.88 (1:1 PE:Et2O); !H (400 MHz, CDCl3) 7.75 (1H, d, J 7.5, H-1), 
7.36 (1H, d, J 7.5, H-3), 6.82 (1H, app t, J 7.5, H-2), 2.27 (3H, s, CH3), 0.91 (9H, s, 
H-5), 0.10 (6H, s, H-4). 
The compound decomposed to the unprotected phenol on storage (even at low 
temperature), and no further characterisation was obtained. 
KAG/1/25 
 
 
Methyl 2-hydroxy-3-methylbenzoate (110) 
O
O
OH
1
2
3
4
5  
 
To a stirred solution of 3-methyl salicylic acid (500 mg, 3.29 mmol) 95 in MeOH 
(10 mL) was added conc. H2SO4 (1 mL), and the reaction heated to reflux for 19 h. 
The reaction was cooled to 0 °C and solid K2CO3 added portionwise until the pH of 
the reaction was ~ 6. The solvent was then removed under reduced pressure and the 
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resulting solid partitioned between water (25 mL) and CH2Cl2 (25 mL). The organic 
layer was dried over MgSO4 and the volatiles removed under reduced pressure to 
yield the title compound 110 as a colourless oil (147 mg, 27%); Rf 0.80 (1:1 PE:Et2O); 
!H (400 MHz, CDCl3) 11.02 (1H, s, OH), 7.67 (1H, d, J 7.5, H-2), 7.30 (1H, d, J 7.5, 
H-4), 7.67 (1H, t, J 7.5, H-3), 3.93 (3H, s, H-1), 2.26 (3H, s, H-5).  
1H NMR data consistent with literature.129 
KAG/1/24 
  
 
General procedure A – preparation of phenyl esters. 
 
To a stirred solution of carboxylic acid (1 eq.) and a catalytic amount of pyridine (2 
drops) in CH2Cl2 (0.15 M) at 0 °C was added thionyl chloride (1 eq.) dropwise and 
the reaction stirred at rt for 30 minutes under an atmosphere of argon before the 
volatiles were removed under reduced pressure at 0 °C. The resulting gum was 
redissolved in CH2Cl2 (20 mL) at 0 °C, then phenol (2 eq.) followed by pyridine (2 
eq.) added. The reactions were stirred at 0 °C for a further 30 minutes, then allowed to 
warm to room temperature and volatiles removed under reduced pressure. The crude 
products were purified by column chromatography, eluting with 97:3 ! 94:6 
PE:EtOAc. 
 
 
Phenyl 2-hydroxy-3-methylbenzoate (111) 
O
O
OH
1
2
3
4
5
56
7
8
9
10
11
 
 
3-Methyl salicylic acid (500 mg, 3.29 mmol), thionyl chloride (240 µL, 3.29 mmol), 
pyridine (540 µL, 6.58 mmol) and phenol (620 mg, 6.54 mmol) according to general 
procedure A gave the title compound 111 as a pale yellow oil (493 mg, 65%); Rf 0.25 
(95:5 PE:EtOAc); IR "max (neat) 3200, 1686, 1614, 1590, 1492, 1461, 1380, 1329, 
1288, 1193, 1129, 1084, 740; !H (400 MHz, CDCl3) 10.81 (1H, s, OH), 7.97 (1H, d, J 
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7.5, H-7), 7.51–7.47 (2H, m, H-2), 7.43 (1H, d, J 7.5, H-9), 7.34 (1H, t, J 7.5, H-1), 
7.26–7.23 (2H, m, H-3), 6.91 (1H, app t, J 7.5, H-8), 2.34 (3H, s, CH3); !C (100 MHz, 
CDCl3) 169.4 (C-5), 160.6 (C-11), 150.2 (C-4), 137.2 (C-9), 129.6 (C-2), 127.8 (C-7), 
126.9 (C-10), 126.3 (C-1), 121.7 (C-3), 118.8 (C-8), 111.1 (C-6), 15.7 (CH3); m/z 
(ESI) 172 (100), 251 (20) [MNa]+; [HRMS (ESI) calcd. for C14H12NaO3, 251.0679 
Found: [MNa]+ 251.0679 (0.0 ppm error)].  
KAG/1/43 
 
 
Phenyl 4-fluoro-2-hydroxybenzoate (112) 
O
O
OHF
1
2
3
45
6
7
8
9
10
11
 
 
4-Fluoro-2-hydroxybenzoic acid (500 mg, 3.21 mmol), thionyl chloride (233 µL, 3.21 
mmol), pyridine (520 µL, 6.44 mmol), and phenol (606 mg, 6.44 mmol) according to 
general procedure A gave the title compound 112 as a white sticky solid (223 mg, 
32%); m.p. 44–46 °C; Rf 0.35 (96:4 PE:EtOAc); IR "max (neat) 3403, 1654, 1507, 
1476, 1455, 1388, 1341, 1263, 1138, 1121, 1965; !H (400 MHz, CDCl3) 10.74 (1H, s, 
OH), 8.09 (1H, dd, 3JHH 9.0, 3JHF 7.0, H-8), 7.46 (2H, t, J 8.0, H-2), 7.32 (1H, t, J 8.0, 
H-1), 7.20 (2H, d, J 8.0, H-3), 6.75–6.79 (2H, m, H-7, H-10); !C (100 MHz, CDCl3) 
168.4 (C-5), 167.5 (d, 1JCF 254.0, C-9), 164.4 (d, 3JCF 13.0, C-11), 150.0 (C-4), 132.7 
(d, 3JCF 12.0, C-7), 129.8 (C-2), 126.6 (C-1), 121.7 (C-3), 108.7 (d, 4JCF 1.5, C-6), 
108.0 (d, 4JCF 23.0, C-8/C-10), 104.7 (d, 4JCF 24.0, C-8/C-10); !F (376 MHz, MeOD) 
–102.5 (ddd J 7.0, 7.0, 5.0); m/z (ESI) 125 (100) 233 (10), [MH]+ [HRMS (ESI) 
calcd. for C13H10FO3, 233.0608 Found: [MH]+ 233.0608 (1.6 ppm error)]. 
KAG/1/70 
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Phenyl 2-hydroxy-3-isopropyl-6-methylbenzoate (113) 
O
O
OH
1
2
3
45
67
8
9
10
11
12 13
14
 
 
2-Hydroxy-3-isopropyl-6-methylbenzoic acid (500 mg, 2.58 mmol), thionyl chloride 
(216 µL, 2.58 mmol), pyridine (420 µL, 5.20 mmol) and phenol (489 mg, 5.20 mmol) 
according to general procedure A gave the title compound 113 as a pale yellow oil 
(313 mg, 45%); Rf 0.23 (97:3 PE:Et2O); IR !max (neat) 3413, 1666, 1612, 1492, 1414, 
1160, 1136, 799, 637; "H (400 MHz, CDCl3) 11.36 (1H, s, OH), 7.46 (2H, t, J 7.0, H-
2), 7.33–7.31 (1H, m, H-1), 7.30 (1H, d, J 8.0, H-10), 7.21–7.18 (2H, m, H-3), 6.77 
(1H, d, J 8.0, H-9), 3.36 (1H, sept, J 7.0, H-12), 2.67 (3H, s, H-8), 1.23 (6H, d, J 7.0, 
H-13); "C (100 MHz, CDCl3) 171.2 (C-5), 161.0 (C-14), 150.0 (C-4), 138.6 (C-7), 
134.9 (C-11), 131.7 (C-9/C-10/C-1), 129.8 (C-2), 122.8 (C-9/C-10/C-1), 126.5 (C-
9/C-10/C-1), 121.8 (C-3), 111.1 (C-6), 26.6 (C-12), 24.3 (C-13), 22.5 (C-8); m/z (ESI) 
271 (100), [MH]+; [HRMS (ESI) calcd. for C17H19O3, 271.1329. Found: [MH]+ 
271.1331 (0.9 ppm error)]. 
KAG/1/69 
 
 
Phenyl 5-chloro-2-hydroxybenzoate (114) 
O
O
OH
Cl
1
2
3
45
6
7
8
9
10
11
 
5-Chloro-2-hydroxybenzoic acid (500 mg, 2.89 mmol), thionyl chloride (211 µL, 2.89 
mmol), pyridine (467 µL, 5.78 mmol) and phenol (540 mg, 5.76 mmol) according to 
general procedure A gave the title compound 114 as a white solid (363 mg, 34%); 
m.p. 87–89 °C; Found: C, 62.86; H, 3.71, C13H9ClO3 requires C, 62.79; H, 3.65%; Rf 
0.33 (95:5 PE:Et2O); IR !max (neat) 3566, 1685, 1614, 1599, 1473, 1454, 1103, 829, 
799, 756; "H (400 MHz, CDCl3) 10.45 (1H, s, OH), 8.05 (1H, d, J 2.5, H-7), 7.49–
7.44 (3H, m, H-9, H-2), 7.33 (1H, tt, J 7.5, 1.0, H-1), 7.22–7.19 (2H, m, H-3), 6.99 
(1H, d, J 9.0, H-10); "C (100 MHz, CDCl3) 168.1 (C-5), 160.8 (C-11), 149.9 (C-4), 
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126.5 (C-9), 129.8 (C-7), 129.6 (C-2), 126.7 (C-8), 124.4 (C-1), 121.6 (C-3), 119.6 
(C-10), 112.8 (C-6); m/z (ESI) 246 (100), [MH]+; [HRMS (ESI) calcd. for 
C13H1035ClO3, 249.0313. Found: [MH]+ 249.0300 (1.4 ppm error)]. 
KAG/1/52 
 
General procedure B – Ester displacement and cyclisations 
 
A mixture of 3-[1,3]dioxolan-2-ylpropylamine 94 (1.3 eq.) and phenyl ester (1 eq.) in 
a sealed tube was heated under microwave irradiation at 135 oC for 10 minutes (50 W 
input power). The resulting gum was allowed to cool to rt, dissolved in CH2Cl2 (5 
mL) and SnCl2!2H2O (2 eq.) added in a single portion. The reaction was allowed to 
stir at rt for 18 h whereupon it was diluted with CHCl3 (5 mL), treated with K2CO3 (4 
eq.) and stirring continued for a further 30 min. The mixture was filtered through a 
short pad of Celite, washing with CHCl3 (3 x 10 mL). The volatiles were removed 
under reduced pressure and the crude products purified by column chromatography, 
eluting with Et2O. 
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8-Methyl-1,2,3,9a-tetrahydro-9-oxa-3a-aza-cyclopenta[b]naphthalen-4-one (96) 
1
2 3
4
56
12
13
O
N
O
78
9
10
11
 
 
3-[1,3]Dioxolan-2-ylpropylamine (37 mg, 0.285 mmol), phenyl 2-hydroxy-3-
methylbenzoate 111 (50 mg, 0.219 mmol) and SnCl2!2H2O (99 mg, 0.438 mmol) 
according to general procedure B gave the title compound 96 as a colourless solid (70 
mg, 98%); m.p. 111–113 oC; Rf 0.25 (Et2O); IR "max (nujol mull) 2955, 2924, 2855, 
1669, 1440, 1073; #H (400 MHz, CDCl3) 7.76 (1H, d, J 7.5, H-9), 7.26 (1H, d, J 7.5, 
H-11), 6.99 (1H, app t, J 7.5, H-10), 5.46 (1H, app t, J 6.0, H-2), 3.84 (1H, dt, J 11.5, 
7.5, H-5a), 3.61 (1H, ddd, J 11.5, 8.0, 5.0, H-5b), 2.49–2.39 (1H, m, H-3a), 2.33–2.24 
(1H, m, H-3b), 2.23 (3H, s, Me), 2.16–2.07 (1H, m, H-4a), 1.99–1.88 (1H, m, H-4b); 
#C (100 MHz, CDCl3) 161.3 (C-7), 155.5 (C-13), 134.9 (C-11), 125.8 (C-8), 125.4 (C-
9), 121.9 (C-10), 119.4 (C-12), 88.2 (C-2), 44.3 (C-5), 32.0 (CH3), 21.4 (C-3), 15.4 
(C-4); m/z (ESI) 204 (100), [MH]+; [HRMS (ESI) calcd. for C12H14NO2, 204.1019. 
Found: [MH]+ 204.1034 (1.7 ppm error)]. 
KAG/1/36 
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1,2,3,3a-Tetrahydro-pyrrolo[2,1,b][1,3]benzoxanin-9-one (122) 
O
N
O
1
2 3
4
5
67
8
9
10
11
12 13  
 
3-[1,3]Dioxolan-2-ylpropylamine 94 (80 mg, 0.607 mmol), phenyl salicylate 115 (100 
mg, 0.467 mmol) and SnCl2!2H2O (211 mg, 0.934 mmol) according to general 
procedure B gave the title compound 122 as a colourless oil (69 mg, 75%); Rf 0.22 
(Et2O); IR "max (nujol mull) 2884, 1667, 1611, 1468, 1347; #H (400 MHz, CDCl3) 
7.93 (1H, dd, J 7.5, 1.5, H-9), 7.42 (1H, td, J 7.5, 2.0, H-11), 7.11 (1H, td, J 7.5, 1.0, 
H-10), 6.96 (1H, dd, J 7.5, 1.0, H-12), 5.50 (1H, t, J 6.0, H-2), 3.81–3.88 (1H, m, H-
5a), 3.59–3.66 (1H, m, H-5b), 2.40–2.47 (1H, m, H-3a), 2.21–2.30 (1H, m, H-3b), 
2.07–2.16 (1H, m, H-4a), 1.89–1.99 (1H, m, H-4b); #C (100 MHz, CDCl3) 160.9 (C-
7), 157.2 (C-13), 133.7 (C-11), 127.9 (C-9), 122.6 (C-10), 119.7 (C-8), 116.4 (C-12), 
88.4 (C-2), 44.3 (C-5), 31.9 (C-3), 21.3 (C-4); m/z (ESI) 190 (100), [MH]+, 212 (8) 
[MNa]+; [HRMS (ESI) calcd. for C11H12NO2, 190.0863. Found: [MH]+ 190.0863 (0.2 
ppm error)]. 
KAG/1/36 
 
 
6-Fluoro-1,2,3,3a-tetrahydro-pyrrolo[2,1,b][1,3]benzoxanin-9-one (119) 
O
N
O
2 3
4
5
67
8
9
10
11
12 13F  
 
Phenyl 4-fluoro-2-hydroxybenzoate (112) (75 mg, 0.323 mmol), 3-[1,3]dioxolan-2-
ylpropylamine 94 (55 mg, 0.419 mmol) and SnCl2!2H2O (146 mg, 0.646 mmol) 
according to general procedure B gave the title compound 119 as a colourless solid 
(70 mg, 98%); m.p. 79–81 oC; Rf 0.44 (Et2O); IR "max (neat) 1666, 1618, 1450, 1261, 
1154, 766; #H (400 MHz, CDCl3) 7.86 (1H, dd, J 9.0, 7.0, H-9), 6.74 (1H, td, J 10.0, 
2.0, H-12), 6.60 (1H, dd, J 10.0, 2,0, H-10), 5.45 (1H, t, J 6.0, H-2), 3.73–3.80 (1H, 
m, H-5a), 3.57–3.51 (1H, m, H-5b), 2.41–2.34 (1H, m, H-3a), 2.23–2.14 (1H, m, H-
Chapter 6 
 
 133 
3a), 2.09–2.01 (1H, m, H-4a), 1.94–1.84 (1H, m, H-4b); !C (100 MHz, CDCl3) 165.9 
(d, J 252.0, C-11), 164.6 (C-7), 158.9 (C-13), 130.0 (d, J 11.0, C-9), 116.2 (C-8), 
110.3 (d, J 22.0, C-10), 104.3 (d, J 25.0, C-12), 88.9 (C-2), 44.3 (C-5), 31.9 (C-3), 
21.3 (C-4); !F (376 MHz, CDCl3) –103.8 (ddd, J 10.0, 10.0, 9.0); m/z (ESI) 230 (100), 
[MNa]+; [HRMS (ESI) calcd. for C11H10FNNaO2, 230.0588. Found: [MNa]+ 
230.0592 (1.9 ppm error)]. 
KAG/1/75 
 
 
7-Chloro-1,2,3,3a-tetrahydro-pyrrolo[2,1,b][1,3]benzoxanin-9-one (121) 
O
N
O
2 3
4
5
67
8
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11
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Cl
 
 
3-[1,3]Dioxolan-2-ylpropylamine 94 (103 mg, 0.784 mmol), phenyl 5-chloro-2-
hydroxybenzoate 114 (150 mg, 0.603 mmol) and SnCl2"2H2O (272 mg, 1.21 mmol) 
according to general procedure B to gave the title compound 121 as a sticky 
colourless solid (125 mg, 87%), m.p. 63–64 oC; Rf 0.36 (Et2O); IR #max (neat) 1669, 
1609, 1451, 1413, 1346, 825, 713; !H (400 MHz, CDCl3) 7.83 (1H, d, J 2.5, H-9), 
7.31 (1H, dd, J 9.0, 3.0, H-11), 6.87 (1H, d, J 9.0, H-12), 5.43 (1H, t, J 5.5, H-2), 
3.81–3.75 (1H, m, H-5), 3.59–3.53 (1H, m, H-5), 2.43–2.35 (1H, m, H-3), 2.24–2.16 
(1H, m, H-3), 2.10–2.03 (1H, m, H-4), 1.95–1.86 (1H, m, H-4); !C (100 MHz, CDCl3) 
159.7 (C-7), 155.7 (C-13), 133.5 (C-9), 127.9 (C-10), 127.5 (C-11), 120.8 (C-8), 
118.0 (C-12), 88.6 (C-2), 44.2 (C-5), 31.7 (C-3), 21.2 (C-4); m/z (ESI) 224 (100), 
[MH]+; [HRMS (ESI) calcd. for C11H10ClNaNO2, 246.0293. Found: [MNa]+ 246.0293 
(0.2 ppm error)]. 
KAG/1/56 
 
Chapter 6 
 
 134 
5-isoPropyl-8-methyl-1,2,3,3a-tetrahydro-pyrrolo[2,1,b][1,3]benzoxanin-9-one 
(120) 
O
N
O
1
2 3
4
56
7
8910
11
12 13
14
15 16  
 
3-[1,3]Dioxolan-2-ylpropylamine 94 (60 mg, 0.457 mmol), phenyl 2-hydroxy-3-
isopropyl-6-methylbenzoate 113 (100 mg, 0.352 mmol) and SnCl2!2H2O (159 mg, 
0.704 mmol) according to general procedure B gave the title compound 120 as a 
colourless oil (81 mg, 84%); Rf 0.68 (Et2O); IR "max (neat) 2960, 1663, 1579, 1491, 
1428, 1357, 1062, 795; #H (400 MHz, CDCl3) 7.15 (1H, d, J 7.5, H-11), 6.82 (1H, d, J 
7.5, H-10), 5.33 (1H, dd, J 6.0, 5.0, H-2), 3.91–3.84 (1H, m, H-5), 3.55–3.49 (1H, m, 
H-5), 3.18 (1H, sept., J 7.0, H-14), 2.61 (3H, s, Me), 2.43–2.35 (1H, m, H-3), 2.29–
2.21 (1H, m, H-3), 2.16–2.03 (1H, m, H-4), 1.94–1.87 (1H, m, H-4), 1.18 (3H, d, J 
7.0, H-15/H-16), 1.15 (3H, d, J 7.0, H-15/H-16); #C (100 MHz, CDCl3) 162.0 (C-7), 
155.4 (C-13), 138.3 (C-9), 133.9 (C-12), 129.3 (C-11), 125.3 (C-10), 118.4 (C-8), 
87.7 (C-2), 44.7 (C-5), 32.2 (C-3), 26.7 (C-14), 22.7 (C-15/C-16), 22.5 (C-15/C-16), 
21.8 (C-4), 20.7 (Ar-CH3); m/z (ESI) 246 (100), [MH]+; [HRMS (ESI) calcd. for 
C15H20NO2, 246.1489. Found: [MH]+ 246.1493 (2.6 ppm error)].  
KAG/1/74 
 
 
1,2,3,11a-Tetrahydro-11-oxa-3a-aza-cyclopen[b]anthracen-4-one (123) 
O
N
O
1
2 3
4
5678
9
10
11
12
13
14 15 16 17   
 
3-[1,3]Dioxolan-2-ylpropylamine 94 (65 mg, 0.494 mmol), phenyl 3-
hydroxynaphthalene-2-carboxylate 116 (100 mg, 0.378 mmol) and SnCl2!2H2O (171 
mg, 0.757 mmol) according to general procedure B gave the title compound 123 as a 
colourless solid (59 mg, 65%); m.p. 111–114 oC; Rf 0.21 (Et2O); $R  "max (neat) 1664, 
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1661, 1633, 1634, 1436; !H (400 MHz, CDCl3) 8.51 (1H, s, H-9), 7.90 (1H, d, J 8.0, 
H-11), 7.73 (1H, d, J 8.0, H-14), 7.53–7.49 (1H, m, H-13), 7.42–7.38 (1H, m, H-12), 
7.32–7.35 (1H, m, H-16), 5.54 (1H, t, J 6.0, H-2), 3.92–3.87 (1H, m, H-5a), 3.72–3.66 
(1H, m, H-5b), 2.52–2.44 (1H, m, H-3a), 2.33–2.24 (1H, m, H-3b), 2.20–2.13 (1H, m, 
H-4a), 2.02–1.91 (1H, m, H-4b); !C (100 MHz, CDCl3) 161.1 (C-7), 153.6 (C-17), 
136.4 (C-10), 129.5 (C-11, C-9, C-15), 128.5 (C-13), 127.0 (C-14), 125.1 (C-12), 
120.1 (C-8), 112.1 (C-16), 88.6 (C-2), 44.5 (C-5), 32.1 (C-3), 21.2 (C-4); m/z (ESI) 
262 (100), [MNa]+; [HRMS (ESI) calcd. for C15H13NNaO2, 262.0838. Found: [MNa]+ 
262.0843 (0.9 ppm error)]. 
KAG/2/63 
 
 
7a,8,9,10-Tetrahydro-7-oxa-10a-aza-cyclopenta[b]phenanthrene-11-one (124) 
O
N
O
1
2 3
4
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9
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3-[1,3]Dioxolan-2-ylpropylamine 94 (64 mg, 0.492 mmol), phenyl 2-
hydroxynaphthalene-1-carboxylate 117 (100 mg, 0.378 mmol) and SnCl2"2H2O (171 
mg, 0.756 mmol) according to general procedure B gave the title compound 124 as a 
colourless solid (51 mg, 56%); m.p. 104–107 oC; Rf 0.24 (Et2O); IR #max (neat) 1658, 
1634, 1631, 1443, 763; !H (400 MHz, CDCl3) 8.20 (1H, dd, J 8.5, 1.0, H-10), 7.92 
(1H, d, J 9.0, H-16), 7.81 (1H, d, J 8.0, H-12), 7.59–7.49 (3H, m, H-11, H-13, H-15), 
5.65 (1H, t, J 5.5, H-2), 3.93–3.87 (1H, m, H-5a), 3.68–3.62 (1H, m, H-5b), 2.57–2.40 
(2H, m, H-3), 2.22–2.13 (1H, m, H-4a), 2.05–1.94 (1H, m, H-4b); !C (100 MHz, 
CDCl3) 161.5 (C-7), 154.8 (C-17), 136.6 (C-14), 128.5 (C-12), 127.8 (C-15), 126.3 
(C-11), 123.8 (C-9), 123.2 (C-16), 122.8 (C-10), 122.1 (C-13), 114.3 (C-8), 89.1 (C-
2), 44.6 (C-5), 32.1 (C-3), 21.7 (C-4); m/z (ESI) 262 (100), [MNa]+; [HRMS (ESI) 
calcd. for C15H13NNaO2, 262.0838. Found: [MNa]+ 262.0840 (0.2 ppm error)]. 
KAG/2/64. 
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3-[1,3]Dioxolan-2-ylpropionic acid (127). 
O
O
OH
O
1
2
3
4
5
6
 
 
Prepared according to the procedure described by Shea and co-workers.80  
A solution of 2-(2-bromoethyl)-1,3-dioxolane (1.3 mL, 11.0 mmol) in THF (10 mL) 
along with a crystal of iodine to initiate reaction was added dropwise to a stirred 
suspension of magnesium turnings (0.94 g, 38.7 mmol) in THF (20 mL) at 15–20 oC, 
under an atmosphere of argon. The reaction mixture was stirred for 2 h before being 
cooled to –78 oC. A large excess of dry ice (30 g, crushed to a powder under an 
atmosphere of argon) was then slowly added to the reaction vessel. The resulting 
slurry was slowly allowed to warm to rt and stirred for 1 h. The reaction was 
quenched by the addition of aqueous NH4Cl (sat., 20 mL), filtered, the volatiles 
removed under reduced pressure, then extracted with Et2O (20 mL). The aqueous 
phase was acidified to pH 3 and extracted with EtOAc (3 x 20 mL). The organic 
layers were combined, dried over MgSO4 and the volatiles were removed under 
reduced pressure to give the title compound 127 as a colourless solid (1.08 g, 67%); 
m.p. 35–37 oC; IR !max (neat) 3450, 2963, 2892, 1711, 1412, 1140; "H (400 MHz, 
CDCl3) 4.97 (1H, t, J 4.0, H-3), 3.99–3.95 (2H, m, H-1/H-2), 3.88–3.84 (2H, m, H-
1/H-2), 2.48 (2H, t, J 7.5, H-5), 2.03 (2H, td, J 7.5, 4.0, H-4); "C (100 MHz, CDCl3) 
179.2 (C-6), 102.9 (C-3), 65.1 (C-1, C-2), 28.4 (C-4), 27.9 (C-5); m/z (ESI) 169 (100), 
[MNa]+, 147 (100), [MH]+; [HRMS (ESI) calcd. for C6H11O4, 147.0648. Found: 
[MH]+ 147.0652. (0.2 ppm error)]. 
1H NMR data consistent with literature.80 
KAG/1/89 
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General procedure C – Mixed anhydride coupling and cyclisation. 
 
According to the procedure developed by Cayley et al.64 
Isobutyl chloroformate (1 eq.) was added dropwise to a stirred solution of 3-
[1,3]dioxolan-2-ylpropionic acid 127 (1 eq.) and N-methylpiperidine (1 eq.) in 
CH2Cl2 (8 mL) at –10 oC (acetone-ice bath). After exactly 2 min an ice cold solution 
of amine (1.1 eq.) in CH2Cl2 (2 mL) was added dropwise and stirring continued at –10 
oC for 1 h, then the reaction was allowed to warm to rt and stirred for a further 1 h. 
The solution was then filtered through a short pad of silica gel, eluting with EtOAc (3 
x 10 mL) and the volatiles removed under reduced pressure. The resulting amides 
were redissolved in CH2Cl2 (5 mL), SnCl2!2H2O (2 eq.) added in a single portion and 
the reaction stirred at rt for 18–24 h. The mixture was filtered through a short pad of 
Celite and washed with CHCl3 (3 x 15 mL). The volatiles were removed under 
reduced pressure and the crude products purified by column chromatography.  
 
 
2,3,3a,5-Tetrahydro-1H-benzo[d]pyrrolo[2,1 b][1,3]oxazin-1-one (137) 
1
2
3
4
56
N
O
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Prepared from 2-amino benzyl alcohol 135 (106 mg, 0.752 mmol) and acid 127 (100 
mg, 0.684 mmol) according to general procedure C. The crude amide was stirred with 
SnCl2!2H2O (309 mg, 1.37 mmol) for 24 h and the crude product purified by column 
chromatography. Eluting with Et2O gave the title compound 137 as a colourless solid 
(104 mg, 80%); m.p. 89–90 °C; Rf 0.38 (Et2O); IR "max (neat) 1695, 1494, 1490, 
1215, 1080; #H (400 MHz, CDCl3) 8.30 (1H, d, J 8.5, Ar-H), 7.27–7.26 (1H, m, Ar-
H), 7.10 (1H, td, J 7.5, 1.0, Ar-H), 7.02 (1H, br d, J 7.5, Ar-H), 5.27 (1H, dd, J 7.0, 
5.0, H-4), 5.05 (1H, d, J 15.0, H-5a), 4.90 (1H, d, J 15.0, H-5b), 2.61–2.47 (3H, m, H-
2, H-3a), 2.11–2.01 (1H, m, H-3b); #C (125 MHz, CDCl3) 172.0 (C-1), 134.2 (ArC), 
127.7 (ArCH), 124.4 (ArCH), 124.3 (ArCH), 123.8 (ArC), 119.6 (ArCH), 87.2 (C-
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58.1 (C-5), 30.1 (C-2), 24.8 (C-3); m/z (ESI) 212 (100), [MNa]+; [HRMS (ESI) calcd. 
for C11H11NNaO2, 212.0682. Found: [MNa]+ 212.0687 (2.2 ppm error)]. 
KAG/1/91 
 
3,3a-Dihydro-2H,5H-pyrrolo[2,1-a][3,1]benzothiazine-1-one (140) 
1
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3
4
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Prepared from (2-aminophenyl)methane thiol 138 (106 mg, 0.752 mmol) and 3-
[1,3]dioxolan-2-ylpropionic acid 127 (100 mg, 0.684 mmol) according to general 
procedure C. The crude amide was stirred with SnCl2!2H2O (309 mg, 1.36 mmol) for 
18 h and the crude product purified by column chromatography. Eluting with 97:3 
CH2Cl2: MeOH gave the title compound, although not pure. The impure product was 
dissolved in MeOH and loaded onto an SCX column. Washing with MeOH then 
elution with 9:1 MeOH:7 N NH3 in MeOH and concentration gave the title compound 
140 as a pale yellow oil (105 mg, 86%); Rf 0.65 (9:1 CH2Cl2: MeOH); IR "max (neat) 
3430, 2095, 1643, 1468, 1210, 1104; #H (400 MHz, CDCl3) 8.25 (1H, dd, J 8.0, 1.0, 
Ar-H), 7.30 (1H, br t, J 8.0, Ar-H), 7.17–7.15 (1H, m, Ar-H), 7.10 (1H, br d, J 8.0, 
Ar-H), 5.05–5.02 (1H, m, H-4), 4.30 (1H, d, J 17.0, H-5a), 3.70 (1H, d, J 17.0, H-5b), 
2.57–2.68 (3H, m, H-2, H-3a), 2.03–1.98 (1H, m, H-3b); #C (100 MHz, CDCl3) 173.2 
(C-1), 135.9 (ArC), 128.7 (ArCH), 127.6 (ArCH), 124.4 (ArCH), 123.5 (ArC), 122.7 
(ArCH), 60.9 (C-4), 31.0 (C-5), 30.5 (C-2), 23.9 (C-3); m/z (ESI) 228 (100), [MNa]+; 
[HRMS (ESI) calcd. for C11H11NNaOS, 228.0454. Found: [MNa]+ 228.0459 (2.1 ppm 
error)]. 
KAG/2/48 
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4-Methyl-3,3a,4,9-tetrahydro-2H-pyrrolo[2,1-b]quinazoin-1-one (149) 
1 2
3
456
7
8
9 10 11
N
N
O
 
 
Prepared from 2-methylaminobenzylamine 147 (60 mg, 0.437 mmol) and 3-
[1,3]dioxolan-2-ylpropionic acid 127 (58 mg, 0.397 mmol) according to general 
procedure C. The crude amide was stirred with SnCl2!2H2O (179 mg, 0.794 mmol) 
for 18 h and the crude product purified by preparative TLC. Eluting with 1:1 
PE:EtOAc gave the title compound 149 as a colourless oil (35 mg, 43%); Rf 0.31 (1:1 
PE:EtOAc); IR "max (neat) 1685, 1498, 1447, 1369, 1307, 1273, 1212; #H (400 MHz, 
CDCl3) 7.16 (1H, t, J 7.5, Ar-H), 7.03 (1H, d, J 7.5, Ar-H), 6.81–6.79 (2H, m, Ar-H), 
4.85 (1H, d, J 17.0, H-11a), 4.56 (1H, t, J 6.0, H-4), 4.25 (1H, d, J 17.0, H-11b), 2.81 
(3H, s, NCH3), 2.57–2.36 (3H, m, H-2, H-3a), 2.09–2.02 (1H, m, H-3b); #C (100 
MHz, CDCl3) 173.5 (C-1), 145.7 (ArC), 128.0 (ArCH), 126.8 (ArCH), 119.6 (ArC), 
119.2 (ArCH), 113.7 (ArCH), 71.9 (C-4), 41.1 (C-11), 33.8 (NCH3), 29.5 (C-2), 28.8 
(C-3); m/z (ESI) 225 (100), [MNa]+; [HRMS (ESI) calcd. for C12H14N2NaO, 
225.0998. Found: [MNa]+ 225.1006 (3.5 ppm error)]. 
KAG/2/46 
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2-(Methylamino)benzonitrile (154) 
1234
5
6
7
N
H
CN
 
To a stirred solution of 2-aminobenzonitrile 151 (1.00 g, 8.46 mmol) in THF (30 mL) 
at –50 °C under an atmosphere of argon was added n-butyl lithium in hexane (1.45 M, 
2.63 mL, 3.81 mmol) dropwise. The reaction was stirred at –50 °C for 30 minutes, 
then warmed to rt for 45 minutes. After recooling to –50 °C methyl iodide (237 µL, 
3.81 mmol) in THF (20 mL) was added dropwise and the reaction allowed to warm to 
rt and stirred for 16 h. The reaction was quenched by the addition of water (50 mL), 
then extracted with EtOAc (50 mL). The volatiles were removed under reduced 
pressure to yield crude product, which was purified by column chromatography. 
Eluting with 4:1 PE:Et2O gave the title compound 154 as a white solid (409 mg, 
81%). m.p. 60–63 °C (lit 62–64 oC130); Found: C, 72.7; H, 6.15, N 21.32 C8H8N2 
requires C, 72.7; H, 6.10 N, 21.20%; Rf 0.23 (4:1 PE:Et2O); !H (400 MHz, CDCl3) 
7.42–7.35 (2H, m, H-3, H-5), 6.68–6.62 (2H, m, H-4, H-6), 4.66 (1H, s, NH), 2.90 
(3H, d, J 5.0, NMe).  
1H NMR data consistent with literature.130 
KAG/2/23 
 
2-(Aminomethyl)-N-methylaniline (147) 
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To a stirred solution of LiAlH4 in THF (1.00 M, 4.52 mL, 4.52 mmol) under a stream 
of nitrogen was added dropwise 2-(methylamino)benzonitrile 154 (300 mg, 2.26 
mmol) in THF (20 mL). The resulting solution was stirred at rt for 4 h. The reaction 
was quenched by the careful addition of a mixture of Celite and Na2SO4"10H2O (1:1) 
until the evolution of gas was complete (~3 g). The slurry was then filtered and 
washed with Et2O. Removal of the volatiles under reduced pressure gave the title 
compound 147 as a pale yellow oil (309 mg, 100%); IR #max (neat) 3368, 2914, 1626, 
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1605, 1585, 1515, 1467, 1427, 1168, 749; !H (400 MHz, CDCl3) 7.22 (1H, t, J 8.0, H-
5), 7.03 (1H, d, J 8.0, H-3), 6.64–6.67 (2H, m, H-4, H-6), 3.89 (2H, s, H-1), 2.84 (3H, 
s, NCH3); !C (100 MHz, CDCl3) 149.1 (C-7) 128.9 (C-3/C-5), 128.7 (C-3/C-5), 128.6 
(C-2), 116.3 (C-4), 109.9 (C-6), 45.5 (C-1), 30.4 (NCH3); m/z (ESI) 137 (100), 
[MH]+; [HRMS (ESI) calcd. for C8H13N2, 137.1073. Found: [MH]+ 137.1069 (3.1 
ppm error)]. 
KAG/2/24 
 
 
(2-Nitrophenyl)methanethiol (143) 
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2-Nitrobenzyl bromide 142 (500 mg, 2.33 mmol) and thiourea (177 mg, 2.33 mmol) 
in water (20 mL) were heated to reflux for 2 h, then NaOH (93 mg, 2.33 mmol) in 
water (1 mL) added and the reaction maintained at reflux for a further 2 h. After 
cooling to rt the pH was adjusted to 2 (monitored with pH meter) by the dropwise 
addition of aqueous HCl (1 M), then extracted with CHCl3 (3 x 25 mL). The organic 
layers were combined and dried over MgSO4, the volatiles were removed under 
reduced pressure to yield the crude product, which was purified by column 
chromatography. Eluting with 4:1 PE:Et2O gave the title compound 143 as an orange-
yellow oil (123 mg, 31%); Rf 0.43 (4:1 PE:Et2O); IR "max (neat) 3066, 2951, 2855, 
1608, 1577, 1523, 1429, 1344, 1309, 861; !H (400 MHz, CDCl3) 8.00–7.98 (1H, m, 
H-6), 7.58–7.34 (3H, m, H-3, H-4, H-5), 4.00 (2H, d, J 8.5, H-1), 2.14 (1H, t, J 8.5, 
SH); !C (100 MHz, CDCl3) 137.1 (C-7), 133.8 (C-6), 133.7 (C-2), 131.7 (C-4), 128.3 
(C-3/C-5), 125.5 (C-3/C-5), 26.6 (C-1); m/z (ESI) 192 (90), [MNa]+; [HRMS (ESI) 
calcd. for C7H7NNaO2S, 192.0090. Found: [MNa]+ 192.0099 (4.9 ppm error)]. 
KAG/2/30 
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(2-(Methylamino)phenyl)methanethiol (138) 
1234
5
6
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To a stirred solution of (2-nitrophenyl)methanethiol 143 (100 mg, 0.591 mmol) in 
THF (5 mL) under an argon atmosphere was added in a single portion SnCl2!2H2O 
(293 mg, 1.29 mmol) and the reaction stirred at rt for 16 h. The reaction was 
quenched by the addition of aqueous NaHCO3 (sat., 3 mL) and then extracted with 
CH2Cl2 (2 x 10 mL). The resulting emulsion was filtered through a sinter, then the 
layers separated and the organic layer loaded onto a 1 g SCX column. The column 
was washed with MeOH, then the product eluted with 9:1 CH2Cl2: 6 N NH3 in 
MeOH. Removal of the volatiles under reduced pressure gave the title compound 138 
as a yellow oil (68 mg, 83%); IR "max (neat) 3355, 3220, 3024, 1622, 1581, 1493, 
1458, 1313, 1276, 1156, 750; #H (400 MHz, CDCl3) 7.11 (1H, td J 7.5, 1.5, H-5), 6.99 
(1H, dd, J 7.5, 1.5, H-3), 6.73 (1H, td, J 7.5, 1.0, H-4), 6.66 (1H, dd, J 7.5, 1.0, H-6), 
3.66 (2H, s, H-1); #C (100 MHz, CDCl3) 145.2 (ArC), 131.6 (ArCH), 129.3 (ArCH), 
120.9 (ArC), 118.7 (ArCH), 116.4 (ArCH), 40.5 (C-1); m/z (ESI) 277 (100), [2M-H]+; 
[HRMS (ESI) calcd. for C14H17N2S2 277.0828. Found: [2M-H]+ 277.0830 (0.7 ppm 
error)]. 
KAG/2/38 
Methyl 3R,8S-5-oxohexahydropyrrolo[2, 1-b]thiazole-3-carboxylate ((–)-158) 
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Prepared from L-cysteine dimethyl ester dihydrochloride (159) (128 mg, 0.376 mmol) 
and acid 127 (100 mg, 0.684 mmol) according to general procedure C. The crude 
amide was stirred with SnCl2!2H2O (309 mg, 1.37 mmol) for 72 h and the crude 
product purified by column chromatography. Eluting with Et2O gave the title 
compound (–)-158 as a colourless oil (82 mg, 59% over two steps); Rf 0.20 (1:1 
PE:EtOAc); #H (400 MHz, CDCl3) 5.19 (1H, dd, J 7.0, 4.0, H-3), 5.08 (1H, dd, J 7.5, 
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4.5, H-1), 3.73 (3H, s, CO2Me), 3.38 (1H, dd, J 11.5, 7.5, H-2a), 3.33 (1H, dd, J 11.5, 
4.5, H-2b), 2.73–2.60 (1H, m, H-5), 2.59–2.48 (2H, m, H-5, H-4a), 2.19–2.09 (1H, m, 
H-4b). 
Data consistent with literature64 
KAG/2/55 
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6.2 ABC core compounds 
 
 (1R,2S)-Cyclohex-4-ene-1,2-diyldimethanol (179) 
1
3
4
2 OH
HO  
 
To a stirred suspension of lithium aluminium hydride (54.6 g, 1.44 mol) in THF (1.5 
L) at 0 °C under an atmosphere of argon was added a solution of cis-1,2,3,6-
tetrahydrophthalic anhydride (164) (100 g, 657 mmol) in THF (500 mL). Upon 
complete addition, the reaction mixture was allowed to warm to rt at which it was 
stirred for 4 h. The reaction was then cooled to 0 °C and a mixture of Celite and 
Na2SO4!10H2O 1:1 (~300 g) was added in portions until no more gas evolution was 
observed. The reaction mixture was filtered and the solids washed with EtOAc (2 x 1 
L). The organic phases were combined and volatiles removed under reduced pressure 
to yield the crude product, which was purified by column chromatography. Eluting 
with 7:3 PE:EtOAc! EtOAc gave the title compound 179 as a colourless oil (90.7 g, 
97%); Rf 0.22 (EtOAc); !H (400 MHz, CDCl3) 5.69–5.53 (2H, t, J 1.5, H-1), 3.73 (2H, 
dd, J 11.0, 7.0, H-4a), 3.59 (2H, dd, J 11.0, 3.5, H-4b), 3.20 (2H, br s, OH), 2.17–2.00 
(6H, m, H-2, H-3).  
1H-NMR data were consistent with those reported in the literature.101 
KAG/2/15 
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Acetic acid (1R,6S)-6-acetoxymethyl-cyclohex-3-enylmethyl ester (205)  
O
O
O
O
1
3
4
2
5  
To a stirred solution of diol 179 (90.0 g, 633 mmol) in CH2Cl2 (1 L) at 0 °C was 
added pyridine (154 mL, 1.90 mol) in a single portion followed by acetyl chloride 
(112 mL, 1.58 mol) dropwise. The reaction was allowed to warm to rt where it was 
stirred for 16 h. To this was added CH2Cl2 (600 mL) and water (800 mL). The layers 
were separated and then the organic layer was washed with aqueous HCl (2 M, 2 x 
400 mL) and brine (400 mL). The solvent was removed and the crude oil purified by 
column chromatography. Eluting with 95:5!9:1 PE:EtOAc gave the title compound 
205 as a colourless oil (174 g, quant.) contaminated with trace acetic acid; Rf 0.19 
(9:1 PE:EtOAc); !H (400 MHz, CDCl3) 5.64–5.63 (2H, m, H-1), 4.11 (2H, dd, J 15.0, 
9.0, H-4a), 4.03 (2H, dd, J 15.0, 10.0, H-4b), 2.27–2.14 (4H, m, H-2a, H-3), 2.06 (6H, 
s, H-5), 1.97–1.90 (2H, m, H-2b).  
1H NMR data consistent with literature.60 
KAG/7/92 
 
 
((1R,6S)-6-(Hydroxymethyl)cyclohex-3-enyl)methyl ethanoate ((–)-206) 
O
OH
1
2
3
4
5
6
7
8
O9  
To a stirred emulsion of diacetate 205 (87.0 g, 0.385 mol) in aqueous phosphate 
buffer (potassium dihydrogen phosphate / disodium hydrogen phosphate, Fluka, 
800 mL, pH 7) in a 2 L jacketed vessel at 25 °C was added porcine pancreatic lipase 
(PPL, Sigma Type II, 100-400 units/mg, 8.20 g). As the reaction proceeded, the pH 
was kept constant by the addition of aqueous NaOH (2 M) from an autoburette (pH 
set to 7.00). After 20 h, approximately 80 mL of NaOH solution had been added 
(~80% conversion). The reaction mixture was then filtered through a pad of Celite 
and the solids were washed with EtOAc (1 L). The filtrate was extracted with EtOAc 
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(2 x 1 L) and the combined organic layers were dried over Na2SO4. The solvent was 
removed under reduced pressure to give the crude product, which was purified by 
column chromatography. Eluting with 95:5!8:2 iso-hexane: EtOAc gave the title 
compound (–)-206 as a colourless oil (57.1 g, 80%); Rf 0.16 (7:3 PE:EtOAc); [!]D –
19.3 (c 2.2, CHCl3) (Lit.131 –19.0 (c 4.0, CHCl3); "H (400 MHz, CDCl3) 5.68–5.62 
(2H, m, H-3, H-4), 4.20 (1H, dd, J 11.0, 6.0 Hz, H-8a), 3.96 (1H, dd, J, 11.0, 7.5 Hz, 
H-8b), 3.72–3.57 (2H, m, H-7), 2.29–2.08 (4H, m, H-2a, H-1, H-6, H-5a), 2.07 (3H, s, 
H-10), 2.01–1.72 (3H, m, H-2b, H-5b, OH).  
1H NMR data consistent with literature.131 
KAG/7/97 
 
 
((1R,6S)-6-(Benzyloxymethyl)cyclohex-3-enyl)methyl ethanoate ((+)-207) 
O
O
1
2
3
4
5
6
7 8
O
13
9
10
11
12
14
15  
 
To a stirred solution of alcohol (–)-206 (15.0 g, 81.5 mmol) in !,!,!-trifluorotoluene 
(200 mL) was added magnesium oxide (6.67 g, 32.6 mmol) and 2-benzyloxy-N-
methylpyridinium triflate (41.0 g, 122 mmol). The resulting slurry was stirred at 83 
°C for 20 h, then filtered through Celite washing with EtOAc (300 mL). The filtrate 
was concentrated under reduced pressure to give the crude product as a pale yellow 
oil, which was purified by column chromatography. Eluting with 7:3 PE:EtOAc gave 
the title compound (+)-207 as a colourless oil (1.16 g, 72%) along with starting 
material (–)-206 (3.75 g, 25%), giving a BRSM yield of 97%; Rf 0.50 (7:3 
PE:EtOAc); [!]D +11.0 (c 1.8, CHCl3) (Lit.54+11.1(c 1,2, CHCl3); (400 MHz, CDCl3) 
7.38–7.28 (5H, m, H-10, H-11, H-12), 5.67–5.60 (2H, m, H-3, H-4), 4.51 (2H, s, H-
8), 4.11 (1H, dd, J 11.0, 5.5, H-7a), 4.01 (1H, dd, J 11.0, 8.0, H-7b), 3.50 (1H, dd, J 
9.0, 6.5, H-13a), 3.41 (1H, dd, J 9.0, 7.0, H-13b), 2.28–1.91 (9H, m, H-1, H-2, H-5, 
H-6, H-15). 
KAG/8/4 
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((1RS,6SR)-6-(Benzyloxymethyl)cyclohex-3-enyl)methanol (180) 
HO
O
1
2
3
4
5
6
7 8 9 10
11
12
13  
 
To a stirred suspension of NaH (60% in mineral oil, 2.37 g, 71.9 mmol) (washed with 
PE and THF before use) in THF (100 mL) at –10 °C was added dropwise (1RS,2SR)-
cyclohex-4-ene-1,2-diyldimethanol (179) (9.30 g, 65.4 mmol) in THF (50 mL). The 
reaction was warmed to rt and stirred for 1 h. The reaction was then cooled to 0 °C 
and benzyl bromide (8.54 mL, 71.9 mmol) in THF (50 mL) added dropwise. When 
the addition was complete the reaction was allowed to warm to rt then stirred at rt for 
18 h. The reaction was quenched by the addition of aqueous NH4Cl (sat.,150 mL), 
then extracted with Et2O (3 x 100 mL). The organic layers were combined and dried 
over Na2SO4, the volatiles removed under reduced pressure to give the title compound 
180 as pale yellow oil (10.1 g, 66%) which required no further purification; Rf 0.24 
(1:1 PE:Et2O); !H (400 MHz, CDCl3) 7.38–7.27 (5H, m, H-10, H-11, H-12), 5.64–
5.56 (2H, m, H-3, H-4), 4.55 (1H, d, J 12.0, H-8a), 4.52 (1H, d, J 12.0, H-8b), 3.67–
3.53 (3H, m, H-7a, H-13), 3.41 (1H, dd, J 9.5, 4.5, H-7b), 3.55 (1H, br s, OH), 2.27–
1.93 (6H, m, H-1, H-2, H-5, H-6). 
1H-NMR Data were consistent with those reported in the literature.132 
KAG/2/17 
 
 
((1R,6S)-6-(Benzyloxymethyl)cyclohex-3-enyl)methanol ((+)-180) 
HO
O
1
2
3
4
5
6
7 8 9 10
11
12
13  
 
To a stirred solution of acetate (+)-207 (21.3 g, 77.7 mmol) in MeOH (300 mL) and 
water (150 mL) at 0 °C was added lithium hydroxide monohydrate (36.0 g, 85.8 
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mmol). The ice-bath was removed and the reaction mixture was stirred for 45 min. 
The MeOH was then removed under reduced pressure and the residue partitioned 
between EtOAc (800 mL) and brine (800 mL). The aqueous phase was extracted 
using EtOAc (2 x 500 mL). The organic layers were combined, dried over Na2SO4 
and concentrated under reduced pressure to give the title compound (+)-180 as a 
colourless oil (17.9 g, 99%) which was used without any further purification; Rf 0.24 
(1:1 PE:Et2O); 
Data as for racemate ±180 except 
[!]D +4.7 (c 1.2, CHCl3 ) (Lit.54+3.8 (c 1.1, CHCl3)) 
KAG/8/27 
 
(1RS,6SR)-Methyl 6-(benzyloxymethyl)cyclohex-3-enecarboxylate (165) 
OO
O
1
2
3
4
5
6
7 8 9 10
11
12
1314  
 
To a stirred solution of the crude alcohol 180 (6.00 g, 25.8 mmol) in acetone (100 
mL) at 0 °C was added dropwise freshly prepared Jones’ reagent (33.5 mmol, ~15 
mL). The reaction was allowed to warm to rt, then recooled to 0 °C and iso-propyl 
alcohol (~10 mL, until the reaction remained green) was added carefully dropwise to 
quench excess Jones’ reagent. The volatiles were removed under reduced pressure to 
give a green gum, which was partitioned between water (300 mL) and CH2Cl2 (2 x 
200 mL). The organic layers were combined and dried over Na2SO4, and the volatiles 
removed under reduced pressure. The resulting oil was dissolved in MeOH (50 mL) 
and acetyl chloride (1.28 mL 18.1 mmol) added in a single portion. The reaction was 
stirred for 48 h at rt. The MeOH was removed under reduced pressure and the yellow 
residue dissolved in CH2Cl2 (100 mL) and washed twice with aqueous NaHCO3 (sat., 
50 mL). The organic layer was then dried over Na2SO4 and the volatiles removed 
under reduced pressure to yield the crude compound, which was purified by column 
chromatography. Eluting with 7:3 PE:EtOAc gave the title compound 165 as a 
colourless oil (3.10 g, 46%); Rf 0.56 (1:1 PE:Et2O); "H (400 MHz, CDCl3) 7.36–7.27 
(5H, m, H-10, H-11, H-12), 5.67–5.60 (2H, m, H-3, H-4), 4.46 (2H, s, H-8), 3.59 (3H, 
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s, H-14), 3.49 (1H, dd, J 9.0, 5.0, H-7a), 3.42 (1H, dd, J 9.0, 7.0, H-7b), 2.82–2.77 
(1H, m, H-1), 2.61–2.53 (1H, m, H-6), 2.36–2.19 (3H, m, H-2, H-5a), 2.11–2.04 (1H, 
m, H-5b).  
1H NMR data consistent with literature.60 
KAG/2/89 
 
 
Methyl-(1R,6S)-6-(Benzyloxymethyl)cyclohex-3-enecarboxylate ((–)-165) 
OO
O
1
2
3
4
5
6
7 8 9 10
11
12
1314  
 
Prepared according to the procedure for ±165 
Data as for racemate ±165 except 
[!]D –14.9 (c 1.2, CHCl3 ) (Lit.54–15.5 (c 1.1, CHCl3); 
KAG/4/8 
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The following two compounds are likely to be both explosive and volatile, and all 
procedures were carried out behind blast shields. 
 
 
1-Azido-3-chloropropane (182) 
1
2
3
Cl N3
 
 
Prepared according to the procedure described by Yao and co-workers.94  
To a stirred solution of 1-bromo-3-chloropropane 181 (5.00 g, 31.7 mmol) in DMF 
(40 mL) under an atmosphere of argon was added in a single portion sodium azide 
(2.06 g, 31.7 mmol) and stirred at rt for 18 h. The reaction was partitioned between 
water (75 mL) and Et2O (75 mL) and the organic layer dried over Na2SO4. The 
volatiles were removed under reduced pressure in an ice-cooled water bath to give the 
title compound 182 as a pale orange oil. The crude product was ~ 80% pure by 1H 
NMR, and was used directly in the subsequent reaction without further purification; 
!H (400 MHz, CDCl3) 3.61 (2H, t, J 6.5, H-3), 3.48 (2H, t, J 7.0, H-1), 1.99 (2H, tt, J 
7.0, 6.5 H-2).  
1H-NMR Data were consistent with those reported in the literature.94 
KAG/2/67 
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1-Azido-3-iodopropane (183) 
I N3
1 2 3
 
 
Prepared according to the procedure described by Yao and co-workers.94  
To a stirred solution of crude 1-azido-3-chloropropane (182) (31.7 mmol if 100%), in 
acetone (100 mL) was added in a single portion sodium iodide (9.52 g, 63.5 mmol), 
then the reaction heated to reflux for 18 h. After cooling the reaction was partitioned 
between water (100 mL) and EtOAc (2 x 100 mL). The organic layers were 
combined, dried over Na2SO4 and the volatiles removed under reduced pressure to 
yield the crude product, which was purified by column chromatography. Eluting with 
9:1 PE:Et2O gave the title compound 183 as a pale yellow oil (4.06 g, 61% over 2 
steps from 181); Rf 0.28 (9:1 PE:Et2O); !H (400 MHz, CDCl3) 3.44 (2H, t, J 6.0, H-3), 
3.25 (2H, t, J 6.5, H-1), 2.04 (2H, tt, J 6.5, 6.0, H-2).  
1H-NMR Data were consistent with those reported in the literature.94 
KAG/2/68 
Later this compound was used successfully without purification. e.g. KAG/8/2 
 
 
(1RS,6SR)-methyl 1-(3-azidopropyl)-6-(benzyloxymethyl)cyclohex-3-
enecarboxylate (177) 
1
3
4
5
7 8 10
11
12
13
14
16
OO
O
N3
2 6
15
17  
 
General procedure: 
To a stirred solution of ester (165) (100 mg, 0.384 mmol), in THF (1 mL) at –78 °C 
was added dropwise base (see Table 3.2). After complete addition the reaction was 
stirred at –78 °C for 2 h, then azide 183 (88 mg, 0.422 mmol) in THF (0.5 mL) was 
added dropwise. The reaction was stirred at –78 °C for 15 minutes, then warmed to rt 
and stirred for 18 h, then partitioned between EtOAc (2 x 5 mL) and aqueous NH4Cl 
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(sat., 5 mL). The organic layers were combined, and the volatiles removed under 
reduced pressure to yield the crude product, which was purified by column 
chromatography. Eluting with 9:1 PE:EtOAc gave the title compound 177 as a 
colourless oil. (Yields see Table 3.2); Rf 0.25 (1:1 PE:Et2O); IR !max (neat) 3443, 
2095, 1727, 1197, 1104, 736, 699; "H (400 MHz, CDCl3) 7.35–7.27 (5H, m, H-10, H-
11, H-12), 5.56 (2H, s, H-3, H-4), 4.42 (2H, H-8), 3.56 (3H, s, H-17), 3.34 (2H, d, J 
7.0, H-7), 3.01-3.22 (2H, m, H-15), 2.39–2.20 (4H, m, H-2, H-5), 1.67–1.54 (4H, m, 
H-13, H-14, H-6), 1.40–1.31 (1H, m, H-13/H-14); "C (100 MHz, CDCl3) 176.6 (C-
16), 138.4 (C-9), 128.4 (C-11), 127.8 (C-10), 127.6 (C-12), 124.3 (C-3/C-4), 124.2 
(C-3/C-4), 73.3 (C-7/C-8), 71.2 (C-7/C-8), 51.6 (C-6), 51.6 (C-1), 45.7 (C-17), 39.1 
(C-2/C-5/C-14/C-15), 32.7 (C-2/C-5/C-14/C-15), 27.3 (C-2/C-5/C-14/C-15), 25.0 (C-
2/C-5/C-14/C-15), 23.8 (C-2/C-5/C-14/C-15); m/z (ESI) 366 (100), [MNa]+; [HRMS 
(ESI) calcd. for C19H25N3NaO3, 366.1788. Found: [MNa]+ 366.1798 (2.6 ppm error)]. 
 
When working on the chiral series the azide was not isolated – see amine below for 
preparation. 
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 (1RS,6SR)-Methyl 1-(3-aminopropyl)-6-(benzyloxymethyl)cyclohex-3-
enecarboxylate (178) 
OO
O
NH2
12
3
4
5
6
7 8
9
10
11
12
13
14
15
16
17  
 
To a stirred solution of azide (177) (400 mg, 1.16 mmol) in THF (10 mL) and water 
(260 µL) was added in a single portion triphenylphosphine (333 mg, 1.28 mmol). The 
reaction was heated to reflux for 2 h. After cooling the volatiles were removed under 
reduced pressure, then the crude product was purified by loading onto an SCX 
column. Washing with MeOH followed by eluting with 9:1 CH2Cl2:7 N NH3 in 
MeOH in CH2Cl2 gave the title compound 178 as a colourless film (303 mg, 82%); Rf 
0.48 (90:9:1 CH2Cl2:MeOH:NH3); IR !max (neat) 3376, 3026, 2926, 2855, 1726, 
1453, 1024, 1104, 689; "H (400 MHz, CDCl3) 7.34–7.27 (5H, m, H-10, H-11, H-12), 
5.55 (2H, t, J 14, H-3, H-4), 4.42 (2H, s, H-8), 3.56 (3H, s, H-17), 3.33 (2H, d, J 7.0, 
H-7), 2.63 (2H, t, J 7.0, H-15), 2.36–2.02 (5H, m, H-2, H-5, H-6), 1.61–1.38 (5H, m, 
H-13, H-14, NH2), 1.23–1.17 (1H, m, H-14/H-13); "C(100 MHz, CDCl3) 176.3 (C-
16), 138.0 (C-9), 127.9 (C-11), 127.3 (C-10), 127.1 (C-12), 124.0 (C-3), 123.8 (C-4), 
72.7 (C-7), 70.8 (C-8), 51.0 (C-17), 45.7 (C-1), 42.5 (C-15), 39.1 (C-6), 32.9 (C-13), 
28.9 (C-14) 27.3 (C-2), 24.9 (C-5); m/z (ESI) 318 (100), [MH]+; [HRMS (ESI) calcd. 
for C19H28NO3, 318.2064 Found: [MH]+ 318.2069 (1.4 ppm error)]. 
KAG/2/78 
 
(1R,6S)-Methyl 1-(3-aminopropyl)-6-(benzyloxymethyl)cyclohex-3-
enecarboxylate ((+)-178) 
 
To a stirred solution of ester (–)-165 (4.00 g, 15.4 mmol), in THF (37 mL) at –78 °C 
was added dropwise KHMDS (0.70 M in toluene, 33.0 mL, 23.1 mmol). After 
complete addition the reaction was stirred at –78 °C for 2 h, then azide 183 (3.90 g, 
18.5 mmol) in THF (19 mL) was added dropwise. The reaction was stirred at –78 °C 
for 15 minutes, warmed to rt and stirred for 18 h, then partitioned between EtOAc (2 
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x 5 mL) and aqueous NH4Cl (sat., 5 mL). The organic layers were combined, and the 
volatiles removed under reduced pressure to yield the crude azide 177. The azide was 
dissolved in THF (120 mL) and water (3.15 mL) and triphenylphosphine (4.47 g, 17.0 
mmol) added. The reaction was heated to reflux for 1 h, then cooled to rt, 
concentrated and purified by loading onto 2 x 20 g SCX columns. Washing with 
MeOH followed by eluting with 9:1 CH2Cl2:7 N NH3 in MeOH gave the title 
compound (+)-178 as a colourless film (3.23 g, 66% over 2 steps). 
Data as for racemate ±178 except 
[!]D +25.7 (c 1.3, CHCl3). 
KAG/8/80 and KAG/8/81 
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 (S)-2,4-O-Isopropylidine-3,4-dihydroxy butyric acid methyl ester (190)99 
O
O
O
O
1
2
3 4 5 6
7
 
 
Prepared according to the procedure described in patent.99  
(S)-Hydroxy butyrolactone 189 (5.00 g, 49.0 mmol), MeOH (15 mL), 2,2-dimethoxy 
propane (10 mL), acetone (5 mL) and p-TSA (466 mg, 2.71 mmol) were mixed and 
heated to reflux for 3 h. The reaction was quenched by the addition of aqueous 
NaHCO3 (sat., 30 mL) and then extracted with Et2O (3 x 50 mL). The organic layers 
were combined, washed with brine (3 x 40 mL), dried over Na2SO4, then the volatiles 
removed under reduced pressure to yield the crude product, which was purified by 
column chromatography. Eluting with 8:2 PE:Et2O gave the title compound 190 as a 
pale yellow oil (4.16 g, 49%); Rf 0.51 (1:1 PE:Et2O); !H (400 MHz, CDCl3) 4.46 (1H, 
app quin., J 6.5, H-4), 4.14 (1H, dd, J 8.0, 6.5, H-3a), 3.70 (3H, s, H-7), 3.64 (1H, dd, 
J 8.0, 6.5, H-3b), 2.27 (1H, dd, J 16.0, 6.5, H-5a), 2.52 (1H, dd, J 16.0, 6.5, H-5b), 
1.40 (3H, s, H-1/H-2), 1.34 (3H, s, H-1/H-2).  
1H NMR data consistent with literature.98 
 KAG/2/82 
 
 
 (S)-2,4-O-Isopropylidine-3,4-dihydroxy butyric acid (170)99 
O
O
O
OH
1
2
3 4 5 6  
 
To a stirred solution of ester 190 (4.16 g, 23.9 mmol) in THF (2.4 mL) and water (12 
mL) was added in a single portion lithium hydroxide monohydrate (1.00 g, 23.9 
mmol) and the reaction stirred at rt for 1 hour. The pH was adjusted to 4 by the 
dropwise addition of aqueous oxalic acid (10%) and then extracted with Et2O (2 x 50 
mL). The organic layers were combined, dried over Na2SO4, then the volatiles 
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removed under reduced pressure to yield the title compound 170 as a pale yellow oil 
(2.03 g, 45%) which was used without further purification; Rf 0.18 (EtOAc); !H (400 
MHz, CDCl3) 4.46 (1H, app quin., J 6.0, H-4), 4.14 (1H, dd, J 8.5, 6.0, H-3a), 3.65 
(1H, dd, J 8.5, 6.0, H-3b), 2.73 (1H, dd, J 16.0, 6.0, H-5a), 2.55 (1H, dd, J 16.0, 6.0, 
H-5b), 1.40 (3H, s, H-1/H-2), 1.36 (3H, s, H-1/H-2).  
1H NMR data consistent with literature.133 
KAG/2/83 
 
 
(1R,6S)-Methyl 6-(benzyloxymethyl)-1-(3-(2-((S)-2,2-dimethyl-1,3-dioxolan-4-
yl)ethanamido)propyl)cyclohex-3-enecarboxylate (186a) and (1S,6R)-methyl 6-
(benzyloxymethyl)-1-(3-(2-((S)-2,2-dimethyl-1,3-dioxolan-4-
yl)ethanamido)propyl)cyclohex-3-enecarboxylate (186b) 
 
1
3
2
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6
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To a stirred solution of amine 178 (65 mg, 0.205 mmol), acid 170 (40 mg, 0.250 
mmol) and DMAP (3 mg, 0.0245 mmol) in CH2Cl2 (1.5 mL) at 0 °C under an 
atmosphere of argon was added in a single portion DCC (65 mg, 0.315 mmol). The 
reaction was stirred at 0 °C for 10 min, then the ice bath removed and the reaction 
allowed to warm to rt, where it was stirred for 30 min. The reaction was filtered 
through a plug of SiO2 to remove the DCU, washing with EtOAc (20 mL). The 
volatiles were removed under reduced pressure to yield the crude product, which was 
purified by column chromatography. Eluting with EtOAc gave the title compounds 
186a and 186b in a 1:1 mixture as a colourless film (80 mg, 91%); Rf: 0.23 (75:25 
PE:EtOAc); IR "max (neat) 3323, 3027, 2929, 1726, 1643, 1554, 1494, 1452, 1370, 
1312, 1246, 1212, 1111, 1066, 736; !H (400 MHz, CDCl3) 7.34–7.42 (5H, m, H-10, 
H-11, H-12), 6.04 (1H, s, NH), 5.54 (2H, s, H-3, H-4), 4.51–4.39 (3H, m, H-8, H-19), 
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4.11 (2H, dd, J 8.0, 6.0, H-20), 3.59 (3H, s, CH3), 3.31 (2H, d, J 7.0, H-7), 3.19 (2H, 
q, J 6.5, H-15), 2.49–3.39 (2H, m, H-18), 2.33–2.19 (2H, m, H-5), 2.06–2.03 (2H, m, 
H-2), 1.67–1.57 (3H, m, H-14, H-6), 1.46 (3H, s, H-21/22), 1.35 (3H, s, H-21/22), 
2.49 (2H, m, H-13); !C (100 MHz, CDCl3) 176.8 (C-16), 170.0 (C-17), 138.4 (C-9), 
128.4 (C-11), 127.8 (C-10), 127.6 (C-12), 124.4 (C-4), 124.3 (C-3), 109.5 (C-23), 
73.2 (C-7), 72.6 (C-19), 71.2 (C-8), 69.2 (C-20), 51.6 (CH3), 45.7 (C-1), 40.7 (C-15), 
39.6 (C-18), 39.2 (C-6), 32.8 (C-13), 27.2 (C-2), 27.0 (C-21/C-22), 25.6 (C-21/C-22), 
25.0 (C-14), 24.5 (C-5); m/z (ESI) 482 (100), [MNa]+ 460 [MH]+; [HRMS (ESI) 
calcd. for C26H37NNaO6, 482.2513. Found: [MNa]+ 482.2521 (1.6 ppm error)]. 
No difference between the diastereoisomers was observed by 1H or 13C NMR. 
 
((1RS,6SR)-1-(3-Aminopropyl)-6-(benzyloxymethyl)cyclohex-3-enyl)methanol 
(199) 
OH2N
HO
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To a stirred solution of ester 165 (2.00 g, 7.68 mmol) in THF (20 mL) at –78 °C under 
an atmosphere of argon was added dropwise KHMDS in toluene (0.67 M, 13.2 mL, 
8.83 mmol) The solution was stirred at –78 °C for 2 h, then azide 183 in THF (10 mL) 
was added dropwise and the reaction allowed to warm to rt and stirred overnight. The 
reaction was partitioned between water (200 mL) and EtOAc (2 x 200 mL), the 
organic layers combined and dried over Na2SO4, then the volatiles removed under 
reduced pressure. The resulting yellow oil was dissolved in Et2O (20 mL) and added 
to a stirred solution of lithium aluminium hydride (4.0 M in Et2O, 15.4 mL, 61.44 
mmol*) diluted in Et2O (20 mL). When the addition was complete the reaction was 
allowed to stir at room temperature for 1 h, then quenched by the portionwise addition 
of Na2SO4"10H2O* until no more effervescence was observed (~10 g). The solids 
                                                
*The reaction was run with an excess of LAH as the THF contained higher than 
normal levels of peroxides which were quenching the reagent. This was due to a 
supply problem. 
* Note: the use of Celite mixed with Na2SO4"10H2O in the quench for this reaction 
resulted in a dramatic loss of yield. It was assumed the very polar amino alcohol stuck 
to the Celite. 
Chapter 6 
 
 158 
were filtered, washed with EtOAc, then the volatiles removed under reduced pressure 
to yield the crude product, which was purified by SCX cartridge. Washing with 
MeOH, then eluting with 9:1 MeOH:7M NH3/MeOH in gave the title compound 199 
as a colourless oil (1.40 g, 67%); IR !max (neat) 3369, 3026, 2925, 1453, 1365, 1265, 
1097, 702; "H (400 MHz, CDCl3) 7.37–7.29 (5H, m, H-10, H-11, H-12), 5.61–5.74 
(2H, m, H-3, H-4), 4.54 (1H, d, J 12.0, H-8a), 4.48 (1H, d, J 12.0, H-8b), 3.64 (1H, d, 
J 12.0, H-16a), 3.63–3.46 (2H, m, H-7), 3.23 (1H, d, J 12.0, H-16b), 2.67-2.68 (2H, 
m, H-15), 2.25–1.64 (10H, br m, H-2, H-5, H-6, H-13, NH2, OH), 1.52–1.24 (2H, m, 
H-14); "C (100 MHz, CDCl3) 137.6 (C-9), 128.6 (C-11), 128.0 (C-12), 127.9 (C-10), 
125.5 (C-3), 124.9 (C-4), 73.5 (C-8), 70.9 (C-7), 64.9 (C-16), 43.0 (C-15), 39.5 (C-6), 
38.7 (C-1), 33.2 (C-2), 32.0 (C-14), 26.9 (C-5), 26.7 (C-13); m/z (ESI) 290 (100), 
[MH]+; [HRMS (ESI) calcd. for C18H28NO2, 290.2115. Found: [MH]+ 290.2106 (3.0 
ppm error)]. 
KAG/4/13 
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((1R,6S)-1-(3-Aminopropyl)-6-(benzyloxymethyl)cyclohex-3-enyl)methanol ((+)-
199) 
Was prepared according to the procedure described above, data was in accordance 
with the racemic material. 
[!]D +12.8 (c 1.0, CHCl3). 
KAG/4/46 
 
N-(3-((1R,6S)-6-(Benzyloxymethyl)-1-(hydroxymethyl)cyclohex-3-enyl)propyl)-2-
((S)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanamide (200a) and N-(3-((1S,6R)-6-
(benzyloxymethyl)-1-(hydroxymethyl)cyclohex-3-enyl)propyl)-2-((S)-2,2-
dimethyl-1,3-dioxolan-4-yl)ethanamide (200b) 
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To a stirred solution of amine 199 (1.82 g, 6.28 mmol) acid 170 (1.0 g, 6.28 mmol) in 
CH2Cl2 at 0 °C under an atmosphere of argon was added in a single portion HATU 
(2.39 g, 6.28 mmol). The reaction was stirred at 0 °C for 30 min, then allowed to 
warm to rt and stirred there overnight. The reaction was partitioned between water 
(150 mL) and EtOAc (150 mL), the aqueous layer washed with EtOAc (150 mL) then 
the organic layers combined and dried over Na2SO4. Removal of the volatiles under 
reduced pressure gave the crude product as a sticky yellow oil, which was purified by 
column chromatography. Eluting with 98:2 EtOAc:MeOH gave the title compounds 
200a and 200b in a 1:1 mixture as a thick colourless oil (2.76 g, quant.) This was 
dried under high vacuum (~1 mbar) with stirring at 60 °C for 5 h, but still contained 
traces of EtOAc; Rf 0.21 (98:2 EtOAc:MeOH); "H (400 MHz, CDCl3) 7.44–7.22 (5H, 
m, H-10, H-11, H-12), 6.32 (1H, br s, NH), 5.58 (1H, br d, J 10.0, H-4), 5.49 (1H, br 
d, J 10.0, H-3), 4.52 (1H, d, J 12.0, H-8a) 4.48 (1H, d, J 12.0, H-8b), 4.42–4.36 (1H, 
m, H-19), 4.11 (1H, dd, J 8.5, 6.0, H-20a), 3.71–3.55 (3H, m, H-7a, H-16a, H-20b), 
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3.51 (1H, dd, J 9.5, 5.0, H-7b), 3.40–3.09 (3H, m, H-16b, H-15), 2.47 (1H, dd, J 15.0, 
7.5, H-18a), 2.39 (1H, dd, J 15.0, 5.5, H-18b), 2.21 (1H, ddd, J 18.5, 5.5, 3.0, H-5a), 
2.07 (1H, brd, J 18.5, H-5b), 1.87–1.62 (4H, m, H-2, H-6, H-13a), 1.49 (2H, app 
quintet, J 7.0, H-14), 1.43 (3H, s, H-21/H-22), 1.36 (3H, s, H-21/H-22), 1.86–1.29 
(1H, m, H-13b). 
1H NMR data consistent with literature.60 
KAG/4/24 
 
 
N-(3-((1R,6S)-6-(Benzyloxymethyl)-1-(hydroxymethyl)cyclohex-3-enyl)propyl)-2-
((S)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanamide ((+)-200)  
was prepared according to the procedure described above, data was in accordance 
with the racemic material. 
[!]D +13.4 (c 1.1, CHCl3) (Lit.54 +11.5 (c 1.1, CHCl3)). 
KAG/4/47 
 
 
N-(3-((1R,6S)-6-(Benzyloxymethyl)-1-formylcyclohex-3-enyl)propyl)-2-((S)-2,2-
dimethyl-1,3-dioxolan-4-yl)ethanamide (66a) and N-(3-((1S,6R)-6-
(benzyloxymethyl)-1-formylcyclohex-3-enyl)propyl)-2-((S)-2,2-dimethyl-1,3-
dioxolan-4-yl)ethanamide (66b) 
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To a stirred solution of alcohol 200 (2.00 g, 4.64 mmol) in CH2Cl2 (100 mL) under an 
atmosphere of argon were added freshly dried 4 Å molecular sieves (2.00 g). This 
solution was stirred for 15 min at rt, before N-methyl-morpholine-N-oxide (650 mg, 
5.56 mmol) was added in a single portion, followed by tetra-n-propylammonium 
perruthenate (122 mg, 0.347 mmol). The reaction was stirred at rt for 2 h. The 
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reaction was filtered through a pad of silica, washing with EtOAc (100 mL) then the 
volatiles removed under reduced pressure to give the title compounds 66a and 66b in 
a 1:1 mixture as a pale brown film which was immediately used crude in the next 
reaction; Rf 0.48 (EtOAc); !H (400 MHz, CDCl3) 9.57 (1H, s, H-13), 7.45–7.18 (5H, 
m, H-10, H-11, H-12), 6.07 (1H, br s, NH), 5.65–5.60 (2H, m, H-3, H-4), 4.44 (1H, d, 
J 12.0, H-8a), 4.39 (1H, d, J 12.0, H-8b), 4.40–4.38 (1H, m, H-19), 4.12 (1H, dd, J 
8.5, 6.0, H-20a), 3.60 (1H, dd, J 8.5, 7.0, H-20b), 3.40–3.36 (2H, m, H-7), 3.20 (2H, 
dd, J 13.0, 7.0, H-15), 2.47 (1H, dd, J 15.0, 7.5, H-18a), 2.41 (1H, dd, J 15.0, 5.0, H-
18b), 2.32–2.19 (3H, m, H-2a, H-6, H-5a), 2.08–1.95 (2H, m, H-2b, H-5b), 1.58–1.53 
(2H, m, H-14), 1.50–1.43 (1H, m, H-13a), 1.42 (3H, s, H-21/H-22), 1.36 (3H, s, H-
21/H-22), 1.32–1.29 (1H, m, H-13b). 
1H NMR data consistent with literature.60 
KAG/4/30 
 
 
N-(3-((1R,6S)-6-(Benzyloxymethyl)-1-formylcyclohex-3-enyl)propyl)-2-((S)-2,2-
dimethyl-1,3-dioxolan-4-yl)ethanamide ((+)-66) 
Was prepared according to the procedure described above, data was in accordance 
with the racemic material. 
KAG/4/50 
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(1R,2'S,6S,9a'S)-6-(Benzyloxymethyl)-2'-(hydroxymethyl)-6',7',8',9a'-tetrahydro-
2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-4'(3'H)-one (172a) and 
(1S,2'S,6R,9a'S)-6-(benzyloxymethyl)-2'-(hydroxymethyl)-6',7',8',9a'-tetrahydro-
2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-4'(3'H)-one (172b) (1:1 
mixture) 
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SnCl2!2H2O (392 mg, 1.74 mmol) was added in a single portion to the crude reaction 
mixture of aldehyde 66 (0.695 mmol) in CH2Cl2 and the reaction stirred at rt for 17 h. 
K2CO3 (1.00 g) was added in a single portion and the reaction stirred for a further 30 
min at rt, before being filtered through a pad of Celite, which was washed with EtOAc 
(50 mL). Removal of the volatiles under reduced pressure gave the crude product, 
which was purified by column chromatography. Eluting with EtOAc gave the title 
compounds 172a and 172b in a 1:1 mixture as a sticky pale yellow oil (198 mg, 77% 
from 200); Rf 0.11 (EtOAc); "H (400 MHz, CDCl3) 7.36–7.27 (10H, m, H-10, H-10', 
H-11, H-11', H-12, H-12'), 5.65–5.54 (4H, m, H-3, H-3', H-4, H-4'), 4.76–4.69 (2H, 
m, H-15a, H-15a'), 4.71–4.68 (2H, m, H-16, H16'), 4.58–4.36 (4H, m, H-8, H-8'), 4.05 
(1H, br dd, J 9.5, 3.5, H-7a'), 3.93 (1H, dd, J 10.0, 5.0, H-7a), 3.75–3.61 (4H, m, H-
20a, H-20a', H-19, H-19'), 3.54–3.40 (2H, m, H-7b, 20b), 3.30 (1H, dd, J 12.0, 6.5, H-
7b'), 3.21 (1H, t, J 10.0, H-20b'), 2.61–1.95 (14H, m, H-18, H-18', H-14, H-14', H-
15b, H-15b', H-5, H-5'), 1.82–1.42 (10H, m, H-2, H-2', H-13, H-13', H-6, H-6'). 
KAG/4/28 
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(1R,2'S,6S,9a'S)-6-(Benzyloxymethyl)-2'-(hydroxymethyl)-6',7',8',9a'-tetrahydro-
2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-4'(3'H)-one ((–)-172) 
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According to the procedure described for the racemic material aldehyde (+)-66 (4.63 
mmol, assuming 100% conversion) and SnCl2!2H2O (2.61 g, 11.6 mmol) gave the 
crude product which was purified by column chromatography. Eluting with 98:2 
EtOAc:MeOH gave the title compound (–)-172 as a pale yellow sticky oil (600 mg, 
36% from 200)*; Rf 0.11 (EtOAc); "H (400 MHz, CDCl3) 7.40–7.25 (5H, m, H-10, H-
11, H-12), 5.58–5.54 (2H, m, H-3, H-4), 4.72 (1H, s, H-16), 4.69–4.67 (1H, m, H-
15a), 4.53 (1H, d, J 12.0, H-8a), 4.48 (1H, d, J 12.0, H-8b), 3.93 (1H, dd, J 10.0, 5.0, 
H-7a), 3.74–3.68 (1H, m, H-19), 3.62 (1H, br d, J 11.0, H-20a), 3.46–3.42 (1H, m, H-
20b), 3.41 (1H, dd, J 10.0, 6.0, H-7b), 2.51 (1H, d, J 12.0, H-18a), 2.46 (1H, d, J 12.0, 
H-18b), 2.41–2.32 (2H, m, H-14a, H-15b), 2.26–2.21 (2H, m, H-5), 1.81–1.71 (3H, 
m, H-2a, H-6, H-14b), 1.56–1.46 (3H, m, H-2b, H-13). 
1H NMR data consistent with literature.60 
KAG/4/52 
 
 
                                                
* The low yield was attributed to the problems experienced with the TPAP oxidation. 
The chromatography conditions were changed from the racemic synthesis as the 
material eluted very slowly in EtOAc 
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(1S,2'S,6R)-6-(Benzyloxymethyl)-2'-((triisopropylsilyloxy)methyl)-6',7',8',9a'-
tetrahydro-2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-4'(3'H)-one 
(203a) and (1R,2'S,6S)-6-(benzyloxymethyl)-2'-((triisopropylsilyloxy)methyl)-
6',7',8',9a'-tetrahydro-2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-
4'(3'H)-one (203b) 
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To a stirred solution of alcohol 172 (50 mg, 0.135 mmol) in CH2Cl2 (1 mL) at 0 ºC 
was added 2,6-lutidine (47 !L, 0.402 mmol) in a single portion, followed by 
triisopropylsilyl trifluoromethanesulfonate (50 mg, 0.162 mmol) in a single portion. 
The reaction was stirred at 0 °C for 5 min, then allowed to warm to rt and stirred for 1 
h. The volatiles were removed under reduced pressure, then the crude product purified 
by column chromatography. Eluting with EtOAc gave the title compounds 203a and 
203b in a 1:1 mixture of inseparable diastereoisomers as a colourless oil (47 mg, 
67%); Rf 0.57 (EtOAc); !H (400 MHz, CDCl3) 7.35–7.24 (10H, m, H-10, H-10', H-11, 
H-11', H-12, H-12'), 5.63–5.21 (4H, m, H-3, H-3', H-4, H-4'), 4.78–4.68 (2H, m, H-
15a, H-15a'), 4.59–4.36 (6H, m, H-16, H-16', H-8, H-8'), 4.21–4.11 (1H, m, H-7a'), 
4.01 (1H, dd, J 9.5, 4.5, H-7a), 3.72–3.44 (6H, m, H-19, H-19', H-20, H-20'), 3.36 
(1H, t, J 9.5, H-7b), 3.23 (1H, dd, J 11.0, 9.5, H-7b'), 2.61–1.36 (24H, m, H-5, H-5', 
H-15b, H-15b', H-18, H-18', H-14, H-14', H-2, H-2', H-6, H-6', H-13, H-13'), 1.07–
1.03 (42H, m, H-21, H-21', H-22, H-22'). 
KAG/4/38 
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(1R,2'S,6S)-6-(Benzyloxymethyl)-2'-((triisopropylsilyloxy)methyl)-6',7',8',9a'-
tetrahydro-2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-4'(3'H)-one 
((–)-203) 
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According to the procedure described for the racemic material alcohol (–)-172 (628 
mg, 1.19 mmol) gave the crude product as a yellow oil, which was purified by column 
chromatography. Eluting with 75:25!25:75 iso-hexane:EtOAc gave the title 
compound (–)-203 as a colourless oil (360 mg, 41%)*; Rf 0.20 (25:75 EtOAc:iso-
hexane); !H (400 MHz, CDCl3) 7.36–7.25 (5H, m, H-10, H-11, H-12), 5.60–5.54 (2H, 
m, H-4, H-3), 4.72 (1H, dddd, J 13.0, 4.5, 2.0, 2.0, H-15a), 4.61 (1H, s, H-16), 4.49 
(1H, d, J 12.0, H-8a), 4.46 (1H, d, J 12.0, H-8b), 4.02 (1H, dd, J 9.5, 4.0, H-7a), 3.74–
3.68 (2H, m, H-17, H-20a), 3.64–3.60 (1H, m, H-20b), 3.37 (1H, dd, J 9.5, 9.5, H-7b), 
2.53–2.36 (4H, m, H-5a, H-15b, H-18), 2.28 (1H, brd, J 18.5, H-14a), 2.15 (1H, brd, J 
18.5 H-5b), 1.92 (1H, dd, J 13.5, 2.0, H-2a), 1.83–1.73 (2H, m, H-6, H-13a), 1.60–
1.49 (2H, m, H-13b, H-14b), 1.40 (1H, dd, J 13.5, 4.5, H-2b), 1.07–1.03 (21H, m, H-
21, H-22). 
1H NMR data consistent with literature.60 
KAG/4/59 
 
 
                                                
* The low yield can partly be attributed to a leak in the purification system’s injection 
port. 
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(6R,11S)-11-(benzyloxymethyl)-2-azaspiro[5.5]undec-8-en-1-one (187) 
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Crude amine 178 (assume 15.5 mmol) was dissolved in MeOH (320 mL) and aquous 
K2CO3 (10%, 80 mL) added. The reaction was stirred at rt for 18 h, the volatiles 
removed under reduced pressure and the crude product purifed by column 
chromatography. Eluting with 9:1!1:1 PE:EtOAc gave the title compound 187 as a 
colourless oil (1.28 g, contaminated with PPh3); Rf 0.58 (1:1 PE:EtOAc); [!]D +65.0 
(c 1.7, CHCl3); IR "max (neat) 3430, 1647, 1099; #H (400 MHz, CDCl3) 7.25–7.18 
(5H, m, H-10, H-11, H-12), 5.58–5.47 (3H, m, H-3, H-4, NH), 4.44 (1H, d, J 11.5, H-
8a), 4.35 (1H, d, J 11.5, H-8b), 3.70 (1H, ddd, J 9.0, 2.0, 1.0, H-7a), 3.41–3.36 (1H, 
m, H-7b), 3.27–3.23 (2H, m, H-14), 2.76–2.68 (2H, m, H-16a, H-2a), 2.42–2.39 (1H, 
m, H-5a), 2.38–2.16 (3H, m, H-6, H-2b, H-16b), 1.93–1.82 (1H, m, H-15a), 1.72–
1.56 (1H, m, H-5b), 1.43-1.38 (1H, m, H-15b); #C (100 MHz, CDCl3) 180.3 (C-13), 
142.6 (C-9), 132.1 (C-11), 131.4 (C-10), 131.2 (C-12), 128.3 (C-3), 127.4 (C-4), 77.0 
(C-7), 74.5 (C-8), 46.1 (C-1), 45.2 (C-14), 40.7 (C-6), 35.0 (C-2), 34.6 (C-16), 27.7 
(C-5), 21.4 (C-15); m/z (ESI) 308 (100), [MNa]+; [HRMS (ESI) calcd. for 
C18H23NNaO2, 308.1621 Found: [MNa]+ 308.1626 (1.7 ppm error)]. 
KAG/8/80 
 
 
(6S,7S,11S)-11-(benzyloxymethyl)-7-hydroxy-2-azaspiro[5.5]undec-8-en-1-one 
(+)-319) 
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To a stirred solution of lactone 187 (2.89 g, 10.1 mmol) in EtOH (142 mL) and water 
(7.5 mL) was added selenium dioxide (1.34 g, 12.2 mmol). The mixture was heated to 
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90 °C under an atmosphere of argon for 3 days. After cooling to rt the volatiles were 
removed under reduced pressure and the residue purified by column chromatography. 
Eluting with 1:1 PE:EtOAc!EtOAc gave the title compound (+)-319 as a yellow oil 
(1.58 g, 52%); Rf 0.21 (30% EtOAc); [!]D +158.3 (c 0.3, CHCl3); IR "max (neat) 3429, 
2928, 1638, 1454, 1364, 1100, 667; #H (400 MHz, CDCl3) 7.35–7.24 (5H, m, H-10, 
H-11, H-12), 5.65–5.58 (3H, m, H-3, H-4, NH), 4.91 (1H, br s, H-2), 4.50 (1H, d, J 
11.5, H-8a), 4.42 (1H, d, J 11.5, H-8b), 3.38–3.71 (1H, m, H-7a), 3.48–3.32 (3H, m, 
H-7b, H-14), 2.38–1.56 (8H, m, H-5, H-6, H-15, H-16, OH); #C (100 MHz, CDCl3) 
175.5 (C-13), 138.4 (C-9), 128.7 (C-11), 128.4 (C-10), 127.6 (C-12), 127.5 (C-3/4), 
125.9 (C-3/4), 73.3 (C-7), 70.4 (C-8), 66.6 (C-2), 47.8 (C-1), 42.1 (C-14), 37.8 (C-6), 
24.3 (C-16), 22.2 (C-5), 17.8 (C-15);m/z (ESI) 324 (100), [MNa]+ 301 (70) [MH]+; 
[HRMS (ESI) calcd. for C18H24NO3, 302.1751. Found: [MH]+ 302.1754 (1.2 ppm 
error)]. 
KAG/8/30 
 
 
 (6S,11S)-11-(Benzyloxymethyl)-2-azaspiro[5.5]undec-8-ene-1,7-dione (320) 
O
O
NH
1
2
3
4
5
6 8
9
7 10
11
12
13
14
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16
O
 
 
To a stirred solution of alcohol 320 (650 mg, 2.15 mmol) in toluene (32 mL) was 
added freshly dried 4 Å molecular sieves (1.30 g) and manganese dioxide (1.96 g, 
21.5 mmol). The reaction was heated at reflux for 18 h, then cooled to rt and filtered 
through a pad of Celite, washing with EtOAc (100 mL). The filtrate was concentrated 
to give the title compound 320 (648 mg, 100%) which was used without further 
purification; Rf 0.88 (1:1 PE:EtOAc); IR "max (neat) 3290, 3031, 2934, 2868, 1651, 
1486, 1453, 1390, 1318, 1104, 737; #H (400 MHz, CDCl3) 7.36–7.23 (5H, m, H-10, 
H-11, H-12), 7.01 (1H, ddd, J 10.0, 5.5, 3.0, H-4), 6.20 (1H, br s, NH), 6.01 (1H, ddd, 
J 10.0, 2.0, 1.5, H-3), 4.52–4.45 (2H, m, H-8), 3.73 (1H, dd, J 9.5, 5.0, H-7a), 3.55 
(1H, dd, J 9.5, 8.0 H-7b), 3.30–3.15 (2H, m, H-14), 2.91–2.83 (1H, m, H-6), 2.56–
2.48 (1H, m, H-5a), 2.39–2.28 (1H, m, H-16a), 2.27–2.09 (2H, m, H-15), 1.93–1.82 
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(1H, m, H-5b), 1.81–1.65 (1H, m, H-16b); !C (100 MHz, CDCl3) 198.7 (C-2), 169.9 
(C-13), 150.5 (C-4), 138.1 (C-9), 128.5 (C-10/C11), 127.9 (C-3), 127.8 (C-12), 127.7 
(C-10/C11), 73.8 (C-8), 71.5 (C-7), 54.1 (C-1), 43.6 (C-6), 42.5 (C-14), 31.4 (C-15), 
28.3 (C-5), 21.5 (C-16); m/z (ESI) 300 (100), [MH]+ 322 (70) [MNa]+; [HRMS (ESI) 
calcd. for C18H22NO3, 300.1595. Found: [MH]+ 300.1603 (3.0 ppm error)]. 
KAG/8/31 
 
 
(6S,7R,11S)-11-(Benzyloxymethyl)-7-(triisopropylsilyloxy)-2-azaspiro[5.5]undec-
8-en-1-one (–)-322) 
O
O
NH
1
2
3
4
5
6 8
9
7 10
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13
14
15
16
O17
18
Si
 
 
To a stirred solution of enone 320 (1.47 g, 4.91 mmol) in MeOH (120 mL) was added 
CeCl3"7H2O (1.83 g, 4.91 mmol). The reaction was stirred at rt under an atmosphere 
of argon for 10 min, before being cooled to –78 °C, and sodium borohydride (372 mg, 
9.82 mmol) added in a single portion. The reaction was stirred for a further 30 min at 
–78 °C, then allowed to warm to rt. The methanol was removed under reduced 
pressure then the resulting slurry partitioned between CH2Cl2 (2 x 50 mL) and 
aqueous HCl (2 M, 75 mL) The layers were separated, the organic layer dried over 
Na2SO4 and the volatiles removed under reduced pressure to give the crude product 
321 which was immediately dissolved in CH2Cl2 (25 mL) and the solution cooled to 0 
°C. To this solution was added 2,6-lutidine (1.10 mL, 9.41 mmol), followed by 
triisopropylsilyl trifluoromethanesulfonate (1.06 mL, 3.96 mmol). The reaction was 
allowed to warm to rt, where it was stirred for 1 h, then water (40 mL) and CH2Cl2 (2 
x 40 mL) added. The organic layers were combined and dried over Na2SO4 and the 
volatiles removed under reduced pressure to give the crude product, which was 
purified by column chromatography. Eluting with 6:4 PE:EtOAc gave the title 
compound 322 as a pale brown oil (703 mg, 15% over 3 steps from (+)-319); Rf 0.39 
(40% 6:4 PE:EtOAc); [#]D –24.1 (c 0.3, CHCl3); IR $max (neat) 3208, 3034, 
2865,1666, 1463, 1390, 1365, 1312, 1116, 1013, 883; !H (400 MHz, CDCl3) 7.25–
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7.24 (5H, m, H-10, H-11, H-12), 5.79–5.56 (3H, m, H-3, H-4, NH), 4.46–4.40 (2H, 
m, H-8), 4.24 (1H, br t, J 3.0, H-2), 3.69 (1H, dd, J 9.0, 5.0, H-7a), 3.35 (1H, dd, J 
9.0, 7.0, H-7b), 3.24–3.18 (1H, m, H-14a), 3.10–3.06 (1H, m, H-14b), 2.51–2.43 (1H, 
m, H-5a), 2.15–2.06 (2H, m, H-6, H-16a), 1.99–1.81 (3H, m, H-5b, H-15), 1.69–1.61 
(1H, m, H-16b), 1.10–0.91 (21H, m, H-17, H-18); !C (100 MHz, CDCl3) 171.8 (C-
13), 138.6 (C-9), 128.8 (C-3/C-4), 128.4 (C-10/C-11), 128.2 (C-3/C-4), 127.5 (C-
10/C-11), 127.4 (C-12), 77.8 (C-2), 73.1 (C-8), 72.6 (C-7), 45.7 (C-1), 44.5 (C-6), 
42.1 (C-14), 34.6 (C-15), 29.4 (C-5), 22.5 (C-16), 18.4 (C-18), 13.5 (C-17); m/z (ESI) 
458 (100), [MH]+ 480 (20) [MNa]+; [HRMS (ESI) calcd. for C27H44NO3Si, 458.3085. 
Found: [MH]+ 458.3086 (0.3 ppm error)]. 
KAG/7/68 
Will Unsworth managed 55% yield over 3 steps 64% BRSM 
WPU743, WPU746, WPU747. 
 
 
(6S,7R,11S)-11-(Hydroxymethyl)-7-(triisopropylsilyloxy)-2-azaspiro[5.5]undec-8-
en-1-one ((–)-323) 
8
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Lithium wire (560 mg, 80.2 mmol) was finely chopped and charged to a 1 L RBF, 
which was flushed with argon. To this was added THF (55 mL) followed by 
naphthalene (3.05 g, 23.8 mmol). The mixture was placed in a sonic bath for 1 h, 
before being cooled to –20 °C, then (6S,7R,11S)-11-(benzyloxymethyl)-7-
(triisopropylsilyloxy)-2-azaspiro[5.5]undec-8-en-1-one ((–)-322) (1.36 g, 2.97 mmol) 
in THF (15 mL) was added via canula. The solution was maintained at –20 °C for 5 
mins (with no stirring), then quenched by the dropwise addition of aqueous NH4Cl 
(sat., 100 mL). The resulting solution was extracted with EtOAc (2 x 150 mL) and 
then the volatiles removed to give the crude product, which was purified by column 
chromatography. Eluting with 35:65 PE:EtOAc!EtOAc!95:5 EtOAc:MeOH gave 
the title compound (–)-323 as a white solid (620 mg, 57%); m.p. 135–136 °C; Found: 
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C, 65.0; H, 9.4, N 3.7 C20H57NO3Si requires C, 65.4; H, 10.1 N, 3.81%; [!]D –108.2 (c 
0.5, CHCl3); Rf 0.12 (EtOAc); IR "max (neat) 3402, 2942, 2865, 1641, 1111, 682; #H 
(400 MHz, CDCl3) 5.90– 5.81 (1H, m, H-4), 5.75 (1H, br s, NH), 5.71–5.64 (1H, m, 
H-3), 2.47–4.32 (1H, m, H-2), 4.03–3.94 (1H, m, H-7a), 3.77–3.71 (1H, m, H-7b), 
3.37–3.25 (2H, m, H-9), 2.53–2.50 (2H, m, H-5), 2.19–2.11 (2H, m, H-11), 1.99–1.94 
(1H, m, H-6), 1.87–1.80 (2H, m, H-10), 1.16–1.06 (21H, m, H-12, H-13); #C (100 
MHz, CDCl3) 173.5 (C-8), 128.6 (C3/C4), 128.0 (C-3/C-4), 76.2 (C-2), 64.8 (C-7), 
47.3 (C-1), 45.8 (C-6), 42.2 (C-9), 33.9 (C-11), 28.7 (C-5), 22.0 (C-10), 18.3 (C-13), 
13.3 (C-12); m/z (ESI) 368 (100), [MH]+ 390 (30) [MNa]+; [HRMS (ESI) calcd. for 
C20H38NO3Si, 368.2615. Found: [MH]+ 368.2608 (1.9 ppm error)]. 
KAG/8/38 
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(6S,7S,11R)-1-Oxo-11-(triisopropylsilyloxy)-2-azaspiro[5.5]undec-9-ene-7-
carbaldehyde ((–)-324) 
8
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O
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To a stirred solution of (6S,7R,11S)-11-(hydroxymethyl)-7-(triisopropylsilyloxy)-2-
azaspiro[5.5]undec-8-en-1-one ((–)-323) (413 mg, 1.12 mmol), in CH2Cl2 (17 mL), 
were added freshly dried 4 Å molecular sieves (600 mg) and N-methyl-morpholine-N-
oxide (158 mg, 1.35 mmol). The reaction was stirred at rt for 10 min, then tetra-n-
propylammonium perruthenate (39.5 mg, 0.266 mmol) added and the reaction stirred 
at rt for 1 h. The reaction mixture was filtered through a plug of Celite, then 
concentrated to give the crude product, which was purified by column 
chromatography. Eluting with 85:15!1:1 PE:EtOAc gave the title compound (–)-324 
as a white solid (334 mg, 81%) m.p. 112–114 °C; Rf 0.42 (1:1 PE:EtOAc); [!]D –78.2 
(c 0.85, CHCl3); IR "max (neat) 3205, 2941, 2865, 1703, 1658, 1492, 1462, 1413, 
1326, 1088, 883; #H (400 MHz, CDCl3) 10.30 (1H, d, J 4.0, H-7), 5.87 (1H, s, NH), 
5.77–5.75 (2H, m, H-3, H-4), 4.48 (1H, s, H-2), 3.37–3.31 (2H, m, H-9), 2.49–2.39 
(2H, m, H-6, H-5a), 2.04–1.95 (2H, m, H-10), 1.84–1.77 (1H, m, H-11a), 1.67–1.61 
(1H, m, H-11b) 1.09–1.04 (21H, m, H-12, H-13); #C (100 MHz, CDCl3) 205.1 (C-7), 
173.5 (C-8), 127.6 (C3/C4), 126.4 (C3/C4), 69.8 (C-2), 52.8 (C-6), 47.2 (C-1), 42.0 
(C-9), 30.7 (C-11), 27.8 (C-5), 19.3 (C-10), 18.2 (C-13), 13.1 (C-12); m/z (ESI) 366 
(100), [MH]+; [HRMS (ESI) calcd. for C20H36NO3Si, 366.2453. Found: [MH]+ 
366.2461 (0.6 ppm error)]. 
WPU 679/680 (best yield) 
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(6S,7R,11R)-11-((E)-2-Iodovinyl)-7-(triisopropylsilyloxy)-2-azaspiro[5.5]undec-8-
en-1-one (–)-343 
8
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An oven dry Schlenk tube was charged with CrCl2 (1.00 g, 8.14 mmol), and the 
contents flame dried under high vacuum. The tube was then allowed to cool and the 
CrCl2 slurried in dry THF (3.94 mL). To this was added a solution of aldehyde (–)-
324 (297 mg, 0.814 mmol) and CH3I (961 mg, 2.44 mmol) in dry 1,4-dioxane (23.7 
mL). The reaction was stirred at rt for 3 h, then quenched by the addition of water (50 
mL), extracted with EtOAc (2 x 50 mL). The combined organic layers were washed 
with brine (50 mL), then dried over MgSO4 and the volatiles removed under reduced 
pressure to give the crude product, which was purified by column chromatography. 
Eluting with 85:15!3:1!1:1 PE:EtOAc gave the title compound (–)-343 as a 
colourless oil (271 mg, 68%); Rf 0.21 (3:1 PE:EtOAc); [!]D –77.9 (c 0.50, CHCl3); IR 
"max (neat) 2941, 2866, 1666, 1464, 1313, 1110, 961; #H (400 MHz, CDCl3) 6.57 (1H, 
dd, J 14.5, 10.0, H-7), 6.12 (1H, d, J 14.5, H-14), 5.78–5.62 (3H, m, H-3, H-4, NH), 
4.26–4.24 (1H, m, H-2), 3.28–3.17 (2H, m, H-9), 5.66–5.56 (1H, m, H-5a), 2.28–2.12 
(2H, m, H-5a, H-6), 1.93–1.71 (4H, m, H-10, H-11) 1.09-1.04 (21H, m, H-12, H-13); 
#C (100 MHz, CDCl3) 170.9 (C-8), 147.9 (C-7), 129.1 (C-3/C-4), 127.3 (C-3/C-4), 
77.2 (C-2), 79.2 (C-14), 52.5 (C-6), 47.6 (C-1), 42.3 (C-9), 35.0 (C-11), 31.1 (C-5), 
21.5 (C-10), 18.3 (C-13), 13.5 (C-12); m/z (ESI) 490 (100), [MH]+, 512 (30) [MNa]+; 
[HRMS (ESI) calcd. for C21H37INO2Si, 490.1643. Found: [MH]+ 490.1643(2.0 ppm 
error)]. 
WPU/683 
Rigorously anhydrous conditions necessary, use a new ampoule of CrC2 each time. 
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(6S,7R,11R)-11-((E)-2-Iodovinyl)-1-methoxy-7-(triisopropylsilyloxy)-2-
azaspiro[5.5]undeca-1,8-diene ((–)-344) 
15
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To s stirred solution of vinyl iodide (–)-343 (435 mg, 0.889 mmol) in CH2Cl2 (10.9 
mL) at rt were added freshly dried 4 Å molecular sieves (450 mg), then K2CO3 (491 
mg, 3.56 mmol), followed by Meerwein’s salt (394 mg, 2.67 mmol). The reaction was 
stirred at rt for 1 h, then diluted with CH2Cl2 (20 mL) and filtered through a plug of 
Celite, washing with CH2Cl2 (40 mL). The volatiles were removed under reduced 
pressure, giving the title compound (–)-344 as a mixed salt (440 mg), which was used 
without further purification. 
 
Data was collected on the free imidate by taking a small sample and performing an 
aqueous workup with aqueous NaHCO3. 
 
Rf 0.90 (EtOAc); [!]D –40.1 (c 1.6, CHCl3); IR "max (neat) 2941, 2865, 2360, 1650, 
1463, 1112, 1064, 974; #H (400 MHz, CDCl3) 6.30 (1H, dd, J 10.0, 14.0), 6.07 (1H, d, 
J 14.0, H-14), 5.68–5.58 (2H, m, H-3, H-4), 4.14–4.09 (1H, m, H-2), 3.50–3.31 (5H, 
m, H-9, H-15), 2.37–2.15 (2H, m, H-6, H-5a), 2.06–1.96 (1H, m, H-11a), 1.89–1.82 
(1H, m, H-5b), 1.69–1.54 (3H, m, H-10, H-11b), 1.19–0.92 (21H, m, H-12, H-13); #C 
(100 MHz, CDCl3) 162.3 (C-8), 148.1 (C-7), 130.0 (C-3/C-4), 126.4 (C-3/C-4), 76.3 
(C-2), 75.9 (C-14), 51.7 (C-15/C-6), 51.5 (C-15/C6), 46.7 (C-9), 49.7 (C-1), 35.8 (C-
11), 31.4 (C-5), 21.0 (C-10), 18.3 (C-13), 13.4 (C-12); m/z (ESI) 504 (100), [MH]+; 
[HRMS (ESI) calcd. for C22H39INO2Si, 504.1789. Found: [MH]+ 504.1802 (2.6 ppm 
error)]. 
WPU/762 
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(6R,7R,11R)-11-((E)-2-Iodovinyl)-7-(triisopropylsilyloxy)-2-azaspiro[5.5]undeca-
1,8-diene (+)-345) 
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To a stirred solution of crude mixed salt (–)-344 (553 mg, assume 1.10 mmol (100% 
based on lactam (–)-343 in 95% EtOH (12 mL) at –40 °C was added NaBH4 (81.2 
mg, 2.20 mmol). The pH of the reaction was monitored and maintained as close to 7 
as possible by the dropwise addition of aqueous HCl (1 M). After 30 min the reaction 
was quenched by the addition of aqueous NaHCO3 (sat., 10 mL) and then extracted 
with CH2Cl2 (3 x 10 mL). Removal of the volatiles under reduced pressure gave the 
crude compound, which was purified by column chromatrography. Eluting with 85:15 
PE:EtOAc gave the title compound (+)-345 as a colourless oil (179 mg, 34%, along 
with 251 mg, 45% of starting material (–)-344) 
 
The starting material recovered (251 mg) was recycled by resubjection to the above 
reduction conditions, giving a further 68 mg product and 163 mg starting material (–)-
344. A further two cycles generated another 38.5 mg and 30 mg of (–)-344, giving a 
total of 328 mg (63% yield) of the isolated product (+)-345 along with 57 mg of the 
starting imidate (–)-344 (70% BRSM); Rf 0.70 (EtOAc); [!]D +16.3 (c 0.90, 
CHCl3); IR "max (neat) 2941, 2685, 1668, 1462, 1247, 1214, 1110, 1067, 883; #H (400 
MHz, CDCl3) 7.88 (1H, s, H-8), 6.59 (1H, dd, J 14.0, 10.0, H-7), 6.08 (1H, d, J 14.0, 
H-14), 5.77–5.70 (2H, m, H-3, H-4), 4.22–4.19 (1H, m, H-2), 3.68–3.58 (1H, m, H-
9a), 3.51–3.40 (1H, m, H-9b), 2.30–2.29 (1H, m, H-6), 2.18–2.08 (2H, m, H-5), 1.99–
1.82 (1H, m, H-11a), 1.67–1.54 (2H, m, H-10), 1.47–1.40 (1H, m, H-11b) 1.09–1.04 
(21H, m, H-12, H-13); #C (100 MHz, CDCl3) 164.9 (C-8), 147.6 (C-7), 129.6 (C-3/C-
4), 125.8 (C-3/C-4), 75.8 (C-2/C-14), 74.1 (C-2/C-14), 50.2 (C-6), 49.3 (C-9), 42.1 
(C-1), 29.0 (C-5/C-11), 28.9 (C5/C11), 19.8 (C10), 18.3 (C-12), 13.0 (C-13); m/z 
(ESI) 474 (100), [MH]+; [HRMS (ESI) calcd. for C21H37INOSi, 474.1684. Found: 
[MH]+ 474.1688 (0.3 ppm error)]. 
WPU/763-766 
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6.3 Short chain DE core compounds 
 
3-(tert-Butyldimethylsilyloxy)propan-1-ol (220) 
OHO
12
3
Si
4
5
6
 
 
To a stirred solution of 1,3-propane diol (10.0 g, 131 mmol) in THF (50 mL) at –10 
°C under an atmosphere of argon was added dropwise n-BuLi (2.7 M in heptane, 53.5 
mL, 145 mmol). The reaction was allowed to warm to 0 °C, where it was stirred for 
30 min. tert-Butyldimethylsilyl chloride (19.8 g, 131 mmol) in THF (25 mL) was 
added dropwise and the reaction allowed to warm to rt and stirred overnight. The 
reaction was partitioned between water (250 mL) and EtOAc (2 x 250 mL). The 
organic layers were combined and dried over MgSO4 and the volatiles removed under 
reduced pressure to give the crude product as a pale yellow oil. This could be used 
crude, or purified by column chromatography. Eluting with 9:1!7:3 iso-
hexane:EtOAc gave the title compound 220 as a pale yellow oil (8.50 g, 35%); Rf 0.23 
(8:2 iso-hexane:EtOAc); !H (400 MHz, CDCl3) 3.82 (2H, t, J 5.5, H-4), 3.79 (2H, t, J 
5.5, H-6), 2.63 (1H, br s, OH), 1.77 (2H, app quin., J 5.5, H-5), 0.89 (9H, s, H-1), 
0.07 (6H, s, H-3). 
1H NMR data consistent with literature.134 
KAG/4/75 
 
 
3-(tert-Butyldimethylsilyloxy)propanal (221) 
OO
12
3
Si
4
5
6
 
 
To a stirred solution of oxalyl chloride (1.48 mL, 17.0 mmol) in CH2Cl2 (15 mL) at –
78 °C under an atmosphere of argon was added DMSO (2.21 mL, 31.1 mmol) in 
CH2Cl2 (2 mL). The internal temperature was monitored and the addition rate 
controlled such that it remained below –60 °C. The resulting mixture was stirred at –
78 °C for 10 min, then 3-(tert-butyldimethylsilyloxy)propan-1-ol (220) (2.69 g, 14.1 
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mmol) in CH2Cl2 (20 mL) added dropwise maintaining the internal temperature below 
–60 °C. The reaction was stirred at –78 °C for 1 h, before being quenched by the 
addition of triethylamine (9.82 mL, 70.6 mmol) and the reaction warmed to rt. The 
reaction was diluted with CH2Cl2 (150 mL) and washed with aqueous HCl (2 M, 2 x 
150 mL) and water (2 x 150 mL). The organic layer was dried over MgSO4 then the 
volatiles removed under reduced pressure to give the title compound 221 as a brown 
oil (1.91 g, 74%) which was used without further purification; Rf 0.46 (8:2 iso-
hexane:EtOAc); !H (400 MHz, CDCl3) 9.79 (1H, t, J 2.0, H-6), 3.98 (2H, t, J 6.0, H-
4), 2.58 (2H, td, J 6.0, 2.0, H-5), 0.87 (9H, s, H-1), 0.05 (6H, s, H-3). 
1H NMR data consistent with literature.135 
KAG/4/79 
It should be noted that this compound appeared unstable at room temperature. 
 
 
5-(tert-Butyldimethylsilyloxy)pent-1-yn-3-ol (214) 
O
OH 12
3
Si4
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8  
 
To a stirred solution of ethynylmagnesium bromide 222 (0.5 M in THF, 21.2 mL, 
10.6 mmol) at 0 °C under an atmosphere of argon was added slowly 3-(tert-
butyldimethylsilyloxy)propanal (221) (1.80 g, 9.63 mmol) in THF (5 mL). The 
reaction was stirred at 0 °C for 30 min, then allowed to warm to rt and stirred for 30 
min. The reaction was quenched by the addition of aqueous NaHCO3 solution (sat., 
20 mL) then the THF removed under reduced pressure. The remaining yellow oil was 
partitioned between water (50 mL) and Et2O (2 x 50 mL). The organic layers were 
combined, dried over MgSO4 and the volatiles removed under reduced pressure to 
give the crude product as a yellow oil, which was purified by column 
chromatography. Eluting with 3:1 iso-hexane:EtOAc gave the title compound 214 as a 
yellow oil (1.25 g, 61%); Rf 0.31 (3:1 iso-hexane:EtOAc); !H (400 MHz, CDCl3) 
4.71–4.61 (1H, m, H-6), 4.05 (1H, ddd, J 10.0, 8.0, 4.0, H-4a), 3.84 (1H, ddd, J 10.0, 
6.5, 4.0, H-4b), 3.50 (1H, br s, OH), 2.46 (1H, d, J 2.0, H-8), 2.01 (1H, ddt J 18.5, 
8.0, 4.0, H-5a), 1.87 (1H, dddd, J 18.5, 13.0, 6.5, 4.0, H-5b), 0.89 (9H, t, J 3.0, H-1), 
0.08 (6H, d, J 3.0, H-3).  
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KAG/4/64 
1H NMR data consistent with literature.104 
 
This was not the most repeatable procedure for synthesis of this compound. Yields 
varied with polymerisation and deprotection of the TBS group observed on several 
occasions. When attention was turned to the synthesis of the longer chain analogue a 
different procedure was used (see Section 6.4 for details). If this compound was to be 
synthesised again we would recommend the route used for the longer chain 
compound. 
 
 
(R)-5-(tert-Butyldimethylsilyloxy)pent-1-yn-3-ol ((+)-214) and (S)-5-(tert-
butyldimethylsilyloxy)pent-1-yn-3-yl ethanoate ((!)-231) 
O
OH
Si
   
O
O 12
3
Si4
5
6
7
8
O
910
 
 
To a stirred solution of alcohol 214 (3.00 g, 14.0 mmol) in n-hexane (100 mL) under 
an atmosphere of argon was added powdered 4 Å molecular sieves (3.60 g), followed 
by vinyl acetate (8.01 mL, 84.0 mmol), then Amano lipase (3.00 g). The mixture was 
stirred at 35 ºC, and monitored by removing 60 µL aliquots for GC. After 3.5 h the 
conversion reached 50%, and the reaction was filtered through a pad of Celite 
washing with EtOAc (150 mL). The volatiles were removed under reduced pressure 
to give the crude product, which was purified by column chromatography. Eluting 
with 8:2! 6:4 iso-hexane:EtOAc gave acetate (!)-231 as a colourless oil (1.63 g, 
45%, 91% theoretical) and alcohol (+)-214 (1.32 g, 44%, 88% theoretical). 
 
 
(R)-5-(tert-Butyldimethylsilyloxy)pent-1-yn-3-ol (+)-214) 
Data as for racemate (±)-214 except 
["]D +16.3 (c 8.25, CHCl3) (Lit.104 +14.8 (c 8.25, CHCl3)). 
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(S)-5-(tert-Butyldimethylsilyloxy)pent-1-yn-3-yl ethanoate ((!)-231) 
 
Rf 0.49 (3:1 iso-hexane:EtOAc); "H (400 MHz, CDCl3) 5.48 (1H, dt, J 7.0, 2.0, H-6), 
3.79–3.69 (2H, m, H-4), 2.45 (1H, d, J 2.0, H-8), 2.08 (3H, s, H-10), 2.07–1.91 (2H, 
m, H-5), 0.89 (9H, s, H-1), 0.02 (6H, s, H-3). 
KAG/4/66 
1H NMR data consistent with literature.104 
 
 
(S)-5-(tert-Butyldimethylsilyloxy)pent-1-yn-3-ol ((!)-214) 
O
OH 1
2
3
Si
4
5
6
7  
 
To a stirred solution of acetate (!)-231 (1.40 g, 5.46 mmol) in MeOH (20 mL) and 
water (10 mL) at 0 ºC was added lithium hydroxide monohydrate (252 mg, 6.01 
mmol), then the reaction allowed to warm to rt, and stirred for an hour. The reaction 
was partitioned between water (100 mL) and Et2O (2 x 100 mL), the organic layers 
combined and dried over MgSO4, then the volatiles removed under reduced pressure 
to give the title compound (!)-214 as a colourless oil (1.12 g, 95%). 
Data as for racemate (±)-214 except 
[#]D –19.5 (c 8.25, CHCl3). 
KAG/4/88 
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(S)-((R)-5-(tert-Butyldimethylsilyloxy)pent-1-yn-3-yl) 3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate (233) 
O
1
2
3
Si4
5
67
O
O
OMe
F3C
9
8
1011
12
13
14
 
To a stirred solution of alcohol (+)-214 (50 mg, 0.233 mmol) in pyridine (1 mL) at 0 
°C under argon was added (R)-(–)-!-methoxy-!(trifluoromethyl)phenylacetyl 
chloride (56 µL, 0.299 mmol) in a single portion. The reaction was allowed to warm 
to rt, where it was stirred for an hour. The cloudy solution was partitioned between 
water (25 mL) and Et2O (2 x 25 mL), the organic layers combined and dried over 
MgSO4 to give the title compound 233 as a colourless oil (92 mg, 92 %) which was 
used without further purification; Rf 0.52 (4:1 iso-hexane:EtOAc); "H (500 MHz, 
CDCl3) 7.56–7.52 (2H, m, ArCH), 7.43–7.37 (3H, m, ArCH), 5.70 (1H, ddd, J 8.5, 
6.5, 2.5, H-6), 3.79–3.68 (2H, m, H-3), 3.55 (3H, s, OMe), 2.50 (1H, d, J 2.5, H-8), 
2.15–1.99 (2H, m, H-5), 0.89 (9H, s, H-1), 0.05 (6H, s, H-3); "C (125 MHz, CDCl3) 
165.7 (C-9), 132.1 (C-11), 129.7 (C-12/C-13/C-14), 128.5 (C-12/C-13/C-14), 127.7 
(C-12/C-13/C-14), 126.6 (q, 1JCF 274, CF3), 78.9 (C-7), 77.1 (C-10), 74.9 (C-8), 63.3 
(C-6), 55.1 (OCH3), 37.5 (C-4), 29.8 (C-5), 29.0 (C-1), 18.4 (C-2), –5.3 (C-3); "F (470 
MHz, CDCl3) –72.03 (s, minor CF3), –72.32 (s, major CF3). 
19F NMR integration indicated an d.r of 93:7, meaning an e.r of 93:7 or e.e of 86% for 
the precursor alcohol. The diastereoisomers were also observable in the 1H NMR peak 
for the OMe group ("= 3.55 ) but were closer and less accurate to integrate. The 
diastereoisomers were not observed by 13C NMR. 
KAG/4/86 
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(S)-((S)-5-(tert-Butyldimethylsilyloxy)pent-1-yn-3-yl) 3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate (232) 
11
12
13
14
O
1
2
3
Si4
5
67
O
O
OMe
F3C
9
8
10
 
 
According to the procedure for 233. 
Colourless oil (90 mg, 90 %) 
 
Rf 0.52 (4:1 iso-hexane:EtOAc); !H (400 MHz, CDCl3) 7.41–7.35 (2H, m, ArCH), 
7.32–7.28 (3H, m, ArCH), 5.72 (1H, ddd, J 8.5, 6.5, 2.5, H-6), 3.85–3.51 (5H, m, H-
4, OCH3), 2.55 (1H, d, J 2.5, H-8), 2.13–1.91 (2H, m, H-5), 0.87 (9H, br t, J 4.0, H-
1), 0.01 (6H, d, J 4.0, H-3); !C (100 MHz, CDCl3) 165.7 (C-9), 132.4 (C-11), 129.8 
(C-12/C-13/C-14), 128.5 (C-12/C-13/C-14), 127.4 (C-12/C-13/C-14), 125.9 (q, 1JCF 
270, CF3), 80.0 (C-7), 77.2 (C-10), 75.0 (C-8), 62.9 (C-6), 58.1 (OCH3), 37.6 (C-4), 
29.8 (C-5), 29.0 (C-1), 18.3 (C-2), –5.4 (C-3); !F (376 MHz, CDCl3) –71.08 (s, major 
CF3), –72.10 (s, minor CF3). 
19F NMR integration indicated an d.r of 90:10, meaning an e.r. of 90:10 or a e.e. of 
80% for the precursor alcohol. The diastereoisomers were not observed by 1H or 13C 
NMR. 
KAG/4/88 
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tert-Butyl 5-(trifluoromethylsulfonyloxy)-3,4-dihydropyridine-1(2H)-carboxylate 
(213) 
N
O
S
O O
OO
F F
F
1
2
3
4
5
6
7
 
According to the procedure described by Vicart et al.136 
To a stirred solution of freshly distilled diisopropylamine (984 µL, 7.03 mmol) in 
THF (15 mL) at 0 °C under an atmosphere of argon was added slowly n-butyl lithium 
(1.34 M in hexane, 5.25 mL, 7.03 mmol). The resulting solution was stirred at 0 °C 
for 15 min, before being cooled to –78 °C. N-Boc-3-piperidone (1.00 g, 5.02 mmol) 
in THF (3 mL) was added dropwise to this solution, and it was stirred at –78 °C for 
15 min. N-Phenyl-bis(trifluoromethanesulfonimide) (1.79 g, 5.02 mmol) in THF (5 
mL) was added dropwise, and the solution allowed to warm slowly to rt overnight. 
The volatiles were removed under reduced pressure, then the crude product 
immediately purified by column chromatography. Eluting with 92:8 PE:Et2O gave the 
title compound 213 as a pale brown oil as a mixture of 2 rotamers (659 mg, 42%); Rf 
0.59 (4:1 PE:Et2O); !H (400 MHz, CDCl3) 7.24, 7.09 (1H, 2 x s, H-7), 3.51 (2H, br s, 
H-4), 2.42 (2H, t, J 5.5, H-6), 1.95 (2H, app quin., J 5.5, H-5), 1.48 (9H, s, H-1). 
1H NMR data consistent with literature.136 
KAG/7/6, KAG/5/52 
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tert-Butyl 5-(5-(tert-butyldimethylsilyloxy)-3-hydroxypent-1-ynyl)-3,4-
dihydropyridine-1(2H)-carboxylate (125) 
N
OO
OH
O 1
2
3
4
5
67
9
10
11
12
Si
8
13
14
15
16
 
 
To a stirred solution of triflate 213 (488 mg, 1.47 mmol) and alcohol 214 (380 mg, 
1.77 mmol) in distilled diisopropylamine (9.60 mL) was added flame dried lithium 
chloride (186 mg, 4.41 mmol), copper iodide (14 mg, 0.0735 mmol) and Pd(PPh3)4 
(42 mg, 0.0363 mmol) followed by dry degassed DMF (2.4 mL). The reaction was 
purged with argon before being heated to 45 °C for 1 h. The volatiles were removed 
under reduced pressure, then the residue partitioned between water (50 mL) and 
EtOAc (2 x 50 mL). The organic layers were combined, dried over Na2SO4 and the 
volatiles removed under reduced pressure to give the crude product as a brown oil, 
which was purified by column chromatography. Eluting with 7:3 PE:Et2O gave the 
title compound 215 as a pale brown oil as a mixture of 2 rotamers (537 mg, 92%); Rf 
0.37 (7:3 PE:Et2O); IR !max (neat) 3440, 2953, 2930, 2856, 1709, 1631, 1471, 1384, 
1308, 1254, 1159, 1112, 835, 776; "H (400 MHz, CDCl3); 7.22, 7.07 (1H, 2 x s, H-
10), 4.70 (1H, br s, H-6), 4.02–3.97 (1H, m, H-14a), 3.82–3.78 (1H, m, H-14b), 3.48 
(2H, br s, H-4), 2.12 (2H, t, J 5.5, H-5), 1.99–1.76 (4H, m, H-15, H-16), 1.46 (9H, s, 
H-13), 0.87 (9H, s, H-1), 0.06 (6H, s, H-3); "C (100 MHz, CDCl3) 151.7 (C-11), 131.6 
(C-10), 98.4 (C-9), 87.2 (C-8), 85.6 (C-7), 81.6 (C-12), 62.5 (C-6), 61.3 (C-4), 41.1 
(C-14), 39.0 (C-5), 28.3 (C-13), 26.0 (C-16), 25.9 (C-1), 21.2 (C-15), 18.2 (C-2), –5.4 
(C-3); m/z (ESI) 396 (100), [MH]+ 418 (65) [MNa]+; [HRMS (ESI) calcd. for 
C21H38NO4Si, 396.2565. Found: [MH]+ 396.2567 (0.3 ppm error)]. 
KAG/3/46 
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tert-Butyl 5-(5-(tert-butyldimethylsilyloxy)-3-hydroxypentyl)-3,4-
dihydropyridine-1(2H)-carboxylate (216) 
 
 
N
OO
OH
O 1
2
3
4
56
7
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To a stirred solution of alcohol 215 (450 mg, 1.14 mmol) in EtOAc (13 mL), was 
added Et3N (475 µL) followed by Pd/C (23 mg). The reaction was purged with H2, 
then stirred under an atmosphere of H2 at rt overnight. The reaction was filtered 
through a pad of Celite, washed with EtOAc and the volatiles removed under reduced 
pressure to give the title compound 216 as a pale brown oil, which was used 
immediately without further purification; Rf 0.26 (7:3 PE:Et2O); IR !max (neat) 3467, 
2930, 2857, 1700, 1472, 1395, 1365, 1316, 1158, 1092, 836; "H (400 MHz, CDCl3) 
6.65, 6.52 (1H, 2 x s, H-10), 3.89–3.75 (3H, m, H-6, H-14), 3.45–3.41 (2H, m, H-4), 
2.13–2.08 (1H, m, H-15a), 2.01–1.93 (3H, m, H-5, H-15b), 1.79–1.74 (2H, m, H-7), 
1.64–1.44 (4H, m, H-8, H-16), 1.45 (9H, s, H-13), 0.86 (9H, s, H-1), 0.05 (6H, s, H-
3); 
The 13C NMR displays an ~1:1 mixture of rotamers for many signals. 
"C (100 MHz, CDCl3) 152.8, 152.4 (C-11), 120.5, 210.1 (C-10), 118.2, 117.6 (C-9), 
80.3, 80.2 (C-12), 71.9, 71.8 (C-6), 62.9, 62.8 (C-4), 45.8. 42.2 (C-14), 41.2 (C-5), 
38.4, 38.3 (C-7), 31.6, 31.5 (C-8), 25.9 (C-13), 25.2, 25.1 (C-16), 21.9, 21.8 (C-15), 
18.2 (C-2), –5.4 (C-1), –5.5 (C-3); m/z (ESI) 400 (73), [MH]+ 422 (100) [MNa]+; 
[HRMS (ESI) calcd. for C21H41NNaO4Si, 422.2697. Found: [MNa]+ 422.2704 (1.6 
ppm error)]. 
KAG/3/47 
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tert-Butyl 2-(2-(tert-butyldimethylsilyloxy)ethyl)hexahydro-2H-pyrano[2,3-
b]pyridine-8(8aH)-carboxylate (217)  
N
O O
O
O
1
2
3
4
5
6 7 8 9
10
11 12
13
14
15
16
Si
 
 
To a stirred solution of crude alcohol 216 (1.14 mmol assuming 100% conversion) in 
CH2Cl2 (19 mL) was added 183 µL of HCl (0.1 M solution of HCl in a 20:1 mixture 
of CH2Cl2: MeOH). The mixture was stirred for 5 min, then SiO2 (900 mg) was added 
and the volatiles removed under reduced pressure to give a pale yellow oil, which was 
purified immediately by column chromatography. Eluting with 9:1!2:8 PE:Et2O 
gave the title compound 217 as a colourless oil (219 mg, 67%); Rf 0.27 (8:2 PE:Et2O); 
IR !max (neat) 3422, 2933, 2862, 1696, 1415, 1366, 1274, 1159, 1091, 1052, 987, 938, 
737; "H (400 MHz, CDCl3); 5.31, 5.11 (1H, 2 x br s, H-11), 3.81–3.46 (2H, m, H-4a, 
H-10), 3.68 (2H, t, J 6.5, H-13), 2.97–2.83 (1H, m, H-4b), 1.80–1.53 (7H, m, H-7, H-
12, H-8, H-9), 1.45 (9H, s, H-1), 1.3–1.63 (4H, m, H-5, H-6), 0.87 (9H, s, H-16), 0.03 
(6H, d, J 1.0, H-14); 
The 13C NMR displays an ~1:1 mixture of rotamers for many signals. 
"C (100 MHz, CDCl3) 153.4 (C-3), 82.7 (C-11), 79.8 (C-2), 74.7 (C-10), 59.9 (C-13), 
39.8, 39.6 (C-4), 39.4, 39.1 (C-12), 34.0 (C-7), 28.9 (C-8/9), 28.4 (C-1), 26.4 (C-8/9), 
26.1 (C-16), 28.4 (C5/6), 23.2 (C-5/6), 18.4 (C-15), –5.7 (C-14); m/z (ESI) 400 (25), 
[MH]+ 422 (100) [MNa]+; [HRMS (ESI) calcd. for C21H41NNaO4Si, 422.2697. 
Found: [MNa]+ 422.2703 (1.3 ppm error)]. 
KAG/3/49 
 
 
tert-Butyl 2-(2-hydroxyethyl)hexahydro-2H-pyrano[2,3-b]pyridine-8(8aH)-
carboxylate (230) 
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To crude alcohol 216 (1.56 mmol assuming 100% conversion) in CH2Cl2 (19 mL) 
was added SnCl2!2H2O in a single portion (877 mg, 3.90 mmol). The reaction was 
stirred at rt for 2 h, before being filtered through a plug of Celite, washing with 
CH2Cl2 (50 mL). The filtrate was concentrated under reduced pressure, then purified 
by column chromatography. Eluting with 2:8 PE:Et2O gave the title compound 230 as 
a colourless film (281 mg, 63% over 2 steps from 215); Rf 0.41 (7:3 PE:Et2O); IR "max 
(neat) 3423, 2932, 2861, 1701, 1452, 1413, 1365, 1313, 1275, 1249, 1159, 1127, 
1091, 1052, 983; #H (400 MHz, CDCl3); 5.35, 5.19 (1H, 2 x br s, H-11), 3.91–3.62 
(4H, m, H-13, H-4a, H-10), 2.89 (1H, br s, H-4b), 1.85–1.60 (8H, m, H-7, H-5, H-6a, 
H-9, H-12), 1.45 (10H, br s, H-1, H-6b), 1.36–1.23 (2H, m, H-8);  
The 13C NMR displays a 1:1 mixture of rotamers for many signals. 
#C (100 MHz, CDCl3) 155.6 (C-3), 82.8, 81.7 (C-11), 78.5, 78.4 (C-10), 80.4 (C-2), 
62.1, 61.6 (C-13), 40.1, 39.4 (C-4), 37.5 (C-12), 33.7 (C-7), 28.6 (C-6), 28.4 (C-1), 
26.3 (C9/C5), 24.8 (C-9/C-5), 23.0 (C-8); m/z (ESI) 308 (100), [MNa]+; [HRMS 
(ESI) calcd. for C15H27NNaO4, 308.1832. Found: [MNa]+ 308.1839 (2.0 ppm error)]. 
 
(2S,4aS,8aR)-tert-butyl 2-(2-(tert-butyldimethylsilyloxy)ethyl)hexahydro-2H-
pyrano[2,3-b]pyridine-8(8aH)-carboxylate ((–)-217) 
N
OO
O OTBS
H
H
 
 
According to the procedure for (±)-217  
29% over 3 steps from (+)-214 
Data as for racemate (±)-217 except 
[$]D –1.5 (c 1.1, CHCl3). 
KAG/5/60 
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(2R,4aR,8aS)-tert-butyl 2-(2-(tert-butyldimethylsilyloxy)ethyl)hexahydro-2H-
pyrano[2,3-b]pyridine-8(8aH)-carboxylate ((+)-217) 
N
OO
O OTBS
H
H
 
According to the procedure for (±)-217   
13% over 3 steps from (–)-214 
Data as for racemate (±)-217 except 
[!]D +1.8 (c 1.2, CHCl3). 
KAG/5/58 
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6.4 Long chain DE core compounds 
 
6-(tert-Butyldimethylsilyloxy)hexan-1-ol (249) 
O
HO
1234
5
Si
6
7
8
9  
 
Prepared according to the procedure described by McDougal and co-workers.134  
To a stirred suspension of sodium hydride (10.1 g, 253 mmol) in THF (350 mL) at rt 
under an atmosphere of argon was added dropwise 1,6-hexane diol (30.0 g, 253 
mmol) in THF (150 mL). The solution was stirred at rt under a flow of nitrogen for 45 
min. tert-Butyldimethylsilyl chloride (38.1 g, 253 mmol) was added portionwise and 
the reaction stirred for a further 45 min at rt. The reaction was quenched by the 
addition of aqueous K2CO3 (10%, 200 mL) and then extracted with Et2O (2 x 250 
mL). The organic layers were combined and the volatiles removed under reduced 
pressure to give the title compound 249 as a colourless oil (49.9 g, 85%) which was 
used without further purification; Rf 0.42 (7:3 PE:EtOAc); !H (400 MHz, CDCl3) 
3.75–3.42 (4H, m, H-4, H-9), 1.62–1.41 (8H, m, H-5, H-6, H-7, H-8), 0.81 (9H, s, H-
3), 0.03 (6H, s, H-1). 
KAG/7/15 
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8-(tert-Butyldimethylsilyloxy)oct-1-yn-3-ol (26) 
O 1
2
3
4
5
Si
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7
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OH
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The telescoped Swern-Griganard reaction was carried out according to the procedure 
described by Ireland.112 
 
To a stirred solution of oxalyl chloride (7.64 mL, 90.3 mmol) in THF (200 mL) at –78 
°C was added dropwise DMSO (6.72 mL, 94.6 mmol) under a flow of nitrogen. The 
internal temperature was monitored and the addition rate maintained such that it did 
not exceed –60 °C. The solution was allowed to warm to –35 °C, then recooled to –78 
°C. Alcohol 249 (20.0 g, 86.0 mmol) in THF (150 mL) was added dropwise 
maintaining the internal temperature below –60 °C. The reaction was allowed to 
warm to –35 °C, where it was stirred for 15 min. Triethylamine (60.0 mL, 430 mmol) 
was added in a single portion and the solution warmed to rt briefly before being 
recooled to –78 °C. Ethynylmagnesium bromide 222 (0.5 M in THF, 860 mL, 430 
mmol) was added dropwise, then the solution warmed to rt and stirred for 2 h. The 
reaction was quenched by the addition of 10% NH4OH in aqueous NH4Cl (sat., 800 
mL) then extracted with Et2O (2 x 1 L). The organic layers were combined, dried over 
Na2SO4 and the volatiles removed under reduced pressure to yield the crude product 
which was purified by column chromatography. Eluting with 85:15 PE:EtOAc gave 
the title compound 26 as an orange oil (13.8 g, 63 %); Rf 0.55 (7:3 PE:EtOAc); IR 
!max (neat) 3310, 2931, 2858, 1470, 1388 1254, 1099, 836; "H (400 MHz, CDCl3) 
4.44 (1H, dt, J 6.0, 2.0, H-9), 3.56 (2H, t, J 6.0, H-4), 2.42 (1H, d, J 2.0, H-11), 1.21–
1.67 (8H, m, H-5, H-6, H-7, H-8), 0.84 (9H, s, H-1), 0.01 (6H, s, H-3); "C (100 MHz, 
CDCl3) 84.9 (C-10), 72.8 (C-11), 63.1 (C-4), 62.2 (C-9), 37.6 (C-8), 32.7 (C-5), 26.0 
(C-1), 25.4 (C-6/7), 24.8 (C-6/7) 18.4 (C-2), –0.1 (C-3); m/z (ESI) 257 (100), [MH]+ 
279 (35) [MNa]+; [HRMS (ESI) calcd. for C14H29O2Si, 257.1931. Found: [MH]+ 
257.1932 (0.3 ppm error)]. 
KAG/6/57 (eg) 
 
 
Chapter 6 
 
 189 
6-Hydroxy-N-methoxy-N-methylhexanamide (24) 
8
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Prepared according to the procedure described by Sulikowski and co-workers.52 
To a stirred solution of !-caprolactone (11.4 g, 100 mmol) and N,O-
dimethylhydroxylamine hydrochloride (19.5 g, 200 mmol) in CH2Cl2 (200 mL) at 0 
°C was added trimethyl aluminium (2.0 M in hexane, 100 mL, 200 mmol) dropwise 
via canula. The reaction was stirred at 0 °C for 1 h, then quenched by portionwise 
addition to a stirred solution of aqueous Rochelle’s salt (sat., 400 mL) (CAUTION, 
gas evolution). Extraction with EtOAc (2 x 500 mL) gave the title compound 24 as a 
pale yellow oil which (13.3 g, 76%) which was used without further purification; Rf 
0.14 (1:1 PE:EtOAc); "H (400 MHz, CDCl3) 3.66 (3H, s, H-8), 3.62 (2H, t, J 6.5, H-
1), 3.16 (3H, s, H-7), 2.41 (2H, t, J 7.0, H-5), 1.68–1.55 (5H, m, H-2, H-4, OH), 1.44–
1.37 (2H, m, H-3). 
1H NMR data consistent with literature.52 
KAG/8/39 
This reaction was scaled to the 100 mL bottles of Me3Al available. Batches were 
processed to avoid scaling up any further.  
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6-(tert-Butyldimethylsilyloxy)-N-methoxy-N-methylhexanamide (25) 
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Prepared according to the procedure described by Sulikowski and co-workers.52 
To a stirred solution of alcohol 24 (27.0 g, 154 mmol) in DMF (55 mL) was added 
tertbutyldimethylsilyl chloride (28.9 g, 192 mmol) and imidazole (26.2 g, 386 mmol). 
The reaction was stirred at rt for 1 h, before being partitioned between water (200 
mL) and Et2O (2 x 300 mL). The organic layer was washed with water (3 x 300 mL) 
and brine (300 mL), then dried and the volatiles removed under reduced pressure to 
give the title compound 25 as a pale yellow oil (45 g, 100%) which was used without 
further purification; Rf 0.46 (8:2 PE:EtOAc); !H (400 MHz, CDCl3) 3.63 (3H, s, H-
11), 3.56 (2H, t, J 6.5, H-4), 3.13 (3H, s, H-10), 2.38 (2H, t, J 7.5, H-8), 1.63–1.46 
(4H, m, H-5, H-7), 1.37–1.30 (2H, m, H-6), 0.84 (9H, s, H-1), 0.00 (6H, s, H-3). 
1H NMR data consistent with literature.52 
KAG/8/46 
 
 
8-(tert-Butyldimethylsilyloxy)oct-1-yn-3-one (277) 
6
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Prepared according to the procedure described by Sulikowski and co-workers.52 
To neat Weinreb amide 25 (45.0 g, 154 mmol) was added ethynylmagnesium bromide 
(0.5 M in THF, 616 mL, 308 mmol). The mixture was heated to 50 °C for 1 h, cooled 
to rt, then partitioned between water (400 mL) and Et2O (3 x 400 mL). The organic 
layers were combined, dried over Na2SO4, then the volatiles removed under reduced 
pressure to give the crude product as a brown oil, which was purified by column 
chromatography. Eluting with 9:1 PE:Et2O gave the title compound 277 as a orange 
oil (20.6 g, 87% from alcohol 24); Rf 0.37 (9:1 PE:EtOAc); !H (400 MHz, CDCl3) 
3.59 (2H, t, J 6.5, H-4), 3.21 (1H, s, H-11), 2.60 (2H, t, J 7.4, H-8), 1.68 (2H, dd, J 
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7.5. 7.5, H-7), 1.57–1.50 (2H, m, H-5), 1.41–1.34 (2H, m, H-6), 0.89 (9H, s, H-1), 
0.04 (6H, s, H-3); 
1H NMR data consistent with literature.52 
KAG/8/47 
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 (R)-8-(tert-Butyldimethylsilyloxy)oct-1-yn-3-ol ((+)-26) 
6
7OH
O 1
2
3
4
5
Si8
9
10
 
 
To neat stirred ketone 277 (6.00 g, 23.6 mmol) at 0 °C was added (R)-Alpine Borane 
(0.5 M in THF, 66.0 mL, 33.0 mmol). The reaction was allowed to warm to rt, where 
it was stirred for 48 h. The solvent was removed under reduced pressure, then the 
residual oil dissolved in Et2O (150 mL) and ethanolamine (4.3 mL, 66.1 mmol) added 
in a single portion. The solution was stirred at rt for 1 h, then the solid formed 
removed by filtration. Concentration of the filtrate gave the crude product as a dark 
yellow oil, which was purified by column chromatography. Eluting with 9:1 
PE:EtOAc gave the title compound (+)-26 as a pale yellow oil (4.28 g, 71%). 
Data as for racemate (±)-26 except 
[!]D +5.0 (c 1.2, CHCl3) (Lit.52 +3.0 (c 1.2, CHCl3)). 
KAG/7/90 
 
 
(S)-8-(tert-Butyldimethylsilyloxy)oct-1-yn-3-ol ((–)-26) 
6
7OH
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According to the procedure for (+)-26 (S)-Alpine borane and ketone 277 gave the title 
compound (–)-26 as a pale yellow oil. 
Data as for racemate (+)-26 except 
[!]D –2.2 (c 1.2, CHCl3). 
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tert-Butyl 5-(8-(tert-butyldimethylsilyloxy)-3-hydroxyoct-1-ynyl)-3,4-
dihydropyridine-1(2H)-carboxylate (27) 
1
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Alcohol 26 (4.37 g, 17.02 mmol) was added neat to triflate 213 (4.7 g, 14.2 mmol). 
To this mixture was added flame dried lithium chloride (1.80 g, 42.6 mmol), copper 
iodide (135 mg, 0.709 mmol) and Pd(PPh3)4 (410 mg, 0.355 mmol). After each 
addition the flask was evacuated and purged with argon. Degassed DMF (20 mL) and 
freshly distilled diispropylamine (84 mL) were added via syringe. The reaction was 
heated to 40 °C for 18 h. On cooling the mixture was partitioned between water (300 
mL) and EtOAc (2 x 250 mL). The organic layers were combined and the volatiles 
removed under reduced pressure to give a black oil which was purified by column 
chromatography. Eluting with 7:3 PE:EtOAc gave the title compound 251 as a brown 
oil (1.49 g, 75%); Rf 0.26 (3:1 PE:EtOAc); IR !max (neat) 3423, 2930, 2857, 1708, 
1632, 1468, 1385, 1308, 1254, 1159, 1102, 1047, 905; "H (400 MHz, CDCl3) 7.25, 
7.10 (1H, 2 x s, H-13), 4.47–4.50 (1H, br m, H-9), 3.60 (2H, t, J 6.5, H-4), 3.50 (2H, 
br s, H-17), 2.14 (2H, br t, J 6.0, H-19), 1.81–1.36 (19H, m, H-5, H-6, H-7, H-8, H-
16, H-18), 0.84 (9H, s, H-1), 0.06 (6H, s, H-3); "C (100 MHz, CDCl3) 151.7 (C-15), 
131.6, 129.8 (C-13), 98.2 (C-12), 87.8 (C10/C-11/C-15), 85.5 (C10/C-11/C-15), 81.8 
(C10/C-11/C-15), 63.1 (C-9), 62.9 (C-4). 41.5 (C-17), 38.0 (C-8), 32.7 (C-5), 28.2 (C-
16), 26.0 (C-1), 25.9 (C-6/C-7/C-18), 25.5 (C-6/C-7/C-18), 25.0 (C-6/C-7/C-18), 21.1 
(C-19), 18.5 (C-2) –5.1 (C-3); m/z (ESI) 420 (100) [M-H2O]+ 438 (70) [MH]+; 
[HRMS (ESI) calcd. for C24H44NO4Si, 438.3034. Found: [MH]+ 438.3023 (2.6 ppm 
error)]. 
KAG/6/41 (eg) 
 
Yields for this reaction were variable (25%-91%). Key points to a high yield were:  
Thorough degassing, especially of DMF 
Flame drying LiCl immediately before use 
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Quick column with little silica – isn’t so stable on standing. In later stages this 
material was used without purification. 
 
 (2SR,4aRS,8aSR)-tert-Butyl 2-(5-hydroxypentyl)hexahydro-2H-pyrano[2,3-
b]pyridine-8(8aH)-carboxylate (253) 
1 2 3
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To a stirred solution of alkyne 251 (1.29 g, 2.97 mmol) in EtOAc (40 mL) was added 
triethylamine (1.26 mL, 9.00 mmol) followed by palladium on carbon (20% w/w, 65 
mg). The was evacuated and purged with hydrogen. The reaction was stirred at rt for 
18 h. The palladium was removed by filtration through a pad of Celite, washing with 
EtOAc (100 mL). The volatiles were removed under reduced pressure to yield tert-
butyl 5-(8-(tert-butyldimethylsilyloxy)-3-hydroxyoctyl)-3,4-dihydropyridine-1(2H)-
carboxylate (252) as a pale brown oil. The oil was dissolved in CH2Cl2 and 
SnCl2!2H2O was added in a single portion (1.67 g, 7.43 mmol). The reaction was 
stirred at rt for 2 h, before being filtered through a plug of Celite, washing with 
CH2Cl2 (100 mL). The filtrate was concentrated under reduced pressure, then purified 
by column chromatography. Eluting with 3:7 PE:Et2O gave the title compound 253 as 
a colourless film (330 mg, 63% over 3 steps from 27); Rf 0.22 (4:6 PE:EtOAc); IR 
"max (neat) 3437, 2928, 1681, 1365, 1313, 1276, 1158, 1094, 1025, 990; #H (400 
MHz, CDCl3) 5.30, 5.10 (1H, 2 x s, H-11), 3.76 (1H, t, J 13.0, H-10), 3.63–3.52 (2H, 
m, H-16), 3.43–3.30 (1H, m, H-4a), 2.93–2.78 (1H, m, H-4b), 1.79–1.23 (26H, m, H-
1, H-5, H-6, H-7, H-8, H-9, H-12, H-13, H-14, H-15);  
As observed with the shorter chain compounds the 13C NMR displays an ~1:1 mixture 
of rotamers for many signals. 
#C (100 MHz, CDCl3) 155.6, 155.1 (C-3), 82.6, 81.3 (C-11), 79.7, 79.5 (C-10), 77.6, 
77.5 (C-2), 63.2, 63.5 (C-16), 39.8 (CH2), 36.1 (CH2), 33.9 (C-7), 32.8 (CH2), 28.9 
(CH2), 28.3 (C-1), 26.3 (CH2), 25.9 (CH2), 25.3, 25.0 (CH2), 24.7 (CH2), 23.1 (C-5); 
m/z (ESI) 228 (100) 328 (40) [MH]+ 350 (45) [MNa]+; [HRMS (ESI) calcd. for 
C18H34NO4, 328.2491. Found: [MH]+ 257.1932 (0.3 ppm error)]. 
KAG/6/57 
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(2R,4aS,8aR)-tert-Butyl 2-(5-hydroxypentyl)hexahydro-2H-pyrano[2,3-
b]pyridine-8(8aH)-carboxylate ((–)-253) 
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Prepared according to the procedure for (±)-27 and (±)-253 using enantio-enriched 
(+)-250. The intermediate alkyne was not isolated. 30% over 3 steps. 
Data as for racemate (±)-253 except 
[!]D –13.0 (c 1.2, CHCl3). 
KAG/8/13 
 
(2S,4aR,8aS)-tert-Butyl 2-(5-hydroxypentyl)hexahydro-2H-pyrano[2,3-
b]pyridine-8(8aH)-carboxylate ((+)-253) 
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Prepared according to the procedure for (±)-27 and (±)-253 using enantio-enriched (–
)-250. The intermediate alkyne was not isolated. 14% over 3 steps. 
Data as for racemate (±)-253 except 
[!]D +17.5 (c 1.4, CHCl3). 
KAG/8/64 
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(2SR,4aRS,8aSR)-tert-Butyl 2-(5-oxopentyl)hexahydro-2H-pyrano[2,3-
b]pyridine-8(8aH)-carboxylate (264) and (2SR,4aRS,8aSR)-tert-Butyl 2-(7-
ethoxy-5,7-dioxoheptyl)hexahydro-2H-pyrano[2,3-b]pyridine-8(8aH)-
carboxylate (254) 
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To a stirred solution of alcohol 253 (310 mg, 0.948 mmol) in CH2Cl2 (10mL) were 
added freshly dried powdered 4 Å molecular sieves (600 mg), the reaction was stirred 
at rt under argon to 15 min, before the addition of 4-methylmorpholine N-oxide (134 
mg, 1.14 mmol) followed by tetrapropylammonium perruthenate (25 mg, 0.0711 
mmol). The reaction was stirred at rt for 1 h, then filtered through a plug of silica, 
washing with CH2Cl2. Removal of the volatiles under vacuum gave tert-butyl 2-(5-
oxopentyl)hexahydro-2H-pyrano[2,3-b]pyridine-8(8aH)-carboxylate 264 as a pale 
brown oil, which was used immediately as it proved unstable. To a stirred solution of 
aldehyde 264 (assuming 0.948 mmol) in CH2Cl2 (10 mL) was added SnCl2!2H2O (21 
mg, 0.0948 mmol) and ethyl diazo acetate (120 mg, 1.05 mmol). The reaction was 
stirred for 1 h at rt, then filtered through a pad of Celite. Washing with CH2Cl2 (50 
mL) gave the crude product as a yellow oil, which was purified by column 
chromatography. Eluting with 7:3 PE:EtOAc gave the title compound 254 as a sticky 
pale yellow oil (215 mg, 55% over 2 steps from alcohol 253). 
 
Aldehyde 264 
Rf 0.68 (1:1 PE:EtOAc); "H (400 MHz, CDCl3) 9.72 (1H, s, H-16), 5.28, 5.07 (1H, 2 x 
s, H-11), 3.74 (1H, t, J 13.0, H-10), 3.47–3.23 (1H, m, H-4a), 2.79–2.98 (1H, m, H-
4b), 2.38 (2H, t, J 6.0, H-15), 1.59–1.23 (24H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-
12, H-13, H-14). 
KAG/7/9 
#-keto ester 254 
Rf 0.48 (7:3 PE:EtOAc); IR $max (neat) 2932, 2859, 1744, 1701, 1453, 1411, 1365, 
1312, 1257, 1158, 1094, 1019, 989; "H (400 MHz, CDCl3) 5.28, 4.92 (1H, 2 x s, H-
11), 4.21–4.13 (2H, m, H-19), 3.77 (1H, br t, J 13.0, H-10), 3.45–3.27 (3H, m, H-16, 
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H-4a), 2.98–2.83 (1H, m, H-4b), 2.52 (2H, t, J 7.0, H-15), 1.80–1.15 (27H, m, H-1, 
H-5, H-6, H-7, H-8, H-9, H-12, H-13, H-14, H-20);  
The 13C NMR showed a ~1:1 mixture of rotamers 
!C (100 MHz, CDCl3) 202.8 (C-17), 167.2 (C-18), 155.5, 155.0 (C-3), 82.6, 81.3 (C-
11), 79.9, 79.5 (C-10), 77.3 (C-2), 61.2 (C-19), 59.8 (C-17), 52.0 (C-15), 42.8 (CH2), 
39.8, 39.4 (C-4), 35.6 (CH2), 33.8 (CH2), 28.3 (C-1), 26.2 (CH2), 25.7 (CH2), 25.0 
(CH2), 24.6 (CH2), 23.1 (CH2), 23.0 (CH2), 14.0 (CH2); m/z (ESI) 312 (100), [M–
Boc+H]+ 434 (35) [MNa]+; [HRMS (ESI) calcd. for C22H37NNaO6, 434.2513. Found: 
[MNa]+ 434.2507 (1.3 ppm error)]. 
KAG/7/10 (eg) 
 
 
(2R,4aS,8aR)-tert-Butyl 2-(7-ethoxy-5,7-dioxoheptyl)hexahydro-2H-pyrano[2,3-
b]pyridine-8(8aH)-carboxylate ((–)-254) 
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Pale yellow oil. 62% over 2 steps. 
Prepared according to the procedure for (±)-254 
Data as for racemate (±)-254except 
["]D –27.1 (c 1.3, CHCl3). 
KAG/8/65 + KAG/8/66 
 
(2S,4aR,8aS)-tert-Butyl 2-(7-ethoxy-5,7-dioxoheptyl)hexahydro-2H-pyrano[2,3-
b]pyridine-8(8aH)-carboxylate ((+)-254)  
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Pale yellow oil 48% over 2 steps. 
Prepared according to the procedure for (±)-254 
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Data as for racemate (±)-254 except 
[!]D +26.4 (c 1.35, CHCl3). 
KAG/8/67 + KAG/8/68 
 
(2S,4aR,8aS)-tert-Butyl 2-((R)-7-ethoxy-5-hydroxy-7-oxoheptyl)hexahydro-2H-
pyrano[2,3-b]pyridine-8(8aH)-carboxylate (255a) and (2R,4aS,8aR)-tert-butyl 2-
((R)-7-ethoxy-5-hydroxy-7-oxoheptyl)hexahydro-2H-pyrano[2,3-b]pyridine-
8(8aH)-carboxylate (255b) as a 1:1 mixture of diastereoisomers. 
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According to the procedure of Genet et al.115 
 
Bis(2-methylallyl)(1,5-cyclooctadiene)ruthenium (I) (4 mg, 0.0125 mmol) and (R)-
BINAP (8 mg, 0.0125 mmol) were charged to a Schlenk tube. After 3 vacuum/ argon 
cycles degassed acetone (2 mL) was added, followed by HBr (0.29 M in MeOH 
prepared from 48% aq HBr, 0.11 mL). The reaction was allowed to stir for 30 minutes 
at rt, then the volatiles removed under reduced pressure to give the catalyst as an 
oxygen-sensitive yellow-brown solid. "-Keto ester 254 was dissolved in distilled 
MeOH (3 mL) and added to the catalyst. The reaction was purged with hydrogen, 
heated to 40 °C and stirred for 19 h. After cooling the hydrogen was removed, the 
resulting brown oil passed though a silica pad, eluting with EtOAc (20 mL) to give 
the title compounds 255a and 255b as a brown oil (146 mg, 68%) which was used 
without further purification; Rf 0.26 (7:3 PE:EtOAc); IR #max (neat) 3481, 2933, 1735, 
1704, 1412, 1366, 1313, 1248, 1160, 1031, 989; $H (400 MHz, CDCl3) 5.27, 5.08 
(1H, 2 x s, H-11), 4.13–3.98 (2H, m, H-19), 3.97–3.92 (1H, m, H-16), 3.77–3.70 (1H, 
m, H-10), 3.42–3.25 (1H, m, H-4a), 3.10–2.81 (2H, m, H-4b, OH), 2.48–2.32 (2H, m, 
H-17), 1.81–1.17 (29H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-12, H-13, H-14, H-15, H-
20); $C (100 MHz, CDCl3) 172.9 (C-18), 155.1, 155.3 (C-3), 82.5, 81.9 (C-11), 79.6, 
79.4 (C-10), 77.2 (C-2), 67.7 (C-16), 60.4 (C-19), 41.1 (CH2) 39.7 (CH2), 38.9 (CH2), 
36.2 (CH2), 35.7, 35.6 (C-7), 33.7 (CH2), 28.7 (CH2), 28.1 (C-1) 26.0 (CH2), 25.3 
(CH2), 24.5 (CH2), 22.9 (CH2), 20.8 (C-20); m/z (ESI) 314 (100), [M-Boc+H]+ 414 
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(50) [MH]+; [HRMS (ESI) calcd. for C22H40NO6, 414.2850. Found: [MH]+ 414.2841 
(2.1 ppm error)]. 
KAG/7/11  
 
(2R,4aS,8aR)-tert-Butyl 2-((R)-7-ethoxy-5-hydroxy-7-oxoheptyl)hexahydro-2H-
pyrano[2,3-b]pyridine-8(8aH)-carboxylate ((–)-255a) 
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Prepared according to the procedure for (±)-255 
Brown oil (1.08 g, 100%); Rf 0.26 (7:3 PE:EtOAc); [!]D –0.1 (c 2.0, CHCl3); IR "max 
(neat) 3427, 2932, 2361, 2340, 1704, 1366, 1159; #H (400MHz, CDCl3) 5.27, 5.08 
(1H, 2 x s, H-11), 4.13–3.98 (2H, m, H-19), 3.97–3.92 (1H, m, H-16), 3.77–3.70 (1H, 
m, H-10), 3.42–3.25 (1H, m, H-4a), 3.10–2.81 (2H, m, H-4b, OH), 2.48–2.32 (2H, m, 
H-17), 1.81–1.17 (29H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-12, H-13, H-14, H-15, H-
20); #C (100 MHz, CDCl3) 172.9 (C-18), 155.1, 155.3 (C-3), 82.5, 81.9 (C-11), 79.6, 
79.4 (C-10), 77.2 (C-2), 67.7 (C-16), 60.4 (C-19), 41.1 (CH2) 39.7 (CH2), 38.9 (CH2), 
36.2 (CH2), 35.7, 35.6 (C-7), 33.7 (CH2), 28.7 (CH2), 28.1 (C-1) 26.0 (CH2), 25.3 
(CH2), 24.5 (CH2), 22.9 (CH2), 20.8 (C-20); 
m/z (ESI) 436 (100), [M+Na]+ 414 (10) [MH]+; [HRMS (ESI) calcd. for C22H40NO6, 
414.2856. Found: [MH]+ 414.2850 (1.3 ppm error)]. 
KAG/8/69 
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(2S,4aR,8aS)-tert-Butyl 2-((R)-7-ethoxy-5-hydroxy-7-oxoheptyl)hexahydro-2H-
pyrano[2,3-b]pyridine-8(8aH)-carboxylate ((+)-255b) 
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Prepared according to the procedure for (±)-255 
Brown oil (990 mg, 100%); Rf 0.26 (7:3 PE:EtOAc); [!]D +60.3 (c 2.0, CHCl3); IR 
"max (neat) 3452, 2934, 2360, 2339, 1735, 17041454, 1366; #H (400 MHz, CDCl3) 
5.27, 5.08 (1H, 2 x s, H-11), 4.13–3.98 (2H, m, H-19), 3.97–3.92 (1H, m, H-16), 
3.77–3.70 (1H, m, H-10), 3.42–3.25 (1H, m, H-4a), 3.10–2.81 (2H, m, H-4b, OH), 
2.48–2.32 (2H, m, H-17), 1.81–1.17 (29H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-12, H-
13, H-14, H-15, H-20); #C (100 MHz, CDCl3) 172.9 (C-18), 155.1, 155.3 (C-3), 82.5, 
81.9 (C-11), 79.6, 79.4 (C-10), 77.2 (C-2), 67.7 (C-16), 60.4 (C-19), 41.1 (CH2) 39.7 
(CH2), 38.9 (CH2), 36.2 (CH2), 35.7, 35.6 (C-7), 33.7 (CH2), 28.7 (CH2), 28.1 (C-1) 
26.0 (CH2), 25.3 (CH2), 24.5 (CH2), 22.9 (CH2), 20.8 (C-20); m/z (ESI) 436 (100), 
[M+Na]+ 414 (15) [MH]+; [HRMS (ESI) calcd. for C22H40NO6, 414.2850. Found: 
[MH]+ 414.2857 (1.8 ppm error)]. 
KAG/8/72 
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(2S4aR,8aS)-tert-Butyl 2-((R)-5-(tert-butyldimethylsilyloxy)-7-ethoxy-7-
oxoheptyl)hexahydro-2H-pyrano[2,3-b]pyridine-8(8aH)-carboxylate (266a) and 
(2R,4aS,8aR)-tert-butyl 2-((R)-5-(tert-butyldimethylsilyloxy)-7-ethoxy-7-
oxoheptyl)hexahydro-2H-pyrano[2,3-b]pyridine-8(8aH)-carboxylate (266b) 
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To a stirred solution of alcohol 255 (120 mg, 0.290 mmol) in CH2Cl2 (2.5 mL) at 0 °C 
was added 2,6-lutidine (68 µL, 0.582 mmol) followed by tert-butyldimethylsilyl 
trifluoromethanesulfonate (67 µL, 0.290 mmol). The reaction was allowed to warm to 
rt, and stirred for 15 min before being quenched by the addition of aqueous NaHCO3 
(sat., 10 mL). The mixture was extracted with CH2Cl2 (3 x 15 mL), the organic layers 
combined, dried over Na2SO4 and the volatiles removed under reduced pressure to 
give the crude product, which was purified by column chromatography. Eluting with 
8:2 PE:EtOAc gave the title compounds 266a and 266b as a colourless film (105 mg, 
69%). Rf 0.82 (8:2 PE:EtOAc); IR !max (neat) 2893, 2858, 1738, 1365, 1312, 1253, 
1160, 1094, 990; "H (400 MHz, CDCl3) 5.27, 5.08 (1H, 2 x s, H-11), 4.14–4.06 (3H, 
m, H-19, H-16), 3.80–3.74 (1H, m, H-10), 3.42–3.25 (1H, m, H-4a), 3.10–2.81 (1H, 
m, H-4b), 2.48–2.32 (2H, m, H-17), 1.81–1.17 (29H, m, H-1, H-5, H-6, H-7, H-8, H-
9, H-12, H-13, H-14, H-15, H-20), 0.84 (9H, s, H-23), 0.03 (6H, d, J 9.0, H-21);  
The 13C NMR showed a ~ 1:1 mixture of rotamers for some signals. 
"C (100 MHz, CDCl3) 172.1 (C-18), 152.8, 153.1 (C-3), 82.8, 81.5 (C-11), 79.6, 79.4 
(C-10), 77.7 (C-2), 69.6 (C-16), 60.4 (C-19), 42.8 (C-17), 39.9 (CH2), 39.2 (CH2), 
37.6 (CH2), 36.2 (CH2), 34.1 (C-7), 29.0 (CH2), 28.5 (C-1), 26.3 (CH2), 25.9 (C-23), 
25.2 (CH2), 24.8 (C-22), 23.2 (CH2), 18.1 (CH2), 14.3 (C-20), –4.4 (C-21); m/z (ESI) 
528 (100), [MH]+ 428 (80) [M–BocH]+; [HRMS (ESI) calcd. for C28H54NO6Si, 
528.3715. Found: [MH]+ 528.3706 (1.7 ppm error)]. 
KAG/7/13 (eg) 
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(2R,4aS,8aR)-tert-Butyl 2-((R)-5-(tert-butyldimethylsilyloxy)-7-ethoxy-7-
oxoheptyl)hexahydro-2H-pyrano[2,3-b]pyridine-8(8aH)-carboxylate (266a) 
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Prepared according to the procedure for 266 
Pale yellow oil (880 mg, 83% over 2 steps from 254); Rf 0.82 (8:2 PE:EtOAc); [!]D –
21.6 (c 0.85, CHCl3); IR "max (neat) 2930, 2857, 1736, 1704, 1463, 1410, 1365 1251, 
1159, 1093, 836; #H (400 MHz, CDCl3) 5.27, 5.08 (1H, 2 x s, H-11), 4.14–4.06 (3H, 
m, H-19, H-16), 3.80–3.74 (1H, m, H-10), 3.42–3.25 (1H, m, H-4a), 3.10–2.81 (1H, 
m, H-4b), 2.48–2.32 (2H, m, H-17), 1.81–1.17 (29H, m, H-1, H-5, H-6, H-7, H-8, H-
9, H-12, H-13, H-14, H-15, H-20), 0.84 (9H, s, H-23), 0.03 (6H, d, J 9.0, H-21); 
The 13C NMR showed a ~ 1:1 mixture of rotamers for some signals. 
 #C (100 MHz, CDCl3) 172.1 (C-18), 152.8, 153.1 (C-3), 82.8, 81.5 (C-11), 79.6, 79.4 
(C-10), 77.7 (C-2), 69.6 (C-16), 60.4 (C-19), 42.8 (C-17), 39.9 (CH2), 39.2 (CH2), 
37.6 (CH2), 36.2 (CH2), 34.1 (C-7), 29.0 (CH2), 28.5 (C-1), 26.3 (CH2), 25.9 (C-23), 
25.2 (CH2), 24.8 (C-22), 23.2 (CH2), 18.1 (CH2), 14.3 (C-20), –4.4 (C-21); m/z (ESI) 
550 (100), [M+Na]+ 528 (70) [MH]+; [HRMS (ESI) calcd. for C28H54NO6Si, 
528.3715. Found: [MH]+ 528.3725 (1.9 ppm error)]. 
KAG/8/70 
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(2S,4aR,8aS)-tert-Butyl 2-((R)-5-(tert-butyldimethylsilyloxy)-7-ethoxy-7-
oxoheptyl)hexahydro-2H-pyrano[2,3-b]pyridine-8(8aH)-carboxylate (266b) 
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Prepared according to the procedure for 266 
Pale yellow oil (860 mg, 74% over 2 steps from 254); Rf 0.82 (8:2 PE:EtOAc); [!]D 
+11.2 (c 1.0, CHCl3); IR "max (neat) 2930, 2857, 1736, 1704, 1462, 1409, 1365, 1253, 
1159, 1093; #H (400 MHz, CDCl3) 5.27, 5.08 (1H, 2 x s, H-11), 4.14–4.06 (3H, m, H-
19, H-16), 3.80–3.74 (1H, m, H-10), 3.42–3.25 (1H, m, H-4a), 3.10–2.81 (1H, m, H-
4b), 2.48–2.32 (2H, m, H-17), 1.81–1.17 (29H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-
12, H-13, H-14, H-15, H-20), 0.84 (9H, s, H-23), 0.03 (6H, d, J 9.0, H-21); 
The 13C NMR showed a ~ 1:1 mixture of rotamers for some signals. 
#C (100 MHz, CDCl3) 172.1 (C-18), 152.8, 153.1 (C-3), 82.8, 81.5 (C-11), 79.6, 79.4 
(C-10), 77.7 (C-2), 69.6 (C-16), 60.4 (C-19), 42.8 (C-17), 39.9 (CH2), 39.2 (CH2), 
37.6 (CH2), 36.2 (CH2), 34.1 (C-7), 29.0 (CH2), 28.5 (C-1), 26.3 (CH2), 25.9 (C-23), 
25.2 (CH2), 24.8 (C-22), 23.2 (CH2), 18.1 (CH2), 14.3 (C-20), –4.4 (C-21); m/z (ESI) 
550 (100), [M+Na]+ 528 (60) [MH]+; HRMS (ESI) calcd. for C28H54NO6Si, 528.3715. 
Found: [MH]+ 528.3720 (1.0 ppm error)]. 
KAG/8/70 
 
Chapter 6 
 
 204 
(R)-7-((2S,4aR,8aS)-8-(tert-Butoxycarbonyl)octahydro-2H-pyrano[2,3-b]pyridin-
2-yl)-3-(tert-butyldimethylsilyloxy)heptanoic acid (267a) and (R)-7-
((2R,4aS,8aR)-8-(tert-butoxycarbonyl)octahydro-2H-pyrano[2,3-b]pyridin-2-yl)-
3-(tert-butyldimethylsilyloxy)heptanoic acid (267b) 
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To a stirred solution of ester (105 mg, 0.199 mmol) 266 in EtOH (1 mL) was added 
aqueous sodium hydroxide (1 M, 0.60 mL, 0.600 mmol) and the reaction heated to 
100 °C for 5 h. After cooling to rt the reaction was partitioned between water (50 mL) 
and EtOAc (3 x 50 mL) and the volatiles removed under reduced pressure to give the 
title compounds 267a and 267b as a colourless film (96 mg, 97%); Rf 0.12 (4:6 
PE:EtOAc); IR !max (neat) 2931, 1707, 1390, 1366, 1254, 1160, 1093, 990; "H (400 
MHz, CDCl3) 5.31, 5.11 (1H, 2 x s, H-11), 4.14–4.04 (1H, m, H-16), 3.81–3.74 (1H, 
m, H-10), 3.43–3.29 (1H, m, H-4a), 3.00–2.81 (1H, m, H-4b), 2.56–2.43 (2H, m, H-
17), 1.80–1.20 (26H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-12, H-13, H-14, H-15), 0.87 
(9H, s, H-21), 0.07 (6H, d, J 9.0, H-19); 
The 13C NMR showed a ~ 1:1 mixture of rotamers for some signals. 
"C (100 MHz, CDCl3) 176.3 (C-18), 155.2, 155.6 (C-3), 82.8, 81.6 (C-11), 80.0, 79.9 
(C-10), 77.7 (C-2), 69.5 (C-16), 42.2 (C-17), 40.0 (CH2), 39.2 (CH2), 37.4 (CH2), 36.0 
(CH2), 34.0 (C-7), 28.8 (CH2), 28.4 (C-1), 26.2 (CH2), 25.7 (C-23), 25.4 (CH2), 25.3 
(CH2), 24.8 (C-22), 23.2 (CH2), –4.4 (C-21); m/z (ESI) 500 (100), [MH]+; [HRMS 
(ESI) calcd. for C26H50NO6Si, 500.3402. Found: [MH]+ 500.3392 (2.1 ppm error)]. 
KAG/7/14 
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(R)-7-((2R,4aS,8aR)-8-(tert-Butoxycarbonyl)octahydro-2H-pyrano[2,3-b]pyridin-
2-yl)-3-(tert-butyldimethylsilyloxy)heptanoic acid (267a) 
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Prepared according to the procedure for 267 
Pale yellow oil (620 mg, 74%); Rf 0.12 (4:6 PE:EtOAc); [!]D –15.4 (c 1.0, CHCl3)  
IR "max (neat) 2932, 2858, 1735, 1708, 1471, 1365, 1254, 1159, 1093; #H (400 MHz, 
CDCl3) 5.31, 5.11 (1H, 2 x s, H-11), 4.14–4.04 (1H, m, H-16), 3.81–3.74 (1H, m, H-
10), 3.43–3.29 (1H, m, H-4a), 3.00–2.81 (1H, m, H-4b), 2.56–2.43 (2H, m, H-17), 
1.80–1.20 (26H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-12, H-13, H-14, H-15), 0.87 
(9H, s, H-21), 0.07 (6H, d, J 9.0, H-19);  
The 13C NMR showed a ~ 1:1 mixture of rotamers for some signals. 
#C (100 MHz, CDCl3) 176.3 (C-18), 155.2, 155.6 (C-2), 82.8, 81.6 (C-11), 80.0, 79.9 
(C-10), 77.7 (C-2), 69.5 (C-16), 42.2 (C-17), 40.0 (CH2), 39.2 (CH2), 37.4 (CH2), 36.0 
(CH2), 34.0 (C-7), 28.8 (CH2), 28.4 (C-1), 25.7 (C-23), 26.2 (CH2), 25.4 (CH2), 25.3 
(CH2), 24.8 (C-22), 23.2 (CH2), –4.4 (C-21); m/z (ESI) 522 (100), [M+Na]+ 500 (40) 
[MH]+; HRMS (ESI) calcd. for C26H50NO6Si, 500.3402. Found: [MH]+ 500.3404 (0.5 
ppm error)]. 
KAG/8/71 
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(R)-7-((2S,4aR,8aS)-8-(tert-Butoxycarbonyl)octahydro-2H-pyrano[2,3-b]pyridin-
2-yl)-3-(tert-butyldimethylsilyloxy)heptanoic acid (267b) 
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Prepared according to the procedure for 267 
Pale yellow oil (708 mg, 88%); Rf 0.12 (4:6 PE:EtOAc); [!]D +11.9 (c 1.7, CHCl3); 
IR "max (neat) 2931, 2857, 1736, 1704, 1365, 1311, 1253, 1159, 1093; #H (400 MHz, 
CDCl3) 5.31, 5.11 (1H, 2 x s, H-11), 4.14–4.04 (1H, m, H-16), 3.81–3.74 (1H, m, H-
10), 3.43–3.29 (1H, m, H-4a), 3.00–2.81 (1H, m, H-4b), 2.56–2.43 (2H, m, H-17), 
1.80–1.20 (26H, m, H-1, H-5, H-6, H-7, H-8, H-9, H-12, H-13, H-14, H-15), 0.87 
(9H, s, H-21), 0.07 (6H, d, J 9.0, H-19);  
The 13C NMR showed a ~ 1:1 mixture of rotamers for some signals. 
#C (100 MHz, CDCl3) 176.3 (C-18), 155.2, 155.6 (C-2), 82.8, 81.6 (C-11), 80.0, 79.9 
(C-10), 77.7 (C-2), 69.5 (C-16), 42.2 (C-17), 40.0 (CH2), 39.2 (CH2), 37.4 (CH2), 36.0 
(CH2), 34.0 (C-7), 28.8 (CH2), 28.4 (C-1), 26.2 (CH2), 25.7 (C-23), 25.4 (CH2), 25.3 
(CH2), 24.8 (C-22), 23.2 (CH2), –4.4 (C-21); m/z (ESI) 522 (100), [MNa]+ 500 (40) 
[MH]+; [HRMS (ESI) calcd. for C26H50NO6Si, 500.3702. Found: [MH]+ 500.3414 
(2.5 ppm error)]. 
KAG/8/74  
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(E)-8-(tert-Butyldimethylsilyloxy)-1-(tributylstannyl)oct-1-en-3-ol (268) 
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To a stirred solution of alkyne 250 (250 mg, 0.976 mmol) in toluene (10 mL) was 
added tributyltinhydride (392 µL, 1.46 mmol) followed by AIBN (8 mg, 0.049 
mmol). The reaction was heated to 70 °C for 13 h, then cooled to rt and concentrated 
to a colourless oil, which was purified by column chromatography. Eluting with 9:1 
PE:Et2O gave the title compound 268 as a colourless oil (280 mg, 52%); Rf 0.65 (8:2 
PE:Et2O); Found: C, 56.7; H, 10.1. C26H56O2SiSn requires C, 57.0; H, 10.3%; IR !max 
(neat) 3348, 2955, 2928, 2956, 1462, 1254, 1101, 1005, 990; "H (400 MHz, CDCl3) 
6.12 (1H, dd, J 19.0, 1.0, H-10), 5.91 (1H, dd, J 19.0, 5.0, H-11), 4.09–4.02 (1H, m, 
H-9), 3.60 (2H, t, J 6.5, H-4), 1.59–1.27 (20H, m, H-5, H-6, H-7, H-8, H-13, H-14), 
0.94–0.87 (24H, m, H-1, H-12, H-15) 0.02 (6H, s, H-3); "C (100 MHz, CDCl3) 151.2 
(C-10), 127.7 (C-11), 75.7 (C-9), 63.3 (C-4), 37.1 (C-8), 33.0 (C-5), 29.2 (C-13/C-
14), 27.4 (C-13/C-14), 26.1 (C-1), 25.9 (C-7/C-8), 25.3 (C-7/C-8), 18.5 (C-2), 13.8 
(C-15), 9.6 (C-12), –5.15 (C-3); 
m/z (TOF FD+) 548.3 (100), 546.3 (75), 547.3 (47), 544.1 (40), 545.3 (34.2), 549.3 
(33), 550.3 (18) 552.31 (16), 551.3 (5), 553.3 (5) 
KAG/6/61 
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(E)-tert-Butyl 5-(8-(tert-butyldimethylsilyloxy)-3-hydroxyoct-1-enyl)-3,4-
dihydropyridine-1(2H)-carboxylate (269) 
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To a stirred solution of stannane 268 (710 mg, 1.29 mmol) in NMP (4 mL) was added 
lithium chloride (291 mg, 6.87 mmol), 2-furylphosphine (42 mg, 0.181 mmol) and 
Bis(dibenzylideneacetone)palladium(0) (30 mg, 0.0522 mmol). The flask was purged 
with argon, then triflate 213 (450 mg, 1.35 mmol) in NMP (8 mL) was added 
dropwise. The reaction was stirred at rt for 21 h, then partitioned between Et2O (2 x 
25 mL) and water (25 mL). The organic layers were combined, dried over Na2SO4 
and the volatiles removed under reduced pressure to give the title compound 269 as a 
pale brown oil (517 mg, 86%) containing traces of Sn residues; Rf 0.16 (3:1 PE:Et2O); 
IR !max (neat) 3451, 2930, 2857, 1705, 1644, 1472, 1390, 1318, 1254, 1159, 1104, 
835; "H (400 MHz, CDCl3) 6.97, 6.82 (1H, 2 x s, H-13), 6.16 (1H, d, J 15.5, H-10), 
5.48–5.38 (1H, m, H-11), 4.17–4.10 (1H, m, H-9), 3.60–3.53 (5H, m, H-4, H-17, 
OH), 2.20–1.24 (21H, m, H-5, H-6, H-7, H-8, H-16, H-18, H-19), 0.09 (9H, s, H-1), 
0.03 (6H, s, H-3); m/z (ESI) 422 (100), [M-H2O]+ 462 (20) [MNa]+; [HRMS (ESI) 
calcd. for C24H45NNaO4Si, 462.3010. Found: [MNa]+ 462.3013 (0.6 ppm error)]. 
KAG/6/71 
This compound eliminated water on standing, either neat or in any NMR solvents. 
Attempts to collect NMR data longer than 1H experiments resulted in the observation 
of an unassignable mixture of the desired product and the eliminated 272. 
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6.5 Coupled compounds 
 
R DE core 
 
(2R,4aS,8aR)-tert-Butyl 2-(4-((1S,2R,2'R,6R,9a'R)-6-((E)-2-iodovinyl)-4'-oxo-2-
(triisopropylsilyloxy)-3',4',6',7',8',9a'-hexahydro-2'H-spiro[cyclohex[3]ene-1,9'-
pyrido[2,1-b][1,3]oxazine]-2'-yl)butyl)hexahydro-2H-pyrano[2,3-b]pyridine-
8(8aH)-carboxylate (346R) 
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To imine (+)-345 (145 mg, 0.306 mmol) was added carboxylic acid 267a (184 mg, 
0.367 mmol) in THF (3.2 mL). The mixture was cooled to 0 °C and DIPEA (98 uL, 
0.566 mmol) added, followed by T3P 50% solution in THF (292 mg, 0.459 mmol). 
The reaction was allowed to warm to rt, and stirred for 20 h, before being quenched 
by the addition of water (5 mL). The mixture was extracted with EtOAc (3 x 10 mL), 
the organic layers combined, washed with brine and dried over MgSO4. Removal of 
the volatiles under reduced pressure gave the intermediate which was dissolved in 
CH2Cl2 (3.2 mL) and SnCl2!2H2O (170 mg, 0.765 mmol) added. The reaction was 
stirred at rt for 1h, before excess K2CO3 was added and the solids removed by 
filtration. Concentration of the filtrate gave the crude compound, which was purified 
by flash column chromatography. Eluting with 8:2!7:3 PE:EtOAc gave the title 
compound 346R as a pale yellow film (102 mg, 40%); Rf 0.89 (EtOAc); ["]D +11.8 (c 
0.5, CHCl3); IR #max (neat) 2935, 2864, 1702, 1413, 1365, 1159, 1082, 1061, 990; $H 
(400 MHz, CDCl3) 7.02 (1H, dd, J 14.5, 10.5, H-16), 5.97 (1H, d, J 10.5, H-17), 5.74 
(2H, s, H-12, H-13), 5.32, 5.11 (1H, 2 x s, H-32), 5.27 (1H, s, H-10), 4.29–4.23 (2H, 
m, H-6a, H-11), 3.86–3.72 (2H, m, H-2, H-30), 3.47–3.30 (1H, m, H-24a), 3.00–2.85 
(2H, m, H-24b, H-6b), 2.62–2.56 (2H, m, H-3a, H-15), 2.37 (1H, dd, J 15.5, 9.0, H-
3b), 2.29–2.23 (1H, m, H-14a), 2.11–2.03 (1H, m, H-14b), 1.83–1.20 (30H, m, H-7, 
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H-8, H-21, H-25, H-26, H-27, H-28, H-29, H-33, H-34, H-35, H-36), 1.09–1.04 (21H, 
m, H-18, 19); !C (100 MHz, CDCl3) 171.4 (C-4), 151.3, 150.9 (C-22), 148.1 (C-16), 
127.2 (C-12/C-13), 127.1 (C-12/13), 82.7, 81.1 (C-32), 81.4 (C-10), 79.6 (C-30), 75.3 
(C-17), 71.5 (C-2), 70.8 (C-11), 46.3 (C-15), 42.0 (C-9), 39.9 (CH2), 39.2 (CH2), 38.3 
(CH2), 38.2 (CH2), 34.0 (C-27), 29.5 (C-3), 28.9 (C-23), 28.4 (C-21), 26.5-24.8 (7C, 
m, CH2), 23.2 (CH2), 20.2 (CH2), 18.4 (C-19), 12.9 (C-18); m/z (ESI) 863 (100), 
[MNa]+ 841 [MNa]+; [HRMS (ESI) calcd. for C41H69IN2NaO6Si, 863.3862. Found: 
[MNa]+ 863.3836 (2.9 ppm error)]. 
WPU 760/770 
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(1S,2R,2'R,6R,9a'R)-6-((E)-2-Iodovinyl)-2'-(4-((2R,4aS,8aR)-octahydro-2H-
pyrano[2,3-b]pyridin-2-yl)butyl)-2-(triisopropylsilyloxy)-6',7',8',9a'-tetrahydro-
2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-4'(3'H)-one (357R) 
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To a stirred solution of Boc-protected 346R (102 mg, 0.121 mmol) in CH2Cl2 (1.7 
mL) was added 2,6-lutidine (39.9 µL, 0.342 mmol) followed by tert-
butyldimethylsilyl trifluoromethanesulfonate (52.5 µL 0.228 mmol). The reaction was 
stirred at rt for 20 h, then quenched by the addition of aqueous NH4Cl (sat, 2 mL) and 
extracted with EtOAc (3 x 10 mL). The volatiles were removed under reduced 
pressure, the intermediate silyl carbamate dissolved in THF (1.70 mL), cooled to –30 
°C and TBAF (0.114 mL, 0.114 mmol) added. The reaction was allowed to warm to –
20 °C, then quenched by the addition of aqueous NaOH (0.5 M, 1 mL) and extracted 
with Et2O. Concentration gave the crude compound, which was purified by flash 
column chromatography. Eluting with 94:5:1EtOAc:MeOH:Et3N gave the title 
compound 347R as a pale yellow oil (47 mg, 56%); Rf 0.21 
(94:5:1EtOAc:MeOH:Et3N); [!]D +44.2 (c 1.0, CH2Cl2); IR "max (neat) 2934, 2863, 
2360, 2340, 1681, 1081, 1062, 669; #H (400 MHz, C6D6) 7.23 (1H, dd, J 14.5, 10.5, 
H-16), 5.97 (1H, d, J 14.5, H-17) 5.64–5.59 (1H, m, H-12/H-13), 5.47–5.43 (1H, m, 
H-12/H-13), 5.37 (1H, s, H-10), 4.52–4.47 (1H, m, H-6a), 4.23–4.21 (1H, m, H-32), 
4.12 (1H, br d, J 4.0, H-11), 3.72–3.67 (1H, m, H-2), 3.27–3.15 (2H, m, H-30, H-3a), 
2.80–2.82 (1H, m, H-6a), 2.59–2.43 (4H, m, H-3b, H-15, H-24), 1.95–0.97 (45H, m, 
H-7, H-8, H-14, H-18, H-19, H-25, H-26, H-27, H-28, H-29, H-33, H-34, H-35, H-36, 
NH); #C (100 MHz, C6D6) 170.9 (C-4), 148.7 (C-16), 127.4 (C-12/C-13), 127.3 (C-
12/C-13), 86.2 (C-32), 81.3 (C-10), 76.7 (C-30), 75.6 (C-17), 71.9 (C-2), 70.7 (C-11), 
46.0 (C-15), 42.1 (C-9), 39.9 (C-3), 38.8 (C-24), 38.5 (C-6), 36.8 (CH2), 35.8 (CH2), 
34.2 (C-27), 29.6 (CH2), 29.3 (CH2), 26.9 (CH2), 26.8 (CH2), 26.3 (CH2), 26.2 (C-8), 
26.0 (C-14), 24.5 (C-25), 20.5 (C-7), 18.7 (C-19), 13.2 (C-18); m/z (ESI) 741 (100), 
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[MH]+; [HRMS (ESI) calcd. for C36H62IN2O4Si, 741.3518. Found: [MH]+ 741.3527 
(1.2 ppm error)]. 
WPU 729/730 
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S DE core 
 
(2S,4aR,8aS)-tert-butyl 2-(4-((1S,2R,2'R,6R,9a'R)-6-((E)-2-iodovinyl)-4'-oxo-2-
(triisopropylsilyloxy)-3',4',6',7',8',9a'-hexahydro-2'H-spiro[cyclohex[3]ene-1,9'-
pyrido[2,1-b][1,3]oxazine]-2'-yl)butyl)hexahydro-2H-pyrano[2,3-b]pyridine-
8(8aH)-carboxylate (346S) 
8
11
12
N 2
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Prepared according to the procedure described for 346R 
49% over 2 steps. 
[!]D +34.5 (c 1.5, CH2Cl2); Rf 0.89 (EtOAc); IR "max (neat) 2936, 2965, 1698, 1414, 
1365, 1159, 1082, 1062, 989;#H (400 MHz, CDCl3) 7.02 (1H, dd, J 14.5, 10.5, H-16), 
5.97 (1H, d, J 10.5, H-17), 5.74 (2H, s, H-12, H-13), 5.32, 5.11 (1H, 2 x s, H-32), 
5.27 (1H, s, H-10), 4.29–4.23 (2H, m, H-6a, H-11), 3.86–3.72 (2H, m, H-2, H-30), 
3.47–3.30 (1H, m, H-24a), 3.00–2.85 (2H, m, H-24b, H-6b), 2.62–2.56 (2H, m, H-3a, 
H-15), 2.37 (1H, dd, J 15.5, 9.0, H-3b), 2.29–2.23 (1H, m, H-14a), 2.11–2.03 (1H, m, 
H-14b), 1.83–1.20 (30H, m, H-7, H-8, H-21, H-25, H-26, H-27, H-28, H-29, H-33, H-
34, H-35, H-36), 1.09–1.04 (21H, m, H-18, 19); #C (100 MHz, CDCl3) 171.4 (C-4), 
151.3, 150.9 (C-22), 148.1 (C-16), 127.2 (C-12/C-13), 127.1 (C-12/13), 82.7, 81.1 (C-
32), 81.4 (C-10), 79.6 (C-30), 75.3 (C-17), 71.5 (C-2), 70.8 (C-11), 46.3 (C-15), 42.0 
(C-9), 39.9 (CH2), 39.2 (CH2), 38.3 (CH2), 38.2 (CH2), 34.0 (C-27), 29.5 (C-3), 28.9 
(C-23), 28.4 (C-21), 26.5-24.8 (7C, m, CH2), 23.2 (CH2), 20.2 (CH2), 18.4 (C-19), 
12.9 (C-18); m/z (ESI) 863 (100), [MNa]+ 841 (25) [MH]+; [HRMS (ESI) calcd. for 
C41H70IN2O6Si, 841.4042. Found: [MH]+ 841.4031 (1.3 ppm error)]. 
WPU781, WPU 782. 
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(1S,2R,2'R,6R,9a'R)-6-((E)-2-iodovinyl)-2'-(4-((2S,4aR,8aS)-octahydro-2H-
pyrano[2,3-b]pyridin-2-yl)butyl)-2-(triisopropylsilyloxy)-6',7',8',9a'-tetrahydro-
2'H-spiro[cyclohex[3]ene-1,9'-pyrido[2,1-b][1,3]oxazin]-4'(3'H)-one (347S) 
8
11
12
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Prepared according to the procedure described for 347R 
88% over 2 steps. 
[!]D +16.6 (c 1.0, CH2Cl2); Rf 0.21 (94:5:1EtOAc:MeOH:Et3N); IR "max (neat) 2927, 
2863, 1681, 1651, 1463, 1442, 1061, 994; #H (400 MHz, C6D6) 7.23 (1H, dd, J 14.5, 
10.5, H-16), 5.97 (1H, d, J 14.5, H-17) 5.64–5.59 (1H, m, H-12/H-13), 5.47–5.43 
(1H, m, H-12/H-13), 5.37 (1H, s, H-10), 4.52–4.47 (1H, m, H-6a), 4.23–4.21 (1H, m, 
H-32), 4.12 (1H, br d, J 4.0, H-11), 3.72–3.67 (1H, m, H-2), 3.27–3.15 (2H, m, H-30, 
H-3a), 2.80–2.82 (1H, m, H-6a), 2.59–2.43 (4H, m, H-3b, H-15, H-24), 1.95–0.97 
(45H, m, H-7, H-8, H-14, H-18, H-19, H-25, H-26, H-27, H-28, H-29, H-33, H-34, H-
35, H-36, NH); #C (100 MHz, C6D6) 171.1 (C-4), 148.7 (C-16), 127.4 (C-12/C-13), 
127.3 (C-12/C-13), 86.2 (C-32), 81.3 (C-10), 76.2 (C-30), 75.7 (C-17), 71.9 (C-2), 
70.6 (C-11), 46.0 (C-15), 42.1 (C-9), 39.9 (C-3), 38.8 (C-24), 38.5 (C-6), 36.6 (CH2), 
35.9 (CH2), 34.3 (C-27), 29.6 (CH2), 29.1 (CH2), 26.8 (CH2), 26.7 (CH2), 26.3 (CH2), 
26.2 (C-8), 25.5 (C-14), 24.5 (C-25), 20.5 (C-7), 18.7 (C-19), 13.2 (C-18); m/z (ESI) 
679 (100), [MH]+ 479 (80), 457 (70), 440 (20); [HRMS (ESI) calcd. for 
C41H67N4O4Si, 679.4865. Found: [MH]+ 679.4838 (3.9 ppm error)]. 
WPU783, WPU787. 
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HPLC details. 
Chiral alcohol/benzoate ester from alpine borane reduction. 
HPLC details: 
Sample prep: ~0.5 mg/mL in EtOH 
All solvents were HPLC grade (Fisher) 
Instrument: Agilent 1100 HPLC with Diode Array detector. 
Column: Chiralpak IA-3 50 mm x 4.6 mm i.d. (Daicel, supplied by Chiral 
Technologies (Europe) 
Column temperature: 20 °C 
Detector wavelength: 220 nm 
Injection Vol: 2 µl 
Conditions: Iso-cratic; 100% iso-hexane; 1.0 mL/min. 
Run-time: 20 min 
 
Benzoate ester of Noyori prodict 
 
Instrument: Agilent 1100 HPLC with Diode Array Detector. 
Column: Chiralpak AD-3; 50mm x 4.6mm ID 
Column Temp: 20 °C 
Injection: 2 !l 
Detector Wavelength: 220 nm (16nm bandwidth) 
Mobile Phase: Isocratic; 95% Iso-Hexane (HPLC grade, Fisher); 5% Ethanol (HPLC 
grade, Fisher) 
Run time: 30 mins (but could be cut to 5mins) 
Samples prepared as ~1 mg/mL solutions in Ethanol (as above) and injected in 
duplicate
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Abstract: Tin(II) chloride dihydrate-mediated deacetalisation–
bicyclisation procedures for the construction of novel polycyclic
heterocycles from amides possessing a pendant acetal group are re-
ported. Optimisation and scoping studies are described; using this
methodology, a range of known, and novel, ring-fused heterocyclic
systems have been prepared, some in enantiomerically pure form.
Key words: heterocycles, tin(II) chloride dihydrate, deacetalisa-
tion, bicyclisation, tandem processes
The formation of novel polycyclic heterocycles is of great
interest to the synthetic organic chemist. This interest is
not purely of an academic nature but also based on the fact
that polycyclic heterocycles are considered to be ‘privi-
leged structures’ in the pharmaceutical and agrochemical
industries.1 Thus, new methods for the construction of
such compounds with low molecular weights are invalu-
able in the search for bioactive lead compounds. In this
paper we report the preparation of a range of polycyclic
heterocyclic systems using a tin(II) chloride dihydrate
(SnCl2·2H2O) mediated deprotection–bicyclisation se-
quence in the key step. Tin(II) chloride is widely used as
a reducing agent and as a Lewis acid catalyst2 and, as its
dihydrate, has been employed as a mild reagent for the
deprotection of acetals.3
This research was inspired by recent natural product stud-
ies in our group which featured the use of SnCl2·2H2O-
mediated deprotection–cyclisation processes. As illustrat-
ed in Scheme 1, treatment of acetal 1 with SnCl2·2H2O
gave the racemic [6,6,6,6]-tetracyclic core 2 of the HIV-1
integrase inhibitors integrastatins A and B via a presumed
sequence of acetal deprotection, debenzylation, hemi-ace-
tal formation, and alkene etherification.4 More recently, in
an effort directed towards the total synthesis of the macro-
Scheme 1
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cyclic marine alkaloid ‘upenamide,5 it was found that
SnCl2·2H2O can be employed in the key step for the con-
struction of the core systems 4,6 67 and 88 from the res-
pective precursors 3, 5 and 7. The SnCl2·2H2O
deacetalisation–bicyclisation procedure was subsequently
employed by Han and Ong to prepare the iron tricarbon-
yl–cyclohexadiene analogue 10,9 thus establishing still
further its mild nature and synthetic utility. It should be
noted that a number of acid-catalysed deprotection–bicy-
clisation procedures have been reported leading to related
O/N-bicyclic acetals10 as well as to N/N-bicyclic sys-
tems.11,12 For example (Scheme 1), in 2006, Blaauw and
co-workers converted acetal 11 into bicycle 12, which
was subsequently transformed into the natural product
(–)-dysibetaine PP.11
The generality and simplicity of the SnCl2·2H2O cyclisa-
tion procedures, coupled with the novelty of the heterocy-
cles produced, encouraged us to investigate further
applications of this methodology. Preliminary results
were published in a recent communication.13 We have
since carried out additional optimisation and scoping
studies and now present a more detailed discussion of this
one-pot, tandem deprotection–bicyclisation procedure.
Four variants of the tandem deprotection–bicyclisation
procedure were investigated and these are outlined in ret-
rosynthetic form in Scheme 2. It was envisaged that the
most useful, general coupling partners would be the diox-
olane-acids 15 and the dioxolane-amines 22. Thus, vari-
ants A and B would both utilise dioxolane-acids 15 as the
coupling partner. In Variant A, bicycles 13 would be pre-
pared from amides 14 which would in turn be prepared by
coupling dioxolane-acids 15 with w-functionalised ali-
phatic amines 16. In Variant B, the benzannelated ana-
logues, tricycles 17, would be prepared via amides 18
from dioxolane-acids 15 with w-functionalised aryl
amines 19. 
Similarly, in Variant C, bicycles 20 would be prepared
from amides 21, which would in turn be obtained by cou-
pling dioxolane-amines 22 with w-functionalised aliphat-
ic acids 23. Variant D would then involve the preparation
of the benzannelated analogues, tricycles 24, from amides
25 derived from dioxolane-amines 22 and w-functiona-
lised aryl acids 26.
(i) Heterocycles via Variant A
Having identified four variants for the construction of
novel polycyclic heterocycles by tandem deprotection–
bicyclisation procedures, we initially decided to evaluate
the feasibility of Variant A starting from L-cysteine meth-
yl ester hydrochloride (16a; Scheme 3). Thus, coupling of
the readily available dioxolane-acid 15a14 with amine 16a
using the mixed anhydride method gave the required
amide 14a in 60% purified yield. We were delighted to
observe that treatment of amide 14a with SnCl2·2H2O in
dichloromethane for 72 hours gave methyl 5-oxohexa-
hydropyrrolo[2,1-b]thiazole-3-carboxylate (13a)15 in 70%
yield. This one-pot tandem deprotection–bicyclisation
process produced 13a as a single diastereoisomer {[a]D23
–250.7 (c 1.25, CHCl3)}, which was tentatively assigned
the (presumed thermodynamically preferred) 3R,7aS-
configuration shown, on the basis of NMR studies. 
Attempts to combine the two-step amide-formation–
deprotection–bicyclisation sequence into a single one-pot
Scheme 2
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process failed. However, it was found that minimal puri-
fication (filtration through silica gel and removal of the
volatiles in vacuo) of the intermediate amide 14a prior to
treatment with SnCl2·2H2O in dichloromethane was suffi-
cient to provide the bicycle 13a in 68% isolated yield (as
compared to the 42% overall yield for the two-step pro-
cess involving purification of intermediate 14a). 
At this stage we screened a range of mineral, organic and
Lewis acids in the deprotection–bicyclisation process
(Table 1). In view of related cyclisation sequences, dilute
hydrochloric acid10 and p-TsOH·H2O11 were studied first
(entries 1 and 2) but mixtures of products were obtained
and the yields of compound 13a were disappointing. The
widely used Lewis acid, BF3·Et2O, gave a similarly low
yield (entry 3), as did SnBr2 and SnCl4 (entries 4 and 5).
Anhydrous SnCl2 gave an improved yield (57%, entry 6)
but the original procedure using SnCl2·2H2O proved to be
the best (68% over two steps from 15a, entry 7). A likely
rationale is that SnCl2·2H2O slowly releases dilute hydro-
chloric acid to aid acetal cleavage in addition to the Lewis
acidic Sn(II) to aid the bicyclisation process; this theory is
supported by the fact that addition of potassium carbonate
to the SnCl2·2H2O reaction resulted in a dramatic loss of
activity. However, it is noteworthy that CuCl2·2H2O, a re-
agent which efficiently hydrolyses acetals when used in
ethanol,16 proved to be totally ineffective in dichloro-
methane (entry 8).
It should be noted that the ability of tin(II) chloride to act
as a reductant can also be exploited. Thus, processing of
the disulfide, L-cysteine dimethyl ester dihydrochloride
27, through the same coupling and SnCl2·2H2O conditions
via amide 28 gave the same heterocycle 13a in 59% over-
all yield (Scheme 4). In the second step, the SnCl2·2H2O
is mediating the three-step disulfide reduction–deprotec-
tion–bicyclisation sequence.
Next, three further examples were explored in order to in-
dicate the generality of the procedure (Scheme 5). Thus,
amide formation between acid 15a and L-serine derivative
16b followed by treatment with SnCl2·2H2O induced the
desired deacetalisation–bicyclisation reaction to give the
novel heterocycle 13b {[a]D23 –124.3 (c 1.0, CHCl3)} in
moderate yield over the two-step process. In a similar
manner, amide formation between acid 15a and 3-amino-
propanol (16c) followed by deacetalisation–bicyclisation
gave the known heterocyclic system 13c17 {hemi-aminal
proton: dH = 4.94 ppm, 1 H, dd, J = 6.5, 2.8 Hz; IR 1690
cm–1; Lit.17 dH = 4.94 ppm, 1 H, m; IR 1690 cm–1}. The
novel, higher homologue 13d was then prepared from 4-
aminobutanol (16d) in reasonable yield over the two
steps. 
(ii) Heterocycles via Variant B
Our attention next turned to the second combination of
coupling partners outlined in Scheme 2, in which the same
dioxolane-acid 15a is coupled with w-functionalised aryl
amines 19 to generate benzannelated tricycles 17, via
amides 18. The initial example explored was unsuccess-
Scheme 3
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Table 1 Yields of 13a from 15a Using the Deprotection–Bicyclisa-
tion Process
Entry Reagent Solvent Temp Time 
(h)
Yield 
(%)
1 10% aq HCl CH2Cl2 r.t. 72 39
2 p-TsOH·H2O (cat) PhMe reflux 2 29
3 BF3·Et2O (2 equiv) CH2Cl2 r.t. 24 26
4 SnBr2 (2 equiv) CH2Cl2 r.t. 72 35
5 SnCl4 (2 equiv) CH2Cl2 r.t. 72 5
6 SnCl2 (2 equiv) CH2Cl2 r.t. 72 57
7 SnCl2·2H2O (2 equiv) CH2Cl2 r.t. 72 68
8 CuCl2·2H2O (2 equiv) CH2Cl2 r.t. 24 0
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ful: conversion of 2-aminophenol (19a) into amide 18a
was straightforward, but all attempts to effect the cyclisa-
tion to give 17a failed (Scheme 6). On the assumption that
this failure was due to the low nucleophilicity of the phe-
nolic group and/or to ring strain in the product, w-func-
tionalised anilines 19b–d were studied. In the case of the
corresponding thiophenol 19b, coupling again proceeded
smoothly but in this example, treatment with SnCl2·2H2O
promoted the desired deacetalisation–bicyclisation reac-
tion to give the novel heterocycle 17b accompanied by the
cyclisation precursor 29.
Encouraged by this partial success, we investigated the
use of 2-aminobenzyl alcohol 19c and the corresponding
thiol 19d (Scheme 6). In both cases, the coupling and
deacetalisation–bicyclisation proceeded smoothly, giving
the novel benzannelated heterocycles 17c and 17d in 80
and 86% overall yields, respectively. Finally, in a slight
variation, the N-methylated diamine 30 was subjected to
the coupling–deacetalisation–bicyclisation sequence to
produce the linear tricyclic adduct 32 in 43% overall
yield, further illustrating the potential of this methodolo-
gy.
(iii) Heterocycles Via Variant C
Having established the viability of procedures utilising di-
oxolane-acid 15a for heterocycle formation, we moved on
to explore the potential of dioxolane-amines 22, initially
looking at their coupling with w-functionalised aliphatic
acids 23 (Scheme 7). In the initial example, amine 22a18
was coupled to (R)-mandelic acid 23a; it was established
that 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl-
uronium hexafluorophosphate (HATU)-mediated peptide
coupling was preferable to the mixed anhydride method
for the formation of amide 21a. The SnCl2·2H2O-mediat-
ed deacetalisation–bicyclisation proceeded cleanly, if in
modest yield, to give the novel bicyclo[3.3.0]octane het-
erocyclic products 20a as a separable mixture of two dia-
stereoisomers. In a similar manner, N-Boc-L-alanine
(23b) was converted into an inseparable mixture of novel
diazabicyclo[3.3.0]octanes 20b (ratio established by
NMR spectroscopy).19 In both 20a and 20b, the major dia-
stereoisomer was tentatively assigned by inspection of
molecular models (NMR and NOE studies were uninfor-
mative). Finally in this section, amine 22a and N-Boc-L-
serine 23c gave the bicyclo[4.3.0]nonane adduct 20c as a
single diastereoisomer in 46% yield {[a]D22 +32.5 (c 0.95,
CHCl3)}.
(iv) Heterocycles via Variant D
The final variant to be explored utilised dioxolane-amine
22a and w-functionalised aryl acids 26 (m = 0) to produce
benzannelated products 24 (Scheme 8). Once again, the
coupling procedure to produce the intermediate amides 25
proved problematic. Using 2-hydroxy-3-methylbenzoic
acid (26a) to ultimately produce heterocycle 24a, the
mixed anhydride procedure (ClCO2iBu) gave no product
and HATU gave the required product 24a in only 45%
yield. Turning to other activated acid derivatives, the acid
chloride and methyl ester derived from 26a gave only
trace amounts of product 24a after attempted coupling and
treatment with SnCl2·2H2O. However, we were delighted
to find that the phenyl ester derivative 33 underwent effi-
cient coupling to amine 22a under microwave irradiation
(MW) and deacetalisation–bicyclisation using
SnCl2·2H2O gave the expected product 24a in almost
quantitative yield. 
Attempts to develop a tandem process were unsuccessful;
heating the mixture of 22a, 33 and SnCl2·2H2O under mi-
crowave conditions resulted in complete degradation of
the starting materials. However, a telescoped procedure
Scheme 5
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was developed that proved to be extremely straightfor-
ward; after heating the amine and ester together neat in a
microwave system, the resulting amide was then dis-
solved directly in dichloromethane and SnCl2·2H2O was
added in a single portion. After stirring at room tempera-
ture, the desired heterocycles could then be isolated by
flash chromatography. These conditions were then ap-
plied to a range of phenyl esters,20 producing novel poly-
cyclic heterocycles 24b–g (Scheme 8). These hetero-
cycles all show characteristic 1H and 13C NMR signals
(hemi-aminal protons between d = 5.33 and 5.65 ppm;
hemi-aminal carbons at d = 87.7–89.0 ppm; e.g. 24a, dH =
5.46 ppm; dC = 88.4 ppm).
In summary, we have developed a mild, cheap and simple
method of producing a diverse range of polycyclic hetero-
cycles from commercially available or easily accessible
starting materials using amide coupling followed by a
tin(II) chloride mediated deacetalisation–bicyclisation se-
quence. The products, several of which have been ob-
tained in diastereoselective processes, should be of
interest both in their own right and as building blocks for
the production of more complex target molecules. We are
currently investigating the application of this methodolo-
gy to complex natural product targets.
Et2O was dried using an MBraun MPS solvent purification system.
Anhydrous THF was obtained by distillation over sodium ben-
zophenone. Petroleum ether (PE) refers to light petroleum ether, bp
40–60 °C. All reagents were used as supplied by the manufacturers,
unless otherwise stated. SnCl2·2H2O was purchased from Aldrich
and used without further purification. 3-[1,3]-Dioxolan-2-ylpropi-
onic acid (15a) was prepared by the method of Shea and co-work-
ers;14 all data were in accordance with the assigned structure, and 1H
NMR data was in accordance with the literature.14 3-[1,3]-Diox-
olan-2-ylpropylamine (22a) was prepared by the method of Shimi-
zu and co-workers;18 all data were in accordance with the assigned
structure, and 1H NMR data was in accordance with the literature.18
Flash column chromatography was performed using Fluka silica gel
60 at a low positive pressure. Analytical TLC was performed on alu-
minium sheets precoated with Merck silica gel 60 F254, and visual-
ised with ultraviolet light (254 nm), aq KMnO4 or alcoholic vanillin
solutions, as appropriate. Preparative TLC was performed on What-
man Partasil K6F precoated 60 Silica Gel Glass plates, and visual-
ised under UV light (254 nm). SCX refers to prepacked Varian
BondElut SCX columns (1 g). All melting points were taken on a
Gallenkamp apparatus. 1H NMR spectra were recorded at 400 MHz
on a JEOL ECX 400 spectrometer or at 270 MHz on a JEOL ECX
270 spectrometer and are reported as follows: chemical shift (d,
ppm), multiplicity, coupling constant J (to the nearest 0.5 Hz), num-
ber of protons, assignment. Residual protic solvent CHCl3
(dH = 7.26 ppm) or DMSO (dH = 2.50 ppm) was used as an internal
reference. 13C NMR spectra were recorded at 100 MHz on a JEOL
ECX 400 spectrometer or at 125 MHz on a Bruker AV500 spec-
trometer. The central peak of CDCl3 (dC = 77.0 ppm) or DMSO
(dC = 39.4 ppm) was used as an internal reference. 19F NMR spectra
were recorded at 376 MHz on a JEOL ECX 400 spectrometer.
Chemical shifts are reported in parts per million (ppm) to the nearest
0.01 ppm for 1H and the nearest 0.1 ppm for 13C and 19F. Infrared
spectra were carried out on a ThermoNicolet IR100 spectrometer
and are recorded as a liquid film or a Nujol® mull between NaCl
disks. Absorption maxima are reported in wavenumbers (cm–1) and
only selected absorbencies are reported. Mass spectra and accurate
mass measurements were recorded on a Micromass Autospec spec-
trometer. 
Microwave irradiation refers to the use of a CEM ‘Discovery’ reac-
tor, with reactions contained in 10 mL CEM tubes with Intellivent®
caps.
Methyl 2-(3-[1,3]Dioxolan-2-ylpropionylamino)-3-mercapto-
propanoate (14a)
Isobutyl chloroformate (44 mL, 0.34 mmol) was added dropwise to
a solution of acid 15a14 (50 mg, 0.34 mmol) and N-methylpiperidine
(41 mL, 0.34 mmol) in CH2Cl2 (4 mL) at –10 °C (acetone–ice bath).
After exactly 2 min, an ice-cold solution of L-cysteine methyl ester
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hydrochloride (16a; 62 mg, 0.36 mmol) and N-methylpiperidine (44
mL, 0.36 mmol) in CH2Cl2 (1 mL) was added dropwise and stirring
was continued at –10 °C for 1 h and then the reaction mixture was
slowly allowed to warm to r.t. and stirred for a further 1 h. The so-
lution was then filtered through a short pad of silica gel, washing
through with EtOAc (3 × 5 mL) and the volatiles removed from the
filtrate in vacuo to give the crude amide 14a, which was used imme-
diately in the subsequent cyclisation reaction without further purifi-
cation. If so desired, the crude amide 14a could be purified by flash
column chromatography (SiO2, EtOAc), to give the title compound
14a.
Yield: 54 mg (60%); clear colourless oil; [a]D23 +41.9 (c 1.00,
CHCl3); Rf = 0.40 (EtOAc).
IR (neat): 3300 (br), 2955, 2886, 1740, 1659, 1531, 1439, 1242,
1215, 1140, 1042 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.36 (t, J = 9.0 Hz, 1 H, SH),
1.98–2.03 (m, 2 H, CH2), 2.37 (t, J = 7.5 Hz, 2 H, CH2C=O), 2.96
(dd, J = 9.0, 4.0 Hz, 2 H, CH2SH), 3.76 (s, 3 H, CO2CH3), 3.82–
3.87 (m, 2 H, OCH2), 3.92–3.99 (m, 2 H, OCH2), 4.86 (dt, J = 7.5,
4.0 Hz, 1 H, CHCO2CH3), 4.92 [t, J = 4.0 Hz, 1 H, CH(OCH2)2],
6.71 (br d, J = 7.5 Hz, 1 H, NHCO).
13C NMR (100 MHz, CDCl3): d = 26.7, 28.9, 30.1, 52.7, 53.5, 64.9,
103.1, 170.6, 172.2.
MS (ESI): m/z (%) = 286 (20) [M + Na]+, 264 (100) [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C10H18NO5S: 264.0900;
found: 264.0907 (3.3 ppm error).
Methyl (3R,8S)-5-Oxohexahydropyrrolo[2,1-b]thiazole-3-car-
boxylate (13a)
Method A: From Purified 14a
Amide 14a (100 mg, 0.38 mmol) was dissolved in CH2Cl2 (5 mL)
and SnCl2·2H2O (0.17 g, 0.76 mmol) added. The reaction mixture
was stirred for 72 h at r.t. then diluted with CHCl3 (5 mL) and treat-
ed with K2CO3 (0.25 g, 1.8 mmol). Stirring was continued for a fur-
ther 30 min then the mixture was filtered through a short pad of
Celite®, washing through with CHCl3 (3 × 10 mL). The filtrate was
concentrated in vacuo and the crude product was purified by flash
column chromatography (SiO2, PE–EtOAc, 1:1), to give the title
compound 13a.
Yield: 53 mg (70%); clear colourless oil; [a]D23 –250.7 (c 1.25,
CHCl3); Rf = 0.33 (PE–EtOAc, 1:1).
IR (neat): 2954, 1743, 1709, 1437, 1388, 1285, 1218, 1177 cm–1.
1H NMR (400 MHz, CDCl3): d = 2.09–2.19 (m, 1 H, CHH), 2.48–
2.59 (m, 2 H, CHHC=O, CHH), 2.60–2.73 (m, 1 H, CHHC=O),
3.33 (dd, J = 11.5, 4.5 Hz, 1 H CHHS), 3.38 (dd, J = 11.5, 7.5 Hz,
1 H, CHHS), 3.73 (s, 3 H, CO2CH3), 5.08 (dd, J = 7.5, 4.5 Hz, 1 H,
CHCO2CH3), 5.19 (dd, J = 7.0, 4.0 Hz, 1 H, NCHS).
13C NMR (100 MHz, CDCl3): d = 24.6, 31.0, 36.1, 52.7, 57.6, 66.3,
170.2, 176.3.
MS (ESI): m/z (%) = 202 (100) [M + H]+, 142 (10) [M – CO2Me]+.
HRMS (ESI): m/z [M + H]+ calcd for C8H12NO3S: 202.0532; found:
202.0539 (3.3 ppm error).
Method B: Telescoped Procedure
Unpurified amide 14a (see above) was redissolved in CH2Cl2 (5
mL). SnCl2·2H2O (0.17 g, 0.75 mmol) was added to this solution
and the reaction mixture was stirred at r.t. for 72 h, whereupon it
was diluted with CHCl3 (5 mL) and then treated with K2CO3 (0.25
g, 1.8 mmol). Stirring was continued for a further 30 min then the
mixture was filtered through a short pad of Celite®, washing
through with CHCl3 (3 × 10 mL). The filtrate was concentrated in
vacuo and the crude product was purified by flash column chroma-
tography (SiO2, PE–EtOAc, 1:1), to give the title compound 13a.
Yield: 46 mg (68% over two steps from 15a); clear colourless oil.
Method C: From Disulfide 27
L-Cysteine dimethyl ester dihydrochloride (27; 128 mg, 0.37 mmol)
and 3-[1,3]dioxolan-2-ylpropionic acid (15a; 100 mg, 0.68 mmol)
were converted into amide 28 according to the procedure used for
amide 14a (see above). The unpurified amide 28 was then treated
with SnCl2·2H2O (306 mg, 1.36 mmol) for 72 h following the pro-
cedure used in methods A and B above. The crude product was pu-
rified by flash column chromatography (SiO2, Et2O), to give the title
compound 13a.
Yield: 82 mg (59% over two steps); clear colourless oil.
Methyl (3S,8S)-5-Oxohexahydropyrrolo[2,1-b]oxazole-3-car-
boxylate (13b)
Prepared from L-serine methyl ester hydrochloride (16b; 56 mg,
0.36 mmol) and 3-[1,3]dioxolan-2-ylpropionic acid (15a; 50 mg,
0.34 mmol) according to the procedures described for the prepara-
tion of compound 13a. The unpurified amide was stirred with
SnCl2·2H2O (153 mg, 0.68 mmol) for 12 h and the crude product
was purified by flash column chromatography (SiO2, Et2O), to yield
the title compound 13b.
Yield: 21 mg (34% over two steps); clear colourless oil; [a]D23
–124.3 (c 1.0, CHCl3); Rf = 0.24 (Et2O).
IR (neat): 2956, 2921, 1719, 1403, 1279, 1212, 1173, 1007 cm–1.
1H NMR (400 MHz, CDCl3): d = 2.06–2.17 (m, 1 H, CHH), 2.38–
2.56 (m, 2 H, CHHC=O, CHH), 2.65–2.75 (m, 1 H, CHHC=O),
3.78 (s, 3 H, CO2CH3), 3.91 (dd, J = 8.5, 6.5 Hz, 1 H, CHHO), 4.36
(t, J = 8.5 Hz, 1 H, CHHO), 4.68 (dd, J = 8.5, 6.5 Hz, 1 H,
CHCO2CH3), 5.20 (dd, J = 6.0, 2.0 Hz, 1 H, NCHO).
13C NMR (100 MHz, CDCl3): d = 23.8, 30.9, 52.7, 56.0, 69.5, 93.0,
170.6, 179.5.
MS (ESI): m/z (%) = 186 (100) [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C8H12NO4: 186.0761; found:
186.0761 (0.1 ppm error).
Tetrahydropyrrolo[2,1-b][1,3]oxazin-6-one (13c)
Prepared from 3-amino-1-propanol (16c; 55 mL, 0.71 mmol) and 3-
[1,3]dioxolan-2-ylpropionic acid (15a; 100 mg, 0.68 mmol) accord-
ing to the procedures described for the preparation of compound
13a. The unpurified amide was stirred with SnCl2·2H2O (306 mg,
1.36 mmol) for 12 h, then the crude product was purified by flash
column chromatography (SiO2, MeOH–CH2Cl2, 5:95), to give the
title compound 13c.
Yield: 54 mg (56% over two steps); clear colourless oil; Rf = 0.46
(MeOH–CH2Cl2, 5:95).
IR (neat): 2960, 2864, 1690, 1451, 1277, 1076, 1053 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.44–1.50 (m, 1 H, CHHCNO),
1.74–1.93 (m, 2 H, CH2), 2.22–2.39 (m, 2 H, CHHC=O, CHH),
2.45–2.54 (m, 1 H, CHHC=O), 3.08 (td, J = 13.0, 4.0 Hz, 1 H,
CHHN), 3.71 (td, J = 12.0, 2.0 Hz, 1 H, CHHO), 4.06–4.12 (m, 1 H,
CHHO), 4.15–4.21 (m, 1 H, CHHN), 4.94 (dd, J = 6.5, 2.5 Hz, 1 H,
NCHO). Consistent with published data.16
13C NMR (100 MHz, CDCl3): d = 24.6, 24.7, 28.8, 38.6, 67.0, 88.0,
173.5.
MS (CI, NH3): m/z (%) = 159 (80) [M + NH4]+, 142 (100) [M + H]+.
HRMS (ESI): m/z [M + Na]+ calcd for C7H11NO2Na: 164.0682;
found: 164.0680 (1.3 ppm error).
Hexahydropyrrolo[2,1-b][1,3]oxazepin-7-one (13d)
Prepared from 4-amino-1-butanol (16d; 33 mL, 0.36 mmol) and 3-
[1,3]dioxolan-2-ylpropionic acid (15a; 50 mg, 0.34 mmol) accord-
ing to the procedure described for the preparation of compound 13a.
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The unpurified amide was stirred with SnCl2·2H2O (153 mg, 0.68
mmol) for 12 h and the crude product was purified by flash column
chromatography (SiO2, MeOH–CH2Cl2, 5:95), to yield the title
compound 13d.
Yield: 30 mg (57% over two steps); clear colourless oil; Rf = 0.30
(MeOH–CH2Cl2, 5:95).
IR (neat): 2931, 1689, 1419, 1374, 1279, 1186, 1099 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.65–1.95 (m, 5 H, CH2), 2.21–
2.35 (m, 2 H, CHHC=O, CHH), 2.47–2.58 (m, 1 H, CHHC=O),
3.20 (ddd, J = 13.5, 6.5, 3.0 Hz, 1 H, CHHN), 3.46–3.53 (m, 1 H,
CHHO), 3.57–3.66 (m, 1 H, CHHN), 3.82–3.89 (m, 1 H, CHHO),
5.06 (dd, J = 6.5, 2.5 Hz, 1 H, NCHO).
13C NMR (100 MHz, CDCl3): d = 25.6, 26.4, 29.4, 30.9, 42.5, 68.8,
90.3, 174.8.
MS (ESI): m/z (%) = 156 (100) [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C8H14NO2: 156.1019; found:
156.1018 (0.5 ppm error).
2,3,3a,5-Tetrahydro-1H-benzo[d]pyrrolo[2,1-b][1,3]oxazin-1-
one (17c)
Prepared from 2-aminobenzyl alcohol (19c; 89 mg, 0.72 mmol) and
acid 15a (100 mg, 0.72 mmol) according to the procedure described
for the preparation of compound 13a. The crude amide was stirred
with SnCl2·2H2O (324 mg, 1.44 mmol) for 24 h and the crude prod-
uct was purified by flash column chromatography (SiO2, Et2O), to
yield the title compound 17c.
Yield: 104 mg (80%); colourless solid; mp 89–90 °C; Rf = 0.38
(Et2O).
IR (neat): 1695, 1494, 1490, 1215, 1080 cm–1.
1H NMR (270 MHz, CDCl3): d = 2.01–2.10 (m, 1 H,
CHHCH2C=O), 2.47–2.61 (m, 3 H, CH2C=O, CHHCH2C=O), 4.90
(d, J = 15.0 Hz, 1 H, Ar-CH2O), 5.05 (d, J = 15.0 Hz, 1 H, Ar-
CH2O), 5.27 (dd, J = 7.0, 5.0 Hz, 1 H, OCHN), 7.02 (br d, J = 7.5
Hz, 1 H, Ar-H), 7.10 (td, J = 7.5, 1.0 Hz, 1 H, Ar-H), 7.26–7.27 (m,
1 H, Ar-H), 8.30 (d, J = 8.5 Hz, 1 H, Ar-H).
13C NMR (125 MHz, CDCl3): d = 24.8, 30.1, 58.1, 87.2, 119.6,
123.8, 124.3, 124.4, 127.7, 134.2, 172.0.
MS (ESI): m/z (%) = 212 (100) [M + Na]+.
HRMS (ESI): m/z [M + Na]+ calcd for C11H11NO2Na: 212.0682;
found: 212.0687 (2.2 ppm error).
3,3a-Dihydro-2H,5H-pyrrolo[2,1-a][3,1]benzothiazine-1-one 
(17d)
Prepared from (2-aminophenyl)methane thiol21 (19d; 106 mg, 0.75
mmol) and 3-[1,3]dioxolan-2-ylpropionic acid (15a; 100 mg, 0.68
mmol) according to the procedure for compound 13a. The crude
amide was stirred with SnCl2·2H2O (306 mg, 1.36 mmol) for 18 h
and the crude product was partially purified by flash column chro-
matography (MeOH–CH2Cl2, 3:97). The impure product was dis-
solved in MeOH and loaded onto an SCX column. Washing with
MeOH then elution with ~0.5M methanolic ammonia and concen-
tration gave the title compound 17d.
Yield: 105 mg (86%); pale-yellow oil; Rf = 0.65 (MeOH–CH2Cl2,
1:10).
IR (neat): 3430, 2095, 1643, 1468, 1210, 1104 cm–1.
1H NMR (400 MHz, CDCl3): d = 2.03–2.11 (m, 1 H, CHH), 2.57–
2.68 (m, 3 H, CH2=O, CHH), 3.70 (d, J = 17.0 Hz, 1 H, ArCH2N),
4.30 (d, J = 17.0 Hz, 1 H, ArCH2), 5.02–5.05 (m, 1 H, NCHS), 7.10
(br d, J = 8.0 Hz, 1 H, Ar-H), 7.15–7.17 (m, 1 H, Ar-H), 7.30 (br t,
J = 8.0 Hz, 1 H, Ar-H), 8.25 (dd, J = 8.0, 1.0 Hz, 1 H, Ar-H).
13C NMR (100 MHz, CDCl3): d = 23.9, 30.5, 31.0, 60.9, 122.7,
123.5, 124.4, 127.6, 128.7, 135.9, 173.2.
MS (ESI): m/z (%) = 228 (100) [M + Na]+.
HRMS (ESI): m/z [M + Na]+ calcd for C11H11NOSNa: 228.0454;
found: 228.0459 (2.1 ppm error).
4-Methyl-3,3a,4,9-tetrahydro-2H-pyrrolo[2,1-b]quinazoin-1-
one (32)
Prepared from 2-methylaminobenzylamine (30; 60 mg, 0.43
mmol)22 and 3-[1,3]dioxolan-2-ylpropionic acid (15a; 58 mg, 0.39
mmol) according to the procedure described for the preparation of
compound 13a. The crude amide was stirred with SnCl2·2H2O (175
mg, 0.78 mmol) for 18 h and the crude product was purified by pre-
parative TLC (EtOAc–PE, 1:1) to yield the title compound 32.
Yield: 35 mg (43%); colourless oil; Rf = 0.31 (EtOAc–PE, 1:1).
IR (neat): 1685, 1498, 1447, 1369, 1307, 1273, 1212 cm–1.
1H NMR (400 MHz, CDCl3): d = 2.02–2.09 (m, 1 H,
CHHCH2C=O), 2.36–2.57 (m, 3 H, CHHCH2C=O, CH2C=O), 2.81
(s, 3 H, NCH3), 4.25 (d, J = 17.0 Hz, 1 H, ArCHH), 4.56 (t, J = 6.0
Hz, 1 H, NCHN), 4.85 (d, J = 17.0 Hz, 1 H, ArCHH), 6.79–6.81 (m,
2 H, Ar-H), 7.03 (d, J = 7.5 Hz, 1 H Ar-H), 7.16 (t, J = 7.5 Hz, 1 H,
Ar-H).
13C NMR (100 MHz, CDCl3): d = 28.8, 29.5, 33.8, 41.1, 71.9, 113.7,
119.2, 119.6, 126.8, 128.0, 145.7, 173.5.
MS (ESI): m/z (%) = 225 (100) [M + Na]+.
HRMS (ESI): m/z [M + Na]+ calcd for C12H14N2ONa: 225.0998;
found: 225.1006 (3.5 ppm error).
(2R)-2-Phenyltetrahydropyrrolo[2,1-b]oxazol-3-one (20a)
A solution of 3-[1,3]dioxolan-2-ylpropylamine (22a; 0.10 g, 0.76
mmol) in CH2Cl2 (1 mL) was added dropwise to a solution of (R)-
(–)-mandelic acid (23a; 0.12 g, 0.80 mmol) and DIPEA (0.16 mL,
0.91 mmol) in CH2Cl2 (5 mL) at 0 °C. This was followed immedi-
ately by the portionwise addition of HATU (0.32 g, 0.84 mmol) to
the reaction. The yellow solution was stirred at 0 °C for 1 h and then
allowed to slowly warm to r.t. and stirred for a further 1 h. The re-
action was filtered through a short pad of silica, washing through
with EtOAc (3 × 10 mL). The volatiles were removed from the fil-
trate under reduced pressure to yield the crude amide (contaminated
with tetramethylurea). The unpurified amide was redissolved in
CH2Cl2 (8 mL), SnCl2·2H2O (0.38 g, 1.67 mmol) was added, and the
reaction mixture was stirred at r.t. for 12 h. The mixture was diluted
with CHCl3 (8 mL) and then treated with K2CO3 (0.5 g, 3.6 mmol)
and stirring was continued for a further 30 min. The mixture was fil-
tered through a short pad of Celite®, washing through with CHCl3
(3 × 10 mL). The filtrate was concentrated in vacuo and the crude
product was purified by flash column chromatography (SiO2,
EtOAc), to give the title compound 20a.
Yield: 54 mg (43% over two steps); mixture of diastereoisomers
[2:1, separable by careful chromatography: Rf = 0.50 (major), 0.55
(minor) (EtOAc)]; clear colourless oil.
IR (neat): 2979, 2945, 2894, 1717, 1413, 1309, 1091, 911 cm–1.
1H NMR (400 MHz, CDCl3): d (mixture of diastereoisomers) =
1.69–2.26 (m, 4 H, CH2), 3.07–3.17 (m, 1 H, CHHN), 3.74–3.84
(m, 1 H, CHHN), 5.38 [s, 1 H, CHC=O (minor)], 5.45 [s, 1 H,
CHC=O (major)], 5.59–5.63 [m, 1 H, NCHO (major)], 5.66–5.70
[m, 1 H, NCHO (minor)], 7.30–7.50 (m, 5 H, Ar-H).
13C NMR (100 MHz, CDCl3): d (minor diastereoisomer given in
brackets) = 24.3, (24.0), 31.50, (31.45), 43.0, (42.4), 83.7, (83.3),
(94.2), 92.7, 126.9, (125.6), 128.5, (128.4), 128.7, (128.6), (136.1),
135.6, (173.6), 173.1.
MS (ESI): m/z (%) = 204 (100) [M + H]+.
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HRMS (ESI): m/z [M + H]+ calcd for C12H14NO2: 204.1019; found:
204.1020 (0.5 ppm error).
tert-Butyl (2S)-2-Methyl-3-oxohexahydropyrrolo[1,2-a]imida-
zole-1-carboxylate (20b)
Prepared from 3-[1,3]dioxolan-2-ylpropylamine (22a; 0.10 g, 0.76
mmol) and N-Boc-L-alanine (23b; 0.15 g, 0.80 mmol) according to
the procedure described for the preparation of compound 20a. The
crude amide was stirred with SnCl2·2H2O (342 mg, 1.52 mmol) for
12 h and the crude product 20b was purified by flash column chro-
matography (SiO2, EtOAc), to yield the title compound 20b as an
inseparable mixture of diastereoisomers (3:1).
Yield: 0.10 g (55% over two steps); clear colourless oil; Rf = 0.45
(EtOAc).
IR (neat): 2977, 2933, 1705, 1477, 1450, 1418, 1175, 1136, 1043
cm–1.
1H NMR (400 MHz, DMSO-d6, 80 °C): d (mixture of diastereoiso-
mers) = 1.33 [d, J = 7.0 Hz, 3 H, CH3 (major)], 1.37 [d, J = 6.5 Hz,
3 H, CH3 (minor)], 1.45 [s, 9 H, t-Bu (minor)], 1.45 [s, 9 H, t-Bu
(major)], 1.26–1.50 (occluded m, 1 H, CH2), 1.90–2.07 (m, 2 H,
CH2), 2.14–2.30 (m, 1 H, CH2), 2.98–3.06 (m, 1 H, CHHN), 3.50–
3.60 (m, 1 H, CHHN), 4.02 [q, J = 6.5 Hz, 1 H, CHC=O (minor)],
4.21 [q, J = 7.0 Hz, 1 H, CHC=O (major)], 5.06 [dd, J = 8.5, 5.5 Hz,
1 H, NCHN (major)], 5.08–5.10 [m, 1 H, NCHN (minor overlaying
major diastereoisomer)].
13C NMR (100 MHz, DMSO-d6, 80 °C): d (minor diastereoisomer
given in brackets) = 17.7 (both diastereoisomers), 23.2, (23.3), 27.6,
(27.61), 32.2 (both diastereoisomers), 40.9, (40.5), 56.4 (both dias-
tereoisomers), 74.6, (74.4), 79.5, (79.3), 152.6 (both diastereoiso-
mers), 172.3 (both diastereoisomers).
MS (ESI): m/z (%) = 263 (10) [M + Na]+, 241 (100), [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C12H21N2O3: 241.1547; found:
241.1554 (2.9 ppm error).
tert-Butyl (3S,8aR)-(4-Oxohexahydropyrrolo[2,1-b][1,3]oxazin-
3-yl)carbamate (20c)
Prepared from 3-[1,3]dioxolan-2-ylpropylamine (22a; 0.10 g, 0.76
mmol) and N-Boc-L-serine (23c; 0.16 g, 0.80 mmol) according to
the procedure described for the preparation of compound 20a. The
crude amide was stirred with SnCl2·2H2O (342 mg, 1.52 mmol) for
12 h and the crude product 20c was purified by flash column chro-
matography (SiO2, EtOAc), to yield the title compound 20c.
Yield: 90 mg (46% over two steps); colourless solid; single diaste-
reoisomer; mp 104–106 °C; [a]D22 32.5 (c 0.95, CHCl3); Rf = 0.30
(EtOAc).
IR (Nujol mull): 3343, 2922, 2853, 1724, 1666, 1519, 1458, 1252,
1165, 1000 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.44 (s, 9 H, t-Bu), 1.19–2.02 (m,
3 H, CH2, CHHCHNO), 2.20–2.28 (m, 1 H, CHHCHNO), 3.35
(ddd, J = 11.5, 7.5, 5.5 Hz, 1 H, CHHN), 3.64 (dd, J = 13.5, 10.5
Hz, 1 H, CHHO), 3.82 (dt, J = 11.5, 7.0 Hz, 1 H, CHHN), 4.34–
4.40 (m, 2 H, CHHO, CHC=O), 5.08 (t, J = 5.0 Hz, 1 H, NCHO),
5.53 (br s, 1 H, NH).
13C NMR (100 MHz, CDCl3): d = 21.5, 28.3, 32.5, 45.0, 49.0, 68.7,
80.1, 87.0, 155.8, 166.4.
MS (ESI): m/z (%) = 257 (40) [M + H]+, 201 (100).
HRMS (ESI): m/z [M + H]+ calcd for C12H21N2O4: 257.1496; found:
257.1502 (2.4 ppm error).
8-Methyl-1,2,3,9a-tetrahydro-9-oxa-3a-azacyclopenta[b]naph-
thalen-4-one (24a)
A mixture of 3-[1,3]dioxolan-2-yl-propylamine (22a; 37 mg, 0.28
mmol) and phenyl 2-hydroxy-3-methylbenzoate (33; 50 mg, 0.22
mmol) in a sealed tube, was heated under microwave irradiation at
135 °C for 10 min (50 W input power). The resulting gum was al-
lowed to cool to r.t., dissolved in CH2Cl2 (5 mL) and SnCl2·2H2O
(100 mg, 0.44 mmol) was added in a single portion. The reaction
was allowed to stir at r.t. for 18 h whereupon it was diluted with
CHCl3 (5 mL) and then treated with K2CO3 (130 mg, 0.94 mmol)
and stirring was continued for a further 30 min. The mixture was fil-
tered through a short pad of Celite®, washing with CHCl3 (3 × 10
mL). The filtrate was concentrated in vacuo and purified by flash
chromatography (SiO2; Et2O) to give the title compound 24a.
Yield: 70 mg (98%); colourless solid; mp 111–113 °C; Rf = 0.25
(Et2O).
IR (Nujol mull): 2955, 2924, 2855, 1669, 1440, 1073 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.88–1.99 (m, 1 H,
NCHOCH2CHH), 2.07–2.16 (m, 1 H, NCHOCH2CHH), 2.23 (s,
3 H, CH3), 2.24–2.33 (m, 1 H, NCHOCHH), 2.39–2.49 (m, 1 H,
NCHOCHH), 3.61 (ddd, J = 11.5, 8.0, 5.0 Hz, 1 H, CONCHH),
3.84 (dt, J = 11.5, 7.5 Hz, 1 H, CONCHH), 5.46 (t, J = 6.0 Hz, 1 H,
NCHO), 6.99 (t, J = 7.5 Hz, 1 H, Ar-H), 7.26 (d, J = 7.5 Hz, 1 H,
Ar-H), 7.76 (dd, J = 7.5, 1.0 Hz, 1 H, Ar-H).
13C NMR (100 MHz, CDCl3): d = 15.4, 21.4, 32.0, 44.3, 88.2, 119.4,
121.9, 125.4, 125.8, 134.9, 155.5, 161.3.
MS (ESI): m/z (%) = 204 (100) [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C12H14NO2: 204.1019; found:
204.1023 (1.7 ppm error).
1,2,3,3a-Tetrahydropyrrolo[2,1-b][1,3]benzoxanin-9-one (24b)
Prepared from 3-[1,3]dioxolan-2-ylpropylamine (22a; 79 mg, 0.61
mmol), phenyl salicylate (26b; 100 mg, 0.47 mmol) and
SnCl2·2H2O (212 mg, 0.94 mmol) according to the procedure de-
scribed for compound 24a. Flash chromatography (SiO2; Et2O),
yielded the title compound 24b.23 
Yield: 68.5 mg (75%); colourless oil; Rf = 0.22 (Et2O).
IR (neat): 2884, 1667, 1611, 1468, 1347 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.89–1.99 (m, 1 H,
NCHOCH2CHH), 2.07–2.16 (m, 1 H, NCHOCH2CHH), 2.21–2.30
(m, 1 H, NCHOCHH), 2.40–2.47 (m, 1 H, NCHOCHH), 3.59–3.66
(m, 1 H, CONCHH), 3.81–3.88 (m, 1 H, CONCHH), 5.50 (t,
J = 6.0 Hz, 1 H, NCHO), 6.96 (dd, J = 7.5, 1.0 Hz, 1 H, Ar-H), 7.11
(td, J = 7.5, 1.0 Hz, 1 H, Ar-H), 7.42 (td, J = 7.5, 2.0 Hz, 1 H, Ar-
H), 7.93 (dd, J = 7.5, 1.5 Hz, 1 H, Ar-H).
13C NMR (100 MHz, CDCl3): d = 21.3, 31.9, 44.3, 88.4, 116.4,
119.7, 122.6, 127.9, 133.7, 157.2, 160.9.
MS (ESI): m/z (%) = 190 (100) [M + H]+, 212 (8) [M + Na]+.
HRMS (ESI): m/z [M + H]+ calcd for C11H12NO2: 190.0863; found:
190.0863 (0.2 ppm error).
6-Fluoro-1,2,3,3a-tetrahydro-pyrrolo[2,1-b][1,3]benzoxanin-9-
one (24c)
Prepared from 3-[1,3]dioxolan-2-ylpropylamine (22a; 55 mg, 0.41
mmol), phenyl 4-fluoro-2-hydroxybenzoate (26c; 75 mg, 0.32
mmol) and SnCl2·2H2O (144 mg, 0.64 mmol) according to the pro-
cedure described for compound 24a. Flash chromatography (SiO2;
Et2O), yielded the title compound 24c.
Yield: 70 mg (98%); colourless solid; mp 79–81 °C; Rf = 0.44
(Et2O).
IR (neat): 1666, 1618, 1450, 1261 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.84–1.94 (m, 1 H,
NCHOCH2CHH), 2.01–2.09 (m, 1 H, NCHOCH2CHH), 2.14–2.23
(m, 1 H, NCHOCHH), 2.34–2.41 (m, 1 H, NCHOCHH), 3.51–3.57
(m, 1 H, CONCHH), 3.73–3.80 (m, 1 H, CONCHH), 5.45 (t, 1 H,
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J = 6.0 Hz, NCHO), 6.60 (dd, J = 10.0, 2.0 Hz, 1 H, Ar-H), 6.74 (td,
J = 10.0, 2.0 Hz, 1 H, Ar-H), 7.86 (dd, J = 7.0, 9.0 Hz, 1 H, Ar-H). 
13C NMR (100 MHz, CDCl3): d = 21.3, 31.9, 44.3, 88.9, 104.3 (d,
J = 25.0 Hz), 110.3 (d, J = 22.0 Hz), 116.2, 130.0 (d, J = 11.0 Hz),
158.9, 160.9, 164.6, 165.9 (d, J = 252.0 Hz).
19F NMR (376 MHz, CDCl3): d = –103.8 (ddd, J = 10.3, 10.2, 9.0
Hz).
MS (ESI): m/z (%) = 230 (100) [M + Na]+.
HRMS (ESI): m/z [M + Na]+ calcd for C11H10NFO2Na: 230.0588;
found: 230.0592 (1.9 ppm error).
7-Chloro-1,2,3,3a-tetrahydropyrrolo[2,1-b][1,3]benzoxanin-9-
one (24d)
Prepared from 3-[1,3]dioxolan-2-ylpropylamine (22a; 120 mg, 0.60
mmol), phenyl 5-chloro-2-hydroxybenzoate (26d; 150 mg, 0.91
mmol) and SnCl2·2H2O (410 mg, 1.82 mmol) according to the pro-
cedure described for compound 24a. Flash chromatography (SiO2;
Et2O) yielded the title compound 24d.
Yield: 125 mg (87%); sticky colourless solid; mp 63–64 °C;
Rf = 0.36 (Et2O).
IR (neat): 1669, 1609, 1451, 1413, 1346 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.86–1.95 (m, 1 H,
NCHOCH2CHH), 2.03–2.10 (m, 1 H, NCHOCH2CHH), 2.16–2.24
(m, 1 H, NCHOCHH), 2.35–2.43 (m, 1 H, NCHOCHH), 3.53–3.59
(m, 1 H, CONCHH), 3.75–3.81 (m, 1 H, CONCHH), 5.43 (t,
J = 5.5 Hz, 1 H, NCHO), 6.87 (d, J = 9.0 Hz, 1 H, Ar-H), 7.31 (dd,
J = 9.0, 3.0 Hz, 1 H, Ar-H), 7.83 (d, J = 2.5 Hz, 1 H, Ar-H).
13C NMR (100 MHz, CDCl3): d = 21.2, 31.7, 44.2, 88.6, 118.0,
120.8, 127.5, 127.9, 133.5, 155.7, 159.7.
MS (ESI): m/z (%) = 224 (100) [M + H]+.
HRMS (ESI): m/z [M + Na]+ calcd for NaC11H10ClNO2: 246.0292;
found: 246.0293 (0.2 ppm error).
5-Isopropyl-8-methyl-1,2,3,3a-tetrahydropyrrolo[2,1-
b][1,3]benzoxanin-9-one (24e)
Prepared from 3-[1,3]dioxolan-2-ylpropylamine (22a; 67 mg, 0.51
mmol), phenyl 2-hydroxy-3-isopropyl-6-methylbenzoate (26e; 100
mg, 0.30 mmol) and SnCl2·2H2O (135 mg, 0.60 mmol) according to
the procedure described for compound 24a. Flash chromatography
(SiO2; Et2O) yielded the title compound 24e.
Yield: 81 mg (84%); colourless oil; Rf = 0.68 (Et2O).
IR (neat): 2960, 1663, 1491, 1428 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.15 (d, J = 7.0 Hz, 3 H, CHCH3),
1.18 (d, J = 7.0 Hz, 3 H, CHCH3), 1.87–1.94 (m, 1 H,
NCHOCH2CHH), 2.03–2.16 (m, 1 H, NCHOCH2CHH), 2.21–2.29
(m, 1 H, NCHOCHH), 2.35–2.43 (m, 1 H, NCHOCHH), 2.61 (s,
3 H, CH3), 3.18 [quint, J = 7.0 Hz, 1 H, CH(CH3)2], 3.49–3.55 (m,
1 H, CONCHH), 3.84–3.91 (m, 1 H, CONCHH), 5.33 (dd, J = 6.0,
5.0 Hz, 1 H, NCHO), 6.82 (d, J = 7.5 Hz, 1 H, Ar-H), 7.15 (d,
J = 7.5 Hz, 1 H, Ar-H).
13C NMR (100 MHz, CDCl3): d = 20.7, 21.8, 22.5, 22.7, 26.7, 32.2,
44.7, 87.7, 118.4, 125.3, 129.3, 133.9, 138.3, 155.4, 162.0. 
MS (ESI): m/z (%) = 246 (100) [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C15H20NO2: 246.1489; found:
246.1493 (2.6 ppm error).
1,2,3,11a-Tetrahydro-11-oxa-3a-azacyclopenta[b]anthracen-4-
one (24f)
Prepared from 3-[1,3]dioxolan-2-ylpropylamine (22a; 64 mg, 0.64
mmol), phenyl 3-hydroxynaphthalene-2-carboxylate (26f; 100 mg,
0.49 mmol) and SnCl2·2H2O (220 mg, 0.98 mmol) according to the
procedure described for compound 24a. Flash chromatography
(SiO2; Et2O) yielded the title compound 24f.
Yield: 59 mg (65%); colourless solid; mp 111–114 °C; Rf = 0.21
(Et2O).
IR (neat): 1664, 1633, 1436 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.91–2.02 (m, 1 H,
NCHOCH2CHH), 2.13–2.20 (m, 1 H, NCHOCH2CHH), 2.24–2.33
(m, 1 H, NCHOCHH), 2.44–2.52 (m, 1 H, NCHOCHH), 3.66–3.72
(m, 1 H, CONCHH), 3.87–3.92 (m, 1 H, CONCHH), 5.54 (t,
J = 11.0 Hz, 1 H, NCHO), 7.33 (m, 1 H, Ar-H), 7.38–7.42 (m, 1 H,
Ar-H), 7.49–7.53 (m, 1 H, Ar-H), 7.73 (d, J = 8.0 Hz, 1 H, Ar-H),
7.90 (d, J = 8.0 Hz, 1 H, Ar-H), 8.51 (s, 1 H, Ar-H).
13C NMR (100 MHz, CDCl3): d = 21.2, 32.1, 44.5, 88.6, 112.1,
120.1, 125.1, 127.0, 128.5, 129.5 (3 × C), 136.4, 153.6, 161.1.
MS (ESI): m/z (%) = 262 (100) [M + Na]+, 240 (30) [M + H]+.
HRMS (ESI): m/z [M + Na]+ calcd for C15H13NO2Na: 262.0838;
found: 262.0843 (0.9 ppm error).
7a,8,9,10-Tetrahydro-7-oxa-10a-azacyclopenta[b]phenan-
threne-11-one (24g)
Prepared from 3-[1,3]dioxolan-2-yl-propylamine (22a; 64 mg, 0.64
mmol) and phenyl 2-hydroxynaphthalene-1-carboxylate (26g; 100
mg, 0.49 mmol) according to the procedure described for compound
24a. Flash chromatography (SiO2; Et2O) yielded the title compound
24g.
Yield: 51 mg (56%); colourless solid; mp 104–107 °C; Rf = 0.24
(Et2O). 
IR (neat): 1658, 1443, 763 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.94–2.05 (m, 1 H,
NCHOCH2CHH), 2.13–2.22 (m, 1 H, NCHOCH2CHH), 2.40–2.57
(m, 2 H, NCHOCH2), 3.62–3.68 (m, 1 H, CONCHH), 3.87–3.93
(m, 1 H, CONCHH), 5.65 (t, J = 5.5 Hz, 1 H, NCHO), 7.49–7.59
(m, 3 H, Ar-H), 7.81 (d, J = 8.0, 1.0 Hz, 1 H, Ar-H), 7.92 (d, J = 9.0
Hz, 1 H, Ar-H), 8.20 (dd, J = 8.5, 1.0 Hz, 1 H, Ar-H).
13C NMR (100 MHz, CDCl3): d = 21.7, 32.1, 44.6, 89.1, 114.3,
122.1, 122.8, 123.2, 123.8, 126.3, 127.8, 128.5, 136.6, 154.8, 161.5.
MS (ESI): m/z (%) = 362 (100) [M + Na]+.
HRMS (ESI): m/z [M + Na]+ calcd for C15H13NO2Na: 262.0838;
found: 262.0840 (0.2 ppm error).
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Appendix 2 – Selected NMR spectra 
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Appendix 3 – Crystal data for (+)-319 
rjt1011 
 
Will Unsworth 
Crystal Submitted on: 
 
Data Collected on: 
16/11/2010 
Structure Solved by: 
Adrian Whitwood 
 
 
Table 1: Crystal data and structure refinement for rjt1011 
Identification code rjt1011 
Empirical formula C18H23NO3 
Formula weight 301.37 
Temperature!/!K 109.6 
Crystal system triclinic 
Space group P-1 
a!/!Å, b!/!Å, c!/!Å 6.6179(4), 10.4551(6), 12.6299(8) 
"/°, #/°, $/° 66.362(6), 84.587(5), 78.614(5) 
Volume!/!Å3 784.69(8) 
Z 2 
%calc!/!mg mm-3 1.276 
µ!/!mm!1 0.086 
F(000) 324 
Crystal size!/!mm3 0.1450 ! 0.1366 ! 0.0743 
Theta range for data collection 3.1341 to 59.9252° 
Index ranges -9 " h " 9, -14 " k " 14, -17 " l " 17 
Reflections collected 7805 
Independent reflections 4152[R(int) = 0.0194] 
Data/restraints/parameters 4152/0/207 
Goodness-of-fit on F2 1.064 
Final R indexes [I>2& (I)] R1 = 0.0430, wR2 = 0.0987 
Final R indexes [all data] R1 = 0.0521, wR2 = 0.1045 
Largest diff. peak/hole!/!e Å-3 0.411/-0.231 
Table 2 Fractional Atomic Coordinates (!104) and Equivalent Isotropic Displacement 
Parameters (Å2!103) for rjt1011. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ 
tensor. 
Atom x y z U(eq) 
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C1 -2266.8(17) -6643.8(12) -3231.8(9) 13.3(2) 
C2 -645.4(18) -7310.6(13) -2315.4(10) 15.9(2) 
C3 -852.0(18) -8376.1(13) -1309(1) 17.1(2) 
C4 -2778.1(18) -9012.5(12) -932.9(10) 15.8(2) 
C5 -4594.3(17) -8063.5(11) -1708.5(9) 12.9(2) 
C6 -3887.0(17) -7603.8(11) -3009.8(9) 12.0(2) 
C7 -2996.3(18) -8905.5(12) -3299(1) 16.0(2) 
C8 -4649(2) -9766.2(13) -3215.8(11) 21.0(3) 
C9 -6300(2) -8872.1(14) -4102.2(12) 24.9(3) 
C10 -5777.7(17) -6755.3(12) -3751.8(9) 13.3(2) 
C11 -5439.3(18) -6823.9(12) -1352.4(9) 14.8(2) 
C12 -7013(2) -6311.6(14) 200.7(12) 23.9(3) 
C13 -8519(2) -6726.9(12) 1193.0(11) 19.6(3) 
C14 -8371(2) -6380.0(16) 2132.7(12) 28.9(3) 
C15 -9849(3) -6633.2(19) 3011.3(13) 39.1(4) 
C16 -11463(3) -7263.0(17) 2970.4(14) 41.1(4) 
C17 -11609(2) -7638.7(16) 2054.3(15) 36.3(4) 
C18 -10148(2) -7362.5(14) 1159.3(12) 25.6(3) 
N1 -6835.3(16) -7425.3(12) -4156.3(9) 18.6(2) 
O1 -1242.4(13) -6386.5(9) -4328.1(7) 17.27(19) 
O2 -6384.0(13) -5489.2(9) -3913.2(7) 16.10(18) 
O3 -6459.5(13) -7374.2(9) -252.4(7) 16.88(19) 
Table 3 Anisotropic Displacement Parameters (Å2!103) for rjt1011. The Anisotropic 
displacement factor exponent takes the form: -2!2[h2a*2U11+...+2hka!b!U12] 
Atom U11 U22 U33 U23 U13 U12 
C1 10.4(5) 15.9(5) 10.8(5) -2.8(4) 0.1(4) -1.5(4) 
C2 10.3(5) 22.5(5) 14.6(5) -7.3(4) -1.8(4) -1.4(4) 
C3 13.1(5) 22.2(6) 14.1(5) -6.5(4) -3.5(4) 1.5(4) 
C4 16.3(5) 15.4(5) 11.4(5) -2.0(4) -1.9(4) 0.7(4) 
C5 12.0(5) 13.4(5) 10.9(5) -2.9(4) 0.4(4) -1.4(4) 
C6 10.4(5) 13.4(5) 10.2(5) -3.3(4) -0.5(4) -0.3(4) 
C7 14.7(5) 16.7(5) 15.8(5) -7.0(4) -0.4(4) 0.8(4) 
C8 24.5(6) 18.7(5) 22.2(6) -10.6(5) -0.7(5) -3.5(5) 
C9 23.7(7) 26.6(6) 30.3(7) -16.5(6) -6.1(5) -3.5(5) 
C10 10.3(5) 18.0(5) 9.0(5) -3.7(4) 1.4(4) -1.0(4) 
C11 16.0(5) 15.5(5) 10.7(5) -3.4(4) 2.2(4) -2.5(4) 
C12 30.3(7) 20.4(6) 24.8(6) -13.2(5) 11.7(5) -9.4(5) 
C13 23.9(6) 15.2(5) 17.4(6) -6.7(4) 5.9(5) -0.7(4) 
C14 31.5(8) 32.3(7) 24.9(7) -15.8(6) 1.5(6) -0.9(6) 
C15 47.8(10) 45.8(9) 19.8(7) -15.8(7) 5.9(6) 4.1(8) 
Appendix 3 
 
 251 
C16 46.8(10) 33.2(8) 28.0(8) -4.6(6) 22.4(7) 0.1(7) 
C17 32.3(8) 23.9(7) 46.7(9) -9.5(6) 17.6(7) -9.7(6) 
C18 30.7(7) 20.1(6) 27.6(7) -11.6(5) 7.9(5) -7.0(5) 
N1 13.0(5) 24.6(5) 19.1(5) -10.1(4) -3.9(4) -0.1(4) 
O1 11.4(4) 22.9(4) 10.1(4) 0.0(3) -0.1(3) -0.8(3) 
O2 13.9(4) 16.5(4) 13.1(4) -2.6(3) -1.2(3) 1.6(3) 
O3 22.0(4) 15.0(4) 12.6(4) -5.7(3) 6.1(3) -3.2(3) 
Table 4 Bond Lengths for rjt1011. 
Atom Atom Length/Å   
Ato
m 
Atom Length/Å 
C1 C2 1.5063(15)   C9 N1 1.4589(17) 
C1 C6 1.5422(16)   C10 N1 1.3377(16) 
C1 O1 1.4302(13)   C10 O2 1.2427(14) 
C2 C3 1.3294(16)   C11 O3 1.4327(13) 
C3 C4 1.5034(17)   C12 C13 1.5007(17) 
C4 C5 1.5364(15)   C12 O3 1.4160(16) 
C5 C6 1.5689(15)   C13 C14 1.390(2) 
C5 C11 1.5259(17)   C13 C18 1.3852(19) 
C6 C7 1.5408(17)   C14 C15 1.386(2) 
C6 C10 1.5320(15)   C15 C16 1.376(3) 
C7 C8 1.5195(17)   C16 C17 1.380(3) 
C8 C9 1.5195(18)   C17 C18 1.3924(19) 
Table 5 Bond Angles for rjt1011. 
Atom Atom 
Ato
m 
Angle/˚   Atom Atom Atom Angle/˚ 
C1 C6 C5 107.95(9)   C13 C18 C17 120.10(14) 
C2 C1 C6 110.78(9)   C14 C13 C12 119.52(12) 
C2 C3 C4 123.64(10)   C15 C14 C13 120.78(15) 
C3 C2 C1 124.20(11)   C15 C16 C17 119.95(14) 
C3 C4 C5 111.04(9)   C16 C15 C14 119.92(15) 
C4 C5 C6 109.44(9)   C16 C17 C18 120.31(15) 
C7 C6 C1 110.94(9)   C18 C13 C12 121.40(12) 
C7 C6 C5 111.12(9)   C18 C13 C14 118.92(13) 
C7 C8 C9 109.66(10)   N1 C9 C8 111.86(11) 
C8 C7 C6 111.25(10)   N1 C10 C6 118.80(10) 
C10 C6 C1 109.46(9)   O1 C1 C2 107.65(9) 
C10 C6 C5 107.72(9)   O1 C1 C6 112.13(10) 
C10 C6 C7 109.57(10)   O2 C10 C6 120.27(11) 
C10 N1 C9 128.17(11)   O2 C10 N1 120.79(10) 
C11 C5 C4 109.20(10)   O3 C11 C5 107.67(9) 
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C11 C5 C6 113.96(9)   O3 C12 C13 111.36(10) 
C12 O3 C11 110.15(9)           
Table 6 Hydrogen Bonds for rjt1011. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
N1 
H1
A 
O11 0.896(17) 2.066(17) 2.9005(13) 154.5(15) 
O1 
H1
B 
O22 0.888(19) 1.797(19) 2.6825(11) 174.9(18) 
1-1+X,+Y,+Z; 2-1-X,-1-Y,-1-Z 
Table 7 Torsion Angles for rjt1011. 
A B C D Angle/˚ 
C1 C2 C3 C4 -2.8(2) 
C1 C6 C7 C8 -173.45(9) 
C1 C6 C10 N1 146.79(11) 
C1 C6 C10 O2 -37.54(14) 
C2 C1 C6 C5 48.65(12) 
C2 C1 C6 C7 -73.33(12) 
C2 C1 C6 C10 165.63(10) 
C2 C3 C4 C5 -13.53(17) 
C3 C4 C5 C6 47.12(13) 
C3 C4 C5 C11 -78.25(12) 
C4 C5 C6 C1 -66.06(11) 
C4 C5 C6 C7 55.80(12) 
C4 C5 C6 C10 175.83(9) 
C4 C5 C11 O3 -70.78(11) 
C5 C6 C7 C8 66.45(12) 
C5 C6 C10 N1 -96.08(12) 
C5 C6 C10 O2 79.59(12) 
C5 C11 O3 C12 171.49(10) 
C6 C1 C2 C3 -16.01(17) 
C6 C5 C11 O3 166.52(9) 
C6 C7 C8 C9 62.75(13) 
C6 C10 N1 C9 -7.91(18) 
C7 C6 C10 N1 24.92(14) 
C7 C6 C10 O2 
-
159.41(10) 
C7 C8 C9 N1 -42.41(15) 
C8 C9 N1 C10 16.65(19) 
C10 C6 C7 C8 -52.47(12) 
C11 C5 C6 C1 56.52(12) 
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C11 C5 C6 C7 178.38(9) 
C11 C5 C6 C10 -61.59(12) 
C12 C13 C14 C15 174.05(13) 
C12 C13 C18 C17 
-
175.16(13) 
C13 C12 O3 C11 166.02(10) 
C13 C14 C15 C16 1.4(2) 
C14 C13 C18 C17 0.3(2) 
C14 C15 C16 C17 -0.1(2) 
C15 C16 C17 C18 -1.1(2) 
C16 C17 C18 C13 1.0(2) 
C18 C13 C14 C15 -1.5(2) 
O1 C1 C2 C3 
-
138.95(12) 
O1 C1 C6 C5 168.94(8) 
O1 C1 C6 C7 46.97(12) 
O1 C1 C6 C10 -74.07(11) 
O2 C10 N1 C9 176.44(12) 
O3 C12 C13 C14 142.46(13) 
O3 C12 C13 C18 -42.12(17) 
Table 8 Hydrogen Atom Coordinates (Å!104) and Isotropic Displacement Parameters 
(Å2!103) for rjt1011. 
Atom x y z U(eq) 
H1 -2973 -5715 -3212 16 
H2 605 -6946 -2466 19 
H3 280 -8757 -799 21 
H4A -3125 -9135 -122 19 
H4B -2533 -9960 -968 19 
H5 -5707 -8637 -1575 15 
H7B -2397 -8587 -4091 19 
H7A -1879 -9511 -2756 19 
H8A -5275 -10071 -2430 25 
H8B -4025 -10625 -3359 25 
H9A -5799 -8848 -4873 30 
H9B -7549 -9316 -3900 30 
H11A -4301 -6368 -1295 18 
H11B -6422 -6107 -1933 18 
H12B -7633 -5412 -416 29 
H12A -5759 -6151 465 29 
H14 -7242 -5964 2173 35 
H15 -9748 -6372 3641 47 
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H16 -12477 -7439 3573 49 
H17 -12712 -8088 2034 44 
H18 -10267 -7610 525 31 
H1A -8080.0(3) -6938(17) 
-
4432(14) 
28(4) 
H1B -2070.0(3) -5750.0(2) 
-
4880(16) 
41(5) 
Crystal Data. C18H23NO3, M =301.37, triclinic, a = 6.6179(4) Å, b = 10.4551(6) Å, c = 
12.6299(8) Å, ! = 66.362(6)°, " = 84.587(5)°, # = 78.614(5)°, U = 784.69(8) Å3, T = 109.6, space 
group P-1 (no. 2), Z = 2, µ(Mo K!) = 0.086, 7805 reflections measured, 4152 unique (Rint = 0.0194) 
which were used in all calculations. The final wR(F2) was 0.1045 (all data) 
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Abbreviations 
 
Ac  Acetyl 
AIBN  Azo-iso-butyronitrile 
aq.  Aqueous 
Ar  Aryl (unspecified) 
9-BBN  9-Borabicyclo[3.3.1]nonane 
BINAP (1,1!-Binaphthalene-2,2!-diyl)bis(diphenylphosphine) 
Bn  Benzyl 
Boc  Tert-butyloxycarbonyl 
b.p.  Boiling point 
br  Broad 
Bu  Butyl 
Cbz  Carboxybenzyl 
CbzCl  Carboxybenzyl chloride 
COD  Cis,cis-1,5-Cyclooctadiene 
!  Chemical shift 
d  Doublet 
dba  Dibenzylideneacetone 
DBU  1,8-Diazabicyclo[5.4.0]undec-7-ene 
DDQ  2,3-Dichloro-5,6-dicyanobenzoquinone 
d.e.  Diastereisomeric excess 
DEA  Diethylamine 
DEAD  Diethyl azodicarboxylate 
DIAD  Di-iso-propyl azodicarboxyate 
DIBAL-H Di-iso-butylaluminium hydride 
DIPEA N,N-Di-iso-propylethylamine 
DMAP  4-N,N-Dimethylaminopyridine 
DMBMP 2,6-Di-tert-butyl-4-methylpyridine 
DMF  N,N-Dimethylformamide 
DMP  Dess–Martin Periodinane 
DMSO  Dimethyl sulfoxide 
DPPA  Diphenyl phosphoryl azide 
d.r.  Diastereoisomeric ratio 
Abbreviations 
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DSC  Differential scanning calorimetry 
e.e.   Enantiomeric excess 
e.r.  Enatiomeric ratio 
ESI  Electrospray ionisation 
Et  Ethyl 
eq.  Equivalent 
ether  Diethyl ether 
g  Gram(s)  
h  Hour(s) 
HATU O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetra-methyluronium 
hexafluorophosphate 
HMDS  Hexamethyldisilazane 
HMPA  Hexamethylphosphoramide 
HPLC  High-performance liquid chromatography 
Hz  Hertz 
i  Iso 
IBX  2-Iodoxybenzoic acid 
ImH  1H-Imidazole 
IR  Infra-red 
J  Coupling constant in Hz 
LDA  Lithium di-iso-propylamide 
m  Meta 
m  Multiplet  
M  Molar 
M+  Molecular ion 
mCPBA Meta-chloroperoxybenzoic acid 
Me  Methyl 
min  Minute(s) 
mL  Millilitre 
mmol  Millimole 
m.p.  Melting point 
Ms  Methanesulfonyl (mesyl) 
MS  Mass Spectrometry 
MS  Molecular sieves 
Abbreviations 
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MTPA  !-Methoxy-!-(trifluoromethyl)phenylacetic acid 
MTPACl !-Methoxy-!-(trifluoromethyl)phenylacetyl chloride 
µW  Microwave 
m/z  Mass to charge ratio 
NIS  N-Iodosuccinimide 
NMP  N-Methyl-piperidine 
NMO  N-Methylmorpholine-N-oxide 
NMM  N-Methylmorpholine 
NMR  Nuclear magnetic resonance 
nOe  Nuclear Overhauser effect 
o  Ortho 
p  Para 
PCC  Pyridinium chlorochromate 
PG  Protecting group (unspecified) 
PE  Petroleum ether (that fraction which boils at 40-60 °C) 
Ph  Phenyl 
Phth  Phthaloyl 
PMB  Para-methoxybenzyl 
PPA  Polyphosphoric acid 
ppm  Parts per million 
PPL II  Porcine pancreas lipase type II 
PPTS  Pyridinium para-toluenesulfonate 
PTSA  Para-toluenesulfonic acid 
Pr  Propyl 
Pv  Pivaloyl 
Py  Pyridine 
q  Quartet 
quint  Quintet 
R  Alkyl group (unspecified) 
Rf  Retention factor 
r.s.m.  Recovered starting material 
rt  Room temperature 
s  Singlet 
s.m.  Starting material 
Abbreviations 
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SCX                Strong cation exchange 
t  Tert 
t  Triplet 
T3P®  Propylphosphonic anhydride 
TBAF  Tetrabutylammonium fluoride 
TBS  tert-Butyldimethylsilyl 
TBSCl  tert-Butyldimethylsilyl chloride 
TBSOTf tert-Butyldimethylsilyl triflate 
Tf  Trifluoromethanesulfonyl (triflate) 
TFA  Trifluoroacetic acid 
TFAA  Trifluoroacetic anhydride 
THF  Tetrahydrofuran 
TIPS  Tri-iso-propylsilyl 
TIPSCl Tri-iso-propylsilyl chloride 
TLC  Thin layer chromatography 
TMS  Trimethylsilyl 
TPAP  Tetra-n-propylammonium perruthenate 
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